MainTitle,geneCount,AUC,P.Value,adj.P.Value,ID,aspect,allNames,rank
regulation of cellular amino acid metabolic process,55,0.265,1.78e-9,1.11e-5,GO:0006521,BP,,1
mitochondrial protein complex,118,0.347,1.05e-8,6.57e-5,GO:0098798,CC,,2
regulation of cellular amine metabolic process,71,0.305,1.37e-8,8.54e-5,GO:0033238,BP,,3
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,67,0.305,3.49e-8,2.17e-4,GO:0031146,BP,,4
peptidase complex,79,0.323,5.39e-8,3.36e-4,GO:1905368,CC,,5
cellular amine metabolic process,112,0.353,8.92e-8,5.56e-4,GO:0044106,BP,,6
endopeptidase complex,61,0.302,9.03e-8,5.62e-4,GO:1905369,CC,,7
structural constituent of ribosome,144,0.372,1.25e-7,7.77e-4,GO:0003735,MF,,8
proteasome complex,60,0.304,1.48e-7,9.19e-4,GO:0000502,CC,,9
inner mitochondrial membrane protein complex,100,0.351,2.81e-7,0.00175,GO:0098800,CC,,10
amine metabolic process,117,0.364,3.8e-7,0.00236,GO:0009308,BP,,11
detection of chemical stimulus involved in sensory perception,144,0.621,5.63e-7,0.0035,GO:0050907,BP,,12
ribosomal subunit,168,0.391,1.19e-6,0.00742,GO:0044391,CC,,13
detection of stimulus involved in sensory perception,189,0.601,1.77e-6,0.011,GO:0050906,BP,,14
mitochondrial membrane part,168,0.394,2.45e-6,0.0152,GO:0044455,CC,,15
negative regulation of cell cycle G2/M phase transition,75,0.349,6.62e-6,0.0412,GO:1902750,BP,,16
cellular response to zinc ion,17,0.184,6.66e-6,0.0414,GO:0071294,BP,,17
detection of chemical stimulus,172,0.598,9.58e-6,0.0595,GO:0009593,BP,,18
negative regulation of G2/M transition of mitotic cell cycle,73,0.351,1.03e-5,0.0639,GO:0010972,BP,,19
ficolin-1-rich granule,116,0.381,1.04e-5,0.0645,"GO:0101002,GO:1904813",CC,ficolin-1-rich granule lumen,20
regulation of G2/M transition of mitotic cell cycle,103,0.376,1.42e-5,0.0882,GO:0010389,BP,,21
detection of chemical stimulus involved in sensory perception of smell,121,0.614,1.53e-5,0.0947,"GO:0050911,GO:0004984",BP,olfactory receptor activity,22
mitochondrial translation,108,0.38,1.57e-5,0.0977,GO:0032543,BP,,23
proteasome accessory complex,23,0.24,1.65e-5,0.102,GO:0022624,CC,,24
regulation of cell cycle G2/M phase transition,111,0.381,1.65e-5,0.103,GO:1902749,BP,,25
"Wnt signaling pathway, planar cell polarity pathway",103,0.377,1.66e-5,0.103,GO:0060071,BP,,26
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,66,0.347,1.77e-5,0.11,GO:0051439,BP,,27
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,65,0.346,1.85e-5,0.115,GO:0051436,BP,,28
organellar ribosome,77,0.359,1.92e-5,0.119,"GO:0000313,GO:0005761",CC,mitochondrial ribosome,29
cellular ketone metabolic process,187,0.409,2.07e-5,0.129,GO:0042180,BP,,30
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,81,0.363,2.12e-5,0.132,GO:2000060,BP,,31
establishment of planar polarity,113,0.385,2.39e-5,0.148,"GO:0001736,GO:0007164",BP,establishment of tissue polarity,32
positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,69,0.354,2.65e-5,0.164,GO:0051437,BP,,33
regulation of establishment of planar polarity,104,0.381,2.66e-5,0.165,GO:0090175,BP,,34
negative regulation of ubiquitin protein ligase activity,71,0.356,2.67e-5,0.165,GO:1904667,BP,,35
positive regulation of ubiquitin protein ligase activity,74,0.359,2.88e-5,0.178,GO:1904668,BP,,36
mitochondrial translational elongation,76,0.362,3.28e-5,0.203,GO:0070125,BP,,37
Fc receptor signaling pathway,174,0.409,3.7e-5,0.229,GO:0038093,BP,,38
Fc-epsilon receptor signaling pathway,116,0.389,3.75e-5,0.232,GO:0038095,BP,,39
transmitter-gated ion channel activity,41,0.314,3.93e-5,0.243,"GO:0022824,GO:0022835",MF,transmitter-gated channel activity,40
melanosome,98,0.38,4.15e-5,0.257,"GO:0042470,GO:0048770",CC,pigment granule,41
positive regulation of ubiquitin-protein transferase activity,90,0.377,5.33e-5,0.33,GO:0051443,BP,,42
mitochondrial translational termination,77,0.367,5.72e-5,0.354,GO:0070126,BP,,43
regulation of cellular ketone metabolic process,140,0.401,5.74e-5,0.355,GO:0010565,BP,,44
bitter taste receptor activity,10,0.867,5.74e-5,0.355,GO:0033038,MF,,45
positive regulation of protein ubiquitination,160,0.408,6.04e-5,0.373,GO:0031398,BP,,46
regulation of ubiquitin protein ligase activity,82,0.372,6.11e-5,0.378,GO:1904666,BP,,47
anaphase-promoting complex-dependent catabolic process,72,0.363,6.15e-5,0.38,GO:0031145,BP,,48
positive regulation of synaptic transmission,115,0.392,6.37e-5,0.394,GO:0050806,BP,,49
glutamate receptor activity,26,0.274,6.48e-5,0.4,GO:0008066,MF,,50
antigen processing and presentation of peptide antigen,171,0.411,6.48e-5,0.401,GO:0048002,BP,,51
antigen processing and presentation of exogenous peptide antigen,158,0.408,7.11e-5,0.439,GO:0002478,BP,,52
antigen processing and presentation of exogenous antigen,160,0.409,7.46e-5,0.461,GO:0019884,BP,,53
"mitochondrial electron transport, NADH to ubiquinone",41,0.324,9.84e-5,0.608,GO:0006120,BP,,54
protein localization to mitochondrion,166,0.413,1.05e-4,0.648,GO:0070585,BP,,55
MAP kinase kinase kinase activity,20,0.75,1.11e-4,0.685,GO:0004709,MF,,56
large ribosomal subunit,103,0.39,1.17e-4,0.721,GO:0015934,CC,,57
regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,95,0.386,1.31e-4,0.811,GO:2000058,BP,,58
establishment of protein localization to mitochondrion,165,0.414,1.33e-4,0.818,GO:0072655,BP,,59
"synaptic transmission, glutamatergic",67,0.365,1.4e-4,0.864,GO:0035249,BP,,60
"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor",46,0.338,1.46e-4,0.901,GO:0016655,MF,,61
sensory perception of chemical stimulus,182,0.582,1.56e-4,0.962,GO:0007606,BP,,62
muscle filament sliding,30,0.301,1.67e-4,1,"GO:0030049,GO:0033275",BP,actin-myosin filament sliding,63
ATP synthesis coupled electron transport,77,0.376,1.78e-4,1,GO:0042773,BP,,64
mitochondrial respiratory chain complex assembly,76,0.376,1.8e-4,1,GO:0033108,BP,,65
cell-cell junction assembly,84,0.618,1.83e-4,1,GO:0007043,BP,,66
proteasome regulatory particle,20,0.259,1.92e-4,1,GO:0005838,CC,,67
translational termination,91,0.387,1.96e-4,1,GO:0006415,BP,,68
intermediate filament,111,0.602,2.09e-4,1,GO:0005882,CC,,69
amino acid binding,57,0.358,2.11e-4,1,GO:0016597,MF,,70
respiratory chain,74,0.375,2.13e-4,1,GO:0070469,CC,,71
oxidative phosphorylation,94,0.389,2.15e-4,1,GO:0006119,BP,,72
neuron spine,121,0.402,2.16e-4,1,GO:0044309,CC,,73
extracellular-glutamate-gated ion channel activity,18,0.249,2.29e-4,1,GO:0005234,MF,,74
chromatin DNA binding,74,0.624,2.3e-4,1,GO:0031490,MF,,75
ketone body metabolic process,11,0.18,2.39e-4,1,GO:1902224,BP,,76
"chemical synaptic transmission, postsynaptic",99,0.393,2.47e-4,1,GO:0099565,BP,,77
intermediate filament cytoskeleton,142,0.589,2.53e-4,1,GO:0045111,CC,,78
regulation of telomerase RNA localization to Cajal body,11,0.182,2.57e-4,1,"GO:1904872,GO:1904874",BP,positive regulation of telomerase RNA localization to Cajal body,79
regulation of transcription from RNA polymerase II promoter in response to hypoxia,73,0.377,2.74e-4,1,GO:0061418,BP,,80
mitochondrial respiratory chain complex I,39,0.332,2.75e-4,1,"GO:0005747,GO:0030964,GO:0045271",CC,"NADH dehydrogenase complex,respiratory chain complex I",81
centriole,103,0.604,2.86e-4,1,GO:0005814,CC,,82
glutamate receptor signaling pathway,73,0.377,2.94e-4,1,GO:0007215,BP,,83
positive regulation of protein modification by small protein conjugation or removal,175,0.421,3.28e-4,1,GO:1903322,BP,,84
mitochondrial ATP synthesis coupled electron transport,76,0.381,3.31e-4,1,GO:0042775,BP,,85
regulation of ubiquitin-protein transferase activity,109,0.4,3.39e-4,1,GO:0051438,BP,,86
mitochondrial respiratory chain,71,0.377,3.44e-4,1,GO:0005746,CC,,87
keratinocyte differentiation,168,0.58,3.54e-4,1,GO:0030216,BP,,88
organellar small ribosomal subunit,25,0.295,3.77e-4,1,"GO:0000314,GO:0005763",CC,mitochondrial small ribosomal subunit,89
excitatory postsynaptic potential,88,0.39,3.79e-4,1,GO:0060079,BP,,90
respiratory chain complex,64,0.371,3.79e-4,1,GO:0098803,CC,,91
RNA localization to Cajal body,12,0.204,3.8e-4,1,"GO:0090670,GO:0090671,GO:0090672",BP,"telomerase RNA localization to Cajal body,telomerase RNA localization",92
T cell receptor signaling pathway,154,0.417,3.84e-4,1,GO:0050852,BP,,93
protein localization to endoplasmic reticulum,117,0.405,3.86e-4,1,GO:0070972,BP,,94
regulation of synaptic plasticity,141,0.413,3.94e-4,1,GO:0048167,BP,,95
7-methylguanosine mRNA capping,28,0.307,4.16e-4,1,GO:0006370,BP,,96
negative regulation of ubiquitin-protein transferase activity,77,0.384,4.41e-4,1,GO:0051444,BP,,97
dendritic spine,119,0.407,4.45e-4,1,GO:0043197,CC,,98
glycosaminoglycan biosynthetic process,103,0.4,4.46e-4,1,GO:0006024,BP,,99
proton-transporting two-sector ATPase complex,44,0.348,4.79e-4,1,GO:0016469,CC,,100
protein localization to synapse,30,0.316,5.02e-4,1,GO:0035418,BP,,101
ionotropic glutamate receptor activity,18,0.264,5.21e-4,1,GO:0004970,MF,,102
membrane budding,96,0.398,5.62e-4,1,GO:0006900,BP,,103
aminoglycan biosynthetic process,104,0.402,5.79e-4,1,GO:0006023,BP,,104
neuron-neuron synaptic transmission,122,0.41,5.97e-4,1,GO:0007270,BP,,105
keratinization,113,0.593,6.34e-4,1,GO:0031424,BP,,106
response to ammonium ion,109,0.405,6.34e-4,1,GO:0060359,BP,,107
"transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding",144,0.582,6.59e-4,1,GO:0001227,MF,,108
sensory perception of smell,139,0.584,6.66e-4,1,GO:0007608,BP,,109
stimulatory C-type lectin receptor signaling pathway,98,0.4,6.77e-4,1,GO:0002223,BP,,110
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",71,0.383,6.79e-4,1,GO:0002479,BP,,111
7-methylguanosine RNA capping,32,0.327,7.07e-4,1,"GO:0009452,GO:0036260",BP,RNA capping,112
cellular ketone body metabolic process,10,0.192,7.36e-4,1,GO:0046950,BP,,113
neurotransmitter receptor activity,73,0.386,7.88e-4,1,GO:0030594,MF,,114
histone demethylase activity,26,0.69,7.92e-4,1,GO:0032452,MF,,115
neurexin family protein binding,12,0.221,8.21e-4,1,GO:0042043,MF,,116
actin crosslink formation,11,0.209,8.28e-4,1,GO:0051764,BP,,117
calcium ion import,142,0.419,8.52e-4,1,GO:0070509,BP,,118
striated muscle thin filament,13,0.234,9.11e-4,1,GO:0005865,CC,,119
threonine-type endopeptidase activity,20,0.286,9.13e-4,1,"GO:0004298,GO:0070003",MF,threonine-type peptidase activity,120
electron transport chain,92,0.4,9.21e-4,1,GO:0022900,BP,,121
histone H3-K9 demethylation,11,0.788,9.53e-4,1,GO:0033169,BP,,122
clathrin binding,55,0.372,9.94e-4,1,GO:0030276,MF,,123
histone demethylation,28,0.68,9.96e-4,1,GO:0016577,BP,,124
innate immune response activating cell surface receptor signaling pathway,99,0.404,9.98e-4,1,GO:0002220,BP,,125
regulation of calcium ion import,88,0.399,0.00107,1,GO:0090279,BP,,126
apoptotic mitochondrial changes,109,0.41,0.00113,1,GO:0008637,BP,,127
extracellular ligand-gated ion channel activity,60,0.378,0.00113,1,GO:0005230,MF,,128
NADH dehydrogenase complex assembly,51,0.368,0.00117,1,"GO:0010257,GO:0032981,GO:0097031",BP,"mitochondrial respiratory chain complex I assembly,mitochondrial respiratory chain complex I biogenesis",129
morphogenesis of a polarized epithelium,124,0.415,0.00118,1,GO:0001738,BP,,130
cellular protein complex disassembly,173,0.429,0.00123,1,GO:0043624,BP,,131
body morphogenesis,41,0.646,0.00123,1,GO:0010171,BP,,132
growth cone,142,0.421,0.00124,1,GO:0030426,CC,,133
Golgi to endosome transport,17,0.726,0.00124,1,GO:0006895,BP,,134
carbohydrate derivative catabolic process,154,0.424,0.00125,1,GO:1901136,BP,,135
'de novo' protein folding,31,0.332,0.00125,1,GO:0006458,BP,,136
response to type I interferon,69,0.612,0.00128,1,GO:0034340,BP,,137
modified amino acid binding,63,0.383,0.00131,1,GO:0072341,MF,,138
type I interferon signaling pathway,65,0.615,0.00131,1,"GO:0060337,GO:0071357",BP,cellular response to type I interferon,139
protein targeting to ER,94,0.404,0.00132,1,GO:0045047,BP,,140
antigen processing and presentation of exogenous peptide antigen via MHC class I,74,0.392,0.00135,1,GO:0042590,BP,,141
histone binding,149,0.576,0.00136,1,GO:0042393,MF,,142
cellular respiration,155,0.425,0.0014,1,GO:0045333,BP,,143
mitochondrial membrane organization,95,0.405,0.00141,1,GO:0007006,BP,,144
adenylate cyclase-modulating G-protein coupled receptor signaling pathway,122,0.416,0.00147,1,GO:0007188,BP,,145
neurotransmitter receptor complex,45,0.363,0.00152,1,GO:0098878,CC,,146
respiratory electron transport chain,91,0.404,0.00152,1,GO:0022904,BP,,147
anterograde synaptic vesicle transport,17,0.278,0.00153,1,"GO:0048490,GO:0099514,GO:0099517",BP,"synaptic vesicle cytoskeletal transport,synaptic vesicle transport along microtubule",148
monocarboxylic acid transmembrane transporter activity,29,0.67,0.00153,1,GO:0008028,MF,,149
cell projection cytoplasm,59,0.381,0.00155,1,GO:0032838,CC,,150
core promoter binding,140,0.577,0.00161,1,GO:0001047,MF,,151
RNA polymerase II distal enhancer sequence-specific DNA binding,55,0.623,0.00162,1,GO:0000980,MF,,152
adult behavior,120,0.417,0.00165,1,GO:0030534,BP,,153
regulation of epithelial cell apoptotic process,53,0.625,0.00167,1,GO:1904035,BP,,154
"transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding",92,0.595,0.00173,1,GO:0001078,MF,,155
keratin filament,39,0.645,0.00175,1,GO:0045095,CC,,156
"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",76,0.604,0.00177,1,GO:0003705,MF,,157
antigen receptor-mediated signaling pathway,185,0.433,0.0018,1,GO:0050851,BP,,158
aminoglycan catabolic process,54,0.377,0.00184,1,GO:0006026,BP,,159
occluding junction,102,0.589,0.00189,1,GO:0070160,CC,,160
positive regulation of actin cytoskeleton reorganization,11,0.229,0.00189,1,GO:2000251,BP,,161
postsynaptic density,194,0.435,0.00191,1,GO:0014069,CC,,162
positive regulation of cellular protein catabolic process,176,0.432,0.00193,1,GO:1903364,BP,,163
site of polarized growth,146,0.426,0.00197,1,GO:0030427,CC,,164
glutamine family amino acid metabolic process,64,0.388,0.00199,1,GO:0009064,BP,,165
postsynaptic specialization,196,0.436,0.00199,1,GO:0099572,CC,,166
microglial cell activation,14,0.262,0.00201,1,GO:0001774,BP,,167
epithelial cell apoptotic process,74,0.604,0.00205,1,GO:1904019,BP,,168
histone lysine demethylation,25,0.678,0.00211,1,GO:0070076,BP,,169
taste receptor activity,14,0.737,0.00211,1,GO:0008527,MF,,170
astrocyte projection,10,0.22,0.00214,1,GO:0097449,CC,,171
protein transporter activity,89,0.406,0.00217,1,GO:0008565,MF,,172
negative regulation of viral process,91,0.593,0.0022,1,GO:0048525,BP,,173
"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor",23,0.316,0.0022,1,GO:0016628,MF,,174
NADH dehydrogenase activity,36,0.353,0.00222,1,"GO:0003954,GO:0008137,GO:0050136",MF,"NADH dehydrogenase (ubiquinone) activity,NADH dehydrogenase (quinone) activity",175
organic acid binding,144,0.426,0.00224,1,GO:0043177,MF,,176
alcohol biosynthetic process,89,0.406,0.00224,1,GO:0046165,BP,,177
multi-organism membrane organization,29,0.336,0.00224,1,GO:0044803,BP,,178
regulation of transcription from RNA polymerase II promoter in response to stress,107,0.414,0.00227,1,GO:0043618,BP,,179
long-term synaptic potentiation,54,0.38,0.00231,1,GO:0060291,BP,,180
paranode region of axon,11,0.765,0.00231,1,GO:0033270,CC,,181
monocarboxylic acid catabolic process,99,0.411,0.00236,1,GO:0072329,BP,,182
regulation of amine transport,66,0.392,0.00243,1,GO:0051952,BP,,183
asymmetric synapse,198,0.438,0.00252,1,GO:0032279,CC,,184
regulation of odontogenesis of dentin-containing tooth,10,0.776,0.00253,1,GO:0042487,BP,,185
myofilament,15,0.275,0.00253,1,GO:0036379,CC,,186
histone demethylase activity (H3-K9 specific),10,0.775,0.00258,1,GO:0032454,MF,,187
neuron to neuron synapse,200,0.438,0.00258,1,GO:0098984,CC,,188
translational elongation,122,0.421,0.00259,1,GO:0006414,BP,,189
amine transport,73,0.398,0.0026,1,GO:0015837,BP,,190
dipeptidase activity,15,0.724,0.00265,1,GO:0016805,MF,,191
glutamine family amino acid catabolic process,23,0.319,0.0027,1,GO:0009065,BP,,192
protein demethylation,30,0.658,0.0027,1,"GO:0006482,GO:0008214",BP,protein dealkylation,193
arginine metabolic process,15,0.277,0.00282,1,GO:0006525,BP,,194
ensheathment of neurons,108,0.583,0.00283,1,"GO:0007272,GO:0008366",BP,axon ensheathment,195
cell junction assembly,180,0.565,0.00285,1,GO:0034329,BP,,196
"negative regulation of gene expression, epigenetic",91,0.59,0.00289,1,GO:0045814,BP,,197
helicase activity,136,0.574,0.00291,1,GO:0004386,MF,,198
demethylase activity,35,0.645,0.00291,1,GO:0032451,MF,,199
basal part of cell,42,0.633,0.00293,1,GO:0045178,CC,,200
exocytic vesicle,146,0.429,0.00293,1,GO:0070382,CC,,201
establishment of protein localization to mitochondrial membrane,14,0.271,0.00296,1,GO:0090151,BP,,202
proteasome core complex,19,0.303,0.00302,1,GO:0005839,CC,,203
response to UV,115,0.58,0.0031,1,GO:0009411,BP,,204
neuron projection terminus,120,0.422,0.00318,1,GO:0044306,CC,,205
carboxylic acid binding,143,0.428,0.00321,1,GO:0031406,MF,,206
antigen processing and presentation of peptide antigen via MHC class I,89,0.41,0.00322,1,GO:0002474,BP,,207
perikaryon,102,0.416,0.00334,1,GO:0043204,CC,,208
establishment of protein localization to endoplasmic reticulum,98,0.414,0.00347,1,GO:0072599,BP,,209
microtubule organizing center part,143,0.571,0.00347,1,GO:0044450,CC,,210
negative regulation of protein ubiquitination,123,0.424,0.00349,1,GO:0031397,BP,,211
protein ubiquitination involved in ubiquitin-dependent protein catabolic process,188,0.438,0.00356,1,GO:0042787,BP,,212
cytosolic large ribosomal subunit,54,0.385,0.0036,1,GO:0022625,CC,,213
synaptic vesicle endocytosis,29,0.344,0.00363,1,GO:0048488,BP,,214
vacuolar lumen,143,0.429,0.00367,1,GO:0005775,CC,,215
protein targeting to mitochondrion,126,0.425,0.00369,1,GO:0006626,BP,,216
head morphogenesis,29,0.656,0.00376,1,GO:0060323,BP,,217
viral budding,21,0.317,0.00376,1,"GO:0046755,GO:1902590,GO:1902592",BP,"multi-organism organelle organization,multi-organism membrane budding",218
amino-acid betaine metabolic process,17,0.297,0.00383,1,GO:0006577,BP,,219
regulation of synapse organization,115,0.422,0.00383,1,GO:0050807,BP,,220
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,90,0.412,0.00387,1,GO:0002504,BP,,221
inner mitochondrial membrane organization,17,0.298,0.00392,1,GO:0007007,BP,,222
fatty acid beta-oxidation,64,0.396,0.00394,1,GO:0006635,BP,,223
oxidoreductase complex,87,0.411,0.00402,1,GO:1990204,CC,,224
"oxidoreductase activity, acting on NAD(P)H",88,0.411,0.00402,1,GO:0016651,MF,,225
bicellular tight junction,100,0.583,0.00402,1,GO:0005923,CC,,226
cytosolic ribosome,104,0.418,0.00403,1,GO:0022626,CC,,227
learning,126,0.426,0.00406,1,GO:0007612,BP,,228
negative regulation of viral life cycle,71,0.599,0.00408,1,GO:1903901,BP,,229
synaptic vesicle localization,130,0.427,0.00412,1,GO:0097479,BP,,230
glycosaminoglycan catabolic process,52,0.385,0.00428,1,GO:0006027,BP,,231
bHLH transcription factor binding,26,0.662,0.00434,1,GO:0043425,MF,,232
non-canonical Wnt signaling pathway,139,0.43,0.00435,1,GO:0035567,BP,,233
positive regulation of osteoblast proliferation,10,0.76,0.00436,1,GO:0033690,BP,,234
regulation of DNA-templated transcription in response to stress,112,0.422,0.0044,1,GO:0043620,BP,,235
response to alkaloid,123,0.426,0.00441,1,GO:0043279,BP,,236
detection of chemical stimulus involved in sensory perception of bitter taste,17,0.699,0.00447,1,GO:0001580,BP,,237
positive regulation of p38MAPK cascade,15,0.711,0.00475,1,GO:1900745,BP,,238
antigen processing and presentation of peptide antigen via MHC class II,89,0.413,0.00476,1,GO:0002495,BP,,239
xenobiotic metabolic process,70,0.402,0.00477,1,GO:0006805,BP,,240
collateral sprouting,24,0.666,0.00482,1,GO:0048668,BP,,241
extracellular matrix assembly,26,0.66,0.00482,1,GO:0085029,BP,,242
small ribosomal subunit,66,0.4,0.00486,1,GO:0015935,CC,,243
phagocytosis,191,0.441,0.00491,1,GO:0006909,BP,,244
positive regulation of canonical Wnt signaling pathway,113,0.423,0.00497,1,GO:0090263,BP,,245
T cell mediated immunity,61,0.604,0.00499,1,GO:0002456,BP,,246
nuclear inner membrane,46,0.62,0.005,1,GO:0005637,CC,,247
isoprenoid metabolic process,99,0.418,0.00501,1,GO:0006720,BP,,248
ionotropic glutamate receptor complex,43,0.376,0.0051,1,GO:0008328,CC,,249
PDZ domain binding,83,0.411,0.00519,1,GO:0030165,MF,,250
post-embryonic development,76,0.593,0.00524,1,GO:0009791,BP,,251
proteoglycan biosynthetic process,56,0.392,0.00524,1,GO:0030166,BP,,252
regulation of actin cytoskeleton reorganization,29,0.35,0.00527,1,GO:2000249,BP,,253
T cell cytokine production,20,0.68,0.00537,1,GO:0002369,BP,,254
regulation of alcohol biosynthetic process,27,0.345,0.00539,1,GO:1902930,BP,,255
layer formation in cerebral cortex,13,0.277,0.0054,1,GO:0021819,BP,,256
copper ion binding,49,0.385,0.00552,1,GO:0005507,MF,,257
positive regulation of proteolysis involved in cellular protein catabolic process,161,0.437,0.00556,1,GO:1903052,BP,,258
virion assembly,32,0.358,0.00562,1,GO:0019068,BP,,259
isoprenoid biosynthetic process,23,0.333,0.00569,1,GO:0008299,BP,,260
spliceosomal tri-snRNP complex,22,0.33,0.00582,1,GO:0097526,CC,,261
mucopolysaccharide metabolic process,102,0.421,0.00602,1,GO:1903510,BP,,262
organelle inheritance,12,0.272,0.00618,1,"GO:0048308,GO:0048313",BP,Golgi inheritance,263
dioxygenase activity,83,0.587,0.00621,1,GO:0051213,MF,,264
proton-transporting V-type ATPase complex,22,0.331,0.00621,1,GO:0033176,CC,,265
fatty acid catabolic process,81,0.412,0.00623,1,GO:0009062,BP,,266
drug transmembrane transporter activity,16,0.697,0.00629,1,GO:0015238,MF,,267
negative regulation of gene silencing,19,0.681,0.00637,1,GO:0060969,BP,,268
secondary alcohol biosynthetic process,45,0.382,0.00637,1,GO:1902653,BP,,269
regulation of nucleotide metabolic process,184,0.442,0.00638,1,GO:0006140,BP,,270
regulation of RNA polymerase II transcriptional preinitiation complex assembly,12,0.274,0.00663,1,GO:0045898,BP,,271
vesicle transport along microtubule,34,0.365,0.00666,1,GO:0047496,BP,,272
protein transmembrane import into intracellular organelle,35,0.367,0.00667,1,GO:0044743,BP,,273
"proton-transporting two-sector ATPase complex, proton-transporting domain",20,0.325,0.00669,1,GO:0033177,CC,,274
mammary gland epithelial cell proliferation,19,0.321,0.00677,1,GO:0033598,BP,,275
mRNA transport,128,0.569,0.0068,1,GO:0051028,BP,,276
fear response,31,0.36,0.0068,1,GO:0042596,BP,,277
glycine binding,11,0.264,0.00682,1,GO:0016594,MF,,278
chondroitin sulfate biosynthetic process,23,0.337,0.00686,1,GO:0030206,BP,,279
negative regulation of multi-organism process,128,0.569,0.00687,1,GO:0043901,BP,,280
activation of MAPKK activity,46,0.615,0.00691,1,GO:0000186,BP,,281
"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism",30,0.357,0.00691,1,GO:0044769,MF,,282
synaptic vesicle transport,123,0.429,0.00692,1,"GO:0048489,GO:0097480,GO:0099003",BP,"establishment of synaptic vesicle localization,vesicle-mediated transport in synapse",283
glucuronosyltransferase activity,15,0.299,0.00698,1,GO:0015020,MF,,284
heart trabecula formation,13,0.284,0.00698,1,GO:0060347,BP,,285
cellular response to amino acid starvation,33,0.364,0.00703,1,GO:0034198,BP,,286
synaptic vesicle recycling,39,0.375,0.00707,1,GO:0036465,BP,,287
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",52,0.608,0.00717,1,GO:0006977,BP,,288
dicarboxylic acid catabolic process,14,0.293,0.0072,1,GO:0043649,BP,,289
regulation of cyclase activity,75,0.41,0.00721,1,GO:0031279,BP,,290
behavioral fear response,29,0.356,0.00722,1,"GO:0001662,GO:0002209",BP,behavioral defense response,291
signal transduction involved in mitotic cell cycle checkpoint,54,0.606,0.00736,1,"GO:0072413,GO:1902402,GO:1902403",BP,"signal transduction involved in mitotic DNA damage checkpoint,signal transduction involved in mitotic DNA integrity checkpoint",292
dense core granule,12,0.277,0.00749,1,GO:0031045,CC,,293
establishment of cell polarity,97,0.579,0.00753,1,GO:0030010,BP,,294
regulation of calcium-mediated signaling,70,0.408,0.00753,1,GO:0050848,BP,,295
regulation of protein dephosphorylation,60,0.4,0.00755,1,GO:0035304,BP,,296
positive regulation of epithelial cell apoptotic process,23,0.661,0.00755,1,GO:1904037,BP,,297
response to isoquinoline alkaloid,28,0.354,0.00761,1,"GO:0014072,GO:0043278",BP,response to morphine,298
ER membrane protein complex,17,0.313,0.00775,1,GO:0072546,CC,,299
chondroitin sulfate proteoglycan biosynthetic process,27,0.352,0.00776,1,GO:0050650,BP,,300
coenzyme binding,166,0.44,0.00776,1,GO:0050662,MF,,301
negative regulation of protein modification by small protein conjugation or removal,130,0.432,0.0078,1,GO:1903321,BP,,302
nucleobase-containing compound transport,197,0.555,0.00797,1,GO:0015931,BP,,303
regulation of neurotransmitter levels,178,0.442,0.00797,1,GO:0001505,BP,,304
positive regulation of sodium ion transmembrane transporter activity,12,0.721,0.008,1,GO:2000651,BP,,305
excitatory extracellular ligand-gated ion channel activity,41,0.38,0.00801,1,GO:0005231,MF,,306
regulation of synapse structure or activity,119,0.43,0.00806,1,GO:0050803,BP,,307
sterol biosynthetic process,49,0.391,0.0081,1,GO:0016126,BP,,308
E-box binding,32,0.635,0.00817,1,GO:0070888,MF,,309
regulation of nucleotide biosynthetic process,123,0.431,0.00819,1,"GO:0030808,GO:1900371",BP,regulation of purine nucleotide biosynthetic process,310
SRP-dependent cotranslational protein targeting to membrane,85,0.417,0.00819,1,GO:0006614,BP,,311
myelination,105,0.575,0.00822,1,GO:0042552,BP,,312
racemase and epimerase activity,14,0.296,0.00825,1,GO:0016854,MF,,313
response to xenobiotic stimulus,79,0.414,0.00829,1,GO:0009410,BP,,314
glutathione binding,10,0.259,0.00831,1,GO:0043295,MF,,315
macrophage activation,44,0.385,0.00831,1,GO:0042116,BP,,316
"energy coupled proton transmembrane transport, against electrochemical gradient",26,0.35,0.00832,1,"GO:0015988,GO:0015991",BP,ATP hydrolysis coupled proton transport,317
regulation of RNA stability,134,0.434,0.00837,1,GO:0043487,BP,,318
release of cytochrome c from mitochondria,51,0.393,0.00848,1,GO:0001836,BP,,319
organic anion transmembrane transporter activity,156,0.561,0.00852,1,GO:0008514,MF,,320
cGMP-mediated signaling,11,0.271,0.00852,1,GO:0019934,BP,,321
glutamate secretion,42,0.383,0.00852,1,GO:0014047,BP,,322
sequestering of metal ion,106,0.426,0.00857,1,GO:0051238,BP,,323
promoter-specific chromatin binding,25,0.652,0.00858,1,GO:1990841,MF,,324
mitochondrial proton-transporting ATP synthase complex,19,0.326,0.00863,1,GO:0005753,CC,,325
signal transduction involved in DNA integrity checkpoint,56,0.602,0.00865,1,"GO:0072401,GO:0072422",BP,signal transduction involved in DNA damage checkpoint,326
cholesterol biosynthetic process,44,0.386,0.00869,1,GO:0006695,BP,,327
cellular response to xenobiotic stimulus,74,0.412,0.00877,1,GO:0071466,BP,,328
glial cell projection,16,0.311,0.00878,1,GO:0097386,CC,,329
enhancer sequence-specific DNA binding,68,0.592,0.0088,1,GO:0001158,MF,,330
negative regulation of Wnt signaling pathway,183,0.444,0.00886,1,GO:0030178,BP,,331
cornified envelope,32,0.634,0.00887,1,GO:0001533,CC,,332
electron carrier activity,89,0.42,0.00887,1,GO:0009055,MF,,333
signal transduction involved in mitotic G1 DNA damage checkpoint,53,0.604,0.00888,1,"GO:0072431,GO:1902400",BP,intracellular signal transduction involved in G1 DNA damage checkpoint,334
"proton-transporting ATPase activity, rotational mechanism",19,0.327,0.009,1,GO:0046961,MF,,335
regulation of mRNA stability,127,0.433,0.00905,1,GO:0043488,BP,,336
organelle fusion,187,0.444,0.00905,1,GO:0048284,BP,,337
regulation of exocytosis,148,0.438,0.00914,1,GO:0017157,BP,,338
proton-transporting ATP synthase complex,20,0.332,0.00914,1,GO:0045259,CC,,339
early endosome membrane,112,0.571,0.00924,1,GO:0031901,CC,,340
regulation of collateral sprouting,18,0.677,0.00929,1,GO:0048670,BP,,341
antioxidant activity,70,0.41,0.00931,1,GO:0016209,MF,,342
signal transduction in response to DNA damage,107,0.573,0.00932,1,GO:0042770,BP,,343
Arp2/3 protein complex,10,0.263,0.00933,1,GO:0005885,CC,,344
G-protein alpha-subunit binding,18,0.323,0.00943,1,GO:0001965,MF,,345
microtubule binding,197,0.554,0.00958,1,GO:0008017,MF,,346
mitochondrial transmembrane transport,69,0.41,0.00979,1,GO:1990542,BP,,347
repressing transcription factor binding,51,0.605,0.00987,1,GO:0070491,MF,,348
protein sumoylation,80,0.584,0.00988,1,GO:0016925,BP,,349
"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",141,0.437,0.00999,1,GO:0007187,BP,,350
cytokine receptor binding,182,0.555,0.0101,1,GO:0005126,MF,,351
regulation of glutamate receptor signaling pathway,34,0.373,0.0102,1,GO:1900449,BP,,352
regulation of purine nucleotide metabolic process,179,0.444,0.0103,1,GO:1900542,BP,,353
symporter activity,112,0.57,0.0103,1,GO:0015293,MF,,354
detoxification,86,0.42,0.0103,1,GO:0098754,BP,,355
localization within membrane,79,0.416,0.0104,1,GO:0051668,BP,,356
"oxidoreductase activity, acting on the CH-CH group of donors",50,0.395,0.0104,1,GO:0016627,MF,,357
misfolded protein binding,13,0.295,0.0105,1,GO:0051787,MF,,358
cellular response to cadmium ion,29,0.363,0.0105,1,GO:0071276,BP,,359
exopeptidase activity,93,0.577,0.0106,1,GO:0008238,MF,,360
physiological muscle hypertrophy,16,0.316,0.0107,1,"GO:0003298,GO:0003301,GO:0061049",BP,"physiological cardiac muscle hypertrophy,cell growth involved in cardiac muscle cell development",361
regulation of postsynaptic membrane potential,121,0.433,0.0109,1,GO:0060078,BP,,362
vacuolar proton-transporting V-type ATPase complex,15,0.31,0.0109,1,GO:0016471,CC,,363
hydrogen-exporting ATPase activity,21,0.339,0.0109,1,GO:0036442,MF,,364
regulation of lymphocyte proliferation,158,0.441,0.0109,1,GO:0050670,BP,,365
"regulation of synaptic transmission, glutamatergic",50,0.396,0.011,1,GO:0051966,BP,,366
regulation of calcium ion transport,178,0.445,0.011,1,GO:0051924,BP,,367
"DNA damage response, signal transduction by p53 class mediator",94,0.576,0.011,1,GO:0030330,BP,,368
chromatin silencing,78,0.583,0.0111,1,GO:0006342,BP,,369
skeletal muscle cell differentiation,55,0.599,0.0112,1,GO:0035914,BP,,370
positive regulation of cell cycle arrest,74,0.585,0.0112,1,GO:0071158,BP,,371
phagosome maturation,39,0.383,0.0113,1,GO:0090382,BP,,372
carbon-carbon lyase activity,46,0.392,0.0113,1,GO:0016830,MF,,373
dopamine receptor signaling pathway,38,0.381,0.0113,1,GO:0007212,BP,,374
aminoglycan metabolic process,148,0.44,0.0113,1,GO:0006022,BP,,375
microtubule organizing center organization,111,0.57,0.0114,1,GO:0031023,BP,,376
vesicle cytoskeletal trafficking,38,0.381,0.0114,1,GO:0099518,BP,,377
phagosome acidification,25,0.354,0.0114,1,GO:0090383,BP,,378
regulation of gene silencing,53,0.6,0.0115,1,GO:0060968,BP,,379
MAP kinase activity,13,0.297,0.0115,1,GO:0004707,MF,,380
telomere maintenance via telomerase,52,0.399,0.0115,1,GO:0007004,BP,,381
BMP signaling pathway,130,0.564,0.0116,1,GO:0030509,BP,,382
UDP-glycosyltransferase activity,111,0.431,0.0116,1,GO:0008194,MF,,383
cellular response to UV,64,0.591,0.0116,1,GO:0034644,BP,,384
regulation of short-term neuronal synaptic plasticity,14,0.305,0.0116,1,GO:0048172,BP,,385
regulation of skeletal muscle contraction,10,0.27,0.0117,1,GO:0014819,BP,,386
cellular response to metal ion,130,0.436,0.0117,1,GO:0071248,BP,,387
CXCR chemokine receptor binding,10,0.73,0.0118,1,GO:0045236,MF,,388
presynapse assembly,16,0.318,0.012,1,GO:0099054,BP,,389
endolysosome membrane,13,0.299,0.012,1,GO:0036020,CC,,390
RNA-dependent DNA biosynthetic process,54,0.401,0.0121,1,GO:0006278,BP,,391
cyclic purine nucleotide metabolic process,123,0.434,0.0122,1,GO:0052652,BP,,392
maintenance of protein location in nucleus,14,0.693,0.0123,1,GO:0051457,BP,,393
lymph vessel morphogenesis,17,0.675,0.0124,1,GO:0036303,BP,,394
centrosome duplication,60,0.593,0.0124,1,GO:0051298,BP,,395
second-messenger-mediated signaling,194,0.448,0.0125,1,GO:0019932,BP,,396
nucleosomal DNA binding,28,0.636,0.0126,1,GO:0031492,MF,,397
organellar large ribosomal subunit,47,0.395,0.0126,1,"GO:0000315,GO:0005762",CC,mitochondrial large ribosomal subunit,398
ubiquitin-specific protease binding,13,0.3,0.0127,1,GO:1990381,MF,,399
carboxypeptidase activity,38,0.617,0.0127,1,GO:0004180,MF,,400
regulation of mononuclear cell proliferation,159,0.443,0.0127,1,GO:0032944,BP,,401
regulation of defense response to virus by virus,25,0.356,0.0127,1,GO:0050690,BP,,402
aggresome,37,0.618,0.0128,1,GO:0016235,CC,,403
histone H3-K9 modification,34,0.623,0.0128,1,GO:0061647,BP,,404
endocardium development,10,0.727,0.0129,1,GO:0003157,BP,,405
regulation of cation channel activity,115,0.433,0.0131,1,GO:2001257,BP,,406
"UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity",13,0.301,0.0131,1,GO:0008499,MF,,407
"nucleotide-excision repair, preincision complex assembly",26,0.36,0.0132,1,GO:0006294,BP,,408
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,29,0.367,0.0133,1,GO:0043928,BP,,409
axonal transport,37,0.382,0.0134,1,GO:0098930,BP,,410
cotranslational protein targeting to membrane,90,0.424,0.0134,1,GO:0006613,BP,,411
multicellular organism metabolic process,111,0.568,0.0134,1,GO:0044236,BP,,412
lipid phosphatase activity,10,0.274,0.0134,1,GO:0042577,MF,,413
core promoter sequence-specific DNA binding,95,0.574,0.0134,1,GO:0001046,MF,,414
regulation of ryanodine-sensitive calcium-release channel activity,25,0.358,0.0137,1,GO:0060314,BP,,415
positive regulation of telomere maintenance,39,0.386,0.0138,1,GO:0032206,BP,,416
demethylation,52,0.599,0.0138,1,GO:0070988,BP,,417
chaperone-mediated protein folding,56,0.405,0.0138,1,GO:0061077,BP,,418
odontogenesis of dentin-containing tooth,69,0.586,0.0139,1,GO:0042475,BP,,419
negative regulation of cell activation,135,0.439,0.0139,1,GO:0050866,BP,,420
proteoglycan metabolic process,78,0.419,0.0139,1,GO:0006029,BP,,421
cyclic nucleotide biosynthetic process,124,0.436,0.0139,1,GO:0009190,BP,,422
fatty acid oxidation,86,0.423,0.014,1,GO:0019395,BP,,423
glutathione derivative metabolic process,18,0.333,0.014,1,"GO:1901685,GO:1901687",BP,glutathione derivative biosynthetic process,424
GTP-dependent protein binding,21,0.345,0.014,1,GO:0030742,MF,,425
phosphatidylserine binding,36,0.382,0.014,1,GO:0001786,MF,,426
dendrite cytoplasm,20,0.341,0.0141,1,GO:0032839,CC,,427
nucleoside triphosphate biosynthetic process,73,0.417,0.0141,1,GO:0009142,BP,,428
membrane coat,86,0.423,0.0141,1,"GO:0030117,GO:0048475",CC,coated membrane,429
negative regulation of MAPK cascade,134,0.438,0.0141,1,GO:0043409,BP,,430
establishment of protein localization to telomere,13,0.304,0.0142,1,GO:0070200,BP,,431
PcG protein complex,36,0.618,0.0144,1,GO:0031519,CC,,432
glycosaminoglycan metabolic process,144,0.441,0.0144,1,GO:0030203,BP,,433
regulation of synapse assembly,79,0.42,0.0144,1,GO:0051963,BP,,434
synaptic cleft,10,0.277,0.0144,1,GO:0043083,CC,,435
viral budding via host ESCRT complex,18,0.333,0.0145,1,GO:0039702,BP,,436
methylation-dependent chromatin silencing,16,0.677,0.0145,1,GO:0006346,BP,,437
RNA polymerase II transcription factor binding,93,0.573,0.0145,1,GO:0001085,MF,,438
positive regulation of telomere maintenance via telomerase,26,0.362,0.0146,1,GO:0032212,BP,,439
cytosolic calcium ion transport,124,0.436,0.0146,1,GO:0060401,BP,,440
response to BMP,134,0.561,0.0147,1,"GO:0071772,GO:0071773",BP,cellular response to BMP stimulus,441
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,63,0.411,0.0147,1,GO:0007193,BP,,442
PML body,88,0.575,0.0147,1,GO:0016605,CC,,443
transport vesicle membrane,159,0.444,0.0148,1,GO:0030658,CC,,444
male sex differentiation,128,0.562,0.0149,1,GO:0046661,BP,,445
terminal bouton,59,0.408,0.015,1,GO:0043195,CC,,446
muscle cell fate commitment,13,0.695,0.015,1,GO:0042693,BP,,447
axon part,169,0.446,0.0151,1,GO:0033267,CC,,448
establishment of protein localization to chromosome,20,0.343,0.0151,1,GO:0070199,BP,,449
"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors",45,0.605,0.0152,1,GO:0016706,MF,,450
cyclin-dependent protein serine/threonine kinase regulator activity,28,0.633,0.0153,1,GO:0016538,MF,,451
secondary active transmembrane transporter activity,188,0.551,0.0156,1,GO:0015291,MF,,452
sulfur compound biosynthetic process,197,0.45,0.0156,1,GO:0044272,BP,,453
calcium ion transport into cytosol,113,0.434,0.0157,1,GO:0060402,BP,,454
"oxidoreductase activity, acting on CH-OH group of donors",111,0.434,0.0157,1,GO:0016614,MF,,455
spliceosomal snRNP assembly,33,0.379,0.0158,1,GO:0000387,BP,,456
cullin family protein binding,13,0.307,0.0159,1,GO:0097602,MF,,457
negative regulation of ERK1 and ERK2 cascade,51,0.402,0.016,1,GO:0070373,BP,,458
negative regulation of calcium ion transport into cytosol,16,0.326,0.016,1,GO:0010523,BP,,459
protein transmembrane transport,52,0.403,0.0161,1,GO:0071806,BP,,460
"transferase activity, transferring alkyl or aryl (other than methyl) groups",48,0.4,0.0161,1,GO:0016765,MF,,461
antigen processing and presentation of exogenous peptide antigen via MHC class II,86,0.425,0.0163,1,GO:0019886,BP,,462
actin cytoskeleton reorganization,79,0.422,0.0164,1,GO:0031532,BP,,463
steroid hormone mediated signaling pathway,161,0.555,0.0165,1,GO:0043401,BP,,464
intracellular protein transmembrane transport,44,0.396,0.0167,1,GO:0065002,BP,,465
cortical actin cytoskeleton organization,28,0.631,0.0167,1,GO:0030866,BP,,466
regulation of response to food,16,0.327,0.0168,1,GO:0032095,BP,,467
ubiquitin-dependent ERAD pathway,65,0.414,0.0168,1,GO:0030433,BP,,468
regulation of embryonic development,105,0.568,0.0169,1,GO:0045995,BP,,469
monovalent inorganic anion homeostasis,13,0.691,0.0169,1,GO:0055083,BP,,470
positive regulation of excitatory postsynaptic potential,23,0.356,0.017,1,GO:2000463,BP,,471
modulation by virus of host process,17,0.333,0.0171,1,GO:0019054,BP,,472
signal transduction involved in cell cycle checkpoint,57,0.591,0.0171,1,GO:0072395,BP,,473
negative regulation of cyclase activity,21,0.35,0.0171,1,GO:0031280,BP,,474
lymph vessel development,23,0.644,0.0171,1,GO:0001945,BP,,475
tRNA methyltransferase activity,22,0.647,0.0171,1,GO:0008175,MF,,476
clathrin-dependent endocytosis,56,0.408,0.0172,1,GO:0072583,BP,,477
sensory perception of bitter taste,21,0.65,0.0172,1,GO:0050913,BP,,478
negative regulation of release of sequestered calcium ion into cytosol,13,0.309,0.0172,1,GO:0051280,BP,,479
amino sugar metabolic process,32,0.378,0.0173,1,GO:0006040,BP,,480
negative regulation of release of cytochrome c from mitochondria,15,0.323,0.0174,1,GO:0090201,BP,,481
organelle envelope lumen,73,0.419,0.0174,1,GO:0031970,CC,,482
regulation of lyase activity,75,0.421,0.0176,1,GO:0051339,BP,,483
regulation of regulated secretory pathway,100,0.431,0.0176,1,GO:1903305,BP,,484
purine nucleoside triphosphate biosynthetic process,57,0.409,0.0177,1,GO:0009145,BP,,485
AP-3 adaptor complex,10,0.284,0.0179,1,GO:0030123,CC,,486
phosphatidylinositol-3-phosphate binding,28,0.629,0.0181,1,GO:0032266,MF,,487
ligand-gated anion channel activity,11,0.294,0.0181,1,GO:0099095,MF,,488
apical junction complex,116,0.564,0.0181,1,GO:0043296,CC,,489
glial cell migration,42,0.395,0.0182,1,GO:0008347,BP,,490
myelin maintenance,12,0.697,0.0182,1,GO:0043217,BP,,491
ionotropic glutamate receptor signaling pathway,24,0.361,0.0183,1,GO:0035235,BP,,492
regulation of dopamine receptor signaling pathway,10,0.285,0.0184,1,GO:0060159,BP,,493
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,29,0.373,0.0184,1,GO:0014808,BP,,494
regulation of cytokine secretion involved in immune response,10,0.285,0.0185,1,GO:0002739,BP,,495
centrosome organization,106,0.566,0.0185,1,GO:0051297,BP,,496
calcium ion transmembrane import into cytosol,99,0.431,0.0185,1,"GO:0097553,GO:1902656",BP,calcium ion import into cytosol,497
coenzyme A metabolic process,14,0.318,0.0186,1,GO:0015936,BP,,498
sequestering of calcium ion,97,0.431,0.0186,1,GO:0051208,BP,,499
negative regulation of inflammatory response,84,0.426,0.0188,1,GO:0050728,BP,,500
myelination in peripheral nervous system,22,0.645,0.0188,1,"GO:0022011,GO:0032292",BP,peripheral nervous system axon ensheathment,501
primary lysosome,124,0.439,0.0188,1,"GO:0005766,GO:0042582",CC,azurophil granule,502
cellular biogenic amine metabolic process,47,0.401,0.0189,1,GO:0006576,BP,,503
cell-matrix adhesion,181,0.551,0.019,1,GO:0007160,BP,,504
lipid oxidation,88,0.428,0.0191,1,GO:0034440,BP,,505
apical junction assembly,52,0.594,0.0191,1,GO:0043297,BP,,506
"retrograde transport, vesicle recycling within Golgi",19,0.655,0.0191,1,GO:0000301,BP,,507
regulation of chromatin silencing,18,0.66,0.0191,1,GO:0031935,BP,,508
regulation of cellular response to hypoxia,10,0.286,0.0192,1,GO:1900037,BP,,509
mitotic cell cycle arrest,13,0.688,0.0192,1,GO:0071850,BP,,510
endoplasmic reticulum subcompartment,19,0.345,0.0193,1,GO:0098827,CC,,511
DNA methylation or demethylation,61,0.587,0.0194,1,GO:0044728,BP,,512
"nuclear-transcribed mRNA catabolic process, exonucleolytic",31,0.379,0.0195,1,GO:0000291,BP,,513
regulation of glutamate secretion,14,0.32,0.0196,1,GO:0014048,BP,,514
MCM complex,11,0.703,0.0196,1,GO:0042555,CC,,515
positive regulation of protein depolymerization,13,0.313,0.0198,1,GO:1901881,BP,,516
protein insertion into membrane,41,0.395,0.0198,1,GO:0051205,BP,,517
nitric oxide mediated signal transduction,20,0.349,0.0198,1,GO:0007263,BP,,518
cranial nerve development,41,0.605,0.0199,1,GO:0021545,BP,,519
regulation of odontogenesis,20,0.65,0.02,1,GO:0042481,BP,,520
"DNA damage response, detection of DNA damage",31,0.379,0.02,1,GO:0042769,BP,,521
regulation of inositol phosphate biosynthetic process,12,0.306,0.0202,1,GO:0010919,BP,,522
alcohol dehydrogenase (NADP+) activity,13,0.314,0.0202,1,GO:0008106,MF,,523
anion:cation symporter activity,36,0.612,0.0203,1,GO:0015296,MF,,524
positive regulation of protein dephosphorylation,32,0.381,0.0203,1,GO:0035307,BP,,525
sarcoplasmic reticulum calcium ion transport,32,0.382,0.0206,1,GO:0070296,BP,,526
alpha-amino acid metabolic process,196,0.452,0.0207,1,GO:1901605,BP,,527
invadopodium,11,0.701,0.0207,1,GO:0071437,CC,,528
positive regulation of peptide secretion,189,0.451,0.0207,1,GO:0002793,BP,,529
positive regulation of protein secretion,177,0.449,0.0207,1,GO:0050714,BP,,530
co-receptor binding,10,0.711,0.0208,1,GO:0039706,MF,,531
negative regulation of canonical Wnt signaling pathway,154,0.446,0.0208,1,GO:0090090,BP,,532
collagen metabolic process,93,0.569,0.0209,1,GO:0032963,BP,,533
mRNA transcription,22,0.642,0.021,1,GO:0009299,BP,,534
growth cone part,17,0.338,0.0211,1,GO:0090723,CC,,535
cellular detoxification,82,0.426,0.0212,1,GO:1990748,BP,,536
negative regulation of MAP kinase activity,64,0.417,0.0212,1,GO:0043407,BP,,537
axon terminus,105,0.435,0.0212,1,GO:0043679,CC,,538
regulation of response to extracellular stimulus,20,0.351,0.0213,1,"GO:0032104,GO:0032107",BP,regulation of response to nutrient levels,539
cytochrome complex assembly,28,0.374,0.0213,1,GO:0017004,BP,,540
protein targeting to membrane,173,0.449,0.0213,1,GO:0006612,BP,,541
protein disulfide isomerase activity,20,0.649,0.0214,1,"GO:0003756,GO:0016864",MF,"intramolecular oxidoreductase activity, transposing S-S bonds",542
regulation of cyclic nucleotide biosynthetic process,114,0.438,0.0214,1,GO:0030802,BP,,543
single-stranded RNA binding,63,0.584,0.0215,1,GO:0003727,MF,,544
purine ribonucleoside triphosphate biosynthetic process,56,0.411,0.0216,1,GO:0009206,BP,,545
peptide transporter activity,99,0.433,0.0216,1,GO:0015197,MF,,546
transcription corepressor activity,191,0.548,0.0216,1,GO:0003714,MF,,547
response to hydroperoxide,15,0.329,0.0217,1,GO:0033194,BP,,548
regulation of myoblast differentiation,41,0.604,0.0217,1,GO:0045661,BP,,549
negative regulation of calcium ion import,19,0.348,0.0218,1,GO:0090281,BP,,550
neuron recognition,34,0.386,0.022,1,GO:0008038,BP,,551
detection of chemical stimulus involved in sensory perception of taste,21,0.644,0.022,1,GO:0050912,BP,,552
response to testosterone,36,0.61,0.0222,1,GO:0033574,BP,,553
contractile fiber,187,0.451,0.0224,1,GO:0043292,CC,,554
establishment or maintenance of transmembrane electrochemical gradient,10,0.708,0.0225,1,GO:0010248,BP,,555
negative regulation of viral entry into host cell,15,0.67,0.0226,1,GO:0046597,BP,,556
chondroitin sulfate catabolic process,12,0.31,0.0226,1,GO:0030207,BP,,557
telomerase RNA binding,15,0.33,0.0227,1,GO:0070034,MF,,558
trabecula formation,22,0.36,0.0227,1,GO:0060343,BP,,559
outer dynein arm assembly,14,0.324,0.023,1,GO:0036158,BP,,560
enhancer binding,81,0.573,0.023,1,GO:0035326,MF,,561
peripheral nervous system development,64,0.582,0.023,1,GO:0007422,BP,,562
negative regulation of BMP signaling pathway,43,0.6,0.0231,1,GO:0030514,BP,,563
RNA destabilization,20,0.647,0.0231,1,GO:0050779,BP,,564
phosphatidylinositol dephosphorylation,24,0.634,0.0231,1,GO:0046856,BP,,565
skeletal muscle contraction,30,0.38,0.0232,1,GO:0003009,BP,,566
organic hydroxy compound transmembrane transporter activity,29,0.622,0.0234,1,GO:1901618,MF,,567
meiotic cell cycle,177,0.549,0.0236,1,GO:0051321,BP,,568
terpenoid metabolic process,82,0.428,0.0237,1,GO:0006721,BP,,569
negative regulation of leukocyte activation,118,0.44,0.0238,1,GO:0002695,BP,,570
positive regulation of gliogenesis,40,0.603,0.0239,1,GO:0014015,BP,,571
mitotic DNA damage checkpoint,83,0.572,0.0239,1,GO:0044773,BP,,572
ATP biosynthetic process,44,0.402,0.024,1,GO:0006754,BP,,573
cellular biogenic amine biosynthetic process,22,0.361,0.0241,1,GO:0042401,BP,,574
ribonucleoside triphosphate biosynthetic process,62,0.417,0.0241,1,GO:0009201,BP,,575
regulation of leukocyte proliferation,165,0.449,0.0242,1,GO:0070663,BP,,576
synapse assembly,137,0.444,0.0242,1,GO:0007416,BP,,577
positive regulation by host of viral transcription,12,0.688,0.0243,1,GO:0043923,BP,,578
viral entry into host cell,94,0.567,0.0243,1,GO:0046718,BP,,579
DNA alkylation,50,0.592,0.0243,1,"GO:0006305,GO:0006306",BP,DNA methylation,580
lyase activity,148,0.446,0.0243,1,GO:0016829,MF,,581
neuron cell-cell adhesion,15,0.332,0.0244,1,GO:0007158,BP,,582
dopamine secretion,23,0.364,0.0244,1,"GO:0014046,GO:0014059",BP,regulation of dopamine secretion,583
regulation of calcium ion transmembrane transport,108,0.437,0.0244,1,GO:1903169,BP,,584
positive regulation of calcium-mediated signaling,32,0.385,0.0245,1,GO:0050850,BP,,585
regulation of sequestering of calcium ion,94,0.433,0.0245,1,GO:0051282,BP,,586
regulation of morphogenesis of an epithelium,159,0.448,0.0246,1,GO:1905330,BP,,587
acyl-CoA dehydrogenase activity,15,0.333,0.0247,1,GO:0003995,MF,,588
modulation of excitatory postsynaptic potential,31,0.384,0.0248,1,GO:0098815,BP,,589
asymmetric protein localization,18,0.653,0.0249,1,GO:0008105,BP,,590
response to mitochondrial depolarisation,17,0.343,0.0249,1,GO:0098780,BP,,591
positive regulation of ERK1 and ERK2 cascade,144,0.446,0.0249,1,GO:0070374,BP,,592
chondroitin sulfate metabolic process,37,0.393,0.025,1,GO:0030204,BP,,593
post-Golgi vesicle-mediated transport,80,0.573,0.0251,1,GO:0006892,BP,,594
solute:cation symporter activity,78,0.573,0.0251,1,GO:0015294,MF,,595
phosphatidylinositol metabolic process,190,0.547,0.0252,1,GO:0046488,BP,,596
regulation of skeletal muscle cell differentiation,16,0.662,0.0253,1,GO:2001014,BP,,597
U4/U6 x U5 tri-snRNP complex,18,0.348,0.0253,1,GO:0046540,CC,,598
inositol phosphate phosphatase activity,19,0.648,0.0254,1,GO:0052745,MF,,599
adenylate cyclase binding,12,0.314,0.0255,1,GO:0008179,MF,,600
negative regulation of calcium-mediated signaling,18,0.348,0.0256,1,GO:0050849,BP,,601
face morphogenesis,25,0.629,0.0257,1,GO:0060325,BP,,602
"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity",11,0.694,0.0257,1,GO:0052629,MF,,603
bicellular tight junction assembly,43,0.598,0.0259,1,GO:0070830,BP,,604
positive regulation of response to DNA damage stimulus,66,0.579,0.0259,1,GO:2001022,BP,,605
G-protein coupled purinergic receptor signaling pathway,16,0.339,0.026,1,GO:0035588,BP,,606
mitochondrial respiratory chain complex III,11,0.306,0.026,1,"GO:0005750,GO:0045275",CC,respiratory chain complex III,607
central nervous system neuron development,69,0.422,0.0261,1,GO:0021954,BP,,608
endocytic vesicle membrane,159,0.449,0.0262,1,GO:0030666,CC,,609
regulation of transcription initiation from RNA polymerase II promoter,22,0.363,0.0262,1,GO:0060260,BP,,610
calcium ion transport from endoplasmic reticulum to cytosol,30,0.383,0.0263,1,GO:1903514,BP,,611
regulation of RNA splicing,90,0.568,0.0263,1,GO:0043484,BP,,612
regulation of calcium ion transmembrane transporter activity,67,0.421,0.0263,1,GO:1901019,BP,,613
cell-cell adhesion mediated by integrin,10,0.703,0.0264,1,GO:0033631,BP,,614
metallopeptidase activity,155,0.552,0.0264,1,GO:0008237,MF,,615
drug transporter activity,19,0.647,0.0265,1,GO:0090484,MF,,616
purinergic receptor activity,17,0.345,0.0265,1,GO:0035586,MF,,617
AU-rich element binding,22,0.637,0.0266,1,GO:0017091,MF,,618
postsynapse assembly,12,0.315,0.0266,1,GO:0099068,BP,,619
cadherin binding involved in cell-cell adhesion,17,0.345,0.0267,1,GO:0098641,MF,,620
purinergic nucleotide receptor activity,13,0.323,0.0268,1,"GO:0001614,GO:0016502",MF,nucleotide receptor activity,621
synaptic vesicle,133,0.444,0.0268,1,GO:0008021,CC,,622
dicarboxylic acid transport,81,0.429,0.0269,1,GO:0006835,BP,,623
response to muscle activity,18,0.651,0.0269,1,GO:0014850,BP,,624
transcription-coupled nucleotide-excision repair,60,0.417,0.027,1,GO:0006283,BP,,625
protein targeting to Golgi,14,0.671,0.0271,1,GO:0000042,BP,,626
positive regulation of Wnt signaling pathway,144,0.447,0.0272,1,GO:0030177,BP,,627
negative regulation of oligodendrocyte differentiation,11,0.308,0.0272,1,GO:0048715,BP,,628
acetylglucosaminyltransferase activity,44,0.404,0.0272,1,GO:0008375,MF,,629
negative regulation of lyase activity,23,0.367,0.0273,1,GO:0051350,BP,,630
axon cytoplasm,37,0.395,0.0275,1,GO:1904115,CC,,631
carboxy-lyase activity,33,0.389,0.0278,1,GO:0016831,MF,,632
nuclear membrane part,13,0.676,0.0279,1,GO:0044453,CC,,633
regulation of calcium ion transport into cytosol,77,0.427,0.028,1,GO:0010522,BP,,634
telomere maintenance via telomere lengthening,60,0.418,0.028,1,GO:0010833,BP,,635
regulation of mitochondrion organization,196,0.454,0.0281,1,GO:0010821,BP,,636
amine biosynthetic process,23,0.368,0.0284,1,GO:0009309,BP,,637
positive regulation of inositol phosphate biosynthetic process,10,0.3,0.0287,1,GO:0060732,BP,,638
actin filament,81,0.43,0.0289,1,GO:0005884,CC,,639
regulation of neuronal synaptic plasticity,49,0.41,0.029,1,GO:0048168,BP,,640
phenol-containing compound biosynthetic process,37,0.396,0.0291,1,GO:0046189,BP,,641
cardiac cell fate commitment,11,0.69,0.0291,1,GO:0060911,BP,,642
miRNA metabolic process,17,0.653,0.0292,1,GO:0010586,BP,,643
relaxation of cardiac muscle,17,0.653,0.0292,1,GO:0055119,BP,,644
histone H3-K36 methylation,10,0.699,0.0293,1,GO:0010452,BP,,645
cofactor transport,22,0.634,0.0294,1,GO:0051181,BP,,646
macrophage migration,22,0.366,0.0295,1,GO:1905517,BP,,647
response to cocaine,43,0.404,0.0297,1,GO:0042220,BP,,648
regulation of cell growth involved in cardiac muscle cell development,10,0.302,0.0298,1,GO:0061050,BP,,649
negative regulation of ATPase activity,11,0.311,0.0298,1,GO:0032780,BP,,650
monoamine transport,66,0.423,0.0299,1,GO:0015844,BP,,651
acetylcholine receptor signaling pathway,22,0.366,0.0299,1,"GO:0095500,GO:1903831,GO:1905144,GO:1905145",BP,"signal transduction involved in cellular response to ammonium ion,response to acetylcholine,cellular response to acetylcholine",652
regulation of establishment of protein localization to chromosome,10,0.302,0.0299,1,GO:0070202,BP,,653
regulation of adenylate cyclase activity,63,0.421,0.0299,1,GO:0045761,BP,,654
cellular response to ammonium ion,56,0.416,0.0301,1,GO:0071242,BP,,655
synaptic vesicle membrane,66,0.423,0.0302,1,"GO:0030672,GO:0099501",CC,exocytic vesicle membrane,656
regulation of neurotransmitter receptor activity,34,0.393,0.0302,1,GO:0099601,BP,,657
cellular pigmentation,48,0.41,0.0303,1,GO:0033059,BP,,658
flavin adenine dinucleotide binding,67,0.423,0.0303,1,GO:0050660,MF,,659
regulation of bone development,18,0.353,0.0304,1,GO:1903010,BP,,660
organic hydroxy compound biosynthetic process,172,0.452,0.0305,1,GO:1901617,BP,,661
sterol transporter activity,20,0.64,0.0306,1,GO:0015248,MF,,662
adipose tissue development,32,0.61,0.0308,1,GO:0060612,BP,,663
nucleotide-sugar biosynthetic process,21,0.364,0.0308,1,GO:0009226,BP,,664
positive regulation of acute inflammatory response,22,0.367,0.0308,1,GO:0002675,BP,,665
regulation of skeletal muscle tissue development,43,0.595,0.0308,1,GO:0048641,BP,,666
quinone metabolic process,25,0.375,0.0309,1,GO:1901661,BP,,667
positive regulation of exocytosis,65,0.423,0.031,1,GO:0045921,BP,,668
aminoacyl-tRNA ligase activity,39,0.4,0.031,1,"GO:0004812,GO:0016875,GO:0016876",MF,"ligase activity, forming carbon-oxygen bonds,ligase activity, forming aminoacyl-tRNA and related compounds",669
mitotic G1 DNA damage checkpoint,60,0.581,0.0311,1,"GO:0031571,GO:0044819",BP,mitotic G1/S transition checkpoint,670
cellular oxidant detoxification,81,0.431,0.0312,1,GO:0098869,BP,,671
negative regulation of cardiac muscle tissue growth,13,0.327,0.0312,1,"GO:0055022,GO:0061117",BP,negative regulation of heart growth,672
pre-miRNA processing,12,0.68,0.0312,1,GO:0031054,BP,,673
positive regulation of sodium ion transport,29,0.616,0.0313,1,GO:0010765,BP,,674
MHC class II protein complex binding,15,0.339,0.0313,1,GO:0023026,MF,,675
regulation of myeloid leukocyte mediated immunity,32,0.39,0.0315,1,GO:0002886,BP,,676
regulation of macroautophagy,125,0.444,0.0315,1,GO:0016241,BP,,677
regulation of mitophagy in response to mitochondrial depolarization,14,0.334,0.0317,1,"GO:1904923,GO:1904925",BP,positive regulation of mitophagy in response to mitochondrial depolarization,678
positive regulation of immune effector process,127,0.445,0.0319,1,GO:0002699,BP,,679
morphogenesis of an endothelium,12,0.679,0.032,1,"GO:0003159,GO:0061154",BP,endothelial tube morphogenesis,680
myofibril,180,0.454,0.032,1,GO:0030016,CC,,681
intramolecular transferase activity,24,0.374,0.0321,1,GO:0016866,MF,,682
regulation of release of sequestered calcium ion into cytosol,64,0.422,0.0321,1,GO:0051279,BP,,683
"positive regulation of DNA damage response, signal transduction by p53 class mediator",11,0.687,0.0322,1,GO:0043517,BP,,684
embryonic heart tube development,67,0.576,0.0324,1,GO:0035050,BP,,685
hydrogen transport,140,0.448,0.0325,1,GO:0006818,BP,,686
multicellular organismal macromolecule metabolic process,97,0.563,0.0326,1,GO:0044259,BP,,687
RNA polymerase II repressing transcription factor binding,25,0.623,0.0327,1,GO:0001103,MF,,688
phosphatidate phosphatase activity,12,0.322,0.0327,1,GO:0008195,MF,,689
hormone-mediated signaling pathway,187,0.545,0.0329,1,GO:0009755,BP,,690
"beta-1,3-galactosyltransferase activity",15,0.341,0.0329,1,GO:0048531,MF,,691
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,25,0.377,0.0331,1,GO:0010880,BP,,692
proton transport,138,0.447,0.0331,1,GO:0015992,BP,,693
calcium channel regulator activity,32,0.391,0.0333,1,GO:0005246,MF,,694
regulation of oxidative phosphorylation,16,0.346,0.0333,1,GO:0002082,BP,,695
tRNA modification,53,0.585,0.0333,1,GO:0006400,BP,,696
chromatin assembly or disassembly,128,0.555,0.0334,1,GO:0006333,BP,,697
protein homotetramerization,60,0.421,0.0334,1,GO:0051289,BP,,698
phospholipase C-activating G-protein coupled receptor signaling pathway,80,0.431,0.0337,1,GO:0007200,BP,,699
positive regulation of response to biotic stimulus,31,0.39,0.0338,1,GO:0002833,BP,,700
positive regulation of calcium ion-dependent exocytosis,20,0.363,0.0338,1,GO:0045956,BP,,701
aldo-keto reductase (NADP) activity,19,0.359,0.034,1,GO:0004033,MF,,702
oligopeptide binding,11,0.315,0.034,1,GO:1900750,MF,,703
modulation by virus of host morphology or physiology,28,0.384,0.0342,1,GO:0019048,BP,,704
negative regulation of cyclin-dependent protein kinase activity,21,0.633,0.0342,1,GO:1904030,BP,,705
positive regulation of B cell proliferation,32,0.392,0.0343,1,GO:0030890,BP,,706
positive regulation of synapse assembly,61,0.422,0.0345,1,GO:0051965,BP,,707
compact myelin,14,0.663,0.0347,1,GO:0043218,CC,,708
regulation of cell cycle arrest,97,0.562,0.0347,1,GO:0071156,BP,,709
apical protein localization,11,0.684,0.0348,1,GO:0045176,BP,,710
regulation of angiogenesis,190,0.545,0.0349,1,GO:0045765,BP,,711
negative regulation of I-kappaB kinase/NF-kappaB signaling,49,0.587,0.0349,1,GO:0043124,BP,,712
acute inflammatory response to antigenic stimulus,18,0.357,0.0351,1,GO:0002438,BP,,713
"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",98,0.438,0.0352,1,GO:0016616,MF,,714
release of sequestered calcium ion into cytosol,93,0.437,0.0354,1,"GO:0051209,GO:0051283",BP,negative regulation of sequestering of calcium ion,715
multivesicular body assembly,26,0.381,0.0354,1,GO:0036258,BP,,716
SMN-Sm protein complex,14,0.338,0.0355,1,GO:0034719,CC,,717
apoptotic process involved in morphogenesis,20,0.636,0.0355,1,GO:0060561,BP,,718
transcription initiation from RNA polymerase II promoter,149,0.45,0.0355,1,GO:0006367,BP,,719
vacuole fusion,33,0.394,0.0355,1,GO:0097576,BP,,720
mRNA binding,168,0.547,0.0357,1,GO:0003729,MF,,721
tertiary granule lumen,45,0.409,0.0358,1,GO:1904724,CC,,722
hydrogen ion transmembrane transport,95,0.438,0.0358,1,GO:1902600,BP,,723
positive regulation of lymphocyte proliferation,101,0.44,0.036,1,GO:0050671,BP,,724
regulation of catecholamine secretion,40,0.404,0.0361,1,GO:0050433,BP,,725
chaperone-mediated protein complex assembly,18,0.357,0.0363,1,GO:0051131,BP,,726
receptor clustering,45,0.41,0.0364,1,GO:0043113,BP,,727
regulation of histone methylation,49,0.586,0.0364,1,GO:0031060,BP,,728
protein folding,199,0.457,0.0365,1,GO:0006457,BP,,729
positive regulation of multi-organism process,134,0.448,0.0365,1,GO:0043902,BP,,730
glutamine family amino acid biosynthetic process,17,0.354,0.0366,1,GO:0009084,BP,,731
positive regulation of epithelial to mesenchymal transition,35,0.602,0.0366,1,GO:0010718,BP,,732
forebrain neuron development,31,0.392,0.0368,1,GO:0021884,BP,,733
cyclin-dependent protein serine/threonine kinase inhibitor activity,11,0.682,0.0368,1,GO:0004861,MF,,734
regulation of T cell mediated immunity,41,0.594,0.0369,1,GO:0002709,BP,,735
positive regulation of cation channel activity,41,0.406,0.037,1,GO:2001259,BP,,736
glutathione transferase activity,18,0.358,0.0371,1,GO:0004364,MF,,737
positive regulation of sequence-specific DNA binding transcription factor activity,198,0.543,0.0372,1,GO:0051091,BP,,738
regulation of hormone metabolic process,23,0.626,0.0372,1,GO:0032350,BP,,739
positive regulation of telomere maintenance via telomere lengthening,28,0.386,0.0374,1,GO:1904358,BP,,740
amino acid import,17,0.354,0.0377,1,GO:0043090,BP,,741
negative regulation of fibroblast growth factor receptor signaling pathway,10,0.31,0.0377,1,GO:0040037,BP,,742
"transferase activity, transferring hexosyl groups",166,0.453,0.0379,1,GO:0016758,MF,,743
response to zinc ion,43,0.409,0.0381,1,GO:0010043,BP,,744
protein kinase complex,90,0.563,0.0383,1,GO:1902911,CC,,745
secondary metabolic process,41,0.406,0.0383,1,GO:0019748,BP,,746
intrinsic component of mitochondrial inner membrane,23,0.375,0.0383,1,"GO:0031304,GO:0031305",CC,integral component of mitochondrial inner membrane,747
cerebral cortex radially oriented cell migration,31,0.392,0.0383,1,GO:0021799,BP,,748
lipopolysaccharide binding,18,0.359,0.0387,1,GO:0001530,MF,,749
retinoid metabolic process,68,0.427,0.0387,1,GO:0001523,BP,,750
cAMP biosynthetic process,97,0.439,0.0387,1,"GO:0006171,GO:0030817",BP,regulation of cAMP biosynthetic process,751
palmitoyltransferase complex,11,0.68,0.0387,1,GO:0002178,CC,,752
cellular sodium ion homeostasis,13,0.665,0.0389,1,GO:0006883,BP,,753
establishment or maintenance of cell polarity,158,0.548,0.039,1,GO:0007163,BP,,754
protein targeting to lysosome,17,0.645,0.039,1,GO:0006622,BP,,755
carbohydrate biosynthetic process,171,0.454,0.039,1,GO:0016051,BP,,756
negative regulation of adenylate cyclase activity,20,0.367,0.0391,1,GO:0007194,BP,,757
positive regulation of mitochondrion organization,148,0.451,0.0391,1,GO:0010822,BP,,758
macrophage chemotaxis,19,0.363,0.0393,1,GO:0048246,BP,,759
glomerular mesangium development,13,0.665,0.0393,1,GO:0072109,BP,,760
carbohydrate derivative transporter activity,31,0.607,0.0394,1,GO:1901505,MF,,761
regulation of NMDA receptor activity,16,0.351,0.0394,1,GO:2000310,BP,,762
protein self-association,46,0.588,0.0394,1,GO:0043621,MF,,763
coronary vasculature morphogenesis,12,0.672,0.0395,1,GO:0060977,BP,,764
platelet degranulation,112,0.444,0.0395,1,GO:0002576,BP,,765
G1 DNA damage checkpoint,61,0.576,0.0395,1,GO:0044783,BP,,766
Arp2/3 complex-mediated actin nucleation,33,0.396,0.0395,1,GO:0034314,BP,,767
inclusion body,70,0.571,0.0396,1,GO:0016234,CC,,768
nucleosome binding,44,0.59,0.0397,1,GO:0031491,MF,,769
"nucleotide-excision repair, DNA duplex unwinding",20,0.367,0.0401,1,GO:0000717,BP,,770
intrinsic component of synaptic vesicle membrane,16,0.352,0.0401,1,GO:0098563,CC,,771
lymphocyte proliferation,198,0.458,0.0403,1,GO:0046651,BP,,772
endolysosome,19,0.364,0.0403,1,GO:0036019,CC,,773
chondroitin sulfate proteoglycan metabolic process,39,0.405,0.0404,1,GO:0050654,BP,,774
contractile fiber part,173,0.455,0.0405,1,GO:0044449,CC,,775
"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",15,0.653,0.0405,1,GO:0000466,BP,,776
synaptic vesicle cycle,115,0.445,0.0405,1,GO:0099504,BP,,777
pseudouridine synthesis,17,0.357,0.0407,1,GO:0001522,BP,,778
negative regulation of amine transport,22,0.374,0.0407,1,GO:0051953,BP,,779
negative regulation of catabolic process,183,0.456,0.0407,1,GO:0009895,BP,,780
small nucleolar ribonucleoprotein complex,16,0.352,0.0408,1,GO:0005732,CC,,781
phenol-containing compound metabolic process,86,0.436,0.0408,1,GO:0018958,BP,,782
regulation of B cell proliferation,44,0.411,0.0409,1,GO:0030888,BP,,783
cyclic-nucleotide-mediated signaling,48,0.415,0.0411,1,GO:0019935,BP,,784
unfolded protein binding,91,0.438,0.0413,1,GO:0051082,MF,,785
anterograde axonal transport,29,0.391,0.0414,1,GO:0008089,BP,,786
dicarboxylic acid metabolic process,88,0.437,0.0414,1,GO:0043648,BP,,787
regulation of G-protein coupled receptor protein signaling pathway,113,0.444,0.0416,1,GO:0008277,BP,,788
negative regulation of myoblast differentiation,19,0.635,0.0416,1,GO:0045662,BP,,789
Wnt-protein binding,29,0.391,0.0417,1,GO:0017147,MF,,790
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,72,0.431,0.0417,1,"GO:0002433,GO:0038096",BP,Fc-gamma receptor signaling pathway involved in phagocytosis,791
cerebral cortex radial glia guided migration,23,0.377,0.042,1,"GO:0021801,GO:0022030",BP,telencephalon glial cell migration,792
regulation of monooxygenase activity,48,0.415,0.042,1,GO:0032768,BP,,793
mitochondrial intermembrane space,65,0.427,0.042,1,GO:0005758,CC,,794
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,26,0.615,0.0421,1,GO:1901522,BP,,795
nucleocytoplasmic transporter activity,25,0.617,0.0421,1,GO:0005487,MF,,796
cellular lipid catabolic process,157,0.453,0.0421,1,GO:0044242,BP,,797
"transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding",23,0.622,0.0422,1,GO:0001205,MF,,798
mRNA transcription from RNA polymerase II promoter,18,0.638,0.0423,1,GO:0042789,BP,,799
positive regulation of mononuclear cell proliferation,102,0.442,0.0423,1,GO:0032946,BP,,800
azurophil granule lumen,73,0.431,0.0424,1,GO:0035578,CC,,801
AMP metabolic process,12,0.331,0.0424,1,GO:0046033,BP,,802
negative regulation of nucleotide biosynthetic process,36,0.402,0.0426,1,"GO:0030809,GO:1900372",BP,negative regulation of purine nucleotide biosynthetic process,803
cranial nerve morphogenesis,23,0.622,0.0426,1,GO:0021602,BP,,804
regulation of endothelial cell differentiation,26,0.615,0.0426,1,GO:0045601,BP,,805
mating behavior,20,0.369,0.0427,1,GO:0007617,BP,,806
regulation of cholesterol metabolic process,19,0.366,0.0428,1,GO:0090181,BP,,807
odontogenesis,98,0.559,0.0428,1,GO:0042476,BP,,808
nucleic acid transport,164,0.546,0.0429,1,"GO:0050657,GO:0050658",BP,RNA transport,809
positive regulation of glucose metabolic process,30,0.607,0.0433,1,GO:0010907,BP,,810
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",109,0.444,0.0435,1,GO:0000184,BP,,811
odorant binding,35,0.599,0.0435,1,GO:0005549,MF,,812
polyamine metabolic process,16,0.354,0.0436,1,GO:0006595,BP,,813
proteasome assembly,13,0.339,0.044,1,GO:0043248,BP,,814
regulation of telomere maintenance via telomerase,39,0.407,0.0441,1,GO:0032210,BP,,815
RNA export from nucleus,119,0.553,0.0443,1,GO:0006405,BP,,816
integrin-mediated signaling pathway,84,0.564,0.0443,1,GO:0007229,BP,,817
drug transmembrane transport,19,0.633,0.0446,1,GO:0006855,BP,,818
regulation of T cell cytokine production,15,0.65,0.0446,1,GO:0002724,BP,,819
dendrite extension,28,0.39,0.0447,1,GO:0097484,BP,,820
catechol-containing compound biosynthetic process,19,0.367,0.0447,1,"GO:0009713,GO:0042423",BP,catecholamine biosynthetic process,821
structural constituent of muscle,40,0.408,0.0448,1,GO:0008307,MF,,822
filopodium assembly,52,0.42,0.0449,1,GO:0046847,BP,,823
entry into host cell,108,0.556,0.0449,1,"GO:0030260,GO:0044409,GO:0051806,GO:0051828",BP,"entry into host,entry into cell of other organism involved in symbiotic interaction,entry into other organism involved in symbiotic interaction",824
negative regulation of cellular protein localization,130,0.449,0.045,1,GO:1903828,BP,,825
adenylate cyclase-activating G-protein coupled receptor signaling pathway,53,0.42,0.045,1,GO:0007189,BP,,826
mitotic DNA integrity checkpoint,89,0.562,0.0451,1,GO:0044774,BP,,827
regulation of DNA biosynthetic process,83,0.436,0.0451,1,GO:2000278,BP,,828
carboxylic acid transmembrane transport,87,0.562,0.0452,1,GO:1905039,BP,,829
lipid phosphorylation,99,0.558,0.0452,1,GO:0046834,BP,,830
establishment of RNA localization,166,0.545,0.0452,1,GO:0051236,BP,,831
keratan sulfate metabolic process,30,0.394,0.0452,1,GO:0042339,BP,,832
"protein localization to chromosome, telomeric region",23,0.379,0.0453,1,GO:0070198,BP,,833
DNA helicase activity,43,0.588,0.0458,1,GO:0003678,MF,,834
positive regulation of endoplasmic reticulum unfolded protein response,12,0.666,0.0459,1,GO:1900103,BP,,835
response to UV-C,10,0.682,0.046,1,GO:0010225,BP,,836
ATPase binding,75,0.433,0.0462,1,GO:0051117,MF,,837
"nucleotide-excision repair, DNA damage recognition",19,0.368,0.0463,1,GO:0000715,BP,,838
"regulation of protein localization to chromosome, telomeric region",12,0.334,0.0464,1,GO:1904814,BP,,839
mitotic sister chromatid cohesion,21,0.626,0.0464,1,GO:0007064,BP,,840
positive regulation of neurotransmitter transport,15,0.352,0.0467,1,GO:0051590,BP,,841
ERAD pathway,82,0.436,0.0467,1,GO:0036503,BP,,842
regulation of BMP signaling pathway,73,0.567,0.0467,1,GO:0030510,BP,,843
multicellular organismal response to stress,62,0.427,0.0469,1,GO:0033555,BP,,844
mitotic spindle organization,80,0.564,0.047,1,"GO:0007052,GO:1902850",BP,microtubule cytoskeleton organization involved in mitosis,845
negative regulation of cyclic nucleotide metabolic process,36,0.404,0.0474,1,GO:0030800,BP,,846
Fc-gamma receptor signaling pathway,74,0.433,0.0475,1,GO:0038094,BP,,847
negative regulation of chromatin organization,41,0.589,0.0476,1,GO:1905268,BP,,848
ammonium ion binding,53,0.421,0.0476,1,GO:0070405,MF,,849
negative regulation of axon extension,24,0.383,0.0477,1,GO:0030517,BP,,850
sulfuric ester hydrolase activity,14,0.347,0.0479,1,GO:0008484,MF,,851
cullin-RING ubiquitin ligase complex,152,0.453,0.0479,1,GO:0031461,CC,,852
regulation of transmembrane transporter activity,181,0.457,0.0481,1,GO:0022898,BP,,853
catecholamine secretion,43,0.413,0.0482,1,GO:0050432,BP,,854
mononuclear cell proliferation,200,0.459,0.0485,1,GO:0032943,BP,,855
positive regulation of leukocyte proliferation,106,0.444,0.0486,1,GO:0070665,BP,,856
distal tubule development,11,0.672,0.0486,1,GO:0072017,BP,,857
negative regulation of viral genome replication,42,0.588,0.0486,1,GO:0045071,BP,,858
phosphatidic acid biosynthetic process,32,0.601,0.0488,1,"GO:0006654,GO:0046473",BP,phosphatidic acid metabolic process,859
mRNA 3'-UTR AU-rich region binding,11,0.672,0.0488,1,GO:0035925,MF,,860
intermediate filament organization,18,0.634,0.0488,1,GO:0045109,BP,,861
axo-dendritic transport,43,0.413,0.0491,1,GO:0008088,BP,,862
chromatin assembly,104,0.556,0.0494,1,GO:0031497,BP,,863
PERK-mediated unfolded protein response,21,0.624,0.0495,1,GO:0036499,BP,,864
ruffle membrane,78,0.564,0.0495,1,GO:0032587,CC,,865
perinuclear endoplasmic reticulum,10,0.679,0.0496,1,GO:0097038,CC,,866
"synaptic transmission, dopaminergic",25,0.387,0.0498,1,GO:0001963,BP,,867
regulation of cyclic nucleotide metabolic process,129,0.45,0.0498,1,GO:0030799,BP,,868
male gonad development,108,0.555,0.05,1,"GO:0008584,GO:0046546",BP,development of primary male sexual characteristics,869
DNA replication checkpoint,11,0.329,0.05,1,GO:0000076,BP,,870
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,10,0.679,0.0501,1,GO:1902237,BP,,871
mitochondrial ATP synthesis coupled proton transport,18,0.367,0.0502,1,GO:0042776,BP,,872
inositol tetrakisphosphate phosphatase activity,11,0.67,0.0503,1,GO:0052743,MF,,873
negative regulation of sodium ion transmembrane transport,11,0.33,0.0504,1,GO:1902306,BP,,874
regulation of protein import,154,0.454,0.0504,1,GO:1904589,BP,,875
mRNA destabilization,18,0.633,0.0506,1,GO:0061157,BP,,876
aspartic-type endopeptidase activity,19,0.63,0.0506,1,"GO:0004190,GO:0070001",MF,aspartic-type peptidase activity,877
polarized epithelial cell differentiation,11,0.67,0.0506,1,GO:0030859,BP,,878
Fc receptor mediated stimulatory signaling pathway,77,0.436,0.0507,1,GO:0002431,BP,,879
regulation of early endosome to late endosome transport,15,0.354,0.0509,1,GO:2000641,BP,,880
regulation of macrophage activation,22,0.38,0.051,1,GO:0043030,BP,,881
positive regulation of NIK/NF-kappaB signaling,34,0.597,0.0511,1,GO:1901224,BP,,882
outer mitochondrial membrane protein complex,12,0.337,0.0512,1,GO:0098799,CC,,883
regulation of neuron projection regeneration,25,0.387,0.0514,1,GO:0070570,BP,,884
ubiquitinyl hydrolase activity,95,0.558,0.0515,1,GO:0101005,MF,,885
lymphangiogenesis,15,0.645,0.0516,1,GO:0001946,BP,,886
node of Ranvier,14,0.65,0.0517,1,GO:0033268,CC,,887
positive regulation of dendrite extension,17,0.364,0.0518,1,GO:1903861,BP,,888
centrosome cycle,79,0.563,0.0518,1,GO:0007098,BP,,889
RNA polymerase II transcriptional preinitiation complex assembly,26,0.39,0.052,1,GO:0051123,BP,,890
phosphatidylinositol-3-phosphatase activity,14,0.65,0.0522,1,"GO:0004438,GO:0052744",MF,phosphatidylinositol monophosphate phosphatase activity,891
negative regulation of mast cell activation,10,0.323,0.0522,1,GO:0033004,BP,,892
mating,33,0.402,0.0524,1,GO:0007618,BP,,893
peptide catabolic process,27,0.608,0.0525,1,GO:0043171,BP,,894
"proton-transporting V-type ATPase, V0 domain",10,0.323,0.0529,1,GO:0033179,CC,,895
negative regulation of neuron death,162,0.456,0.0532,1,GO:1901215,BP,,896
dicarboxylic acid transmembrane transporter activity,28,0.394,0.0533,1,GO:0005310,MF,,897
pigment granule organization,25,0.388,0.0534,1,GO:0048753,BP,,898
polyamine biosynthetic process,13,0.345,0.0536,1,GO:0006596,BP,,899
fatty-acyl-CoA binding,14,0.351,0.0537,1,GO:0000062,MF,,900
transmembrane receptor protein serine/threonine kinase binding,13,0.654,0.0538,1,GO:0070696,MF,,901
thiol-dependent ubiquitinyl hydrolase activity,93,0.558,0.053900000000000003,1,GO:0036459,MF,,902
MHC protein complex binding,18,0.369,0.054,1,GO:0023023,MF,,903
fatty acid beta-oxidation using acyl-CoA oxidase,12,0.339,0.054,1,GO:0033540,BP,,904
structural constituent of nuclear pore,16,0.639,0.054,1,GO:0017056,MF,,905
regulation of mRNA metabolic process,114,0.552,0.0542,1,GO:1903311,BP,,906
ribonucleoside monophosphate biosynthetic process,76,0.436,0.0543,1,GO:0009156,BP,,907
myelin assembly,18,0.631,0.0544,1,GO:0032288,BP,,908
centriole assembly,28,0.605,0.0544,1,GO:0098534,BP,,909
proline metabolic process,10,0.324,0.0545,1,GO:0006560,BP,,910
response to potassium ion,11,0.667,0.0545,1,GO:0035864,BP,,911
response to ethanol,108,0.446,0.0549,1,GO:0045471,BP,,912
anterior/posterior pattern specification,152,0.545,0.0552,1,GO:0009952,BP,,913
multivesicular body organization,27,0.393,0.0553,1,GO:0036257,BP,,914
calcium ion transmembrane transport via high voltage-gated calcium channel,10,0.325,0.0553,1,GO:0061577,BP,,915
regulation of cell proliferation involved in kidney development,10,0.675,0.0554,1,GO:1901722,BP,,916
catecholamine metabolic process,48,0.42,0.0554,1,"GO:0006584,GO:0009712",BP,catechol-containing compound metabolic process,917
DNA-directed RNA polymerase III complex,15,0.357,0.0555,1,GO:0005666,CC,,918
DNA modification,75,0.564,0.0556,1,GO:0006304,BP,,919
L-amino acid import,15,0.357,0.0557,1,GO:0043092,BP,,920
DNA damage checkpoint,131,0.549,0.0557,1,GO:0000077,BP,,921
ribosomal small subunit assembly,15,0.357,0.0557,1,GO:0000028,BP,,922
regulation of the force of heart contraction,23,0.615,0.0558,1,GO:0002026,BP,,923
synapse maturation,18,0.37,0.0558,1,GO:0060074,BP,,924
myoblast differentiation,68,0.567,0.056,1,GO:0045445,BP,,925
pre-mRNA binding,25,0.61,0.056,1,GO:0036002,MF,,926
hippocampus development,74,0.436,0.0561,1,GO:0021766,BP,,927
actin polymerization or depolymerization,163,0.457,0.0561,1,GO:0008154,BP,,928
positive regulation of transcription initiation from RNA polymerase II promoter,15,0.358,0.0563,1,GO:0060261,BP,,929
endothelium development,98,0.556,0.0564,1,GO:0003158,BP,,930
Schwann cell development,25,0.61,0.0564,1,GO:0014044,BP,,931
myotube cell development,29,0.398,0.0565,1,GO:0014904,BP,,932
protein import into mitochondrial matrix,13,0.347,0.0566,1,GO:0030150,BP,,933
microtubule nucleation,20,0.623,0.0566,1,GO:0007020,BP,,934
negative regulation of pathway-restricted SMAD protein phosphorylation,10,0.674,0.0567,1,GO:0060394,BP,,935
maintenance of organelle location,10,0.674,0.0567,1,GO:0051657,BP,,936
maturation of 5.8S rRNA,24,0.612,0.0568,1,GO:0000460,BP,,937
magnesium ion homeostasis,11,0.666,0.0569,1,GO:0010960,BP,,938
positive regulation of establishment of protein localization to mitochondrion,97,0.444,0.0569,1,GO:1903749,BP,,939
myosin filament assembly,13,0.348,0.0571,1,GO:0031034,BP,,940
negative regulation of glucose transport,14,0.353,0.0572,1,GO:0010829,BP,,941
RNA polymerase II carboxy-terminal domain kinase activity,14,0.353,0.0572,1,GO:0008353,MF,,942
DNA packaging,136,0.547,0.0575,1,GO:0006323,BP,,943
protein kinase A catalytic subunit binding,14,0.353,0.0575,1,GO:0034236,MF,,944
morphogenesis of a branching structure,170,0.542,0.0575,1,GO:0001763,BP,,945
"proton-transporting ATP synthase complex, coupling factor F(o)",10,0.327,0.0577,1,GO:0045263,CC,,946
cellular response to prostaglandin stimulus,18,0.371,0.0578,1,GO:0071379,BP,,947
regulation of DNA replication,98,0.444,0.0578,1,GO:0006275,BP,,948
"condensed nuclear chromosome, centromeric region",17,0.633,0.0578,1,GO:0000780,CC,,949
small-subunit processome,26,0.393,0.058,1,GO:0032040,CC,,950
centrosome localization,22,0.617,0.058,1,GO:0051642,BP,,951
response to stimulus involved in regulation of muscle adaptation,16,0.637,0.058,1,GO:0014874,BP,,952
regulation of hormone biosynthetic process,16,0.637,0.0582,1,GO:0046885,BP,,953
positive regulation of intrinsic apoptotic signaling pathway,48,0.579,0.0582,1,GO:2001244,BP,,954
RNA methyltransferase activity,46,0.581,0.0584,1,GO:0008173,MF,,955
cysteine-type peptidase activity,160,0.543,0.0584,1,GO:0008234,MF,,956
autophagosome maturation,31,0.402,0.0584,1,GO:0097352,BP,,957
dopamine transport,34,0.406,0.0585,1,GO:0015872,BP,,958
positive regulation of response to endoplasmic reticulum stress,33,0.595,0.0586,1,GO:1905898,BP,,959
diterpenoid metabolic process,75,0.437,0.0586,1,GO:0016101,BP,,960
cellular response to interleukin-1,65,0.568,0.0589,1,GO:0071347,BP,,961
regulation of actin polymerization or depolymerization,140,0.454,0.0589,1,GO:0008064,BP,,962
carnitine metabolic process,13,0.349,0.059,1,GO:0009437,BP,,963
negative regulation of cyclin-dependent protein serine/threonine kinase activity,20,0.622,0.0592,1,GO:0045736,BP,,964
transmembrane receptor protein tyrosine phosphatase activity,16,0.364,0.0593,1,"GO:0005001,GO:0019198",MF,transmembrane receptor protein phosphatase activity,965
negative regulation of protein catabolic process,91,0.443,0.0594,1,GO:0042177,BP,,966
organic acid transmembrane transport,93,0.557,0.0594,1,GO:1903825,BP,,967
central nervous system myelination,15,0.641,0.0594,1,"GO:0022010,GO:0032291",BP,axon ensheathment in central nervous system,968
late endosome,197,0.461,0.0595,1,GO:0005770,CC,,969
negative regulation of sodium ion transport,13,0.349,0.0595,1,GO:0010766,BP,,970
behavioral response to cocaine,13,0.349,0.0595,1,GO:0048148,BP,,971
cofactor catabolic process,17,0.368,0.0595,1,GO:0051187,BP,,972
cristae formation,11,0.336,0.0596,1,GO:0042407,BP,,973
beta-catenin binding,76,0.563,0.0598,1,GO:0008013,MF,,974
pharyngeal system development,23,0.613,0.0599,1,GO:0060037,BP,,975
retina development in camera-type eye,125,0.451,0.0599,1,GO:0060041,BP,,976
spindle organization,131,0.548,0.06,1,GO:0007051,BP,,977
modulation by host of viral transcription,20,0.621,0.06,1,"GO:0043921,GO:0052472",BP,modulation by host of symbiont transcription,978
positive regulation of mitophagy,20,0.379,0.0603,1,GO:1903599,BP,,979
regulation of glomerulus development,12,0.657,0.0604,1,GO:0090192,BP,,980
myosin filament organization,14,0.355,0.0604,1,GO:0031033,BP,,981
1-phosphatidylinositol-3-kinase activity,38,0.588,0.0604,1,GO:0016303,MF,,982
glycoside metabolic process,14,0.355,0.0606,1,GO:0016137,BP,,983
negative regulation of gene silencing by miRNA,10,0.671,0.0606,1,GO:0060965,BP,,984
regulation of pathway-restricted SMAD protein phosphorylation,49,0.578,0.0607,1,GO:0060393,BP,,985
G-protein coupled acetylcholine receptor signaling pathway,16,0.365,0.0608,1,GO:0007213,BP,,986
dsRNA fragmentation,33,0.594,0.0608,1,"GO:0031050,GO:0070918",BP,production of small RNA involved in gene silencing by RNA,987
L-glutamate transport,22,0.385,0.0609,1,GO:0015813,BP,,988
chemokine receptor binding,37,0.589,0.0609,1,GO:0042379,MF,,989
RNA methylation,51,0.576,0.0611,1,GO:0001510,BP,,990
positive regulation of sequestering of calcium ion,14,0.355,0.0611,1,GO:0051284,BP,,991
endonucleolytic cleavage involved in rRNA processing,12,0.656,0.0614,1,"GO:0000478,GO:0000479",BP,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",992
G-protein coupled glutamate receptor signaling pathway,13,0.35,0.0616,1,GO:0007216,BP,,993
"wound healing, spreading of epidermal cells",12,0.656,0.0616,1,GO:0035313,BP,,994
"positive regulation of gene expression, epigenetic",57,0.572,0.0616,1,GO:0045815,BP,,995
regulation of p38MAPK cascade,25,0.608,0.0617,1,GO:1900744,BP,,996
vitamin biosynthetic process,19,0.376,0.0618,1,GO:0009110,BP,,997
embryonic hemopoiesis,17,0.631,0.0618,1,GO:0035162,BP,,998
regulation of synaptic vesicle transport,38,0.412,0.0618,1,GO:1902803,BP,,999
cerebellar granular layer development,12,0.344,0.0619,1,GO:0021681,BP,,1000
histone H3-K9 acetylation,10,0.67,0.0619,1,GO:0043970,BP,,1001
cysteine-type endopeptidase inhibitor activity,41,0.584,0.0622,1,GO:0004869,MF,,1002
production of miRNAs involved in gene silencing by miRNA,32,0.595,0.0623,1,GO:0035196,BP,,1003
phosphatidylinositol phosphate phosphatase activity,28,0.602,0.0623,1,GO:0052866,MF,,1004
nuclear pore organization,15,0.639,0.0623,1,GO:0006999,BP,,1005
positive regulation of sodium ion transmembrane transport,17,0.631,0.0623,1,GO:1902307,BP,,1006
blastocyst growth,14,0.356,0.0625,1,GO:0001832,BP,,1007
lysosomal lumen,82,0.44,0.0625,1,GO:0043202,CC,,1008
regulation of transporter activity,192,0.461,0.0626,1,GO:0032409,BP,,1009
regulation of microtubule-based process,143,0.545,0.0626,1,GO:0032886,BP,,1010
natural killer cell activation involved in immune response,12,0.655,0.0628,1,GO:0002323,BP,,1011
negative regulation of purine nucleotide metabolic process,55,0.427,0.0628,1,GO:1900543,BP,,1012
lysosome localization,57,0.429,0.0628,1,GO:0032418,BP,,1013
negative regulation of transcription regulatory region DNA binding,17,0.37,0.0628,1,GO:2000678,BP,,1014
regulation of smooth muscle cell migration,49,0.577,0.0629,1,GO:0014910,BP,,1015
regulation of catenin import into nucleus,22,0.386,0.0631,1,GO:0035412,BP,,1016
copper ion homeostasis,14,0.357,0.0634,1,GO:0055070,BP,,1017
negative regulation of posttranscriptional gene silencing,11,0.662,0.0634,1,"GO:0060149,GO:0060967",BP,negative regulation of gene silencing by RNA,1018
phospholipid translocation,21,0.617,0.0635,1,GO:0045332,BP,,1019
ligase activity,160,0.457,0.0637,1,GO:0016874,MF,,1020
RNA polymerase III activity,12,0.345,0.0637,1,GO:0001056,MF,,1021
tumor necrosis factor receptor superfamily binding,35,0.591,0.0638,1,GO:0032813,MF,,1022
cellular response to inorganic substance,152,0.456,0.0639,1,GO:0071241,BP,,1023
cytokine secretion involved in immune response,12,0.346,0.0639,1,GO:0002374,BP,,1024
membrane biogenesis,32,0.405,0.064,1,GO:0044091,BP,,1025
embryonic heart tube morphogenesis,58,0.57,0.064,1,GO:0003143,BP,,1026
response to dietary excess,19,0.623,0.0641,1,GO:0002021,BP,,1027
mRNA 3'-UTR binding,55,0.572,0.0642,1,GO:0003730,MF,,1028
response to estradiol,106,0.552,0.0645,1,GO:0032355,BP,,1029
tethering complex,60,0.431,0.0646,1,GO:0099023,CC,,1030
negative regulation of cell cycle phase transition,183,0.46,0.0648,1,GO:1901988,BP,,1031
pyridoxal phosphate binding,48,0.423,0.065,1,"GO:0030170,GO:0070279",MF,vitamin B6 binding,1032
neurotransmitter:sodium symporter activity,17,0.629,0.065,1,GO:0005328,MF,,1033
negative regulation of receptor binding,11,0.661,0.0651,1,GO:1900121,BP,,1034
NIK/NF-kappaB signaling,108,0.449,0.0655,1,GO:0038061,BP,,1035
actin-mediated cell contraction,90,0.444,0.0657,1,GO:0070252,BP,,1036
regulation of NIK/NF-kappaB signaling,46,0.578,0.0658,1,GO:1901222,BP,,1037
toxin transport,32,0.406,0.0658,1,GO:1901998,BP,,1038
negative regulation of protein polymerization,54,0.428,0.0659,1,GO:0032272,BP,,1039
secretory granule organization,28,0.4,0.0659,1,GO:0033363,BP,,1040
"oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor",10,0.332,0.066,1,GO:0016671,MF,,1041
regulation of PERK-mediated unfolded protein response,10,0.668,0.0661,1,GO:1903897,BP,,1042
negative regulation of nucleotide metabolic process,56,0.429,0.0662,1,GO:0045980,BP,,1043
somitogenesis,53,0.573,0.0662,1,GO:0001756,BP,,1044
phosphatidylinositol biosynthetic process,123,0.548,0.0663,1,GO:0006661,BP,,1045
acrosomal membrane,19,0.622,0.0663,1,GO:0002080,CC,,1046
purine nucleoside monophosphate biosynthetic process,65,0.434,0.0664,1,"GO:0009127,GO:0009168",BP,purine ribonucleoside monophosphate biosynthetic process,1047
histone acetylation,129,0.547,0.0664,1,GO:0016573,BP,,1048
poly-purine tract binding,16,0.633,0.0665,1,GO:0070717,MF,,1049
nucleotide transmembrane transporter activity,15,0.637,0.0667,1,GO:0015215,MF,,1050
ESC/E(Z) complex,15,0.637,0.0667,1,GO:0035098,CC,,1051
regulation of cellular respiration,21,0.384,0.0667,1,GO:0043457,BP,,1052
L-glutamate transmembrane transport,13,0.353,0.0667,1,"GO:0089711,GO:0005313,GO:0015172",BP,"L-glutamate transmembrane transporter activity,acidic amino acid transmembrane transporter activity",1053
ATP hydrolysis coupled cation transmembrane transport,51,0.426,0.0669,1,GO:0099132,BP,,1054
nephron morphogenesis,67,0.565,0.067,1,GO:0072028,BP,,1055
sensory perception of pain,81,0.441,0.0675,1,GO:0019233,BP,,1056
chromatin silencing at rDNA,20,0.618,0.0675,1,GO:0000183,BP,,1057
nuclear heterochromatin,27,0.602,0.0678,1,GO:0005720,CC,,1058
ribosomal large subunit biogenesis,51,0.426,0.068,1,GO:0042273,BP,,1059
histone H3 deacetylation,19,0.621,0.0681,1,GO:0070932,BP,,1060
opsonin binding,11,0.659,0.0683,1,GO:0001846,MF,,1061
regulation of mammary gland epithelial cell proliferation,11,0.341,0.0683,1,GO:0033599,BP,,1062
cellular response to decreased oxygen levels,178,0.46,0.0685,1,GO:0036294,BP,,1063
magnesium ion binding,178,0.54,0.0685,1,GO:0000287,MF,,1064
regulation of establishment of protein localization to mitochondrion,109,0.449,0.0686,1,GO:1903747,BP,,1065
beta-tubulin binding,31,0.405,0.0686,1,GO:0048487,MF,,1066
immunoglobulin secretion,14,0.359,0.0686,1,GO:0048305,BP,,1067
thiol-dependent ubiquitin-specific protease activity,72,0.562,0.0686,1,GO:0004843,MF,,1068
regulation of stem cell population maintenance,19,0.621,0.069,1,GO:2000036,BP,,1069
"transcription factor activity, RNA polymerase II transcription factor binding",131,0.546,0.069,1,GO:0001076,MF,,1070
substantia nigra development,39,0.416,0.069,1,GO:0021762,BP,,1071
response to alcohol,158,0.458,0.0692,1,GO:0097305,BP,,1072
dolichol-linked oligosaccharide biosynthetic process,19,0.38,0.0692,1,GO:0006488,BP,,1073
positive regulation of mitotic cell cycle phase transition,52,0.427,0.0696,1,GO:1901992,BP,,1074
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,17,0.627,0.0698,1,GO:0016338,BP,,1075
CCR4-NOT complex,13,0.645,0.0699,1,GO:0030014,CC,,1076
bleb assembly,10,0.666,0.0699,1,GO:0032060,BP,,1077
presynaptic membrane,66,0.435,0.07,1,GO:0042734,CC,,1078
magnesium ion transport,17,0.627,0.0701,1,GO:0015693,BP,,1079
immunological synapse,31,0.406,0.0701,1,GO:0001772,CC,,1080
kidney mesenchyme development,16,0.631,0.0702,1,GO:0072074,BP,,1081
mRNA export from nucleus,95,0.554,0.0703,1,"GO:0006406,GO:0071427",BP,mRNA-containing ribonucleoprotein complex export from nucleus,1082
positive regulation of regulated secretory pathway,38,0.415,0.0704,1,GO:1903307,BP,,1083
cellular response to hypoxia,171,0.46,0.0707,1,GO:0071456,BP,,1084
anion homeostasis,33,0.591,0.0708,1,GO:0055081,BP,,1085
negative regulation of morphogenesis of an epithelium,16,0.63,0.0708,1,GO:1905331,BP,,1086
macromolecule transmembrane transporter activity,19,0.38,0.0709,1,GO:0022884,MF,,1087
angiogenesis involved in wound healing,17,0.627,0.0709,1,GO:0060055,BP,,1088
cellular response to prostaglandin E stimulus,15,0.365,0.071,1,GO:0071380,BP,,1089
pathway-restricted SMAD protein phosphorylation,52,0.572,0.071,1,GO:0060389,BP,,1090
meiotic chromosome segregation,67,0.564,0.0711,1,GO:0045132,BP,,1091
negative regulation of ryanodine-sensitive calcium-release channel activity,11,0.343,0.0713,1,GO:0060315,BP,,1092
very long-chain fatty acid-CoA ligase activity,10,0.335,0.0713,1,GO:0031957,MF,,1093
transcriptional repressor complex,76,0.56,0.0715,1,GO:0017053,CC,,1094
regulation of systemic arterial blood pressure by circulatory renin-angiotensin,13,0.644,0.0715,1,GO:0001991,BP,,1095
MHC class II protein complex,16,0.37,0.0715,1,GO:0042613,CC,,1096
steroid hormone receptor activity,52,0.572,0.0716,1,GO:0003707,MF,,1097
glial cell apoptotic process,14,0.639,0.0718,1,GO:0034349,BP,,1098
lipopolysaccharide-mediated signaling pathway,42,0.42,0.0719,1,GO:0031663,BP,,1099
regulation of toll-like receptor signaling pathway,42,0.42,0.072,1,GO:0034121,BP,,1100
regulation of microtubule cytoskeleton organization,122,0.547,0.0721,1,GO:0070507,BP,,1101
pronucleus,12,0.65,0.0721,1,GO:0045120,CC,,1102
positive regulation of leukocyte cell-cell adhesion,178,0.461,0.0722,1,GO:1903039,BP,,1103
response to toxic substance,187,0.462,0.0725,1,GO:0009636,BP,,1104
proximal/distal pattern formation,23,0.392,0.0725,1,GO:0009954,BP,,1105
activation of protein kinase B activity,25,0.396,0.0728,1,GO:0032148,BP,,1106
phosphatidylinositol phosphorylation,87,0.556,0.0728,1,GO:0046854,BP,,1107
cortical cytoskeleton organization,32,0.592,0.0728,1,GO:0030865,BP,,1108
integral component of nuclear inner membrane,12,0.65,0.0729,1,"GO:0005639,GO:0031229",CC,intrinsic component of nuclear inner membrane,1109
limbic system development,96,0.447,0.0729,1,GO:0021761,BP,,1110
"DNA-templated transcription, initiation",190,0.462,0.0729,1,GO:0006352,BP,,1111
protein insertion into mitochondrial membrane,29,0.404,0.0732,1,GO:0051204,BP,,1112
phosphatidylinositol-3-phosphate biosynthetic process,45,0.577,0.0734,1,GO:0036092,BP,,1113
Golgi stack,115,0.452,0.0737,1,GO:0005795,CC,,1114
regulation of protein import into nucleus,151,0.458,0.074,1,GO:0042306,BP,,1115
negative regulation of mitotic cell cycle phase transition,178,0.461,0.0741,1,GO:1901991,BP,,1116
filamin binding,13,0.357,0.0742,1,GO:0031005,MF,,1117
DNA integrity checkpoint,139,0.544,0.0743,1,GO:0031570,BP,,1118
"mitochondrial electron transport, ubiquinol to cytochrome c",13,0.357,0.0743,1,GO:0006122,BP,,1119
multicellular organismal catabolic process,59,0.567,0.0745,1,GO:0044243,BP,,1120
scaffold protein binding,47,0.425,0.0745,1,GO:0097110,MF,,1121
heart looping,53,0.571,0.0751,1,GO:0001947,BP,,1122
clathrin coat,46,0.424,0.0751,1,GO:0030118,CC,,1123
carbonate dehydratase activity,11,0.655,0.0753,1,GO:0004089,MF,,1124
olfactory bulb interneuron differentiation,12,0.352,0.0754,1,GO:0021889,BP,,1125
positive regulation of glycoprotein biosynthetic process,16,0.628,0.0755,1,GO:0010560,BP,,1126
ribonucleoprotein complex export from nucleus,109,0.549,0.0755,1,GO:0071426,BP,,1127
protein tyrosine phosphatase activity,94,0.447,0.0756,1,GO:0004725,MF,,1128
Rab guanyl-nucleotide exchange factor activity,47,0.425,0.0757,1,GO:0017112,MF,,1129
lamin binding,15,0.632,0.0757,1,GO:0005521,MF,,1130
inflammatory response to antigenic stimulus,34,0.412,0.0759,1,GO:0002437,BP,,1131
positive regulation of execution phase of apoptosis,10,0.662,0.0759,1,GO:1900119,BP,,1132
peptidyl-threonine dephosphorylation,11,0.654,0.0765,1,GO:0035970,BP,,1133
male sex determination,13,0.642,0.0767,1,GO:0030238,BP,,1134
coenzyme A biosynthetic process,10,0.338,0.0767,1,GO:0015937,BP,,1135
ionotropic glutamate receptor binding,21,0.388,0.0767,1,GO:0035255,MF,,1136
Schwann cell differentiation,33,0.589,0.0768,1,GO:0014037,BP,,1137
regulation of AMPA receptor activity,19,0.383,0.0768,1,GO:2000311,BP,,1138
embryonic limb morphogenesis,101,0.551,0.077,1,"GO:0030326,GO:0035113",BP,embryonic appendage morphogenesis,1139
negative regulation of cyclic nucleotide biosynthetic process,33,0.411,0.077,1,GO:0030803,BP,,1140
regulation of neurotransmitter uptake,12,0.353,0.0772,1,GO:0051580,BP,,1141
positive regulation of protein complex disassembly,19,0.383,0.0772,1,GO:0043243,BP,,1142
sequestering of triglyceride,14,0.364,0.0772,1,GO:0030730,BP,,1143
skeletal muscle satellite cell proliferation,10,0.661,0.0773,1,GO:0014841,BP,,1144
lipid translocation,22,0.609,0.0774,1,GO:0034204,BP,,1145
extracellular matrix disassembly,70,0.561,0.0777,1,GO:0022617,BP,,1146
ER to Golgi vesicle-mediated transport,149,0.458,0.0777,1,GO:0006888,BP,,1147
oligosaccharide-lipid intermediate biosynthetic process,20,0.386,0.0779,1,GO:0006490,BP,,1148
serine/threonine protein kinase complex,76,0.559,0.078,1,GO:1902554,CC,,1149
nucleoside bisphosphate metabolic process,28,0.404,0.078,1,"GO:0033865,GO:0033875,GO:0034032",BP,"ribonucleoside bisphosphate metabolic process,purine nucleoside bisphosphate metabolic process",1150
positive regulation of transcription from RNA polymerase I promoter,18,0.62,0.078,1,GO:0045943,BP,,1151
positive regulation of signal transduction by p53 class mediator,16,0.627,0.0783,1,GO:1901798,BP,,1152
ectoderm development,15,0.631,0.0783,1,GO:0007398,BP,,1153
"energy coupled proton transport, down electrochemical gradient",24,0.396,0.0784,1,"GO:0015985,GO:0015986",BP,ATP synthesis coupled proton transport,1154
basal plasma membrane,28,0.596,0.0785,1,GO:0009925,CC,,1155
cellular response to oxygen levels,185,0.462,0.0787,1,GO:0071453,BP,,1156
neuron migration,124,0.454,0.0788,1,GO:0001764,BP,,1157
receptor serine/threonine kinase binding,14,0.636,0.0789,1,GO:0033612,MF,,1158
positive regulation of angiogenesis,106,0.549,0.0789,1,GO:0045766,BP,,1159
inositol phosphate biosynthetic process,18,0.38,0.079,1,GO:0032958,BP,,1160
mitotic nuclear envelope disassembly,38,0.582,0.0791,1,GO:0007077,BP,,1161
spliceosomal snRNP complex,54,0.431,0.0791,1,GO:0097525,CC,,1162
ER-associated misfolded protein catabolic process,11,0.347,0.0791,1,GO:0071712,BP,,1163
adenylyltransferase activity,23,0.606,0.0791,1,GO:0070566,MF,,1164
regulation of execution phase of apoptosis,17,0.623,0.0791,1,GO:1900117,BP,,1165
toll-like receptor 3 signaling pathway,15,0.369,0.0794,1,GO:0034138,BP,,1166
nucleotide transport,19,0.616,0.0795,1,GO:0006862,BP,,1167
vesicle coating,54,0.431,0.0796,1,GO:0006901,BP,,1168
RNA polymerase II core promoter sequence-specific DNA binding,50,0.572,0.0797,1,GO:0000979,MF,,1169
uropod,13,0.36,0.0797,1,"GO:0001931,GO:0031254",CC,cell trailing edge,1170
heparin binding,124,0.546,0.0798,1,GO:0008201,MF,,1171
response to activity,54,0.569,0.0798,1,GO:0014823,BP,,1172
"ATPase activity, coupled to movement of substances",111,0.548,0.0801,1,GO:0043492,MF,,1173
ribonucleoprotein complex localization,110,0.548,0.0801,1,GO:0071166,BP,,1174
peptide hormone processing,25,0.601,0.0802,1,GO:0016486,BP,,1175
forebrain generation of neurons,60,0.435,0.0803,1,GO:0021872,BP,,1176
negative regulation of protein tyrosine kinase activity,22,0.608,0.0803,1,GO:0061099,BP,,1177
positive regulation of nucleotide biosynthetic process,88,0.446,0.0808,1,"GO:0030810,GO:1900373",BP,positive regulation of purine nucleotide biosynthetic process,1178
negative regulation of epithelial cell apoptotic process,27,0.597,0.0808,1,GO:1904036,BP,,1179
protein folding in endoplasmic reticulum,13,0.36,0.0811,1,GO:0034975,BP,,1180
peptide antigen binding,24,0.603,0.0813,1,GO:0042605,MF,,1181
B cell differentiation,86,0.554,0.0814,1,GO:0030183,BP,,1182
positive regulation of neurotransmitter secretion,12,0.355,0.0816,1,GO:0001956,BP,,1183
nephric duct development,13,0.639,0.0819,1,GO:0072176,BP,,1184
negative regulation of cellular catabolic process,129,0.456,0.0819,1,GO:0031330,BP,,1185
antigen binding,52,0.57,0.082,1,GO:0003823,MF,,1186
cellular response to ATP,12,0.355,0.0823,1,GO:0071318,BP,,1187
developmental induction,26,0.598,0.0823,1,GO:0031128,BP,,1188
regulation of actin filament length,141,0.458,0.0824,1,GO:0030832,BP,,1189
sarcomere,161,0.46,0.0827,1,GO:0030017,CC,,1190
presynaptic process involved in chemical synaptic transmission,143,0.458,0.0828,1,GO:0099531,BP,,1191
regulation of release of cytochrome c from mitochondria,40,0.421,0.0828,1,GO:0090199,BP,,1192
muscle myosin complex,19,0.385,0.083,1,GO:0005859,CC,,1193
protein localization to Golgi apparatus,23,0.604,0.083,1,GO:0034067,BP,,1194
genitalia morphogenesis,10,0.658,0.0831,1,GO:0035112,BP,,1195
GABA receptor activity,17,0.379,0.0833,1,GO:0016917,MF,,1196
axoneme assembly,48,0.428,0.0836,1,GO:0035082,BP,,1197
positive regulation of histone methylation,29,0.593,0.0837,1,GO:0031062,BP,,1198
regulation of extracellular matrix organization,27,0.596,0.0837,1,GO:1903053,BP,,1199
pigment accumulation,10,0.342,0.0838,1,"GO:0043476,GO:0043482",BP,cellular pigment accumulation,1200
DNA packaging complex,59,0.565,0.0838,1,GO:0044815,CC,,1201
COPII-coated vesicle budding,56,0.433,0.0839,1,GO:0090114,BP,,1202
purinergic nucleotide receptor signaling pathway,14,0.367,0.0839,1,GO:0035590,BP,,1203
ventricular trabecula myocardium morphogenesis,15,0.629,0.0842,1,GO:0003222,BP,,1204
endocardial cushion development,36,0.583,0.0842,1,GO:0003197,BP,,1205
oxygen transporter activity,11,0.35,0.0843,1,GO:0005344,MF,,1206
isomerase activity,128,0.456,0.0844,1,GO:0016853,MF,,1207
organic acid:sodium symporter activity,21,0.609,0.0844,1,GO:0005343,MF,,1208
small nuclear ribonucleoprotein complex,61,0.436,0.0845,1,GO:0030532,CC,,1209
cell volume homeostasis,16,0.625,0.0846,1,GO:0006884,BP,,1210
sensory perception of taste,38,0.581,0.0847,1,GO:0050909,BP,,1211
"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides",76,0.557,0.0848,1,GO:0016811,MF,,1212
negative regulation of cAMP metabolic process,35,0.416,0.0848,1,GO:0030815,BP,,1213
melanosome organization,24,0.398,0.0848,1,GO:0032438,BP,,1214
glycine metabolic process,14,0.633,0.0848,1,GO:0006544,BP,,1215
regulation of cGMP biosynthetic process,19,0.386,0.0849,1,GO:0030826,BP,,1216
catecholamine transport,55,0.433,0.0853,1,GO:0051937,BP,,1217
neuron fate specification,20,0.611,0.0856,1,GO:0048665,BP,,1218
intrinsic component of mitochondrial membrane,52,0.431,0.0856,1,GO:0098573,CC,,1219
glycerophospholipid biosynthetic process,199,0.535,0.0857,1,GO:0046474,BP,,1220
vesicle fusion,138,0.458,0.0858,1,GO:0006906,BP,,1221
"positive regulation of protein localization to chromosome, telomeric region",10,0.343,0.0859,1,GO:1904816,BP,,1222
striated muscle myosin thick filament assembly,12,0.357,0.0862,1,GO:0071688,BP,,1223
regulation of telomere maintenance via telomere lengthening,45,0.426,0.0864,1,GO:1904356,BP,,1224
positive regulation of insulin secretion,54,0.433,0.0865,1,GO:0032024,BP,,1225
neurotransmitter secretion,134,0.457,0.0868,1,"GO:0007269,GO:0099643",BP,signal release from synapse,1226
inner dynein arm assembly,13,0.363,0.087,1,GO:0036159,BP,,1227
positive regulation of homeostatic process,176,0.462,0.087,1,GO:0032846,BP,,1228
phosphatidylinositol phosphate 5-phosphatase activity,12,0.643,0.087,1,GO:0034595,MF,,1229
RNA stem-loop binding,10,0.656,0.0875,1,GO:0035613,MF,,1230
vascular endothelial growth factor receptor binding,10,0.656,0.0877,1,GO:0005172,MF,,1231
positive regulation of protein complex assembly,195,0.464,0.0879,1,GO:0031334,BP,,1232
regulation of response to biotic stimulus,115,0.454,0.0882,1,GO:0002831,BP,,1233
3'-UTR-mediated mRNA destabilization,11,0.648,0.0886,1,GO:0061158,BP,,1234
negative regulation of cardiac muscle cell apoptotic process,13,0.636,0.0887,1,GO:0010667,BP,,1235
regulation of bicellular tight junction assembly,14,0.631,0.0888,1,GO:2000810,BP,,1236
positive regulation of NF-kappaB transcription factor activity,114,0.546,0.0888,1,GO:0051092,BP,,1237
regulation of vascular permeability,25,0.402,0.089,1,GO:0043114,BP,,1238
branching morphogenesis of an epithelial tube,132,0.543,0.0891,1,GO:0048754,BP,,1239
RNA polymerase II transcription corepressor activity,25,0.598,0.0892,1,GO:0001106,MF,,1240
regulation of amino acid transport,27,0.405,0.0893,1,GO:0051955,BP,,1241
negative regulation of toll-like receptor signaling pathway,24,0.4,0.0895,1,GO:0034122,BP,,1242
"vesicle targeting, rough ER to cis-Golgi",53,0.433,0.0895,1,"GO:0048207,GO:0048208",BP,COPII vesicle coating,1243
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,28,0.407,0.0899,1,GO:0001844,BP,,1244
meiotic cell cycle process,143,0.541,0.0901,1,GO:1903046,BP,,1245
organic hydroxy compound catabolic process,45,0.427,0.0901,1,GO:1901616,BP,,1246
neuropeptide receptor activity,34,0.416,0.0902,1,GO:0008188,MF,,1247
T-helper 1 type immune response,25,0.402,0.0903,1,GO:0042088,BP,,1248
response to fluid shear stress,32,0.587,0.0903,1,GO:0034405,BP,,1249
DNA-templated transcriptional preinitiation complex assembly,31,0.412,0.0904,1,GO:0070897,BP,,1250
regulation of acute inflammatory response to antigenic stimulus,12,0.359,0.0906,1,GO:0002864,BP,,1251
regulation of ATP metabolic process,50,0.431,0.0908,1,GO:1903578,BP,,1252
androgen receptor signaling pathway,63,0.562,0.0909,1,GO:0030521,BP,,1253
purine deoxyribonucleotide metabolic process,11,0.353,0.091,1,GO:0009151,BP,,1254
peptidyl-tyrosine dephosphorylation,93,0.449,0.091,1,GO:0035335,BP,,1255
lamellipodium membrane,18,0.615,0.0911,1,GO:0031258,CC,,1256
phosphatidylinositol 3-kinase activity,64,0.561,0.0911,1,GO:0035004,MF,,1257
protein N-linked glycosylation via asparagine,37,0.42,0.0911,1,GO:0018279,BP,,1258
regulation of epithelial to mesenchymal transition,66,0.56,0.0912,1,GO:0010717,BP,,1259
regulation of receptor activity,120,0.455,0.0912,1,GO:0010469,BP,,1260
UDP-galactosyltransferase activity,26,0.404,0.0913,1,GO:0035250,MF,,1261
nucleoside kinase activity,14,0.37,0.0914,1,GO:0019206,MF,,1262
SMN complex,11,0.353,0.0914,1,GO:0032797,CC,,1263
ESCRT III complex,10,0.346,0.0915,1,GO:0000815,CC,,1264
cell proliferation involved in kidney development,16,0.622,0.0916,1,GO:0072111,BP,,1265
embryonic cranial skeleton morphogenesis,42,0.575,0.0916,1,GO:0048701,BP,,1266
calcium-dependent phospholipid binding,37,0.42,0.0917,1,GO:0005544,MF,,1267
acid secretion,94,0.45,0.0924,1,GO:0046717,BP,,1268
vitamin binding,117,0.455,0.0928,1,GO:0019842,MF,,1269
pigmentation,87,0.448,0.0928,1,GO:0043473,BP,,1270
negative regulation of phagocytosis,12,0.36,0.0928,1,GO:0050765,BP,,1271
exoribonuclease activity,31,0.587,0.0929,1,GO:0004532,MF,,1272
phosphatidylinositol binding,196,0.535,0.093,1,GO:0035091,MF,,1273
collagen catabolic process,55,0.566,0.093,1,GO:0030574,BP,,1274
endoplasmic reticulum tubular network,15,0.375,0.0931,1,GO:0071782,CC,,1275
microtubule organizing center localization,23,0.601,0.0935,1,GO:0061842,BP,,1276
amino acid transmembrane transport,56,0.565,0.0936,1,GO:0003333,BP,,1277
"oxidoreductase activity, acting on the CH-NH group of donors",27,0.407,0.0937,1,GO:0016645,MF,,1278
organophosphate ester transmembrane transporter activity,17,0.617,0.0938,1,GO:0015605,MF,,1279
actin nucleation,43,0.426,0.0939,1,GO:0045010,BP,,1280
DNA-directed DNA polymerase activity,23,0.601,0.0942,1,GO:0003887,MF,,1281
tRNA methylation,22,0.603,0.0945,1,GO:0030488,BP,,1282
T cell proliferation,142,0.459,0.0945,1,GO:0042098,BP,,1283
positive regulation of T cell activation,170,0.463,0.0945,1,GO:0050870,BP,,1284
ATP-dependent helicase activity,89,0.551,0.0946,1,"GO:0008026,GO:0070035",MF,purine NTP-dependent helicase activity,1285
cellular response to ketone,78,0.555,0.0948,1,GO:1901655,BP,,1286
sulfur compound catabolic process,45,0.428,0.0949,1,GO:0044273,BP,,1287
cellular response to thyroid hormone stimulus,14,0.629,0.0949,1,GO:0097067,BP,,1288
protein tyrosine/serine/threonine phosphatase activity,39,0.423,0.095,1,GO:0008138,MF,,1289
positive regulation of cell cycle phase transition,59,0.437,0.0951,1,GO:1901989,BP,,1290
negative regulation of skeletal muscle tissue development,11,0.645,0.0953,1,GO:0048642,BP,,1291
ribosomal small subunit biogenesis,58,0.437,0.0958,1,GO:0042274,BP,,1292
metalloendopeptidase activity,90,0.551,0.0963,1,GO:0004222,MF,,1293
nucleosome assembly,88,0.551,0.0963,1,GO:0006334,BP,,1294
alpha-amino acid catabolic process,88,0.449,0.0965,1,GO:1901606,BP,,1295
mitogen-activated protein kinase binding,22,0.602,0.0966,1,GO:0051019,MF,,1296
adenine nucleotide transmembrane transporter activity,10,0.652,0.097,1,"GO:0000295,GO:0005346",MF,purine ribonucleotide transmembrane transporter activity,1297
protein K11-linked ubiquitination,21,0.395,0.097,1,GO:0070979,BP,,1298
acidic amino acid transport,24,0.402,0.0976,1,GO:0015800,BP,,1299
vitamin transport,25,0.596,0.0979,1,GO:0051180,BP,,1300
regulation of ion transmembrane transporter activity,177,0.464,0.098,1,GO:0032412,BP,,1301
desmosome,20,0.607,0.0982,1,GO:0030057,CC,,1302
spindle assembly,77,0.555,0.0986,1,GO:0051225,BP,,1303
glycosaminoglycan binding,162,0.538,0.0988,1,GO:0005539,MF,,1304
interstitial matrix,12,0.638,0.0988,1,GO:0005614,CC,,1305
T cell mediated cytotoxicity,24,0.597,0.0988,1,GO:0001913,BP,,1306
regulation of anion transmembrane transport,28,0.59,0.0989,1,GO:1903959,BP,,1307
morphogenesis of an epithelial fold,21,0.604,0.0989,1,GO:0060571,BP,,1308
regulation of systemic arterial blood pressure by renin-angiotensin,17,0.616,0.099,1,GO:0003081,BP,,1309
ER-nucleus signaling pathway,43,0.573,0.099,1,GO:0006984,BP,,1310
divalent inorganic cation transmembrane transporter activity,155,0.538,0.0991,1,GO:0072509,MF,,1311
nucleotide-sugar metabolic process,33,0.417,0.0994,1,GO:0009225,BP,,1312
"oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor",13,0.368,0.0995,1,GO:0016668,MF,,1313
potassium ion homeostasis,13,0.632,0.0995,1,GO:0055075,BP,,1314
stereocilium,35,0.58,0.0996,1,GO:0032420,CC,,1315
"DNA catabolic process, endonucleolytic",19,0.609,0.0996,1,GO:0000737,BP,,1316
cofactor transporter activity,16,0.619,0.0999,1,GO:0051184,MF,,1317
membrane lipid metabolic process,166,0.537,0.1,1,GO:0006643,BP,,1318
leading edge membrane,130,0.542,0.1,1,GO:0031256,CC,,1319
transcription initiation from RNA polymerase I promoter,30,0.413,0.1,1,GO:0006361,BP,,1320
late endosome membrane,101,0.453,0.1,1,GO:0031902,CC,,1321
K63-linked polyubiquitin binding,17,0.615,0.1,1,GO:0070530,MF,,1322
transcription elongation from RNA polymerase II promoter,84,0.448,0.101,1,GO:0006368,BP,,1323
positive regulation of cellular response to insulin stimulus,22,0.601,0.101,1,GO:1900078,BP,,1324
ammonium transport,81,0.447,0.101,1,GO:0015696,BP,,1325
regulation of protein kinase A signaling,20,0.606,0.101,1,GO:0010738,BP,,1326
regulation of guanylate cyclase activity,10,0.35,0.101,1,GO:0031282,BP,,1327
membrane assembly,28,0.41,0.101,1,GO:0071709,BP,,1328
positive regulation of peptide hormone secretion,66,0.442,0.101,1,GO:0090277,BP,,1329
regulation of cGMP metabolic process,25,0.405,0.101,1,GO:0030823,BP,,1330
regulation of phospholipid metabolic process,54,0.436,0.101,1,GO:1903725,BP,,1331
"transcriptional repressor activity, RNA polymerase II transcription factor binding",76,0.554,0.101,1,GO:0001191,MF,,1332
"regulation of mRNA splicing, via spliceosome",56,0.563,0.102,1,GO:0048024,BP,,1333
integral component of mitochondrial membrane,51,0.434,0.102,1,GO:0032592,CC,,1334
negative regulation of endocytosis,38,0.423,0.102,1,GO:0045806,BP,,1335
intracellular steroid hormone receptor signaling pathway,113,0.545,0.102,1,GO:0030518,BP,,1336
terpenoid biosynthetic process,11,0.358,0.102,1,GO:0016114,BP,,1337
mitotic spindle pole,11,0.642,0.102,1,GO:0097431,CC,,1338
cellular amino acid catabolic process,102,0.453,0.102,1,GO:0009063,BP,,1339
clathrin-coated vesicle membrane,102,0.453,0.102,1,GO:0030665,CC,,1340
memory,93,0.451,0.103,1,GO:0007613,BP,,1341
regulation of organic acid transport,44,0.429,0.103,1,GO:0032890,BP,,1342
protein acylation,184,0.535,0.103,1,GO:0043543,BP,,1343
neuropeptide hormone activity,25,0.406,0.103,1,GO:0005184,MF,,1344
negative regulation of sodium ion transmembrane transporter activity,10,0.351,0.103,1,GO:2000650,BP,,1345
Golgi transport complex,12,0.364,0.103,1,GO:0017119,CC,,1346
endothelial cell differentiation,84,0.552,0.103,1,GO:0045446,BP,,1347
striated muscle cell development,120,0.457,0.103,1,GO:0055002,BP,,1348
respiratory burst,23,0.402,0.103,1,GO:0045730,BP,,1349
positive regulation of type I interferon production,64,0.441,0.103,1,GO:0032481,BP,,1350
chromosome organization involved in meiotic cell cycle,51,0.566,0.104,1,GO:0070192,BP,,1351
euchromatin,27,0.591,0.104,1,GO:0000791,CC,,1352
cellular component disassembly involved in execution phase of apoptosis,25,0.594,0.104,1,GO:0006921,BP,,1353
neuropeptide signaling pathway,79,0.447,0.104,1,GO:0007218,BP,,1354
regulation of reproductive process,97,0.548,0.104,1,GO:2000241,BP,,1355
acetylgalactosaminyltransferase activity,32,0.417,0.104,1,GO:0008376,MF,,1356
regulation of T cell proliferation,118,0.457,0.104,1,GO:0042129,BP,,1357
determination of heart left/right asymmetry,57,0.562,0.104,1,GO:0061371,BP,,1358
segmentation,78,0.553,0.104,1,GO:0035282,BP,,1359
calcium ion-regulated exocytosis of neurotransmitter,28,0.411,0.104,1,GO:0048791,BP,,1360
establishment of protein localization to Golgi,17,0.614,0.105,1,GO:0072600,BP,,1361
"proton-transporting two-sector ATPase complex, catalytic domain",16,0.383,0.105,1,GO:0033178,CC,,1362
positive regulation of T cell proliferation,72,0.445,0.105,1,GO:0042102,BP,,1363
biological phase,11,0.359,0.105,1,GO:0044848,BP,,1364
negative regulation of mononuclear cell proliferation,55,0.437,0.105,1,"GO:0032945,GO:0050672",BP,negative regulation of lymphocyte proliferation,1365
regulation of telomere maintenance,60,0.439,0.105,1,GO:0032204,BP,,1366
mesenchymal cell apoptotic process,10,0.648,0.105,1,GO:0097152,BP,,1367
positive regulation of cGMP metabolic process,19,0.393,0.105,1,GO:0030825,BP,,1368
intracellular mRNA localization,11,0.641,0.105,1,GO:0008298,BP,,1369
very-low-density lipoprotein particle,12,0.365,0.105,1,"GO:0034361,GO:0034385",CC,triglyceride-rich plasma lipoprotein particle,1370
arylsulfatase activity,10,0.352,0.105,1,GO:0004065,MF,,1371
negative regulation of DNA replication,30,0.415,0.105,1,GO:0008156,BP,,1372
"synaptic transmission, cholinergic",31,0.416,0.106,1,GO:0007271,BP,,1373
peptidyl-asparagine modification,38,0.424,0.106,1,GO:0018196,BP,,1374
organelle membrane fusion,143,0.461,0.106,1,GO:0090174,BP,,1375
negative regulation of muscle cell differentiation,52,0.565,0.106,1,GO:0051148,BP,,1376
AP-type membrane coat adaptor complex,42,0.428,0.106,1,GO:0030119,CC,,1377
regulation of calcium ion-dependent exocytosis,64,0.442,0.107,1,GO:0017158,BP,,1378
ribosome assembly,47,0.432,0.107,1,GO:0042255,BP,,1379
regulation of mitochondrial membrane permeability involved in apoptotic process,56,0.438,0.107,1,GO:1902108,BP,,1380
detection of mechanical stimulus involved in sensory perception,23,0.597,0.107,1,GO:0050974,BP,,1381
hexose catabolic process,46,0.431,0.107,1,GO:0019320,BP,,1382
regulation of long-term neuronal synaptic plasticity,23,0.403,0.107,1,GO:0048169,BP,,1383
Golgi cisterna membrane,70,0.444,0.107,1,GO:0032580,CC,,1384
regulation of mRNA processing,85,0.551,0.107,1,GO:0050684,BP,,1385
carboxylic acid transmembrane transporter activity,107,0.545,0.107,1,GO:0046943,MF,,1386
regulation of sensory perception of pain,26,0.409,0.108,1,"GO:0051930,GO:0051931",BP,regulation of sensory perception,1387
cellular response to alcohol,47,0.432,0.108,1,GO:0097306,BP,,1388
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,27,0.411,0.108,1,"GO:1900739,GO:1900740",BP,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,1389
posttranscriptional gene silencing,62,0.559,0.108,1,GO:0016441,BP,,1390
iron coordination entity transport,10,0.647,0.108,1,GO:1901678,BP,,1391
positive regulation of hormone metabolic process,10,0.647,0.108,1,GO:0032352,BP,,1392
regulation of protein localization to nucleus,194,0.466,0.108,1,GO:1900180,BP,,1393
positive regulation of monooxygenase activity,23,0.403,0.109,1,GO:0032770,BP,,1394
negative regulation of astrocyte differentiation,11,0.36,0.109,1,GO:0048712,BP,,1395
RNA helicase activity,60,0.56,0.109,1,GO:0003724,MF,,1396
syncytium formation,41,0.572,0.109,1,GO:0006949,BP,,1397
hydrogen ion transmembrane transporter activity,93,0.452,0.11,1,GO:0015078,MF,,1398
regulation of inflammatory response to antigenic stimulus,18,0.391,0.11,1,GO:0002861,BP,,1399
detection of mechanical stimulus involved in sensory perception of sound,11,0.639,0.11,1,GO:0050910,BP,,1400
detection of mechanical stimulus,37,0.576,0.11,1,GO:0050982,BP,,1401
regulation of nuclear cell cycle DNA replication,13,0.372,0.111,1,GO:0033262,BP,,1402
actin filament network formation,10,0.354,0.111,1,GO:0051639,BP,,1403
fibroblast apoptotic process,16,0.615,0.111,1,GO:0044346,BP,,1404
NAD biosynthesis via nicotinamide riboside salvage pathway,13,0.628,0.111,1,GO:0034356,BP,,1405
steroid binding,69,0.555,0.111,1,GO:0005496,MF,,1406
solute:sodium symporter activity,40,0.573,0.111,1,GO:0015370,MF,,1407
translation initiation factor binding,25,0.408,0.111,1,GO:0031369,MF,,1408
"regulation of DNA-templated transcription, initiation",30,0.416,0.112,1,GO:2000142,BP,,1409
reflex,16,0.615,0.112,1,GO:0060004,BP,,1410
execution phase of apoptosis,70,0.555,0.112,1,GO:0097194,BP,,1411
protein transmembrane transporter activity,16,0.385,0.112,1,GO:0008320,MF,,1412
prepulse inhibition,13,0.373,0.112,1,GO:0060134,BP,,1413
RNA-dependent ATPase activity,60,0.559,0.112,1,GO:0008186,MF,,1414
centriole replication,26,0.59,0.112,1,GO:0007099,BP,,1415
positive regulation of membrane permeability,54,0.437,0.112,1,GO:1905710,BP,,1416
monosaccharide catabolic process,55,0.438,0.112,1,GO:0046365,BP,,1417
cellular response to interleukin-6,23,0.596,0.112,1,GO:0071354,BP,,1418
cell aggregation,16,0.385,0.113,1,GO:0098743,BP,,1419
platelet alpha granule lumen,56,0.439,0.113,1,GO:0031093,CC,,1420
regulation of histone H3-K9 methylation,19,0.605,0.113,1,GO:0051570,BP,,1421
cellular response to dsRNA,48,0.566,0.113,1,GO:0071359,BP,,1422
COPI-coated vesicle,22,0.402,0.113,1,GO:0030137,CC,,1423
cellular component maintenance,27,0.412,0.113,1,GO:0043954,BP,,1424
intermediate filament-based process,35,0.577,0.114,1,"GO:0045103,GO:0045104",BP,intermediate filament cytoskeleton organization,1425
actin filament polymerization,136,0.461,0.114,1,GO:0030041,BP,,1426
dendritic cell differentiation,33,0.42,0.114,1,GO:0097028,BP,,1427
response to inactivity,12,0.632,0.114,1,GO:0014854,BP,,1428
"signal transducer, downstream of receptor, with serine/threonine kinase activity",84,0.55,0.114,1,GO:0004702,MF,,1429
smooth muscle cell migration,56,0.561,0.114,1,GO:0014909,BP,,1430
sodium ion transmembrane transporter activity,123,0.541,0.114,1,GO:0015081,MF,,1431
Rho guanyl-nucleotide exchange factor activity,76,0.552,0.114,1,GO:0005089,MF,,1432
protein-DNA complex,135,0.539,0.114,1,GO:0032993,CC,,1433
positive regulation of peptidyl-serine phosphorylation,70,0.445,0.114,1,GO:0033138,BP,,1434
regulation of transcription from RNA polymerase II promoter involved in heart development,11,0.637,0.114,1,GO:1901213,BP,,1435
transferrin transport,33,0.421,0.115,1,GO:0033572,BP,,1436
regulation of establishment of cell polarity,19,0.605,0.115,1,GO:2000114,BP,,1437
alkali metal ion binding,17,0.611,0.115,1,GO:0031420,MF,,1438
regulation of cAMP metabolic process,107,0.456,0.115,1,GO:0030814,BP,,1439
"oxidoreductase activity, acting on a sulfur group of donors",50,0.436,0.115,1,GO:0016667,MF,,1440
histone H3-K9 methylation,27,0.588,0.115,1,GO:0051567,BP,,1441
clathrin-coated endocytic vesicle membrane,48,0.434,0.115,1,GO:0030669,CC,,1442
response to thyroid hormone,21,0.599,0.115,1,GO:0097066,BP,,1443
negative regulation of cell cycle G1/S phase transition,85,0.549,0.115,1,GO:1902807,BP,,1444
global genome nucleotide-excision repair,29,0.416,0.115,1,GO:0070911,BP,,1445
regulation of leukocyte degranulation,32,0.42,0.116,1,GO:0043300,BP,,1446
ESCRT complex,23,0.405,0.116,1,GO:0036452,CC,,1447
regulation of neurotransmitter transport,61,0.442,0.116,1,GO:0051588,BP,,1448
positive regulation of neuron death,60,0.441,0.116,1,GO:1901216,BP,,1449
regulation of viral entry into host cell,25,0.591,0.116,1,GO:0046596,BP,,1450
postsynaptic membrane organization,29,0.416,0.116,1,GO:0001941,BP,,1451
regulation of transcription from RNA polymerase II promoter in response to oxidative stress,11,0.637,0.116,1,GO:0043619,BP,,1452
regulation of long-term synaptic potentiation,20,0.398,0.116,1,GO:1900271,BP,,1453
histone lysine methylation,89,0.548,0.116,1,GO:0034968,BP,,1454
lymphocyte costimulation,62,0.442,0.116,1,"GO:0031294,GO:0031295",BP,T cell costimulation,1455
negative regulation of intracellular protein transport,80,0.449,0.117,1,GO:0090317,BP,,1456
excitatory synapse,25,0.409,0.117,1,GO:0060076,CC,,1457
negative regulation of intracellular estrogen receptor signaling pathway,10,0.643,0.117,1,GO:0033147,BP,,1458
histone H4-K16 acetylation,18,0.607,0.117,1,GO:0043984,BP,,1459
channel regulator activity,118,0.458,0.117,1,GO:0016247,MF,,1460
nuclear export,174,0.534,0.118,1,GO:0051168,BP,,1461
mitochondrial fusion,21,0.401,0.118,1,GO:0008053,BP,,1462
aerobic respiration,59,0.441,0.118,1,GO:0009060,BP,,1463
mitochondrial outer membrane permeabilization,50,0.436,0.118,1,GO:0097345,BP,,1464
regulation of filopodium assembly,39,0.428,0.118,1,GO:0051489,BP,,1465
negative regulation of G1/S transition of mitotic cell cycle,83,0.55,0.118,1,GO:2000134,BP,,1466
axonemal dynein complex assembly,26,0.411,0.118,1,GO:0070286,BP,,1467
neuromuscular process controlling posture,15,0.617,0.118,1,GO:0050884,BP,,1468
purine nucleotide transmembrane transporter activity,11,0.636,0.118,1,GO:0015216,MF,,1469
vitamin transporter activity,18,0.606,0.118,1,GO:0051183,MF,,1470
positive regulation of mitochondrial membrane permeability involved in apoptotic process,51,0.437,0.118,1,"GO:1902110,GO:1902686",BP,mitochondrial outer membrane permeabilization involved in programmed cell death,1471
myeloid dendritic cell activation,21,0.402,0.118,1,GO:0001773,BP,,1472
regulation of morphogenesis of a branching structure,47,0.566,0.119,1,GO:0060688,BP,,1473
protein tetramerization,111,0.457,0.119,1,GO:0051262,BP,,1474
carbohydrate transport,153,0.537,0.119,1,GO:0008643,BP,,1475
hemoglobin metabolic process,11,0.636,0.119,1,GO:0020027,BP,,1476
cation-transporting ATPase complex,11,0.636,0.119,1,GO:0090533,CC,,1477
skeletal muscle tissue development,130,0.54,0.119,1,GO:0007519,BP,,1478
positive regulation of endothelial cell differentiation,14,0.62,0.119,1,GO:0045603,BP,,1479
positive regulation of glycoprotein metabolic process,17,0.609,0.119,1,GO:1903020,BP,,1480
cytoskeleton-dependent cytokinesis,41,0.57,0.12,1,GO:0061640,BP,,1481
artery morphogenesis,52,0.562,0.12,1,GO:0048844,BP,,1482
regulation of production of small RNA involved in gene silencing by RNA,15,0.616,0.12,1,GO:0070920,BP,,1483
nephron epithelium morphogenesis,65,0.556,0.12,1,GO:0072088,BP,,1484
GDP-dissociation inhibitor activity,13,0.376,0.12,1,GO:0005092,MF,,1485
NAD-dependent histone deacetylase activity,14,0.62,0.12,1,"GO:0017136,GO:0034979",MF,NAD-dependent protein deacetylase activity,1486
ephrin receptor signaling pathway,83,0.451,0.121,1,GO:0048013,BP,,1487
integral component of synaptic vesicle membrane,14,0.38,0.121,1,GO:0030285,CC,,1488
thymocyte apoptotic process,15,0.616,0.121,1,GO:0070242,BP,,1489
apoptotic nuclear changes,23,0.593,0.121,1,GO:0030262,BP,,1490
negative regulation of microtubule polymerization,10,0.358,0.121,1,GO:0031115,BP,,1491
single-organism membrane fusion,177,0.466,0.121,1,GO:0044801,BP,,1492
positive regulation of receptor recycling,14,0.62,0.121,1,GO:0001921,BP,,1493
regulation of production of miRNAs involved in gene silencing by miRNA,14,0.62,0.121,1,GO:1903798,BP,,1494
positive regulation of hormone secretion,93,0.453,0.121,1,GO:0046887,BP,,1495
negative regulation of glucose import,11,0.365,0.121,1,GO:0046325,BP,,1496
internal peptidyl-lysine acetylation,132,0.539,0.121,1,GO:0018393,BP,,1497
peptide cross-linking,30,0.582,0.122,1,GO:0018149,BP,,1498
negative regulation of calcium ion transmembrane transport,28,0.415,0.122,1,GO:1903170,BP,,1499
regulation of actin filament polymerization,122,0.459,0.122,1,GO:0030833,BP,,1500
keratan sulfate biosynthetic process,26,0.412,0.122,1,GO:0018146,BP,,1501
forebrain neuron differentiation,53,0.439,0.123,1,GO:0021879,BP,,1502
negative regulation of protein serine/threonine kinase activity,112,0.458,0.123,1,GO:0071901,BP,,1503
renal tubule morphogenesis,68,0.554,0.123,1,GO:0061333,BP,,1504
cerebellar cortex development,46,0.434,0.123,1,GO:0021695,BP,,1505
"RNA phosphodiester bond hydrolysis, exonucleolytic",33,0.578,0.123,1,GO:0090503,BP,,1506
cellular defense response,37,0.427,0.123,1,GO:0006968,BP,,1507
gap junction assembly,11,0.634,0.123,1,GO:0016264,BP,,1508
negative regulation of cell junction assembly,20,0.6,0.123,1,GO:1901889,BP,,1509
ubiquitin-like protein-specific protease activity,102,0.544,0.123,1,GO:0019783,MF,,1510
reproductive behavior,29,0.417,0.124,1,GO:0019098,BP,,1511
channel inhibitor activity,33,0.423,0.124,1,GO:0016248,MF,,1512
negative regulation of reproductive process,38,0.572,0.124,1,GO:2000242,BP,,1513
chaperone binding,80,0.45,0.124,1,GO:0051087,MF,,1514
cellular response to lipopolysaccharide,121,0.459,0.125,1,GO:0071222,BP,,1515
adaptive thermogenesis,10,0.64,0.125,1,GO:1990845,BP,,1516
metanephric renal vesicle morphogenesis,14,0.619,0.125,1,GO:0072283,BP,,1517
negative regulation of calcium ion transport,45,0.434,0.125,1,GO:0051926,BP,,1518
regulation of defense response to virus,73,0.448,0.125,1,GO:0050688,BP,,1519
post-embryonic animal morphogenesis,10,0.64,0.125,1,GO:0009886,BP,,1520
termination of RNA polymerase I transcription,27,0.415,0.126,1,GO:0006363,BP,,1521
regulation of sequestering of triglyceride,11,0.367,0.126,1,GO:0010889,BP,,1522
negative regulation of glial cell differentiation,22,0.406,0.126,1,GO:0045686,BP,,1523
P granule,13,0.378,0.126,1,"GO:0043186,GO:0045495,GO:0060293",CC,"pole plasm,germ plasm",1524
hepaticobiliary system development,120,0.54,0.127,1,GO:0061008,BP,,1525
positive regulation of alcohol biosynthetic process,17,0.393,0.127,1,GO:1902932,BP,,1526
glycoprotein binding,89,0.453,0.127,1,GO:0001948,MF,,1527
negative regulation of muscle contraction,21,0.404,0.127,1,GO:0045932,BP,,1528
positive regulation of cell-cell adhesion,200,0.469,0.127,1,GO:0022409,BP,,1529
"phototransduction, visible light",30,0.419,0.127,1,GO:0007603,BP,,1530
regulation of animal organ formation,29,0.582,0.127,1,GO:0003156,BP,,1531
regulation of high voltage-gated calcium channel activity,10,0.361,0.127,1,GO:1901841,BP,,1532
tRNA aminoacylation for protein translation,43,0.433,0.128,1,GO:0006418,BP,,1533
miRNA mediated inhibition of translation,12,0.627,0.128,1,"GO:0035278,GO:0040033,GO:0045974",BP,"negative regulation of translation, ncRNA-mediated,regulation of translation, ncRNA-mediated",1534
positive regulation of Ras protein signal transduction,37,0.428,0.128,1,GO:0046579,BP,,1535
fibroblast growth factor receptor binding,21,0.596,0.128,1,GO:0005104,MF,,1536
organic acid transmembrane transporter activity,113,0.541,0.129,1,GO:0005342,MF,,1537
positive regulation of cyclase activity,54,0.44,0.129,1,GO:0031281,BP,,1538
calcium ion transmembrane transporter activity,119,0.54,0.129,1,GO:0015085,MF,,1539
positive regulation of mitochondrial fission,14,0.383,0.129,1,GO:0090141,BP,,1540
regulation of actin filament depolymerization,42,0.432,0.129,1,GO:0030834,BP,,1541
SUMO transferase activity,14,0.617,0.129,1,GO:0019789,MF,,1542
response to interleukin-6,26,0.586,0.129,1,GO:0070741,BP,,1543
regulation of branching involved in ureteric bud morphogenesis,20,0.598,0.129,1,GO:0090189,BP,,1544
regulation of endothelial cell apoptotic process,32,0.577,0.129,1,GO:2000351,BP,,1545
cellular response to light stimulus,93,0.546,0.13,1,GO:0071482,BP,,1546
positive regulation of sprouting angiogenesis,13,0.621,0.13,1,GO:1903672,BP,,1547
regulation of mast cell activation,33,0.424,0.13,1,GO:0033003,BP,,1548
nose development,14,0.617,0.13,1,GO:0043584,BP,,1549
amine binding,11,0.368,0.13,1,"GO:0043176,GO:0051378",MF,serotonin binding,1550
neurotransmitter transporter activity,23,0.591,0.13,1,GO:0005326,MF,,1551
embryonic hindlimb morphogenesis,24,0.589,0.131,1,GO:0035116,BP,,1552
glutamate metabolic process,24,0.411,0.131,1,GO:0006536,BP,,1553
associative learning,69,0.447,0.131,1,GO:0008306,BP,,1554
rhodopsin mediated signaling pathway,25,0.413,0.131,1,GO:0016056,BP,,1555
cellular copper ion homeostasis,12,0.374,0.131,1,GO:0006878,BP,,1556
modulation of transcription in other organism involved in symbiotic interaction,21,0.595,0.132,1,GO:0052312,BP,,1557
nucleobase-containing compound transmembrane transporter activity,30,0.58,0.132,1,GO:0015932,MF,,1558
tyrosine phosphorylation of Stat1 protein,14,0.616,0.132,1,GO:0042508,BP,,1559
snoRNA binding,23,0.409,0.132,1,GO:0030515,MF,,1560
negative regulation of response to extracellular stimulus,11,0.369,0.132,1,"GO:0032105,GO:0032108",BP,negative regulation of response to nutrient levels,1561
cartilage condensation,15,0.388,0.132,1,GO:0001502,BP,,1562
mitochondrial calcium ion transport,13,0.38,0.133,1,GO:0006851,BP,,1563
positive regulation of oxidative stress-induced cell death,12,0.625,0.133,1,GO:1903209,BP,,1564
sodium ion homeostasis,36,0.572,0.133,1,GO:0055078,BP,,1565
regulation of phagocytosis,54,0.441,0.133,1,GO:0050764,BP,,1566
preribosome,59,0.443,0.133,1,GO:0030684,CC,,1567
ISWI-type complex,10,0.637,0.134,1,GO:0031010,CC,,1568
positive regulation of lipid localization,61,0.444,0.134,1,GO:1905954,BP,,1569
posttranscriptional gene silencing by RNA,61,0.556,0.134,1,GO:0035194,BP,,1570
peptidyl-arginine methylation,12,0.375,0.134,1,GO:0018216,BP,,1571
ATP hydrolysis coupled anion transmembrane transport,11,0.631,0.134,1,"GO:0099133,GO:0043225",BP,ATPase-coupled anion transmembrane transporter activity,1572
regulation of heart growth,44,0.435,0.134,1,GO:0060420,BP,,1573
protein homotrimerization,23,0.41,0.134,1,GO:0070207,BP,,1574
dynein complex,43,0.434,0.134,1,GO:0030286,CC,,1575
histone H2A monoubiquitination,11,0.631,0.134,1,GO:0035518,BP,,1576
aminopeptidase activity,36,0.572,0.134,1,GO:0004177,MF,,1577
meiotic nuclear division,136,0.537,0.134,1,GO:0007126,BP,,1578
negative regulation of leukocyte proliferation,58,0.443,0.134,1,GO:0070664,BP,,1579
regulation of gonad development,13,0.62,0.134,1,GO:1905939,BP,,1580
structural constituent of eye lens,11,0.63,0.135,1,GO:0005212,MF,,1581
calcium channel activity,101,0.543,0.135,1,GO:0005262,MF,,1582
negative regulation of cAMP biosynthetic process,32,0.424,0.135,1,GO:0030818,BP,,1583
regulation of establishment or maintenance of cell polarity,21,0.594,0.135,1,GO:0032878,BP,,1584
positive regulation of vasculature development,120,0.54,0.135,1,GO:1904018,BP,,1585
positive regulation of calcium ion transport,85,0.453,0.135,1,GO:0051928,BP,,1586
activation of MAPK activity,128,0.462,0.136,1,GO:0000187,BP,,1587
bile acid biosynthetic process,28,0.582,0.136,1,GO:0006699,BP,,1588
positive regulation of T cell cytokine production,10,0.636,0.136,1,GO:0002726,BP,,1589
lateral mesoderm development,12,0.376,0.136,1,GO:0048368,BP,,1590
muscle atrophy,11,0.63,0.136,1,GO:0014889,BP,,1591
telomere capping,38,0.43,0.136,1,GO:0016233,BP,,1592
negative regulation of T cell apoptotic process,14,0.615,0.136,1,GO:0070233,BP,,1593
intrinsic apoptotic signaling pathway in response to oxidative stress,43,0.434,0.136,1,GO:0008631,BP,,1594
regulation of ventricular cardiac muscle cell action potential,13,0.619,0.136,1,GO:0098911,BP,,1595
response to interferon-alpha,14,0.615,0.136,1,GO:0035455,BP,,1596
hepatocyte apoptotic process,12,0.624,0.137,1,GO:0097284,BP,,1597
protein ADP-ribosylation,20,0.596,0.137,1,GO:0006471,BP,,1598
unsaturated fatty acid metabolic process,80,0.452,0.137,1,GO:0033559,BP,,1599
monocarboxylic acid binding,44,0.435,0.137,1,GO:0033293,MF,,1600
regulation of chromatin organization,134,0.537,0.137,1,GO:1902275,BP,,1601
muscle cell migration,66,0.553,0.137,1,GO:0014812,BP,,1602
nucleotide-excision repair,91,0.455,0.137,1,GO:0006289,BP,,1603
coated vesicle membrane,156,0.465,0.137,1,GO:0030662,CC,,1604
magnesium ion transmembrane transport,16,0.607,0.138,1,"GO:1903830,GO:0015095",BP,magnesium ion transmembrane transporter activity,1605
regulation of lymphocyte mediated immunity,90,0.545,0.138,1,GO:0002706,BP,,1606
RNA 3'-end processing,96,0.544,0.138,1,GO:0031123,BP,,1607
drug transport,24,0.587,0.138,1,GO:0015893,BP,,1608
protein acetylation,157,0.534,0.139,1,GO:0006473,BP,,1609
positive regulation of mRNA catabolic process,25,0.586,0.139,1,GO:0061014,BP,,1610
telomere cap complex,11,0.371,0.139,1,"GO:0000782,GO:0000783",CC,nuclear telomere cap complex,1611
carboxylic ester hydrolase activity,113,0.46,0.139,1,GO:0052689,MF,,1612
cell cycle checkpoint,190,0.531,0.139,1,GO:0000075,BP,,1613
somatic stem cell population maintenance,63,0.446,0.139,1,GO:0035019,BP,,1614
negative regulation of protein dephosphorylation,23,0.411,0.139,1,GO:0035308,BP,,1615
carbohydrate derivative transport,43,0.565,0.139,1,GO:1901264,BP,,1616
activation of MAPKKK activity,11,0.629,0.139,1,GO:0000185,BP,,1617
positive regulation of endothelial cell apoptotic process,13,0.618,0.139,1,GO:2000353,BP,,1618
calcium-mediated signaling,129,0.462,0.139,1,GO:0019722,BP,,1619
regulation of dendrite extension,19,0.402,0.139,1,GO:1903859,BP,,1620
co-SMAD binding,10,0.365,0.14,1,GO:0070410,MF,,1621
regulation of voltage-gated calcium channel activity,27,0.418,0.14,1,GO:1901385,BP,,1622
positive regulation of metanephros development,13,0.618,0.141,1,GO:0072216,BP,,1623
"proton-transporting ATP synthase activity, rotational mechanism",15,0.39,0.141,1,GO:0046933,MF,,1624
response to muscle inactivity,10,0.634,0.141,1,"GO:0014870,GO:0014877,GO:0014894",BP,"response to muscle inactivity involved in regulation of muscle adaptation,response to denervation involved in regulation of muscle adaptation",1625
telomerase holoenzyme complex,20,0.405,0.141,1,GO:0005697,CC,,1626
regulation of DNA-dependent DNA replication,42,0.434,0.142,1,GO:0090329,BP,,1627
positive regulation of T cell mediated immunity,24,0.587,0.142,1,GO:0002711,BP,,1628
amino sugar biosynthetic process,11,0.372,0.142,1,GO:0046349,BP,,1629
regulation of circadian sleep/wake cycle,17,0.603,0.142,1,GO:0042749,BP,,1630
regulation of acute inflammatory response,55,0.443,0.142,1,GO:0002673,BP,,1631
positive regulation of morphogenesis of an epithelium,26,0.583,0.142,1,GO:1905332,BP,,1632
cGMP biosynthetic process,36,0.429,0.142,1,GO:0006182,BP,,1633
"retrograde transport, endosome to plasma membrane",17,0.397,0.142,1,GO:1990126,BP,,1634
positive regulation of protein export from nucleus,19,0.597,0.142,1,GO:0046827,BP,,1635
regulation of proteasomal protein catabolic process,136,0.463,0.142,1,GO:0061136,BP,,1636
positive regulation of insulin secretion involved in cellular response to glucose stimulus,20,0.405,0.143,1,GO:0035774,BP,,1637
condensed nuclear chromosome,68,0.551,0.143,1,GO:0000794,CC,,1638
tRNA aminoacylation,46,0.438,0.143,1,GO:0043039,BP,,1639
regulation of synaptic vesicle recycling,14,0.387,0.143,1,GO:1903421,BP,,1640
megakaryocyte development,14,0.613,0.143,1,GO:0035855,BP,,1641
negative regulation of intracellular steroid hormone receptor signaling pathway,28,0.58,0.143,1,GO:0033144,BP,,1642
poly(U) RNA binding,16,0.606,0.143,1,GO:0008266,MF,,1643
vesicle targeting,68,0.449,0.143,1,GO:0006903,BP,,1644
nucleoside monophosphate biosynthetic process,83,0.453,0.144,1,GO:0009124,BP,,1645
positive regulation of dephosphorylation,43,0.436,0.144,1,GO:0035306,BP,,1646
heterochromatin organization,13,0.617,0.144,1,GO:0070828,BP,,1647
positive regulation of glial cell differentiation,27,0.581,0.144,1,GO:0045687,BP,,1648
transcription corepressor binding,10,0.633,0.144,1,GO:0001222,MF,,1649
positive regulation of DNA biosynthetic process,55,0.443,0.144,1,GO:2000573,BP,,1650
cysteine-type endopeptidase inhibitor activity involved in apoptotic process,21,0.592,0.145,1,GO:0043027,MF,,1651
protein disulfide oxidoreductase activity,19,0.403,0.145,1,GO:0015035,MF,,1652
regulation of thymocyte apoptotic process,11,0.627,0.145,1,GO:0070243,BP,,1653
positive regulation of macromitophagy in response to mitochondrial depolarization,10,0.367,0.145,1,"GO:0098779,GO:1901526",BP,positive regulation of macromitophagy,1654
methylated histone binding,47,0.561,0.145,1,GO:0035064,MF,,1655
inner ear receptor cell differentiation,49,0.56,0.146,1,GO:0060113,BP,,1656
respiratory system development,182,0.531,0.146,1,GO:0060541,BP,,1657
negative regulation of histone methylation,16,0.605,0.146,1,GO:0031061,BP,,1658
C2H2 zinc finger domain binding,12,0.621,0.146,1,GO:0070742,MF,,1659
axoneme,85,0.454,0.147,1,"GO:0005930,GO:0097014",CC,ciliary plasm,1660
tissue regeneration,49,0.56,0.147,1,GO:0042246,BP,,1661
skeletal muscle acetylcholine-gated channel clustering,10,0.368,0.147,1,GO:0071340,BP,,1662
catenin import into nucleus,24,0.414,0.147,1,GO:0035411,BP,,1663
heparan sulfate proteoglycan binding,17,0.398,0.147,1,GO:0043395,MF,,1664
heart growth,64,0.448,0.147,1,GO:0060419,BP,,1665
polysaccharide biosynthetic process,62,0.447,0.147,1,GO:0000271,BP,,1666
negative regulation of smooth muscle contraction,14,0.388,0.147,1,GO:0045986,BP,,1667
neural nucleus development,56,0.444,0.147,1,GO:0048857,BP,,1668
MHC class II receptor activity,10,0.368,0.147,1,GO:0032395,MF,,1669
nuclear envelope organization,77,0.548,0.147,1,GO:0006998,BP,,1670
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,18,0.401,0.147,1,GO:0010881,BP,,1671
negative regulation of gliogenesis,35,0.429,0.148,1,GO:0014014,BP,,1672
Seh1-associated complex,12,0.379,0.148,1,GO:0035859,CC,,1673
apoptotic process involved in development,26,0.582,0.148,1,GO:1902742,BP,,1674
central nervous system neuron differentiation,153,0.466,0.148,1,GO:0021953,BP,,1675
negative regulation of lymphocyte activation,101,0.458,0.148,1,GO:0051250,BP,,1676
syncytium formation by plasma membrane fusion,39,0.567,0.148,1,GO:0000768,BP,,1677
male meiosis I,11,0.374,0.148,1,GO:0007141,BP,,1678
cellular response to molecule of bacterial origin,127,0.463,0.149,1,GO:0071219,BP,,1679
"alternative mRNA splicing, via spliceosome",43,0.564,0.149,1,GO:0000380,BP,,1680
sphingolipid biosynthetic process,77,0.548,0.149,1,GO:0030148,BP,,1681
positive regulation of small GTPase mediated signal transduction,43,0.436,0.149,1,GO:0051057,BP,,1682
positive regulation of pathway-restricted SMAD protein phosphorylation,37,0.568,0.15,1,GO:0010862,BP,,1683
"DNA-directed RNA polymerase II, holoenzyme",85,0.455,0.15,1,GO:0016591,CC,,1684
positive regulation of mitochondrial membrane permeability,53,0.443,0.15,1,GO:0035794,BP,,1685
complement binding,14,0.611,0.15,1,GO:0001848,MF,,1686
cargo receptor activity,53,0.443,0.15,1,GO:0038024,MF,,1687
oligosaccharyltransferase complex,10,0.368,0.15,1,GO:0008250,CC,,1688
regulation of nuclear-transcribed mRNA poly(A) tail shortening,11,0.625,0.15,1,"GO:0060211,GO:0060213",BP,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,1689
protein binding involved in protein folding,22,0.411,0.15,1,GO:0044183,MF,,1690
cardiac muscle cell development,51,0.442,0.15,1,GO:0055013,BP,,1691
gene silencing by miRNA,57,0.555,0.15,1,GO:0035195,BP,,1692
regulation of membrane lipid distribution,33,0.572,0.15,1,GO:0097035,BP,,1693
regulation of cytoplasmic transport,19,0.405,0.15,1,GO:1903649,BP,,1694
regulation of superoxide anion generation,11,0.375,0.15,1,GO:0032928,BP,,1695
inner ear receptor stereocilium organization,24,0.585,0.15,1,GO:0060122,BP,,1696
negative regulation of mitochondrion organization,43,0.437,0.15,1,GO:0010823,BP,,1697
positive regulation of calcium ion import,43,0.437,0.151,1,GO:0090280,BP,,1698
protein export from nucleus,159,0.533,0.151,1,GO:0006611,BP,,1699
myosin II complex,25,0.417,0.152,1,GO:0016460,CC,,1700
insulin-like growth factor receptor signaling pathway,32,0.573,0.152,1,GO:0048009,BP,,1701
"vesicle targeting, to, from or within Golgi",57,0.445,0.152,1,GO:0048199,BP,,1702
somite development,70,0.55,0.152,1,GO:0061053,BP,,1703
neural crest cell migration,31,0.574,0.152,1,GO:0001755,BP,,1704
TORC1 signaling,24,0.416,0.152,1,GO:0038202,BP,,1705
neuronal cell body membrane,19,0.405,0.152,1,"GO:0032809,GO:0044298",CC,cell body membrane,1706
mammary gland epithelium development,57,0.445,0.152,1,GO:0061180,BP,,1707
aminoacyl-tRNA editing activity,12,0.381,0.152,1,GO:0002161,MF,,1708
protein stabilization,133,0.464,0.152,1,GO:0050821,BP,,1709
integral component of endoplasmic reticulum membrane,127,0.463,0.152,1,GO:0030176,CC,,1710
presynaptic active zone,32,0.427,0.153,1,GO:0048786,CC,,1711
spindle pole,122,0.538,0.153,1,GO:0000922,CC,,1712
response to topologically incorrect protein,173,0.468,0.153,1,GO:0035966,BP,,1713
cellular aldehyde metabolic process,81,0.454,0.154,1,GO:0006081,BP,,1714
insulin receptor substrate binding,11,0.624,0.154,1,GO:0043560,MF,,1715
response to copper ion,21,0.41,0.154,1,GO:0046688,BP,,1716
transcription elongation from RNA polymerase I promoter,27,0.421,0.154,1,GO:0006362,BP,,1717
gamma-catenin binding,10,0.63,0.154,1,GO:0045295,MF,,1718
nephron tubule morphogenesis,64,0.552,0.154,1,GO:0072078,BP,,1719
negative regulation of response to food,10,0.37,0.154,1,"GO:0032096,GO:0032099",BP,negative regulation of appetite,1720
regulation of necroptotic process,17,0.6,0.155,1,GO:0060544,BP,,1721
DNA-dependent DNA replication maintenance of fidelity,28,0.578,0.155,1,GO:0045005,BP,,1722
regulation of cytokine secretion,121,0.462,0.155,1,GO:0050707,BP,,1723
skeletal muscle fiber development,26,0.419,0.155,1,GO:0048741,BP,,1724
nerve development,64,0.551,0.155,1,GO:0021675,BP,,1725
3'-5'-exoribonuclease activity,27,0.579,0.155,1,GO:0000175,MF,,1726
positive regulation of mesenchymal cell proliferation,25,0.582,0.155,1,GO:0002053,BP,,1727
positive regulation of chemokine production,37,0.433,0.156,1,GO:0032722,BP,,1728
response to muramyl dipeptide,14,0.61,0.156,1,GO:0032495,BP,,1729
mitotic cytokinesis,33,0.571,0.156,1,GO:0000281,BP,,1730
"ATP-dependent microtubule motor activity, plus-end-directed",14,0.609,0.156,1,GO:0008574,MF,,1731
intracellular ligand-gated ion channel activity,24,0.584,0.156,1,GO:0005217,MF,,1732
monooxygenase activity,67,0.45,0.156,1,GO:0004497,MF,,1733
interleukin-1-mediated signaling pathway,14,0.609,0.157,1,GO:0070498,BP,,1734
dendrite morphogenesis,114,0.462,0.157,1,GO:0048813,BP,,1735
piRNA metabolic process,12,0.382,0.157,1,GO:0034587,BP,,1736
sex determination,21,0.589,0.157,1,GO:0007530,BP,,1737
glial cell development,80,0.546,0.157,1,GO:0021782,BP,,1738
positive regulation of cytokine secretion,80,0.454,0.158,1,GO:0050715,BP,,1739
phagocytic cup,18,0.404,0.158,1,GO:0001891,CC,,1740
cellular response to gonadotropin stimulus,16,0.602,0.158,1,GO:0071371,BP,,1741
regulation of ion homeostasis,172,0.469,0.159,1,GO:2000021,BP,,1742
nuclear-transcribed mRNA poly(A) tail shortening,32,0.572,0.159,1,GO:0000289,BP,,1743
hindlimb morphogenesis,29,0.576,0.159,1,GO:0035137,BP,,1744
exosomal secretion,17,0.401,0.159,1,GO:1990182,BP,,1745
telomere maintenance,119,0.463,0.159,1,GO:0000723,BP,,1746
error-free translesion synthesis,18,0.404,0.159,1,GO:0070987,BP,,1747
V(D)J recombination,12,0.617,0.159,1,GO:0033151,BP,,1748
negative regulation of synapse organization,12,0.383,0.159,1,GO:1905809,BP,,1749
cardiac cell development,56,0.446,0.16,1,GO:0055006,BP,,1750
fibroblast activation,10,0.628,0.16,1,GO:0072537,BP,,1751
negative regulation of establishment of protein localization,178,0.469,0.16,1,GO:1904950,BP,,1752
negative regulation of calcium ion transmembrane transporter activity,25,0.419,0.16,1,GO:1901020,BP,,1753
ammonium ion metabolic process,173,0.469,0.16,1,GO:0097164,BP,,1754
phosphatidylinositol kinase activity,44,0.561,0.16,1,GO:0052742,MF,,1755
neuron projection extension,135,0.465,0.16,1,GO:1990138,BP,,1756
osteoblast proliferation,23,0.585,0.16,1,GO:0033687,BP,,1757
circadian regulation of gene expression,52,0.556,0.16,1,GO:0032922,BP,,1758
regulation of mitochondrial membrane permeability,64,0.449,0.161,1,GO:0046902,BP,,1759
ion channel regulator activity,82,0.455,0.161,1,GO:0099106,MF,,1760
nucleoside diphosphate kinase activity,18,0.405,0.161,1,GO:0004550,MF,,1761
regulation of endocytosis,179,0.47,0.161,1,GO:0030100,BP,,1762
membrane disassembly,42,0.563,0.161,1,"GO:0030397,GO:0051081",BP,nuclear envelope disassembly,1763
peptidyl-tyrosine autophosphorylation,46,0.56,0.161,1,GO:0038083,BP,,1764
3'-5' exonuclease activity,44,0.561,0.161,1,GO:0008408,MF,,1765
negative regulation of organelle assembly,30,0.574,0.161,1,GO:1902116,BP,,1766
regulation of endoplasmic reticulum unfolded protein response,22,0.586,0.161,1,GO:1900101,BP,,1767
secondary alcohol metabolic process,106,0.461,0.162,1,GO:1902652,BP,,1768
regulation of metanephros development,21,0.588,0.162,1,GO:0072215,BP,,1769
proteasome binding,10,0.628,0.162,1,GO:0070628,MF,,1770
peptidyl-lysine acetylation,136,0.535,0.162,1,GO:0018394,BP,,1771
Hsp70 protein binding,33,0.43,0.162,1,GO:0030544,MF,,1772
establishment of monopolar cell polarity,13,0.612,0.162,1,GO:0061162,BP,,1773
negative regulation of catecholamine secretion,12,0.384,0.163,1,GO:0033604,BP,,1774
ATP-dependent RNA helicase activity,59,0.553,0.163,1,GO:0004004,MF,,1775
negative regulation of kidney development,14,0.608,0.163,1,GO:0090185,BP,,1776
protein phosphatase 2A binding,24,0.418,0.163,1,GO:0051721,MF,,1777
polysaccharide metabolic process,89,0.457,0.163,1,GO:0005976,BP,,1778
cell separation after cytokinesis,14,0.392,0.163,1,GO:0000920,BP,,1779
vascular process in circulatory system,136,0.465,0.164,1,GO:0003018,BP,,1780
negative regulation of nucleocytoplasmic transport,65,0.45,0.164,1,GO:0046823,BP,,1781
histone methylation,109,0.539,0.164,1,GO:0016571,BP,,1782
endocardial cushion morphogenesis,28,0.576,0.164,1,GO:0003203,BP,,1783
tRNA wobble base modification,11,0.621,0.164,1,GO:0002097,BP,,1784
DNA catabolic process,26,0.579,0.164,1,GO:0006308,BP,,1785
"establishment of mitochondrion localization, microtubule-mediated",16,0.6,0.164,1,"GO:0034643,GO:0047497",BP,mitochondrion transport along microtubule,1786
regulation of osteoblast proliferation,21,0.588,0.165,1,GO:0033688,BP,,1787
sperm principal piece,18,0.405,0.165,1,GO:0097228,CC,,1788
Derlin-1 retrotranslocation complex,11,0.379,0.165,1,GO:0036513,CC,,1789
keratinocyte migration,13,0.611,0.165,1,GO:0051546,BP,,1790
response to misfolded protein,23,0.416,0.165,1,GO:0051788,BP,,1791
positive regulation of myeloid leukocyte cytokine production involved in immune response,11,0.379,0.165,1,GO:0061081,BP,,1792
phosphatidylinositol bisphosphate phosphatase activity,25,0.58,0.165,1,GO:0034593,MF,,1793
AMPA glutamate receptor complex,26,0.421,0.166,1,GO:0032281,CC,,1794
ATPase dependent transmembrane transport complex,17,0.597,0.166,1,GO:0098533,CC,,1795
regulation of lipid localization,100,0.46,0.166,1,GO:1905952,BP,,1796
regulation of membrane permeability,68,0.451,0.166,1,GO:0090559,BP,,1797
positive regulation of transcription elongation from RNA polymerase II promoter,14,0.393,0.167,1,GO:0032968,BP,,1798
regulation of hair follicle development,17,0.403,0.167,1,GO:0051797,BP,,1799
phosphatase binding,150,0.467,0.167,1,GO:0019902,MF,,1800
platelet alpha granule,78,0.455,0.167,1,GO:0031091,CC,,1801
gap junction channel activity,11,0.62,0.167,1,GO:0005243,MF,,1802
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,38,0.435,0.167,1,GO:0007157,BP,,1803
mRNA 3'-end processing,76,0.546,0.167,1,GO:0031124,BP,,1804
negative regulation of cellular amide metabolic process,153,0.532,0.167,1,GO:0034249,BP,,1805
auditory receptor cell morphogenesis,12,0.615,0.167,1,GO:0002093,BP,,1806
extracellular exosome biogenesis,18,0.406,0.167,1,GO:0097734,BP,,1807
protein localization to centrosome,23,0.417,0.167,1,"GO:0071539,GO:1905508",BP,protein localization to microtubule organizing center,1808
lipoprotein particle receptor binding,16,0.4,0.167,1,GO:0070325,MF,,1809
exonuclease activity,69,0.548,0.168,1,GO:0004527,MF,,1810
regulation of extrinsic apoptotic signaling pathway,136,0.534,0.168,1,GO:2001236,BP,,1811
histone monoubiquitination,22,0.585,0.168,1,GO:0010390,BP,,1812
DNA replication-dependent nucleosome assembly,14,0.606,0.168,1,"GO:0006335,GO:0034723",BP,DNA replication-dependent nucleosome organization,1813
heterochromatin,60,0.552,0.168,1,GO:0000792,CC,,1814
chromatin remodeling,127,0.535,0.168,1,GO:0006338,BP,,1815
vacuole organization,151,0.467,0.168,1,GO:0007033,BP,,1816
regulation of transcription regulatory region DNA binding,36,0.434,0.168,1,GO:2000677,BP,,1817
epithelial cell development,171,0.531,0.168,1,GO:0002064,BP,,1818
"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",57,0.553,0.169,1,GO:0046934,MF,,1819
regulation of smooth muscle contraction,52,0.445,0.169,1,GO:0006940,BP,,1820
cytochrome complex,24,0.419,0.169,1,GO:0070069,CC,,1821
SWI/SNF superfamily-type complex,67,0.549,0.169,1,GO:0070603,CC,,1822
tumor necrosis factor receptor binding,22,0.585,0.169,1,GO:0005164,MF,,1823
specification of animal organ identity,27,0.576,0.169,1,GO:0010092,BP,,1824
transition metal ion transport,96,0.459,0.169,1,GO:0000041,BP,,1825
protein targeting to vacuole,26,0.578,0.169,1,GO:0006623,BP,,1826
regulation of translational fidelity,16,0.401,0.169,1,GO:0006450,BP,,1827
regulation of protein polymerization,154,0.468,0.17,1,GO:0032271,BP,,1828
positive regulation of Rho protein signal transduction,20,0.411,0.17,1,GO:0035025,BP,,1829
"ATPase activity, coupled to transmembrane movement of substances",96,0.541,0.17,1,GO:0042626,MF,,1830
cellular response to gamma radiation,21,0.586,0.17,1,GO:0071480,BP,,1831
regulation of T cell mediated cytotoxicity,18,0.593,0.171,1,GO:0001914,BP,,1832
pyrimidine-containing compound metabolic process,73,0.454,0.171,1,GO:0072527,BP,,1833
"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen",22,0.584,0.171,1,"GO:0016701,GO:0016702",MF,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen",1834
phosphatidylglycerol acyl-chain remodeling,13,0.61,0.171,1,GO:0036148,BP,,1835
negative regulation of secretion by cell,149,0.467,0.171,1,GO:1903531,BP,,1836
negative regulation of microtubule depolymerization,15,0.602,0.171,1,"GO:0007026,GO:0031114",BP,regulation of microtubule depolymerization,1837
mitochondrial calcium ion homeostasis,22,0.416,0.171,1,GO:0051560,BP,,1838
"DNA binding, bending",17,0.596,0.172,1,GO:0008301,MF,,1839
positive regulation of amine transport,30,0.428,0.172,1,GO:0051954,BP,,1840
urea cycle,10,0.375,0.172,1,"GO:0000050,GO:0019627",BP,urea metabolic process,1841
RNA cap binding complex,12,0.614,0.172,1,GO:0034518,CC,,1842
positive regulation of telomere capping,14,0.395,0.172,1,GO:1904355,BP,,1843
semaphorin receptor activity,11,0.381,0.173,1,GO:0017154,MF,,1844
mitogen-activated protein kinase kinase kinase binding,14,0.395,0.173,1,GO:0031435,MF,,1845
organ induction,17,0.596,0.173,1,GO:0001759,BP,,1846
CCR chemokine receptor binding,21,0.586,0.173,1,GO:0048020,MF,,1847
embryonic placenta morphogenesis,19,0.59,0.173,1,GO:0060669,BP,,1848
cellular response to extracellular stimulus,173,0.47,0.173,1,GO:0031668,BP,,1849
purine ribonucleotide transport,13,0.609,0.173,1,GO:0015868,BP,,1850
apoptotic DNA fragmentation,15,0.602,0.173,1,GO:0006309,BP,,1851
skeletal muscle organ development,137,0.534,0.173,1,GO:0060538,BP,,1852
metaphase plate congression,41,0.439,0.173,1,GO:0051310,BP,,1853
regulation of systemic arterial blood pressure by hormone,27,0.576,0.173,1,GO:0001990,BP,,1854
macromitophagy,17,0.405,0.174,1,GO:0000423,BP,,1855
pyramidal neuron differentiation,10,0.376,0.174,1,GO:0021859,BP,,1856
artery development,72,0.546,0.174,1,GO:0060840,BP,,1857
positive regulation of protein import,88,0.458,0.174,1,GO:1904591,BP,,1858
regulation of viral genome replication,69,0.547,0.174,1,GO:0045069,BP,,1859
pH reduction,46,0.442,0.175,1,GO:0045851,BP,,1860
regulation of cholesterol biosynthetic process,11,0.382,0.175,1,GO:0045540,BP,,1861
embryonic skeletal system morphogenesis,71,0.547,0.175,1,GO:0048704,BP,,1862
social behavior,45,0.442,0.175,1,"GO:0035176,GO:0051703",BP,intraspecies interaction between organisms,1863
UV protection,12,0.613,0.175,1,GO:0009650,BP,,1864
negative regulation of ion transport,109,0.462,0.175,1,GO:0043271,BP,,1865
regulation of type I interferon production,106,0.462,0.175,1,GO:0032479,BP,,1866
axonal growth cone,17,0.405,0.175,1,GO:0044295,CC,,1867
kinesin binding,35,0.566,0.176,1,GO:0019894,MF,,1868
regulation of interleukin-8 secretion,16,0.402,0.176,1,GO:2000482,BP,,1869
B cell proliferation,56,0.448,0.176,1,GO:0042100,BP,,1870
regulation of nitric-oxide synthase activity,40,0.438,0.176,1,GO:0050999,BP,,1871
skeletal muscle cell proliferation,11,0.618,0.176,1,GO:0014856,BP,,1872
positive regulation of DNA replication,47,0.443,0.176,1,GO:0045740,BP,,1873
glucosamine-containing compound metabolic process,18,0.408,0.177,1,GO:1901071,BP,,1874
cerebellum development,85,0.458,0.177,1,GO:0021549,BP,,1875
regulation of TORC1 signaling,20,0.413,0.177,1,GO:1903432,BP,,1876
dendritic spine membrane,10,0.377,0.177,1,GO:0032591,CC,,1877
negative regulation of DNA metabolic process,101,0.461,0.177,1,GO:0051053,BP,,1878
antigen processing and presentation of endogenous antigen,10,0.623,0.178,1,GO:0019883,BP,,1879
nucleosome organization,112,0.537,0.178,1,GO:0034728,BP,,1880
regulation of glycoprotein metabolic process,39,0.562,0.178,1,GO:1903018,BP,,1881
negative regulation of protein processing,28,0.574,0.178,1,"GO:0010955,GO:1903318",BP,negative regulation of protein maturation,1882
ion channel inhibitor activity,32,0.431,0.178,1,GO:0008200,MF,,1883
negative regulation of exocytosis,28,0.427,0.179,1,GO:0045920,BP,,1884
axon extension,97,0.46,0.179,1,GO:0048675,BP,,1885
tRNA export from nucleus,30,0.571,0.179,1,"GO:0006409,GO:0071431",BP,tRNA-containing ribonucleoprotein complex export from nucleus,1886
morphogenesis of a branching epithelium,157,0.531,0.179,1,GO:0061138,BP,,1887
homologous chromosome segregation,45,0.558,0.179,1,GO:0045143,BP,,1888
neurotransmitter transport,179,0.471,0.179,1,GO:0006836,BP,,1889
microtubule depolymerization,23,0.581,0.179,1,GO:0007019,BP,,1890
regulation of multicellular organismal metabolic process,31,0.57,0.179,1,GO:0044246,BP,,1891
microtubule polymerization or depolymerization,73,0.545,0.18,1,GO:0031109,BP,,1892
"regulation of circadian sleep/wake cycle, sleep",16,0.597,0.18,1,GO:0045187,BP,,1893
adenylate cyclase-activating dopamine receptor signaling pathway,10,0.377,0.18,1,GO:0007191,BP,,1894
regulation of mRNA catabolic process,30,0.571,0.18,1,GO:0061013,BP,,1895
axoneme part,23,0.419,0.181,1,GO:0044447,CC,,1896
negative regulation of protein transport,168,0.47,0.181,1,GO:0051224,BP,,1897
phosphorylated carbohydrate dephosphorylation,10,0.622,0.181,1,GO:0046838,BP,,1898
keratan sulfate catabolic process,10,0.378,0.182,1,GO:0042340,BP,,1899
regulation of heart morphogenesis,30,0.57,0.182,1,GO:2000826,BP,,1900
actin filament depolymerization,45,0.442,0.182,1,GO:0030042,BP,,1901
regulation of establishment of protein localization to plasma membrane,42,0.56,0.182,1,GO:0090003,BP,,1902
positive regulation of lyase activity,53,0.447,0.182,1,GO:0051349,BP,,1903
regulation of transforming growth factor beta production,25,0.423,0.182,1,GO:0071634,BP,,1904
positive regulation of mRNA metabolic process,45,0.558,0.182,1,GO:1903313,BP,,1905
G-protein coupled amine receptor activity,38,0.437,0.182,1,GO:0008227,MF,,1906
endothelial cell apoptotic process,38,0.563,0.182,1,GO:0072577,BP,,1907
collagen-activated signaling pathway,11,0.616,0.182,1,GO:0038065,BP,,1908
autonomic nervous system development,36,0.564,0.182,1,GO:0048483,BP,,1909
regulation of neutrophil migration,27,0.574,0.182,1,GO:1902622,BP,,1910
regulation of glycoprotein biosynthetic process,35,0.565,0.183,1,GO:0010559,BP,,1911
voltage-gated chloride channel activity,10,0.622,0.183,1,GO:0005247,MF,,1912
protein localization to chromosome,60,0.45,0.183,1,GO:0034502,BP,,1913
titin binding,12,0.389,0.183,1,GO:0031432,MF,,1914
cochlea development,41,0.44,0.183,1,GO:0090102,BP,,1915
negative regulation of neuron apoptotic process,126,0.466,0.183,1,GO:0043524,BP,,1916
type B pancreatic cell proliferation,19,0.412,0.183,1,GO:0044342,BP,,1917
myeloid dendritic cell differentiation,14,0.397,0.183,1,GO:0043011,BP,,1918
late endosome to vacuole transport,14,0.397,0.183,1,GO:0045324,BP,,1919
membrane raft assembly,10,0.379,0.183,1,GO:0001765,BP,,1920
"Wnt signaling pathway, calcium modulating pathway",37,0.563,0.184,1,GO:0007223,BP,,1921
negative regulation of T cell receptor signaling pathway,17,0.407,0.184,1,GO:0050860,BP,,1922
microvillus organization,22,0.582,0.184,1,GO:0032528,BP,,1923
membrane lipid biosynthetic process,108,0.537,0.184,1,GO:0046467,BP,,1924
protein phosphorylated amino acid binding,43,0.441,0.184,1,GO:0045309,MF,,1925
negative regulation of striated muscle cell apoptotic process,16,0.596,0.184,1,GO:0010664,BP,,1926
cell recognition,113,0.464,0.184,1,GO:0008037,BP,,1927
sterol metabolic process,116,0.464,0.184,1,GO:0016125,BP,,1928
regulation of cholesterol storage,12,0.389,0.184,1,GO:0010885,BP,,1929
positive regulation of skeletal muscle tissue development,21,0.584,0.185,1,GO:0048643,BP,,1930
DNA-directed RNA polymerase complex,105,0.462,0.185,1,"GO:0000428,GO:0055029",CC,nuclear DNA-directed RNA polymerase complex,1931
glial cell proliferation,30,0.43,0.185,1,GO:0014009,BP,,1932
regulation of macrophage cytokine production,11,0.385,0.185,1,GO:0010935,BP,,1933
phosphatidylcholine metabolic process,67,0.547,0.185,1,GO:0046470,BP,,1934
intrinsic component of endoplasmic reticulum membrane,132,0.467,0.186,1,GO:0031227,CC,,1935
extracellular matrix structural constituent,65,0.548,0.186,1,GO:0005201,MF,,1936
positive regulation of cyclic nucleotide biosynthetic process,81,0.457,0.186,1,GO:0030804,BP,,1937
UDP-N-acetylglucosamine metabolic process,13,0.394,0.186,1,GO:0006047,BP,,1938
p38MAPK cascade,31,0.569,0.186,1,GO:0038066,BP,,1939
lateral sprouting from an epithelium,11,0.615,0.186,1,GO:0060601,BP,,1940
androgen receptor binding,40,0.56,0.186,1,GO:0050681,MF,,1941
"translation repressor activity, nucleic acid binding",13,0.606,0.186,1,GO:0000900,MF,,1942
phospholipid-translocating ATPase activity,18,0.59,0.186,1,GO:0004012,MF,,1943
"positive regulation of DNA-templated transcription, initiation",21,0.417,0.187,1,GO:2000144,BP,,1944
receptor recycling,29,0.571,0.187,1,GO:0001881,BP,,1945
negative regulation of fatty acid metabolic process,19,0.412,0.187,1,GO:0045922,BP,,1946
regulation of cholesterol homeostasis,10,0.621,0.187,1,GO:2000188,BP,,1947
"DNA-templated transcription, elongation",108,0.463,0.187,1,GO:0006354,BP,,1948
cellular response to glucagon stimulus,34,0.435,0.188,1,GO:0071377,BP,,1949
positive regulation of smooth muscle cell migration,28,0.572,0.188,1,GO:0014911,BP,,1950
amino acid transmembrane transporter activity,66,0.547,0.188,1,GO:0015171,MF,,1951
histone deacetylase binding,89,0.54,0.188,1,GO:0042826,MF,,1952
tumor necrosis factor-mediated signaling pathway,142,0.468,0.188,1,GO:0033209,BP,,1953
cell cortex region,14,0.601,0.189,1,GO:0099738,CC,,1954
regulation of cell junction assembly,70,0.545,0.189,1,GO:1901888,BP,,1955
toll-like receptor 4 signaling pathway,25,0.424,0.189,1,GO:0034142,BP,,1956
sodium ion binding,11,0.614,0.189,1,GO:0031402,MF,,1957
intracellular estrogen receptor signaling pathway,40,0.56,0.189,1,GO:0030520,BP,,1958
replication fork processing,25,0.576,0.19,1,GO:0031297,BP,,1959
positive regulation of hair follicle development,10,0.38,0.19,1,GO:0051798,BP,,1960
response to cadmium ion,51,0.447,0.19,1,GO:0046686,BP,,1961
dentate gyrus development,17,0.408,0.19,1,GO:0021542,BP,,1962
detection of external stimulus,108,0.537,0.191,1,GO:0009581,BP,,1963
positive regulation of SMAD protein import into nucleus,12,0.609,0.191,1,GO:0060391,BP,,1964
appendage development,139,0.532,0.191,1,"GO:0048736,GO:0060173",BP,limb development,1965
endochondral ossification,24,0.577,0.191,1,"GO:0001958,GO:0036075",BP,replacement ossification,1966
negative regulation of phosphoprotein phosphatase activity,16,0.406,0.191,1,GO:0032515,BP,,1967
plasma lipoprotein particle,28,0.429,0.191,1,"GO:0034358,GO:1990777",CC,lipoprotein particle,1968
striated muscle cell proliferation,49,0.554,0.191,1,GO:0014855,BP,,1969
activated T cell proliferation,34,0.565,0.191,1,GO:0050798,BP,,1970
platelet-derived growth factor receptor signaling pathway,46,0.556,0.191,1,GO:0048008,BP,,1971
negative regulation of defense response,127,0.466,0.191,1,GO:0031348,BP,,1972
cation channel complex,190,0.472,0.192,1,GO:0034703,CC,,1973
neutral amino acid transport,33,0.566,0.192,1,GO:0015804,BP,,1974
response to unfolded protein,155,0.47,0.192,1,GO:0006986,BP,,1975
interleukin-17 production,19,0.413,0.192,1,GO:0032620,BP,,1976
regulation of receptor recycling,22,0.58,0.192,1,GO:0001919,BP,,1977
positive regulation of stress-activated MAPK cascade,116,0.535,0.192,1,GO:0032874,BP,,1978
mitochondrion morphogenesis,18,0.411,0.192,1,GO:0070584,BP,,1979
regulation of insulin-like growth factor receptor signaling pathway,19,0.586,0.192,1,GO:0043567,BP,,1980
cell-cell adherens junction,79,0.458,0.193,1,GO:0005913,CC,,1981
phosphate ion transmembrane transport,10,0.619,0.193,1,"GO:0035435,GO:0015114,GO:1901677",BP,"phosphate ion transmembrane transporter activity,phosphate transmembrane transporter activity",1982
signal peptide processing,16,0.406,0.193,1,GO:0006465,BP,,1983
cyclic nucleotide catabolic process,22,0.58,0.193,1,GO:0009214,BP,,1984
response to UV-B,16,0.594,0.193,1,GO:0010224,BP,,1985
macromolecule deacylation,94,0.539,0.193,1,GO:0098732,BP,,1986
branching involved in ureteric bud morphogenesis,51,0.553,0.193,1,GO:0001658,BP,,1987
innate immune response in mucosa,11,0.387,0.193,1,GO:0002227,BP,,1988
regulation of immunoglobulin secretion,11,0.387,0.194,1,GO:0051023,BP,,1989
potassium ion transmembrane transporter activity,138,0.532,0.194,1,GO:0015079,MF,,1990
positive regulation of interleukin-6 production,54,0.449,0.194,1,GO:0032755,BP,,1991
regulation of epithelial cell differentiation,105,0.537,0.194,1,GO:0030856,BP,,1992
U5 snRNP,18,0.412,0.195,1,GO:0005682,CC,,1993
Schmidt-Lanterman incisure,11,0.613,0.195,1,GO:0043220,CC,,1994
cellular response to osmotic stress,23,0.578,0.195,1,GO:0071470,BP,,1995
negative regulation of glial cell proliferation,13,0.396,0.195,1,GO:0060253,BP,,1996
DNA biosynthetic process,172,0.471,0.195,1,GO:0071897,BP,,1997
chondrocyte proliferation,12,0.392,0.195,1,GO:0035988,BP,,1998
sex chromosome,21,0.582,0.195,1,GO:0000803,CC,,1999
regulation of cartilage development,55,0.449,0.195,1,GO:0061035,BP,,2000
purine nucleotide transport,14,0.6,0.195,1,GO:0015865,BP,,2001
frizzled binding,31,0.433,0.195,1,GO:0005109,MF,,2002
pseudopodium assembly,13,0.604,0.195,1,GO:0031269,BP,,2003
inner ear morphogenesis,84,0.541,0.196,1,GO:0042472,BP,,2004
NADP metabolic process,29,0.431,0.196,1,GO:0006739,BP,,2005
regulation of mononuclear cell migration,30,0.432,0.196,1,GO:0071675,BP,,2006
positive regulation of cellular response to oxidative stress,14,0.6,0.196,1,GO:1900409,BP,,2007
peptidyl-lysine methylation,99,0.538,0.196,1,GO:0018022,BP,,2008
outflow tract septum morphogenesis,19,0.586,0.196,1,GO:0003148,BP,,2009
protein deacylation,93,0.539,0.196,1,GO:0035601,BP,,2010
response to axon injury,58,0.451,0.196,1,GO:0048678,BP,,2011
labyrinthine layer morphogenesis,16,0.593,0.196,1,GO:0060713,BP,,2012
GABA receptor complex,14,0.4,0.196,1,GO:1902710,CC,,2013
retinol metabolic process,26,0.427,0.197,1,GO:0042572,BP,,2014
"exoribonuclease activity, producing 5'-phosphomonoesters",29,0.569,0.197,1,GO:0016896,MF,,2015
positive regulation of ion transport,198,0.473,0.197,1,GO:0043270,BP,,2016
detection of abiotic stimulus,111,0.536,0.197,1,GO:0009582,BP,,2017
Gemini of coiled bodies,10,0.382,0.197,1,GO:0097504,CC,,2018
pericentriolar material,20,0.583,0.197,1,GO:0000242,CC,,2019
regulation of DNA binding,89,0.46,0.197,1,GO:0051101,BP,,2020
purinergic receptor signaling pathway,22,0.421,0.197,1,GO:0035587,BP,,2021
coronary vasculature development,40,0.559,0.197,1,GO:0060976,BP,,2022
scavenger receptor activity,34,0.436,0.197,1,GO:0005044,MF,,2023
ventral spinal cord interneuron fate commitment,12,0.607,0.197,1,"GO:0060579,GO:0060581",BP,cell fate commitment involved in pattern specification,2024
negative regulation of antigen receptor-mediated signaling pathway,20,0.417,0.197,1,GO:0050858,BP,,2025
positive regulation of phospholipid metabolic process,37,0.439,0.197,1,GO:1903727,BP,,2026
regulation of axon regeneration,22,0.421,0.198,1,GO:0048679,BP,,2027
regulation of pH,92,0.461,0.198,1,GO:0006885,BP,,2028
vesicle coat,46,0.445,0.198,1,GO:0030120,CC,,2029
regulation of non-motile cilium assembly,11,0.612,0.198,1,GO:1902855,BP,,2030
pyrimidine-containing compound catabolic process,28,0.43,0.199,1,GO:0072529,BP,,2031
aminoacyl-tRNA synthetase multienzyme complex,10,0.383,0.199,1,GO:0017101,CC,,2032
positive regulation of anion transport,35,0.437,0.199,1,GO:1903793,BP,,2033
neurotrophin receptor binding,10,0.383,0.199,1,GO:0005165,MF,,2034
response to ketone,160,0.529,0.2,1,GO:1901654,BP,,2035
microvillus,65,0.546,0.2,1,GO:0005902,CC,,2036
regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,15,0.404,0.2,1,GO:0039531,BP,,2037
"retrograde vesicle-mediated transport, Golgi to ER",70,0.456,0.2,1,GO:0006890,BP,,2038
sodium ion transport,190,0.527,0.2,1,GO:0006814,BP,,2039
mismatched DNA binding,12,0.607,0.201,1,GO:0030983,MF,,2040
nuclease activity,166,0.529,0.201,1,GO:0004518,MF,,2041
sphingoid metabolic process,12,0.607,0.201,1,GO:0046519,BP,,2042
negative regulation of oxidative stress-induced neuron death,15,0.405,0.201,1,GO:1903204,BP,,2043
4-hydroxyproline metabolic process,12,0.393,0.201,1,GO:0019471,BP,,2044
negative regulation of embryonic development,25,0.574,0.201,1,GO:0045992,BP,,2045
lipid transporter activity,96,0.538,0.201,1,GO:0005319,MF,,2046
U2-type prespliceosome,14,0.599,0.201,1,GO:0071004,CC,,2047
barbed-end actin filament capping,15,0.405,0.202,1,GO:0051016,BP,,2048
cardiac myofibril assembly,14,0.401,0.202,1,GO:0055003,BP,,2049
cholesterol storage,14,0.402,0.202,1,GO:0010878,BP,,2050
developmental cell growth,175,0.472,0.202,1,GO:0048588,BP,,2051
ligand-gated ion channel activity,121,0.466,0.203,1,"GO:0015276,GO:0022834",MF,ligand-gated channel activity,2052
early endosome to late endosome transport,33,0.436,0.203,1,GO:0045022,BP,,2053
positive regulation of nucleotide metabolic process,110,0.465,0.203,1,"GO:0045981,GO:1900544",BP,positive regulation of purine nucleotide metabolic process,2054
white fat cell differentiation,11,0.389,0.203,1,GO:0050872,BP,,2055
phosphatidylinositol bisphosphate kinase activity,59,0.548,0.203,1,GO:0052813,MF,,2056
type I interferon production,107,0.464,0.203,1,GO:0032606,BP,,2057
cellular response to iron ion,10,0.616,0.203,1,GO:0071281,BP,,2058
response to gonadotropin,25,0.573,0.204,1,GO:0034698,BP,,2059
glycoprotein catabolic process,14,0.402,0.204,1,GO:0006516,BP,,2060
synaptic vesicle priming,13,0.602,0.204,1,GO:0016082,BP,,2061
phosphoprotein binding,71,0.456,0.204,1,GO:0051219,MF,,2062
protein O-linked fucosylation,12,0.606,0.204,1,GO:0036066,BP,,2063
regulation of reactive oxygen species metabolic process,137,0.469,0.204,1,GO:2000377,BP,,2064
"regulation of development, heterochronic",11,0.611,0.204,1,GO:0040034,BP,,2065
positive regulation of protein import into nucleus,86,0.46,0.204,1,GO:0042307,BP,,2066
regulation of viral life cycle,151,0.53,0.204,1,GO:1903900,BP,,2067
pattern binding,15,0.595,0.205,1,"GO:0001871,GO:0030247",MF,polysaccharide binding,2068
regulation of vascular smooth muscle cell proliferation,22,0.578,0.205,1,"GO:1904705,GO:1990874",BP,vascular smooth muscle cell proliferation,2069
lipoxygenase pathway,14,0.402,0.205,1,GO:0019372,BP,,2070
regulation of epidermal growth factor-activated receptor activity,23,0.576,0.206,1,GO:0007176,BP,,2071
nuclear DNA replication,25,0.427,0.206,1,GO:0033260,BP,,2072
regulation of response to DNA damage stimulus,145,0.53,0.206,1,GO:2001020,BP,,2073
regulation of phosphorylation of RNA polymerase II C-terminal domain,10,0.615,0.206,1,GO:1901407,BP,,2074
post-embryonic animal organ development,12,0.605,0.206,1,GO:0048569,BP,,2075
sphingolipid metabolic process,125,0.533,0.207,1,GO:0006665,BP,,2076
"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",32,0.435,0.207,1,GO:0000462,BP,,2077
positive regulation of JUN kinase activity,59,0.548,0.207,1,GO:0043507,BP,,2078
regulation of chondrocyte differentiation,39,0.442,0.207,1,GO:0032330,BP,,2079
ESCRT complex disassembly,10,0.385,0.207,1,"GO:1904896,GO:1904903",BP,ESCRT III complex disassembly,2080
DNA replication-independent nucleosome organization,36,0.561,0.207,1,GO:0034724,BP,,2081
negative regulation of actin filament polymerization,43,0.444,0.207,1,GO:0030837,BP,,2082
precatalytic spliceosome,21,0.421,0.208,1,GO:0071011,CC,,2083
high-density lipoprotein particle,17,0.412,0.208,1,GO:0034364,CC,,2084
regulation of chromatin binding,19,0.583,0.208,1,GO:0035561,BP,,2085
structural constituent of myelin sheath,10,0.615,0.208,1,GO:0019911,MF,,2086
lamellipodium,166,0.472,0.208,1,GO:0030027,CC,,2087
nuclear replication fork,39,0.558,0.209,1,GO:0043596,CC,,2088
short-chain fatty acid metabolic process,13,0.399,0.209,1,GO:0046459,BP,,2089
ion gated channel activity,38,0.559,0.209,1,GO:0022839,MF,,2090
cellular response to lithium ion,12,0.395,0.209,1,GO:0071285,BP,,2091
miRNA binding,14,0.597,0.209,1,GO:0035198,MF,,2092
positive regulation of viral process,91,0.462,0.209,1,GO:0048524,BP,,2093
regulation of intracellular estrogen receptor signaling pathway,27,0.57,0.209,1,GO:0033146,BP,,2094
sarcomere organization,38,0.441,0.209,1,GO:0045214,BP,,2095
polysome,41,0.443,0.209,1,GO:0005844,CC,,2096
fructose metabolic process,14,0.403,0.209,1,GO:0006000,BP,,2097
endocytic recycling,30,0.566,0.21,1,GO:0032456,BP,,2098
prostaglandin transport,14,0.403,0.21,1,GO:0015732,BP,,2099
potassium ion import,25,0.572,0.21,1,GO:0010107,BP,,2100
regulation of neurotransmitter secretion,51,0.449,0.21,1,GO:0046928,BP,,2101
positive regulation of protein localization to nucleus,112,0.466,0.211,1,GO:1900182,BP,,2102
maturation of SSU-rRNA,46,0.447,0.211,1,GO:0030490,BP,,2103
cranial skeletal system development,55,0.549,0.211,1,GO:1904888,BP,,2104
activation of GTPase activity,74,0.542,0.211,1,GO:0090630,BP,,2105
regulation of telomere capping,20,0.419,0.212,1,GO:1904353,BP,,2106
negative regulation of binding,124,0.467,0.212,1,GO:0051100,BP,,2107
T cell receptor complex,17,0.413,0.212,1,GO:0042101,CC,,2108
L-ascorbic acid binding,20,0.581,0.212,1,GO:0031418,MF,,2109
regulation of cytoplasmic translation,13,0.6,0.212,1,GO:2000765,BP,,2110
internal protein amino acid acetylation,137,0.531,0.212,1,GO:0006475,BP,,2111
extrinsic apoptotic signaling pathway,187,0.527,0.213,1,GO:0097191,BP,,2112
establishment of protein localization to vacuole,29,0.567,0.213,1,GO:0072666,BP,,2113
cilium movement,57,0.452,0.213,1,GO:0003341,BP,,2114
positive regulation of membrane protein ectodomain proteolysis,14,0.596,0.213,1,GO:0051044,BP,,2115
filopodium,91,0.462,0.213,1,GO:0030175,CC,,2116
regulation of adherens junction organization,51,0.55,0.214,1,GO:1903391,BP,,2117
ceramide metabolic process,70,0.543,0.214,1,GO:0006672,BP,,2118
nucleotide-binding oligomerization domain containing 2 signaling pathway,11,0.608,0.214,1,GO:0070431,BP,,2119
neurotransmitter metabolic process,29,0.433,0.214,1,GO:0042133,BP,,2120
ectodermal placode formation,15,0.593,0.215,1,"GO:0060788,GO:0071697",BP,ectodermal placode morphogenesis,2121
regulation of mitochondrial translation,15,0.408,0.215,1,GO:0070129,BP,,2122
protein neddylation,13,0.401,0.215,1,GO:0045116,BP,,2123
positive regulation of protein targeting to mitochondrion,70,0.457,0.215,1,GO:1903955,BP,,2124
positive regulation of cyclic nucleotide metabolic process,86,0.461,0.216,1,GO:0030801,BP,,2125
regulation of leukocyte mediated cytotoxicity,39,0.557,0.216,1,GO:0001910,BP,,2126
regulation of macrophage migration,15,0.408,0.216,1,GO:1905521,BP,,2127
establishment or maintenance of monopolar cell polarity,14,0.595,0.216,1,GO:0061339,BP,,2128
amino acid activation,47,0.448,0.216,1,GO:0043038,BP,,2129
regulation of exosomal secretion,14,0.405,0.217,1,GO:1903541,BP,,2130
cyclic-nucleotide phosphodiesterase activity,24,0.573,0.217,1,GO:0004112,MF,,2131
vocalization behavior,16,0.411,0.217,1,GO:0071625,BP,,2132
negative regulation of translation,141,0.53,0.217,1,GO:0017148,BP,,2133
nucleosome,53,0.549,0.217,1,GO:0000786,CC,,2134
poly(A)-specific ribonuclease activity,13,0.599,0.218,1,GO:0004535,MF,,2135
immunoglobulin production,69,0.457,0.218,1,GO:0002377,BP,,2136
coenzyme catabolic process,11,0.393,0.218,1,GO:0009109,BP,,2137
mismatch repair complex,10,0.612,0.218,1,GO:0032300,CC,,2138
"exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters",43,0.554,0.218,1,GO:0016796,MF,,2139
cellular response to unfolded protein,118,0.467,0.219,1,GO:0034620,BP,,2140
iron ion import,13,0.599,0.219,1,GO:0097286,BP,,2141
cellular response to electrical stimulus,11,0.393,0.219,1,GO:0071257,BP,,2142
mesodermal cell differentiation,29,0.566,0.219,1,GO:0048333,BP,,2143
cellular response to fatty acid,43,0.446,0.219,1,GO:0071398,BP,,2144
"hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances",98,0.536,0.219,1,GO:0016820,MF,,2145
positive regulation of lipid transport,43,0.446,0.22,1,GO:0032370,BP,,2146
cytokine secretion,138,0.47,0.22,1,GO:0050663,BP,,2147
respiratory chain complex IV assembly,19,0.419,0.22,1,GO:0008535,BP,,2148
positive regulation of cGMP biosynthetic process,17,0.414,0.22,1,GO:0030828,BP,,2149
mononuclear cell migration,51,0.45,0.22,1,GO:0071674,BP,,2150
genetic imprinting,22,0.575,0.221,1,GO:0071514,BP,,2151
humoral immune response,132,0.469,0.221,1,GO:0006959,BP,,2152
cellular response to radiation,140,0.53,0.221,1,GO:0071478,BP,,2153
gonad development,169,0.527,0.221,1,GO:0008406,BP,,2154
calcium activated cation channel activity,25,0.571,0.221,1,GO:0005227,MF,,2155
dicarboxylic acid biosynthetic process,12,0.398,0.221,1,GO:0043650,BP,,2156
pseudopodium organization,14,0.594,0.222,1,GO:0031268,BP,,2157
epithelial tube formation,117,0.533,0.223,1,GO:0072175,BP,,2158
androgen metabolic process,19,0.581,0.223,1,GO:0008209,BP,,2159
liver morphogenesis,17,0.585,0.223,1,GO:0072576,BP,,2160
intrinsic component of Golgi membrane,52,0.549,0.223,1,GO:0031228,CC,,2161
negative regulation of immune response,96,0.464,0.223,1,GO:0050777,BP,,2162
meiosis I,78,0.54,0.223,1,GO:0007127,BP,,2163
oligodendrocyte development,35,0.56,0.223,1,GO:0014003,BP,,2164
interleukin-8 secretion,20,0.421,0.223,1,GO:0072606,BP,,2165
response to interleukin-1,88,0.538,0.224,1,GO:0070555,BP,,2166
regulation of protein homodimerization activity,17,0.585,0.224,1,GO:0043496,BP,,2167
GDP metabolic process,13,0.403,0.224,1,GO:0046710,BP,,2168
regulation of spindle organization,24,0.572,0.224,1,GO:0090224,BP,,2169
tau protein binding,10,0.389,0.224,1,GO:0048156,MF,,2170
granulocyte macrophage colony-stimulating factor production,11,0.394,0.224,1,"GO:0032604,GO:0032645",BP,regulation of granulocyte macrophage colony-stimulating factor production,2171
regulation of peptidyl-threonine phosphorylation,36,0.441,0.224,1,GO:0010799,BP,,2172
beta-catenin destruction complex disassembly,20,0.578,0.225,1,GO:1904886,BP,,2173
"4 iron, 4 sulfur cluster binding",35,0.559,0.225,1,GO:0051539,MF,,2174
lateral plasma membrane,49,0.55,0.225,1,GO:0016328,CC,,2175
regulation of transcription from RNA polymerase I promoter,29,0.565,0.226,1,GO:0006356,BP,,2176
prostaglandin secretion,12,0.399,0.226,1,GO:0032310,BP,,2177
toll-like receptor signaling pathway,107,0.466,0.226,1,GO:0002224,BP,,2178
inositol trisphosphate phosphatase activity,11,0.605,0.226,1,GO:0046030,MF,,2179
purine ribonucleotide catabolic process,33,0.439,0.226,1,GO:0009154,BP,,2180
positive regulation of kidney development,35,0.559,0.227,1,GO:0090184,BP,,2181
negative regulation of histone modification,33,0.561,0.227,1,GO:0031057,BP,,2182
positive regulation of cell cycle G2/M phase transition,20,0.422,0.227,1,GO:1902751,BP,,2183
megakaryocyte differentiation,33,0.561,0.227,1,GO:0030219,BP,,2184
multivesicular body,32,0.438,0.227,1,GO:0005771,CC,,2185
pyrimidine nucleoside monophosphate metabolic process,14,0.593,0.227,1,GO:0009129,BP,,2186
negative regulation of synaptic transmission,58,0.454,0.227,1,GO:0050805,BP,,2187
regulation of cholesterol efflux,17,0.415,0.227,1,GO:0010874,BP,,2188
dopamine receptor binding,15,0.41,0.228,1,GO:0050780,MF,,2189
metanephric mesenchyme development,14,0.593,0.228,1,GO:0072075,BP,,2190
tube formation,129,0.531,0.228,1,GO:0035148,BP,,2191
cleavage involved in rRNA processing,20,0.578,0.228,1,GO:0000469,BP,,2192
kidney morphogenesis,81,0.539,0.228,1,GO:0060993,BP,,2193
regulation of cell fate commitment,22,0.574,0.228,1,GO:0010453,BP,,2194
"transferase activity, transferring pentosyl groups",41,0.554,0.228,1,GO:0016763,MF,,2195
ruffle,150,0.529,0.229,1,GO:0001726,CC,,2196
regulation of B cell activation,92,0.464,0.229,1,GO:0050864,BP,,2197
microtubule bundle formation,68,0.458,0.229,1,GO:0001578,BP,,2198
RNA localization,190,0.525,0.229,1,GO:0006403,BP,,2199
glucose binding,10,0.39,0.229,1,GO:0005536,MF,,2200
death receptor binding,15,0.59,0.229,1,GO:0005123,MF,,2201
regulation of fatty acid oxidation,26,0.432,0.229,1,GO:0046320,BP,,2202
collagen fibril organization,37,0.557,0.229,1,GO:0030199,BP,,2203
Golgi to plasma membrane protein transport,27,0.567,0.229,1,GO:0043001,BP,,2204
sister chromatid cohesion,108,0.534,0.23,1,GO:0007062,BP,,2205
protein serine/threonine kinase activator activity,23,0.572,0.23,1,GO:0043539,MF,,2206
main axon,58,0.546,0.23,1,GO:0044304,CC,,2207
"oxidoreductase activity, oxidizing metal ions",13,0.404,0.23,1,GO:0016722,MF,,2208
negative regulation of leukocyte apoptotic process,37,0.557,0.23,1,GO:2000107,BP,,2209
lamellar body,13,0.404,0.23,1,GO:0042599,CC,,2210
face development,43,0.553,0.23,1,GO:0060324,BP,,2211
solute:proton antiporter activity,19,0.579,0.231,1,GO:0015299,MF,,2212
RNA polymerase complex,107,0.466,0.231,1,GO:0030880,CC,,2213
ureteric bud morphogenesis,55,0.547,0.231,1,GO:0060675,BP,,2214
oxygen transport,12,0.4,0.231,1,GO:0015671,BP,,2215
recombinational repair,84,0.538,0.231,1,GO:0000725,BP,,2216
epithelial tube branching involved in lung morphogenesis,26,0.568,0.231,1,GO:0060441,BP,,2217
protein kinase inhibitor activity,87,0.463,0.231,1,GO:0004860,MF,,2218
establishment of apical/basal cell polarity,11,0.604,0.231,1,GO:0035089,BP,,2219
cholesterol metabolic process,103,0.466,0.232,1,GO:0008203,BP,,2220
long-term memory,28,0.435,0.232,1,GO:0007616,BP,,2221
phagocytic vesicle,96,0.465,0.232,1,GO:0045335,CC,,2222
cellular response to acid chemical,171,0.473,0.232,1,GO:0071229,BP,,2223
positive regulation of microtubule polymerization,18,0.581,0.232,1,GO:0031116,BP,,2224
mesenchymal to epithelial transition involved in metanephros morphogenesis,11,0.604,0.232,1,GO:0003337,BP,,2225
mitochondrion localization,37,0.557,0.232,1,GO:0051646,BP,,2226
negative regulation of G-protein coupled receptor protein signaling pathway,34,0.441,0.232,1,GO:0045744,BP,,2227
positive regulation of cyclin-dependent protein serine/threonine kinase activity,31,0.562,0.232,1,GO:0045737,BP,,2228
serotonin secretion,10,0.391,0.232,1,GO:0001820,BP,,2229
negative regulation of chromosome organization,99,0.535,0.233,1,GO:2001251,BP,,2230
establishment of mitochondrion localization,18,0.581,0.233,1,GO:0051654,BP,,2231
norepinephrine metabolic process,11,0.396,0.233,1,GO:0042415,BP,,2232
protein deacetylation,89,0.537,0.233,1,GO:0006476,BP,,2233
positive regulation of Notch signaling pathway,30,0.437,0.233,1,GO:0045747,BP,,2234
regulation of ruffle assembly,20,0.577,0.233,1,GO:1900027,BP,,2235
regulation of cell-substrate adhesion,164,0.527,0.233,1,GO:0010810,BP,,2236
regulation of natural killer cell activation,20,0.577,0.234,1,GO:0032814,BP,,2237
steroid hormone receptor binding,84,0.538,0.234,1,GO:0035258,MF,,2238
fibroblast proliferation,77,0.461,0.234,1,GO:0048144,BP,,2239
"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",14,0.592,0.235,1,GO:0006978,BP,,2240
regulation of mesonephros development,22,0.573,0.235,1,GO:0061217,BP,,2241
primary alcohol metabolic process,41,0.446,0.235,1,GO:0034308,BP,,2242
phosphatidylserine metabolic process,26,0.567,0.235,1,GO:0006658,BP,,2243
receptor catabolic process,22,0.427,0.235,1,GO:0032801,BP,,2244
regulation of cAMP-dependent protein kinase activity,14,0.408,0.235,1,GO:2000479,BP,,2245
transforming growth factor beta production,26,0.433,0.235,1,GO:0071604,BP,,2246
GABA-A receptor activity,15,0.412,0.235,1,GO:0004890,MF,,2247
virus receptor activity,54,0.547,0.236,1,GO:0001618,MF,,2248
kinase inhibitor activity,91,0.464,0.236,1,GO:0019210,MF,,2249
tRNA transport,31,0.561,0.237,1,GO:0051031,BP,,2250
digestive system development,114,0.532,0.237,1,GO:0055123,BP,,2251
positive regulation of hair cycle,11,0.397,0.237,1,GO:0042635,BP,,2252
immunoglobulin production involved in immunoglobulin mediated immune response,35,0.442,0.237,1,GO:0002381,BP,,2253
phosphatidylethanolamine acyl-chain remodeling,21,0.575,0.237,1,GO:0036152,BP,,2254
positive regulation of glycogen biosynthetic process,13,0.595,0.238,1,GO:0045725,BP,,2255
regulation of protein localization to cell surface,29,0.437,0.238,1,GO:2000008,BP,,2256
negative regulation of T-helper cell differentiation,10,0.608,0.238,1,GO:0045623,BP,,2257
regulation of activated T cell proliferation,30,0.562,0.238,1,GO:0046006,BP,,2258
ventricular cardiac muscle tissue morphogenesis,40,0.554,0.238,1,GO:0055010,BP,,2259
Sin3-type complex,16,0.415,0.238,1,GO:0070822,CC,,2260
regulation of nucleocytoplasmic transport,189,0.475,0.239,1,GO:0046822,BP,,2261
ATP-dependent DNA helicase activity,29,0.563,0.239,1,GO:0004003,MF,,2262
myosin V binding,16,0.415,0.239,1,GO:0031489,MF,,2263
"positive regulation of synaptic transmission, GABAergic",11,0.602,0.239,1,GO:0032230,BP,,2264
fat-soluble vitamin biosynthetic process,10,0.393,0.24,1,GO:0042362,BP,,2265
liver development,117,0.532,0.24,1,GO:0001889,BP,,2266
ATPase complex,18,0.58,0.24,1,GO:1904949,CC,,2267
tRNA processing,93,0.535,0.24,1,GO:0008033,BP,,2268
response to gamma radiation,42,0.552,0.24,1,GO:0010332,BP,,2269
regulation of macromitophagy,14,0.409,0.24,1,GO:1901524,BP,,2270
mitotic metaphase plate congression,34,0.442,0.24,1,GO:0007080,BP,,2271
nitric-oxide synthase binding,16,0.415,0.24,1,GO:0050998,MF,,2272
negative regulation of interleukin-2 production,16,0.415,0.24,1,GO:0032703,BP,,2273
U2-type spliceosomal complex,28,0.564,0.24,1,GO:0005684,CC,,2274
neural retina development,51,0.453,0.242,1,GO:0003407,BP,,2275
NADPH binding,12,0.402,0.242,1,GO:0070402,MF,,2276
cellular response to biotic stimulus,148,0.472,0.242,1,GO:0071216,BP,,2277
regulation of lipid transport,76,0.461,0.242,1,GO:0032368,BP,,2278
amyloid precursor protein metabolic process,31,0.561,0.242,1,GO:0042982,BP,,2279
peptidyl-lysine trimethylation,35,0.557,0.242,1,GO:0018023,BP,,2280
regulation of immunoglobulin production,38,0.445,0.242,1,GO:0002637,BP,,2281
activation of JUN kinase activity,32,0.56,0.243,1,GO:0007257,BP,,2282
neutral amino acid transmembrane transporter activity,29,0.563,0.243,1,GO:0015175,MF,,2283
ubiquitin protein ligase activity involved in ERAD pathway,13,0.406,0.243,1,GO:1904264,MF,,2284
multicellular organismal movement,38,0.445,0.243,1,"GO:0050879,GO:0050881",BP,musculoskeletal movement,2285
phosphate ion transport,15,0.587,0.243,1,GO:0006817,BP,,2286
regulation of dopamine metabolic process,17,0.418,0.243,1,"GO:0042053,GO:0042069",BP,regulation of catecholamine metabolic process,2287
protein kinase C signaling,25,0.567,0.244,1,GO:0070528,BP,,2288
T cell apoptotic process,42,0.552,0.244,1,GO:0070231,BP,,2289
UTP metabolic process,12,0.403,0.244,1,GO:0046051,BP,,2290
heart formation,21,0.573,0.244,1,GO:0060914,BP,,2291
glucose 6-phosphate metabolic process,22,0.428,0.244,1,GO:0051156,BP,,2292
cilium or flagellum-dependent cell motility,26,0.434,0.244,1,GO:0001539,BP,,2293
heterotypic cell-cell adhesion,40,0.553,0.244,1,GO:0034113,BP,,2294
receptor localization to synapse,14,0.41,0.244,1,GO:0097120,BP,,2295
chemokine activity,28,0.564,0.245,1,GO:0008009,MF,,2296
olfactory bulb development,31,0.44,0.245,1,GO:0021772,BP,,2297
L-phenylalanine metabolic process,10,0.394,0.245,1,"GO:0006558,GO:0006559,GO:1902221,GO:1902222",BP,"L-phenylalanine catabolic process,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process",2298
visual behavior,48,0.451,0.245,1,GO:0007632,BP,,2299
corpus callosum development,13,0.407,0.245,1,GO:0022038,BP,,2300
RNA phosphodiester bond hydrolysis,107,0.533,0.246,1,GO:0090501,BP,,2301
regulation of production of molecular mediator of immune response,86,0.464,0.246,1,GO:0002700,BP,,2302
regulation of heat generation,11,0.399,0.246,1,GO:0031650,BP,,2303
basement membrane organization,18,0.579,0.246,1,GO:0071711,BP,,2304
solute:cation antiporter activity,32,0.559,0.246,1,GO:0015298,MF,,2305
bile acid metabolic process,38,0.554,0.246,1,GO:0008206,BP,,2306
cytosolic small ribosomal subunit,42,0.448,0.247,1,GO:0022627,CC,,2307
proteoglycan binding,34,0.443,0.247,1,GO:0043394,MF,,2308
positive regulation of centrosome cycle,10,0.606,0.247,1,GO:0046607,BP,,2309
positive regulation of branching involved in ureteric bud morphogenesis,18,0.579,0.247,1,GO:0090190,BP,,2310
clathrin vesicle coat,24,0.432,0.247,1,GO:0030125,CC,,2311
nucleoside bisphosphate biosynthetic process,16,0.416,0.247,1,"GO:0033866,GO:0034030,GO:0034033",BP,"ribonucleoside bisphosphate biosynthetic process,purine nucleoside bisphosphate biosynthetic process",2312
clathrin-sculpted vesicle,12,0.404,0.248,1,GO:0060198,CC,,2313
NAD+ ADP-ribosyltransferase activity,18,0.579,0.248,1,GO:0003950,MF,,2314
"DNA-directed RNA polymerase II, core complex",14,0.411,0.248,1,GO:0005665,CC,,2315
JAK-STAT cascade involved in growth hormone signaling pathway,12,0.404,0.248,1,GO:0060397,BP,,2316
beta-catenin destruction complex,11,0.399,0.248,1,GO:0030877,CC,,2317
histone H4 acetylation,56,0.545,0.249,1,GO:0043967,BP,,2318
potassium ion binding,13,0.592,0.249,1,GO:0030955,MF,,2319
RNA secondary structure unwinding,41,0.552,0.249,1,GO:0010501,BP,,2320
serine phosphorylation of STAT protein,12,0.596,0.25,1,GO:0042501,BP,,2321
intracellular pH reduction,45,0.45,0.25,1,GO:0051452,BP,,2322
clathrin adaptor complex,29,0.438,0.25,1,GO:0030131,CC,,2323
positive regulation of filopodium assembly,27,0.436,0.25,1,GO:0051491,BP,,2324
RNA modification,107,0.532,0.251,1,GO:0009451,BP,,2325
regulation of cardiac muscle tissue growth,39,0.447,0.251,1,GO:0055021,BP,,2326
modulation by symbiont of host cellular process,20,0.426,0.251,1,GO:0044068,BP,,2327
regulation of gene silencing by miRNA,29,0.562,0.251,1,GO:0060964,BP,,2328
snRNA metabolic process,72,0.461,0.251,1,GO:0016073,BP,,2329
regulation of gene expression by genetic imprinting,13,0.592,0.251,1,GO:0006349,BP,,2330
positive regulation of stress-activated protein kinase signaling cascade,117,0.531,0.251,1,GO:0070304,BP,,2331
"nucleotide-excision repair, preincision complex stabilization",19,0.424,0.251,1,"GO:0006293,GO:0006295",BP,"nucleotide-excision repair, DNA incision, 3'-to lesion",2332
positive regulation of toll-like receptor signaling pathway,15,0.414,0.251,1,GO:0034123,BP,,2333
axonal fasciculation,21,0.428,0.251,1,GO:0007413,BP,,2334
regulation of interferon-gamma-mediated signaling pathway,19,0.576,0.252,1,GO:0060334,BP,,2335
regulation of platelet activation,27,0.436,0.252,1,GO:0010543,BP,,2336
HMG box domain binding,13,0.592,0.252,1,GO:0071837,MF,,2337
regulation of toll-like receptor 4 signaling pathway,12,0.405,0.252,1,GO:0034143,BP,,2338
sphingolipid binding,10,0.395,0.252,1,GO:0046625,MF,,2339
regulation of protein sumoylation,19,0.576,0.253,1,GO:0033233,BP,,2340
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,90,0.535,0.253,1,GO:0002822,BP,,2341
nuclear-transcribed mRNA catabolic process,182,0.475,0.253,1,GO:0000956,BP,,2342
GTPase inhibitor activity,12,0.595,0.253,1,GO:0005095,MF,,2343
hydrogen peroxide catabolic process,20,0.426,0.253,1,GO:0042744,BP,,2344
cyclic nucleotide metabolic process,157,0.474,0.253,1,GO:0009187,BP,,2345
regulation of gastrulation,32,0.558,0.253,1,GO:0010470,BP,,2346
protein trimerization,43,0.45,0.253,1,GO:0070206,BP,,2347
regulation of syncytium formation by plasma membrane fusion,19,0.576,0.254,1,GO:0060142,BP,,2348
disulfide oxidoreductase activity,35,0.444,0.254,1,GO:0015036,MF,,2349
cardioblast differentiation,13,0.591,0.254,1,GO:0010002,BP,,2350
positive regulation of oxidoreductase activity,37,0.446,0.254,1,GO:0051353,BP,,2351
molting cycle,96,0.534,0.254,1,"GO:0042303,GO:0042633",BP,hair cycle,2352
regulation of response to interferon-gamma,20,0.574,0.254,1,GO:0060330,BP,,2353
active ion transmembrane transporter activity,102,0.533,0.255,1,GO:0022853,MF,,2354
epithelial cell maturation,11,0.599,0.255,1,GO:0002070,BP,,2355
positive regulation of gluconeogenesis,10,0.604,0.255,1,GO:0045722,BP,,2356
ribonucleotide catabolic process,34,0.444,0.255,1,GO:0009261,BP,,2357
T-helper 17 cell differentiation,10,0.604,0.256,1,GO:0072539,BP,,2358
ferric iron transport,36,0.445,0.257,1,"GO:0015682,GO:0072512",BP,trivalent inorganic cation transport,2359
histone kinase activity,16,0.582,0.257,1,GO:0035173,MF,,2360
response to arsenic-containing substance,25,0.566,0.257,1,GO:0046685,BP,,2361
regulation of mast cell activation involved in immune response,25,0.434,0.257,1,"GO:0033006,GO:0043304",BP,regulation of mast cell degranulation,2362
negative regulation of DNA biosynthetic process,29,0.439,0.258,1,GO:2000279,BP,,2363
dopamine metabolic process,33,0.443,0.258,1,GO:0042417,BP,,2364
beta-catenin-TCF complex assembly,32,0.558,0.258,1,GO:1904837,BP,,2365
regulation of transcription elongation from RNA polymerase II promoter,23,0.432,0.258,1,GO:0034243,BP,,2366
negative regulation of DNA-dependent DNA replication,17,0.421,0.259,1,GO:2000104,BP,,2367
negative regulation of cell fate commitment,10,0.603,0.259,1,GO:0010454,BP,,2368
regulation of T cell tolerance induction,10,0.603,0.259,1,GO:0002664,BP,,2369
anoikis,29,0.561,0.259,1,GO:0043276,BP,,2370
negative regulation of nitric oxide biosynthetic process,10,0.603,0.259,1,"GO:0045019,GO:1904406",BP,negative regulation of nitric oxide metabolic process,2371
replisome,28,0.562,0.259,1,GO:0030894,CC,,2372
membrane protein proteolysis,53,0.545,0.259,1,GO:0033619,BP,,2373
negative regulation of homeostatic process,161,0.474,0.259,1,GO:0032845,BP,,2374
pyrimidine ribonucleoside triphosphate metabolic process,17,0.421,0.259,1,GO:0009208,BP,,2375
regulation of ERBB signaling pathway,85,0.535,0.26,1,GO:1901184,BP,,2376
regulation of timing of cell differentiation,10,0.603,0.26,1,GO:0048505,BP,,2377
dermatan sulfate proteoglycan biosynthetic process,13,0.41,0.26,1,GO:0050651,BP,,2378
cardiac septum morphogenesis,55,0.544,0.26,1,GO:0060411,BP,,2379
appendage morphogenesis,118,0.53,0.26,1,"GO:0035107,GO:0035108",BP,limb morphogenesis,2380
positive regulation of G2/M transition of mitotic cell cycle,19,0.425,0.26,1,GO:0010971,BP,,2381
membrane docking,161,0.474,0.26,1,GO:0022406,BP,,2382
heterotrimeric G-protein complex,31,0.442,0.261,1,"GO:0005834,GO:1905360",CC,GTPase complex,2383
striated muscle adaptation,33,0.557,0.261,1,GO:0014888,BP,,2384
dermatan sulfate biosynthetic process,11,0.402,0.261,1,GO:0030208,BP,,2385
cerebral cortex cell migration,42,0.45,0.261,1,GO:0021795,BP,,2386
chaperone mediated protein folding requiring cofactor,13,0.41,0.262,1,GO:0051085,BP,,2387
regulation of endothelial cell development,10,0.603,0.262,1,"GO:1901550,GO:1903140",BP,regulation of establishment of endothelial barrier,2388
positive regulation of cell-matrix adhesion,43,0.45,0.262,1,GO:0001954,BP,,2389
microfilament motor activity,18,0.576,0.262,1,GO:0000146,MF,,2390
protein-lipid complex,30,0.441,0.262,1,GO:0032994,CC,,2391
response to osmotic stress,58,0.543,0.262,1,GO:0006970,BP,,2392
smooth muscle tissue development,16,0.581,0.262,1,GO:0048745,BP,,2393
regulation of collagen metabolic process,30,0.559,0.262,1,GO:0010712,BP,,2394
histone acetyltransferase activity,50,0.546,0.262,1,GO:0004402,MF,,2395
mitogen-activated protein kinase kinase binding,13,0.41,0.262,1,GO:0031434,MF,,2396
monocyte chemotaxis,37,0.447,0.262,1,GO:0002548,BP,,2397
response to dopamine,13,0.59,0.262,1,"GO:1903350,GO:1903351",BP,cellular response to dopamine,2398
BLOC-1 complex,15,0.416,0.262,1,GO:0031083,CC,,2399
steroid biosynthetic process,131,0.472,0.263,1,GO:0006694,BP,,2400
positive regulation of glycolytic process,11,0.598,0.263,1,GO:0045821,BP,,2401
regulation of natural killer cell differentiation,10,0.602,0.263,1,GO:0032823,BP,,2402
negative regulation of peptidyl-serine phosphorylation,24,0.566,0.263,1,GO:0033137,BP,,2403
regulation of Arp2/3 complex-mediated actin nucleation,16,0.419,0.264,1,GO:0034315,BP,,2404
intercalated disc,44,0.549,0.264,1,GO:0014704,CC,,2405
sugar transmembrane transporter activity,26,0.563,0.264,1,GO:0051119,MF,,2406
loop of Henle development,10,0.602,0.264,1,GO:0072070,BP,,2407
Wnt-activated receptor activity,14,0.414,0.264,1,GO:0042813,MF,,2408
protein kinase activator activity,60,0.542,0.264,1,GO:0030295,MF,,2409
ATP-dependent microtubule motor activity,19,0.574,0.264,1,GO:1990939,MF,,2410
clathrin coat of trans-Golgi network vesicle,12,0.407,0.265,1,GO:0030130,CC,,2411
NAD+ binding,12,0.593,0.265,1,GO:0070403,MF,,2412
melanin metabolic process,17,0.422,0.265,1,GO:0006582,BP,,2413
dopamine uptake involved in synaptic transmission,11,0.403,0.265,1,"GO:0051583,GO:0051934,GO:0090493,GO:0090494",BP,"catecholamine uptake involved in synaptic transmission,catecholamine uptake,dopamine uptake",2414
negative regulation of substrate adhesion-dependent cell spreading,13,0.589,0.265,1,GO:1900025,BP,,2415
fat-soluble vitamin metabolic process,32,0.443,0.265,1,GO:0006775,BP,,2416
tertiary granule,138,0.472,0.266,1,GO:0070820,CC,,2417
erythrocyte development,21,0.43,0.266,1,GO:0048821,BP,,2418
ventricular cardiac muscle tissue development,43,0.549,0.266,1,GO:0003229,BP,,2419
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,97,0.533,0.266,1,GO:0090101,BP,,2420
nuclear transcriptional repressor complex,30,0.559,0.266,1,GO:0090568,CC,,2421
"positive regulation of DNA-templated transcription, elongation",22,0.432,0.266,1,GO:0032786,BP,,2422
positive regulation of insulin receptor signaling pathway,10,0.601,0.267,1,GO:0046628,BP,,2423
positive regulation of calcium ion transmembrane transporter activity,28,0.439,0.267,1,GO:1901021,BP,,2424
protein kinase C-activating G-protein coupled receptor signaling pathway,26,0.437,0.267,1,GO:0007205,BP,,2425
positive regulation of osteoblast differentiation,53,0.456,0.267,1,GO:0045669,BP,,2426
establishment or maintenance of epithelial cell apical/basal polarity,30,0.559,0.267,1,GO:0045197,BP,,2427
regulation of interleukin-6 production,84,0.465,0.267,1,GO:0032675,BP,,2428
negative regulation of extrinsic apoptotic signaling pathway,86,0.535,0.267,1,GO:2001237,BP,,2429
lipid particle organization,12,0.407,0.267,1,GO:0034389,BP,,2430
glycerophospholipid catabolic process,16,0.58,0.267,1,GO:0046475,BP,,2431
protein N-linked glycosylation,59,0.458,0.267,1,GO:0006487,BP,,2432
regulation of glycogen biosynthetic process,24,0.565,0.267,1,"GO:0005979,GO:0010962",BP,regulation of glucan biosynthetic process,2433
metanephric tubule development,20,0.428,0.268,1,GO:0072170,BP,,2434
positive regulation of protein localization to membrane,98,0.468,0.268,1,GO:1905477,BP,,2435
regulation of interleukin-2 production,40,0.449,0.269,1,GO:0032663,BP,,2436
left/right axis specification,12,0.592,0.269,1,GO:0070986,BP,,2437
embryonic placenta development,74,0.537,0.269,1,GO:0001892,BP,,2438
negative regulation of supramolecular fiber organization,99,0.468,0.27,1,GO:1902904,BP,,2439
"ligase activity, forming carbon-sulfur bonds",36,0.447,0.27,1,GO:0016877,MF,,2440
cellular response to topologically incorrect protein,134,0.472,0.271,1,GO:0035967,BP,,2441
one-carbon metabolic process,31,0.557,0.271,1,GO:0006730,BP,,2442
poly-pyrimidine tract binding,18,0.575,0.271,1,GO:0008187,MF,,2443
inorganic cation import into cell,33,0.555,0.271,1,"GO:0098659,GO:0099587",BP,inorganic ion import into cell,2444
amine catabolic process,23,0.434,0.271,1,GO:0009310,BP,,2445
cerebral cortex neuron differentiation,22,0.432,0.272,1,GO:0021895,BP,,2446
regulation of meiotic cell cycle,26,0.562,0.272,1,GO:0051445,BP,,2447
activin receptor signaling pathway,32,0.556,0.272,1,GO:0032924,BP,,2448
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,34,0.446,0.272,1,GO:1901030,BP,,2449
regulation of rhodopsin mediated signaling pathway,21,0.431,0.272,1,GO:0022400,BP,,2450
regulation of appetite,20,0.429,0.272,1,GO:0032098,BP,,2451
cytoplasmic sequestering of protein,37,0.448,0.273,1,GO:0051220,BP,,2452
regulation of stress fiber assembly,67,0.539,0.273,1,GO:0051492,BP,,2453
negative regulation of smoothened signaling pathway,25,0.563,0.273,1,GO:0045879,BP,,2454
regulation of centriole replication,14,0.585,0.273,1,GO:0046599,BP,,2455
dopaminergic neuron differentiation,28,0.56,0.273,1,GO:0071542,BP,,2456
response to mechanical stimulus,180,0.524,0.273,1,GO:0009612,BP,,2457
guanyl-nucleotide exchange factor complex,13,0.588,0.273,1,GO:0032045,CC,,2458
catecholamine binding,12,0.409,0.274,1,GO:1901338,MF,,2459
DNA polymerase activity,30,0.558,0.274,1,GO:0034061,MF,,2460
"phosphotransferase activity, nitrogenous group as acceptor",11,0.595,0.275,1,GO:0016775,MF,,2461
hydrogen peroxide metabolic process,38,0.449,0.275,1,GO:0042743,BP,,2462
intrinsic apoptotic signaling pathway by p53 class mediator,71,0.538,0.275,1,GO:0072332,BP,,2463
bicarbonate transport,40,0.55,0.275,1,GO:0015701,BP,,2464
modified amino acid transport,20,0.57,0.276,1,GO:0072337,BP,,2465
nucleobase-containing compound kinase activity,46,0.454,0.276,1,GO:0019205,MF,,2466
muscle cell development,134,0.473,0.277,1,GO:0055001,BP,,2467
intrinsic component of mitochondrial outer membrane,22,0.433,0.277,1,GO:0031306,CC,,2468
kinetochore assembly,12,0.409,0.277,1,GO:0051382,BP,,2469
regulation of histone phosphorylation,12,0.409,0.277,1,GO:0033127,BP,,2470
smooth endoplasmic reticulum,29,0.442,0.277,1,GO:0005790,CC,,2471
"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway",28,0.559,0.277,1,"GO:0035872,GO:0070423",BP,nucleotide-binding oligomerization domain containing signaling pathway,2472
protein O-linked mannosylation,12,0.409,0.277,1,GO:0035269,BP,,2473
negative regulation of establishment of protein localization to plasma membrane,10,0.599,0.277,1,GO:0090005,BP,,2474
calcium-release channel activity,16,0.578,0.277,1,"GO:0015278,GO:0099604",MF,ligand-gated calcium channel activity,2475
dermatan sulfate proteoglycan metabolic process,14,0.416,0.277,1,GO:0050655,BP,,2476
positive regulation of mitochondrial calcium ion concentration,10,0.401,0.277,1,GO:0051561,BP,,2477
negative regulation of peptide secretion,95,0.468,0.277,1,GO:0002792,BP,,2478
ovulation,19,0.572,0.277,1,GO:0030728,BP,,2479
Wnt signaling pathway involved in heart development,10,0.599,0.278,1,GO:0003306,BP,,2480
energy homeostasis,30,0.557,0.278,1,GO:0097009,BP,,2481
integrin binding,94,0.532,0.278,1,GO:0005178,MF,,2482
cellular response to glucose starvation,32,0.555,0.278,1,GO:0042149,BP,,2483
Golgi lumen,68,0.462,0.278,1,GO:0005796,CC,,2484
N-acetylglucosamine metabolic process,15,0.419,0.278,1,GO:0006044,BP,,2485
'de novo' posttranslational protein folding,18,0.426,0.279,1,GO:0051084,BP,,2486
tau-protein kinase activity,11,0.406,0.279,1,GO:0050321,MF,,2487
cerebellar cortex morphogenesis,29,0.442,0.279,1,GO:0021696,BP,,2488
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,16,0.422,0.28,1,GO:1902236,BP,,2489
regulation of phosphoprotein phosphatase activity,37,0.449,0.28,1,GO:0043666,BP,,2490
receptor internalization,78,0.465,0.28,1,GO:0031623,BP,,2491
Golgi ribbon formation,10,0.599,0.28,1,GO:0090161,BP,,2492
viral genome replication,94,0.532,0.28,1,GO:0019079,BP,,2493
ribosomal large subunit assembly,20,0.43,0.28,1,GO:0000027,BP,,2494
ceramide biosynthetic process,46,0.546,0.28,1,GO:0046513,BP,,2495
cellular response to leptin stimulus,15,0.419,0.28,1,GO:0044320,BP,,2496
platelet dense granule lumen,10,0.598,0.281,1,GO:0031089,CC,,2497
collecting duct development,12,0.59,0.281,1,GO:0072044,BP,,2498
regulation of dephosphorylation,130,0.473,0.281,1,GO:0035303,BP,,2499
regulation of chemokine production,50,0.456,0.281,1,GO:0032642,BP,,2500
maintenance of location in cell,91,0.533,0.282,1,GO:0051651,BP,,2501
gene silencing by RNA,130,0.527,0.282,1,GO:0031047,BP,,2502
"ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism",30,0.557,0.282,1,GO:0015662,MF,,2503
dermatan sulfate metabolic process,12,0.41,0.282,1,GO:0030205,BP,,2504
dorsal/ventral pattern formation,81,0.535,0.282,1,GO:0009953,BP,,2505
formation of extrachromosomal circular DNA,12,0.41,0.282,1,"GO:0001325,GO:0090656,GO:0090737",BP,"t-circle formation,telomere maintenance via telomere trimming",2506
thalamus development,14,0.417,0.282,1,GO:0021794,BP,,2507
Ral GTPase binding,13,0.414,0.282,1,GO:0017160,MF,,2508
single fertilization,85,0.534,0.282,1,GO:0007338,BP,,2509
regulation of protein tyrosine kinase activity,62,0.54,0.282,1,GO:0061097,BP,,2510
norepinephrine transport,19,0.429,0.283,1,GO:0015874,BP,,2511
myosin filament,16,0.422,0.283,1,GO:0032982,CC,,2512
regulation of axon guidance,20,0.569,0.283,1,GO:1902667,BP,,2513
pro-B cell differentiation,10,0.402,0.284,1,GO:0002328,BP,,2514
mitochondrial RNA processing,12,0.589,0.284,1,GO:0000963,BP,,2515
lymph node development,14,0.583,0.284,1,GO:0048535,BP,,2516
epithelial cell morphogenesis,26,0.561,0.284,1,GO:0003382,BP,,2517
inner ear receptor cell development,37,0.551,0.284,1,GO:0060119,BP,,2518
response to angiotensin,15,0.42,0.285,1,GO:1990776,BP,,2519
I band,118,0.471,0.285,1,GO:0031674,CC,,2520
cartilage morphogenesis,10,0.598,0.285,1,GO:0060536,BP,,2521
peroxisomal membrane,55,0.542,0.285,1,"GO:0005778,GO:0031903",CC,microbody membrane,2522
positive regulation of CREB transcription factor activity,14,0.583,0.285,1,GO:0032793,BP,,2523
negative regulation of interleukin-1 production,13,0.586,0.285,1,GO:0032692,BP,,2524
ciliary tip,44,0.453,0.285,1,GO:0097542,CC,,2525
cAMP metabolic process,121,0.472,0.286,1,GO:0046058,BP,,2526
regulation of DNA methylation,16,0.577,0.286,1,GO:0044030,BP,,2527
placenta development,125,0.528,0.286,1,GO:0001890,BP,,2528
phosphatidylinositol-5-phosphate binding,11,0.593,0.286,1,GO:0010314,MF,,2529
endosome transport via multivesicular body sorting pathway,11,0.593,0.286,1,GO:0032509,BP,,2530
endothelial cell proliferation,102,0.531,0.287,1,GO:0001935,BP,,2531
renal absorption,13,0.585,0.287,1,GO:0070293,BP,,2532
iron ion transport,55,0.458,0.287,1,GO:0006826,BP,,2533
negative regulation of peptidyl-threonine phosphorylation,15,0.421,0.287,1,GO:0010801,BP,,2534
endoplasmic reticulum unfolded protein response,115,0.471,0.287,1,GO:0030968,BP,,2535
endonuclease activity,97,0.531,0.287,1,GO:0004519,MF,,2536
oxygen binding,30,0.444,0.287,1,GO:0019825,MF,,2537
kinetochore,109,0.47,0.287,1,GO:0000776,CC,,2538
nuclear hormone receptor binding,127,0.527,0.287,1,GO:0035257,MF,,2539
negative regulation of humoral immune response,10,0.597,0.287,1,GO:0002921,BP,,2540
collagen binding,57,0.541,0.287,1,GO:0005518,MF,,2541
voltage-gated potassium channel activity,79,0.535,0.287,1,GO:0005249,MF,,2542
negative regulation of cation transmembrane transport,57,0.459,0.287,1,GO:1904063,BP,,2543
regulation of icosanoid secretion,13,0.415,0.288,1,GO:0032303,BP,,2544
regulation of cyclin-dependent protein serine/threonine kinase activity,76,0.535,0.288,1,GO:0000079,BP,,2545
epithelial to mesenchymal transition,114,0.529,0.288,1,GO:0001837,BP,,2546
"signal transducer activity, downstream of receptor",132,0.527,0.288,1,GO:0005057,MF,,2547
estrogen receptor binding,40,0.549,0.288,1,GO:0030331,MF,,2548
branched-chain amino acid metabolic process,22,0.435,0.288,1,GO:0009081,BP,,2549
protein K48-linked ubiquitination,45,0.454,0.288,1,GO:0070936,BP,,2550
chondrocyte differentiation,86,0.467,0.289,1,GO:0002062,BP,,2551
regulation of ATPase activity,56,0.459,0.289,1,GO:0043462,BP,,2552
regulation of axon extension involved in axon guidance,16,0.577,0.289,1,GO:0048841,BP,,2553
low-density lipoprotein particle receptor binding,13,0.415,0.289,1,GO:0050750,MF,,2554
hyaluronan catabolic process,14,0.418,0.29,1,GO:0030214,BP,,2555
BLOC complex,20,0.432,0.29,1,GO:0031082,CC,,2556
phosphatidylcholine binding,14,0.418,0.29,1,"GO:0031210,GO:0050997",MF,quaternary ammonium group binding,2557
embryonic epithelial tube formation,109,0.529,0.29,1,GO:0001838,BP,,2558
regulation of cysteine-type endopeptidase activity,184,0.523,0.29,1,GO:2000116,BP,,2559
Set1C/COMPASS complex,12,0.412,0.29,1,GO:0048188,CC,,2560
SMAD binding,67,0.537,0.29,1,GO:0046332,MF,,2561
exon-exon junction complex,19,0.57,0.291,1,GO:0035145,CC,,2562
HOPS complex,14,0.418,0.291,1,GO:0030897,CC,,2563
renal vesicle morphogenesis,17,0.574,0.291,1,GO:0072077,BP,,2564
insulin receptor signaling pathway,116,0.472,0.291,1,GO:0008286,BP,,2565
negative regulation of leukocyte cell-cell adhesion,81,0.466,0.291,1,GO:1903038,BP,,2566
sulfur compound transport,29,0.557,0.291,1,GO:0072348,BP,,2567
nitrogen cycle metabolic process,12,0.412,0.291,1,GO:0071941,BP,,2568
negative regulation of cytoskeleton organization,107,0.47,0.292,1,GO:0051494,BP,,2569
DNA replication-independent nucleosome assembly,35,0.552,0.292,1,GO:0006336,BP,,2570
ubiquinone metabolic process,14,0.419,0.292,1,GO:0006743,BP,,2571
retina homeostasis,55,0.541,0.292,1,GO:0001895,BP,,2572
parasympathetic nervous system development,14,0.581,0.292,1,GO:0048486,BP,,2573
poly(A) binding,10,0.596,0.292,1,GO:0008143,MF,,2574
negative regulation of cell-substrate adhesion,46,0.545,0.292,1,GO:0010812,BP,,2575
regulation of phospholipid biosynthetic process,12,0.412,0.293,1,GO:0071071,BP,,2576
positive regulation of cAMP biosynthetic process,65,0.462,0.293,1,GO:0030819,BP,,2577
negative regulation of response to wounding,65,0.462,0.293,1,GO:1903035,BP,,2578
mast cell granule,20,0.432,0.294,1,GO:0042629,CC,,2579
establishment of skin barrier,14,0.581,0.294,1,GO:0061436,BP,,2580
guanosine-containing compound biosynthetic process,14,0.419,0.294,1,GO:1901070,BP,,2581
positive regulation of nitric-oxide synthase biosynthetic process,12,0.587,0.294,1,GO:0051770,BP,,2582
mechanoreceptor differentiation,52,0.542,0.294,1,GO:0042490,BP,,2583
monocarboxylic acid transport,127,0.527,0.295,1,GO:0015718,BP,,2584
"negative regulation of CD4-positive, alpha-beta T cell differentiation",11,0.591,0.295,1,GO:0043371,BP,,2585
cardiac muscle cell action potential,62,0.538,0.295,1,GO:0086001,BP,,2586
polypeptide N-acetylgalactosaminyltransferase activity,19,0.431,0.295,1,GO:0004653,MF,,2587
spindle midzone,23,0.563,0.295,1,GO:0051233,CC,,2588
positive regulation of JNK cascade,101,0.53,0.295,1,GO:0046330,BP,,2589
phosphorylation of RNA polymerase II C-terminal domain,16,0.576,0.295,1,GO:0070816,BP,,2590
positive regulation of syncytium formation by plasma membrane fusion,18,0.571,0.295,1,GO:0060143,BP,,2591
U1 snRNP,17,0.573,0.295,1,GO:0005685,CC,,2592
mannose binding,14,0.581,0.296,1,GO:0005537,MF,,2593
negative regulation of cardiac muscle tissue development,21,0.434,0.296,1,GO:0055026,BP,,2594
regulation of skeletal muscle cell proliferation,10,0.596,0.296,1,GO:0014857,BP,,2595
protein destabilization,34,0.448,0.296,1,GO:0031648,BP,,2596
protein processing,187,0.522,0.296,1,GO:0016485,BP,,2597
negative regulation of organ growth,20,0.433,0.296,1,GO:0046621,BP,,2598
carbohydrate phosphorylation,20,0.433,0.296,1,GO:0046835,BP,,2599
vesicle docking,60,0.461,0.297,1,GO:0048278,BP,,2600
lens fiber cell differentiation,24,0.438,0.297,1,GO:0070306,BP,,2601
ATP-dependent chromatin remodeling,55,0.541,0.297,1,GO:0043044,BP,,2602
gonadotropin secretion,13,0.416,0.297,1,GO:0032274,BP,,2603
fatty acid transporter activity,13,0.417,0.297,1,GO:0015245,MF,,2604
phospholipid scrambling,10,0.595,0.298,1,GO:0017121,BP,,2605
pseudouridine synthase activity,12,0.413,0.298,1,GO:0009982,MF,,2606
positive regulation of actin filament polymerization,79,0.466,0.298,1,GO:0030838,BP,,2607
regulation of fibroblast proliferation,76,0.465,0.298,1,GO:0048145,BP,,2608
response to epinephrine,16,0.575,0.298,1,GO:0071871,BP,,2609
negative regulation of protein import into nucleus,56,0.46,0.298,1,"GO:0042308,GO:1904590",BP,negative regulation of protein import,2610
regulation of cell division,115,0.528,0.299,1,GO:0051302,BP,,2611
COP9 signalosome,30,0.445,0.3,1,GO:0008180,CC,,2612
nuclear euchromatin,22,0.564,0.3,1,GO:0005719,CC,,2613
"regulation of DNA-templated transcription, elongation",38,0.451,0.3,1,GO:0032784,BP,,2614
Golgi to plasma membrane transport,41,0.547,0.3,1,GO:0006893,BP,,2615
GABA receptor binding,12,0.414,0.3,1,GO:0050811,MF,,2616
neurotransmitter biosynthetic process,17,0.427,0.3,1,GO:0042136,BP,,2617
maintenance of sister chromatid cohesion,11,0.59,0.3,1,"GO:0034086,GO:0034088",BP,maintenance of mitotic sister chromatid cohesion,2618
phosphatidylcholine biosynthetic process,32,0.553,0.3,1,GO:0006656,BP,,2619
SH3/SH2 adaptor activity,48,0.543,0.301,1,GO:0005070,MF,,2620
spindle localization,30,0.555,0.301,1,GO:0051653,BP,,2621
insulin-like growth factor I binding,12,0.586,0.301,1,GO:0031994,MF,,2622
ectodermal placode development,16,0.575,0.301,1,GO:0071696,BP,,2623
nuclear pore complex assembly,10,0.594,0.301,1,GO:0051292,BP,,2624
mammary gland development,112,0.472,0.301,1,GO:0030879,BP,,2625
cAMP-mediated signaling,39,0.452,0.301,1,GO:0019933,BP,,2626
regulation of neutrophil chemotaxis,25,0.56,0.302,1,GO:0090022,BP,,2627
ERBB signaling pathway,134,0.526,0.302,1,GO:0038127,BP,,2628
oocyte development,34,0.449,0.302,1,GO:0048599,BP,,2629
regulation of neuron apoptotic process,177,0.477,0.302,1,GO:0043523,BP,,2630
nuclear localization sequence binding,22,0.564,0.302,1,GO:0008139,MF,,2631
primary neural tube formation,85,0.532,0.302,1,GO:0014020,BP,,2632
damaged DNA binding,50,0.542,0.302,1,GO:0003684,MF,,2633
negative regulation of neuron differentiation,175,0.477,0.303,1,GO:0045665,BP,,2634
positive regulation of production of molecular mediator of immune response,55,0.46,0.303,1,GO:0002702,BP,,2635
Golgi cisterna,86,0.468,0.303,1,GO:0031985,CC,,2636
regulation of cell killing,43,0.545,0.303,1,GO:0031341,BP,,2637
mRNA splice site selection,23,0.562,0.303,1,GO:0006376,BP,,2638
ATP hydrolysis coupled ion transmembrane transport,62,0.462,0.303,1,GO:0099131,BP,,2639
thiolester hydrolase activity,25,0.44,0.303,1,GO:0016790,MF,,2640
UV-damage excision repair,10,0.594,0.303,1,GO:0070914,BP,,2641
chemokine biosynthetic process,10,0.406,0.303,1,"GO:0042033,GO:0050755",BP,chemokine metabolic process,2642
preganglionic parasympathetic fiber development,13,0.582,0.303,1,GO:0021783,BP,,2643
double-strand break repair via homologous recombination,83,0.533,0.304,1,GO:0000724,BP,,2644
cell migration in hindbrain,13,0.582,0.304,1,GO:0021535,BP,,2645
methyl-CpG binding,17,0.572,0.304,1,GO:0008327,MF,,2646
cardiac septum development,85,0.532,0.304,1,GO:0003279,BP,,2647
regulation of posttranscriptional gene silencing,31,0.553,0.304,1,"GO:0060147,GO:0060966",BP,regulation of gene silencing by RNA,2648
pyrimidine nucleotide metabolic process,45,0.456,0.304,1,GO:0006220,BP,,2649
histone H3-K27 methylation,13,0.582,0.304,1,GO:0070734,BP,,2650
cartilage development,158,0.476,0.304,1,GO:0051216,BP,,2651
microtubule end,20,0.566,0.305,1,GO:1990752,CC,,2652
myofibril assembly,51,0.458,0.305,1,GO:0030239,BP,,2653
GABA-A receptor complex,13,0.418,0.305,1,GO:1902711,CC,,2654
telomere organization,124,0.473,0.305,1,GO:0032200,BP,,2655
RNA polymerase II transcription cofactor activity,83,0.533,0.305,1,GO:0001104,MF,,2656
organelle outer membrane,159,0.476,0.305,1,GO:0031968,CC,,2657
regulation of protein maturation,68,0.536,0.305,1,GO:1903317,BP,,2658
thymus development,38,0.548,0.305,1,GO:0048538,BP,,2659
negative regulation of epithelial cell migration,47,0.457,0.306,1,GO:0010633,BP,,2660
5'-3' exonuclease activity,12,0.585,0.307,1,GO:0008409,MF,,2661
metencephalon development,92,0.469,0.307,1,GO:0022037,BP,,2662
morphogenesis of embryonic epithelium,132,0.526,0.307,1,GO:0016331,BP,,2663
positive regulation of JAK-STAT cascade,48,0.457,0.308,1,"GO:0046427,GO:1904894",BP,positive regulation of STAT cascade,2664
I-kappaB phosphorylation,14,0.421,0.308,1,GO:0007252,BP,,2665
response to ATP,27,0.443,0.308,1,GO:0033198,BP,,2666
lateral ventricle development,11,0.411,0.308,1,GO:0021670,BP,,2667
cellular response to angiotensin,13,0.418,0.308,1,GO:1904385,BP,,2668
protease binding,96,0.47,0.308,1,GO:0002020,MF,,2669
positive regulation of lipid storage,20,0.434,0.309,1,GO:0010884,BP,,2670
regulation of protein processing,67,0.536,0.309,1,GO:0070613,BP,,2671
RNAi effector complex,11,0.589,0.309,1,GO:0031332,CC,,2672
positive regulation of vascular endothelial growth factor receptor signaling pathway,14,0.579,0.309,1,GO:0030949,BP,,2673
mesenchymal cell proliferation,44,0.544,0.309,1,GO:0010463,BP,,2674
lysine-acetylated histone binding,17,0.571,0.309,1,GO:0070577,MF,,2675
mucus secretion,10,0.407,0.309,1,GO:0070254,BP,,2676
positive regulation of receptor-mediated endocytosis,39,0.547,0.31,1,GO:0048260,BP,,2677
regulation of tyrosine phosphorylation of Stat1 protein,12,0.585,0.31,1,GO:0042510,BP,,2678
apicolateral plasma membrane,17,0.571,0.31,1,GO:0016327,CC,,2679
regulation of protein targeting to mitochondrion,79,0.467,0.31,1,GO:1903214,BP,,2680
cell cycle DNA replication,34,0.45,0.31,1,GO:0044786,BP,,2681
translational initiation,172,0.478,0.31,1,GO:0006413,BP,,2682
DNA replication origin binding,10,0.407,0.311,1,GO:0003688,MF,,2683
metanephric nephron morphogenesis,24,0.56,0.311,1,GO:0072273,BP,,2684
cell fate specification,57,0.539,0.311,1,GO:0001708,BP,,2685
regulation of cardiac conduction,64,0.463,0.311,1,GO:1903779,BP,,2686
regulation of kidney development,47,0.543,0.311,1,GO:0090183,BP,,2687
transition metal ion homeostasis,98,0.47,0.311,1,GO:0055076,BP,,2688
"RNA splicing, via endonucleolytic cleavage and ligation",17,0.571,0.311,1,GO:0000394,BP,,2689
positive regulation of cell division,69,0.535,0.312,1,GO:0051781,BP,,2690
potassium ion transport,199,0.521,0.312,1,GO:0006813,BP,,2691
juxtaparanode region of axon,10,0.592,0.312,1,GO:0044224,CC,,2692
negative regulation of cell motility,198,0.479,0.312,1,GO:2000146,BP,,2693
triglyceride biosynthetic process,38,0.547,0.312,1,GO:0019432,BP,,2694
detection of biotic stimulus,14,0.422,0.312,1,GO:0009595,BP,,2695
negative regulation of histone H3-K9 methylation,10,0.592,0.312,1,GO:0051573,BP,,2696
negative regulation of circadian rhythm,13,0.419,0.312,1,GO:0042754,BP,,2697
negative regulation of cell migration,187,0.479,0.313,1,GO:0030336,BP,,2698
positive regulation of transforming growth factor beta production,16,0.427,0.313,1,GO:0071636,BP,,2699
phosphatidylinositol phosphate 4-phosphatase activity,10,0.592,0.313,1,GO:0034596,MF,,2700
positive regulation of cell size,11,0.588,0.313,1,GO:0045793,BP,,2701
cellular response to antibiotic,14,0.578,0.313,1,GO:0071236,BP,,2702
prespliceosome,16,0.573,0.314,1,GO:0071010,CC,,2703
positive regulation of interferon-gamma production,48,0.458,0.314,1,GO:0032729,BP,,2704
mitochondrial outer membrane,143,0.476,0.314,1,GO:0005741,CC,,2705
oligosaccharide biosynthetic process,15,0.425,0.314,1,GO:0009312,BP,,2706
hair follicle maturation,15,0.425,0.314,1,GO:0048820,BP,,2707
steroid hormone secretion,15,0.575,0.314,1,GO:0035929,BP,,2708
chondrocyte differentiation involved in endochondral bone morphogenesis,10,0.592,0.314,1,GO:0003413,BP,,2709
positive regulation of DNA metabolic process,174,0.478,0.315,1,GO:0051054,BP,,2710
positive regulation of translational initiation,18,0.432,0.315,1,GO:0045948,BP,,2711
sodium ion import,13,0.581,0.315,1,GO:0097369,BP,,2712
deoxyribose phosphate metabolic process,29,0.446,0.315,1,GO:0019692,BP,,2713
positive regulation of epithelial cell migration,100,0.529,0.315,1,GO:0010634,BP,,2714
NF-kappaB binding,26,0.557,0.315,1,GO:0051059,MF,,2715
morphogenesis of an epithelial sheet,44,0.544,0.316,1,GO:0002011,BP,,2716
dendritic spine maintenance,12,0.416,0.316,1,GO:0097062,BP,,2717
microtubule anchoring,18,0.568,0.316,1,GO:0034453,BP,,2718
cation-transporting ATPase activity,55,0.461,0.316,1,GO:0019829,MF,,2719
negative regulation of protein localization to cell surface,11,0.413,0.316,1,GO:2000009,BP,,2720
ligand-dependent nuclear receptor binding,20,0.565,0.316,1,GO:0016922,MF,,2721
regulation of monocyte chemotaxis,16,0.428,0.316,1,GO:0090025,BP,,2722
microtubule plus-end,15,0.575,0.317,1,GO:0035371,CC,,2723
negative regulation of transmembrane transport,72,0.466,0.317,1,GO:0034763,BP,,2724
positive regulation of lamellipodium assembly,14,0.423,0.317,1,GO:0010592,BP,,2725
CTP biosynthetic process,15,0.425,0.317,1,"GO:0006241,GO:0046036",BP,CTP metabolic process,2726
phasic smooth muscle contraction,12,0.417,0.318,1,GO:0014821,BP,,2727
C4-dicarboxylate transport,11,0.413,0.318,1,GO:0015740,BP,,2728
retinoic acid metabolic process,16,0.428,0.318,1,GO:0042573,BP,,2729
cellular response to platelet-derived growth factor stimulus,18,0.568,0.318,1,GO:0036120,BP,,2730
azurophil granule membrane,45,0.457,0.318,1,GO:0035577,CC,,2731
zinc ion homeostasis,22,0.439,0.318,1,GO:0055069,BP,,2732
DNA integration,10,0.591,0.318,1,GO:0015074,BP,,2733
protein binding involved in cell-cell adhesion,29,0.446,0.319,1,GO:0098632,MF,,2734
complement activation,45,0.457,0.319,1,GO:0006956,BP,,2735
positive regulation of B cell activation,61,0.463,0.319,1,GO:0050871,BP,,2736
regulation of synapse maturation,12,0.417,0.319,1,GO:0090128,BP,,2737
visual learning,43,0.456,0.319,1,GO:0008542,BP,,2738
SH3 domain binding,114,0.527,0.319,1,GO:0017124,MF,,2739
nephric duct morphogenesis,10,0.591,0.32,1,GO:0072178,BP,,2740
negative regulation of viral transcription,20,0.564,0.32,1,GO:0032897,BP,,2741
vesicle-mediated transport between endosomal compartments,36,0.452,0.321,1,GO:0098927,BP,,2742
aromatic amino acid family metabolic process,24,0.441,0.321,1,GO:0009072,BP,,2743
glycosyl compound catabolic process,34,0.451,0.321,1,GO:1901658,BP,,2744
regulation of axon extension,74,0.467,0.321,1,GO:0030516,BP,,2745
pigment cell differentiation,31,0.448,0.321,1,GO:0050931,BP,,2746
positive regulation of vascular smooth muscle cell proliferation,15,0.574,0.321,1,GO:1904707,BP,,2747
T cell tolerance induction,11,0.586,0.321,1,GO:0002517,BP,,2748
structural constituent of cytoskeleton,94,0.47,0.322,1,GO:0005200,MF,,2749
peptidyl-arginine N-methylation,10,0.41,0.322,1,"GO:0035246,GO:0016273,GO:0016274",BP,"arginine N-methyltransferase activity,protein-arginine N-methyltransferase activity",2750
negative regulation of viral release from host cell,14,0.576,0.322,1,GO:1902187,BP,,2751
response to amino acid,96,0.471,0.322,1,GO:0043200,BP,,2752
positive regulation of myoblast differentiation,17,0.569,0.322,1,GO:0045663,BP,,2753
cargo loading into vesicle,10,0.59,0.322,1,GO:0035459,BP,,2754
skeletal system morphogenesis,165,0.522,0.322,1,GO:0048705,BP,,2755
nucleobase-containing small molecule interconversion,22,0.439,0.322,1,GO:0015949,BP,,2756
branched-chain amino acid catabolic process,19,0.434,0.323,1,GO:0009083,BP,,2757
cell surface receptor signaling pathway involved in heart development,26,0.556,0.323,1,GO:0061311,BP,,2758
negative regulation of systemic arterial blood pressure,13,0.421,0.323,1,GO:0003085,BP,,2759
embryonic body morphogenesis,10,0.59,0.324,1,GO:0010172,BP,,2760
positive chemotaxis,46,0.458,0.324,1,GO:0050918,BP,,2761
negative regulation of interleukin-17 production,10,0.41,0.324,1,GO:0032700,BP,,2762
glycosyl compound metabolic process,131,0.475,0.324,1,GO:1901657,BP,,2763
midbrain development,81,0.468,0.324,1,GO:0030901,BP,,2764
phosphoprotein phosphatase activity,164,0.478,0.324,1,GO:0004721,MF,,2765
chloride channel regulator activity,16,0.571,0.325,1,GO:0017081,MF,,2766
feeding behavior,90,0.47,0.325,1,GO:0007631,BP,,2767
regulation of hydrogen peroxide-induced cell death,22,0.561,0.325,1,GO:1903205,BP,,2768
negative regulation of DNA binding,45,0.458,0.325,1,GO:0043392,BP,,2769
positive regulation of exosomal secretion,13,0.421,0.325,1,GO:1903543,BP,,2770
cellular response to glucocorticoid stimulus,50,0.54,0.326,1,GO:0071385,BP,,2771
regulation of extracellular matrix assembly,11,0.586,0.326,1,GO:1901201,BP,,2772
mRNA cap binding complex,11,0.586,0.326,1,GO:0005845,CC,,2773
regulation of fibroblast migration,29,0.447,0.327,1,GO:0010762,BP,,2774
succinate metabolic process,11,0.415,0.327,1,GO:0006105,BP,,2775
synapsis,34,0.549,0.327,1,GO:0007129,BP,,2776
chemokine production,56,0.462,0.327,1,GO:0032602,BP,,2777
female genitalia development,12,0.418,0.328,1,GO:0030540,BP,,2778
negative regulation of stress fiber assembly,17,0.569,0.328,1,GO:0051497,BP,,2779
response to leptin,19,0.435,0.328,1,GO:0044321,BP,,2780
GTP-Rho binding,17,0.569,0.328,1,GO:0017049,MF,,2781
spliceosomal tri-snRNP complex assembly,11,0.415,0.328,1,GO:0000244,BP,,2782
intercellular bridge,38,0.546,0.329,1,GO:0045171,CC,,2783
peptide-lysine-N-acetyltransferase activity,51,0.54,0.329,1,GO:0061733,MF,,2784
negative regulation of protein complex assembly,103,0.472,0.329,1,GO:0031333,BP,,2785
negative regulation of wound healing,54,0.462,0.329,1,GO:0061045,BP,,2786
regulation of glucose metabolic process,84,0.531,0.33,1,GO:0010906,BP,,2787
diol metabolic process,10,0.589,0.33,1,GO:0034311,BP,,2788
positive regulation of catecholamine secretion,12,0.419,0.33,1,GO:0033605,BP,,2789
chondrocyte development,25,0.444,0.33,1,GO:0002063,BP,,2790
"oxidoreductase activity, acting on a heme group of donors",24,0.443,0.33,1,GO:0016675,MF,,2791
ubiquitin protein ligase activity,176,0.479,0.33,1,GO:0061630,MF,,2792
Lys48-specific deubiquitinase activity,10,0.589,0.33,1,GO:1990380,MF,,2793
T-helper 17 type immune response,11,0.585,0.331,1,GO:0072538,BP,,2794
manganese ion binding,48,0.459,0.331,1,GO:0030145,MF,,2795
SMAD protein complex assembly,13,0.422,0.331,1,GO:0007183,BP,,2796
actinin binding,37,0.454,0.331,1,GO:0042805,MF,,2797
positive regulation of focal adhesion assembly,22,0.44,0.331,1,GO:0051894,BP,,2798
NAD biosynthetic process,24,0.557,0.332,1,GO:0009435,BP,,2799
positive regulation of wound healing,36,0.547,0.332,1,GO:0090303,BP,,2800
thrombin-activated receptor signaling pathway,11,0.416,0.332,1,GO:0070493,BP,,2801
response to nitric oxide,17,0.568,0.333,1,GO:0071731,BP,,2802
positive regulation of cofactor metabolic process,12,0.581,0.333,1,"GO:0051194,GO:0051197",BP,positive regulation of coenzyme metabolic process,2803
positive regulation of extrinsic apoptotic signaling pathway,48,0.54,0.333,1,GO:2001238,BP,,2804
UTP biosynthetic process,11,0.416,0.333,1,GO:0006228,BP,,2805
"negative regulation of DNA damage response, signal transduction by p53 class mediator",14,0.425,0.334,1,GO:0043518,BP,,2806
Ada2/Gcn5/Ada3 transcription activator complex,13,0.423,0.334,1,GO:0005671,CC,,2807
neural tube development,140,0.524,0.334,1,GO:0021915,BP,,2808
regulation of astrocyte differentiation,22,0.441,0.335,1,GO:0048710,BP,,2809
ventral spinal cord interneuron differentiation,14,0.574,0.335,1,GO:0021514,BP,,2810
pyrimidine ribonucleoside metabolic process,30,0.449,0.335,1,GO:0046131,BP,,2811
regulation of protein kinase C signaling,14,0.574,0.336,1,GO:0090036,BP,,2812
regulation of focal adhesion assembly,49,0.54,0.336,1,"GO:0051893,GO:0090109",BP,regulation of cell-substrate junction assembly,2813
positive regulation of neural precursor cell proliferation,41,0.457,0.336,1,GO:2000179,BP,,2814
positive regulation of icosanoid secretion,11,0.416,0.336,1,"GO:0032305,GO:2000193",BP,positive regulation of fatty acid transport,2815
mesonephric tubule morphogenesis,56,0.537,0.336,1,GO:0072171,BP,,2816
forebrain cell migration,58,0.463,0.336,1,GO:0021885,BP,,2817
neurotrophin signaling pathway,31,0.45,0.336,1,GO:0038179,BP,,2818
voltage-gated sodium channel activity,22,0.559,0.336,1,"GO:0005248,GO:1905030",MF,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,2819
serotonin transport,15,0.428,0.337,1,GO:0006837,BP,,2820
positive regulation of lymphocyte migration,18,0.435,0.337,1,GO:2000403,BP,,2821
postsynaptic density organization,13,0.423,0.337,1,"GO:0097106,GO:0099084",BP,postsynaptic specialization organization,2822
heterochromatin assembly,10,0.588,0.337,1,GO:0031507,BP,,2823
regulation of insulin secretion involved in cellular response to glucose stimulus,42,0.457,0.337,1,GO:0061178,BP,,2824
columnar/cuboidal epithelial cell differentiation,86,0.53,0.338,1,GO:0002065,BP,,2825
integral component of mitochondrial outer membrane,21,0.44,0.338,1,GO:0031307,CC,,2826
programmed cell death involved in cell development,12,0.58,0.338,1,GO:0010623,BP,,2827
morphogenesis of an epithelial bud,15,0.571,0.339,1,GO:0060572,BP,,2828
positive regulation of stress fiber assembly,42,0.543,0.339,1,GO:0051496,BP,,2829
embryonic skeletal system development,93,0.529,0.339,1,GO:0048706,BP,,2830
regulation of mitotic spindle organization,23,0.558,0.339,1,GO:0060236,BP,,2831
pyrimidine ribonucleoside triphosphate biosynthetic process,16,0.431,0.339,1,GO:0009209,BP,,2832
voltage-gated anion channel activity,14,0.574,0.339,1,GO:0008308,MF,,2833
integral component of Golgi membrane,48,0.54,0.34,1,GO:0030173,CC,,2834
negative regulation of JNK cascade,29,0.449,0.34,1,GO:0046329,BP,,2835
carbohydrate transmembrane transporter activity,31,0.55,0.34,1,"GO:0015144,GO:1901476",MF,carbohydrate transporter activity,2836
positive regulation of double-strand break repair,12,0.58,0.34,1,GO:2000781,BP,,2837
"positive regulation of synaptic transmission, glutamatergic",19,0.437,0.341,1,GO:0051968,BP,,2838
viral RNA genome replication,19,0.437,0.341,1,"GO:0039694,GO:0039703",BP,RNA replication,2839
IRE1-mediated unfolded protein response,61,0.465,0.341,1,GO:0036498,BP,,2840
positive regulation of protein autophosphorylation,24,0.444,0.341,1,GO:0031954,BP,,2841
pyrimidine nucleoside triphosphate metabolic process,23,0.443,0.341,1,GO:0009147,BP,,2842
establishment or maintenance of apical/basal cell polarity,36,0.546,0.342,1,"GO:0035088,GO:0061245",BP,establishment or maintenance of bipolar cell polarity,2843
annealing activity,12,0.421,0.342,1,GO:0097617,MF,,2844
zinc II ion transport,22,0.441,0.342,1,GO:0006829,BP,,2845
cellular response to growth hormone stimulus,20,0.439,0.342,1,GO:0071378,BP,,2846
positive regulation of glycogen metabolic process,14,0.573,0.342,1,GO:0070875,BP,,2847
positive regulation of interleukin-8 secretion,10,0.413,0.343,1,GO:2000484,BP,,2848
complex of collagen trimers,19,0.563,0.343,1,GO:0098644,CC,,2849
coenzyme biosynthetic process,142,0.477,0.343,1,GO:0009108,BP,,2850
peptidyl-lysine dimethylation,14,0.573,0.343,1,GO:0018027,BP,,2851
organ growth,124,0.475,0.343,1,GO:0035265,BP,,2852
establishment of spindle orientation,17,0.566,0.343,1,GO:0051294,BP,,2853
cellular response to ionizing radiation,54,0.537,0.344,1,GO:0071479,BP,,2854
cellular protein complex localization,27,0.553,0.344,1,GO:0034629,BP,,2855
adenine nucleotide transport,12,0.579,0.344,1,GO:0051503,BP,,2856
removal of superoxide radicals,20,0.439,0.344,1,GO:0019430,BP,,2857
"3',5'-cyclic-nucleotide phosphodiesterase activity",23,0.557,0.344,1,GO:0004114,MF,,2858
positive regulation of calcium ion transmembrane transport,49,0.461,0.345,1,GO:1904427,BP,,2859
regulation of energy homeostasis,18,0.564,0.345,1,GO:2000505,BP,,2860
negative regulation of cell-matrix adhesion,27,0.553,0.345,1,GO:0001953,BP,,2861
phosphoric diester hydrolase activity,81,0.53,0.345,1,GO:0008081,MF,,2862
regulation of membrane repolarization,28,0.448,0.345,1,GO:0060306,BP,,2863
positive regulation of oligodendrocyte differentiation,13,0.576,0.346,1,GO:0048714,BP,,2864
positive regulation of alpha-beta T cell proliferation,15,0.43,0.346,1,GO:0046641,BP,,2865
negative regulation of intrinsic apoptotic signaling pathway,81,0.47,0.347,1,GO:2001243,BP,,2866
regulation of fertilization,17,0.566,0.347,1,GO:0080154,BP,,2867
endodermal cell fate commitment,14,0.427,0.347,1,GO:0001711,BP,,2868
cellular transition metal ion homeostasis,71,0.468,0.347,1,GO:0046916,BP,,2869
signal transduction in absence of ligand,60,0.535,0.347,1,"GO:0038034,GO:0097192",BP,extrinsic apoptotic signaling pathway in absence of ligand,2870
intrinsic apoptotic signaling pathway in response to DNA damage,88,0.529,0.347,1,GO:0008630,BP,,2871
regulation of muscle cell differentiation,146,0.523,0.347,1,GO:0051147,BP,,2872
cardiac muscle tissue growth,58,0.464,0.348,1,GO:0055017,BP,,2873
"blood coagulation, intrinsic pathway",13,0.575,0.348,1,GO:0007597,BP,,2874
"tRNA splicing, via endonucleolytic cleavage and ligation",14,0.572,0.348,1,GO:0006388,BP,,2875
synaptic vesicle fusion to presynaptic active zone membrane,15,0.43,0.348,1,"GO:0031629,GO:0099500",BP,vesicle fusion to plasma membrane,2876
regulation of androgen receptor signaling pathway,26,0.553,0.348,1,GO:0060765,BP,,2877
lipid digestion,16,0.432,0.349,1,GO:0044241,BP,,2878
rRNA modification,29,0.45,0.349,1,GO:0000154,BP,,2879
dynactin binding,10,0.414,0.349,1,GO:0034452,MF,,2880
motile cilium assembly,22,0.558,0.349,1,GO:0044458,BP,,2881
ubiquitin-like protein conjugating enzyme activity,29,0.45,0.349,1,GO:0061650,MF,,2882
platelet-derived growth factor receptor-beta signaling pathway,12,0.578,0.349,1,GO:0035791,BP,,2883
connexin complex,16,0.568,0.349,1,GO:0005922,CC,,2884
RNA polyadenylation,35,0.546,0.349,1,GO:0043631,BP,,2885
cGMP metabolic process,50,0.462,0.349,1,GO:0046068,BP,,2886
transaminase activity,17,0.434,0.35,1,GO:0008483,MF,,2887
glutamate receptor binding,32,0.452,0.35,1,GO:0035254,MF,,2888
negative regulation of adherens junction organization,16,0.568,0.35,1,GO:1903392,BP,,2889
transcription factor import into nucleus,78,0.469,0.35,1,GO:0042991,BP,,2890
hypothalamus development,17,0.434,0.35,1,GO:0021854,BP,,2891
regulation of macrophage chemotaxis,13,0.425,0.35,1,GO:0010758,BP,,2892
negative regulation of muscle hypertrophy,16,0.433,0.35,1,GO:0014741,BP,,2893
negative regulation of muscle organ development,37,0.544,0.351,1,GO:0048635,BP,,2894
mast cell migration,13,0.575,0.351,1,GO:0097531,BP,,2895
positive regulation of myeloid leukocyte mediated immunity,14,0.428,0.351,1,GO:0002888,BP,,2896
regulation of cell size,144,0.523,0.352,1,GO:0008361,BP,,2897
cyclin binding,22,0.557,0.352,1,GO:0030332,MF,,2898
cilium-dependent cell motility,25,0.446,0.352,1,GO:0060285,BP,,2899
regulation of mitochondrial membrane potential,57,0.464,0.353,1,GO:0051881,BP,,2900
negative regulation of fatty acid biosynthetic process,12,0.423,0.353,1,GO:0045717,BP,,2901
regulation of feeding behavior,14,0.428,0.353,1,GO:0060259,BP,,2902
double-strand break repair,167,0.521,0.353,1,GO:0006302,BP,,2903
regulation of fibroblast apoptotic process,13,0.574,0.353,1,GO:2000269,BP,,2904
"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor",14,0.572,0.354,1,GO:0050664,MF,,2905
regulation of organ growth,71,0.468,0.354,1,GO:0046620,BP,,2906
carboxy-terminal domain protein kinase complex,20,0.44,0.354,1,GO:0032806,CC,,2907
metaphase/anaphase transition of mitotic cell cycle,41,0.458,0.355,1,"GO:0007091,GO:0010965,GO:0044784,GO:1905818",BP,"regulation of mitotic sister chromatid separation,metaphase/anaphase transition of cell cycle,regulation of chromosome separation",2908
histone deacetylase activity (H3-K14 specific),11,0.581,0.355,1,"GO:0031078,GO:0032041",MF,NAD-dependent histone deacetylase activity (H3-K14 specific),2909
positive regulation of behavior,16,0.433,0.355,1,GO:0048520,BP,,2910
positive regulation of organic acid transport,24,0.445,0.355,1,GO:0032892,BP,,2911
icosanoid metabolic process,82,0.47,0.355,1,"GO:0006690,GO:1901568",BP,fatty acid derivative metabolic process,2912
negative regulation of muscle cell apoptotic process,25,0.553,0.355,1,GO:0010656,BP,,2913
negative regulation of protein localization to membrane,23,0.444,0.356,1,GO:1905476,BP,,2914
response to interferon-beta,21,0.558,0.356,1,GO:0035456,BP,,2915
hepatocyte proliferation,15,0.569,0.356,1,"GO:0072574,GO:0072575",BP,epithelial cell proliferation involved in liver morphogenesis,2916
ATPase activator activity,20,0.44,0.356,1,GO:0001671,MF,,2917
cholesterol binding,33,0.546,0.356,1,GO:0015485,MF,,2918
positive regulation of adenylate cyclase activity,43,0.459,0.357,1,GO:0045762,BP,,2919
regulation of smoothened signaling pathway,62,0.534,0.357,1,GO:0008589,BP,,2920
regulation of integrin-mediated signaling pathway,12,0.423,0.357,1,GO:2001044,BP,,2921
costamere,19,0.439,0.357,1,GO:0043034,CC,,2922
regulation of cell cycle checkpoint,31,0.548,0.357,1,GO:1901976,BP,,2923
female gonad development,77,0.53,0.358,1,GO:0008585,BP,,2924
glomerular epithelial cell development,12,0.577,0.358,1,GO:0072310,BP,,2925
embryonic digestive tract development,27,0.449,0.358,1,GO:0048566,BP,,2926
muscle alpha-actinin binding,17,0.436,0.359,1,GO:0051371,MF,,2927
negative regulation of secretion,166,0.479,0.359,1,GO:0051048,BP,,2928
intestinal epithelial cell differentiation,12,0.576,0.359,1,GO:0060575,BP,,2929
negative regulation of striated muscle tissue development,36,0.544,0.359,1,GO:0045843,BP,,2930
blood microparticle,89,0.472,0.359,1,GO:0072562,CC,,2931
positive regulation of chromatin organization,79,0.53,0.36,1,GO:1905269,BP,,2932
"regulation of synaptic transmission, dopaminergic",15,0.432,0.36,1,GO:0032225,BP,,2933
acetyl-CoA biosynthetic process from pyruvate,14,0.57,0.361,1,GO:0006086,BP,,2934
kinase activator activity,66,0.533,0.362,1,GO:0019209,MF,,2935
ribosomal small subunit binding,11,0.579,0.362,1,GO:0043024,MF,,2936
positive regulation of reactive oxygen species metabolic process,71,0.469,0.362,1,GO:2000379,BP,,2937
regulation of superoxide metabolic process,22,0.444,0.362,1,GO:0090322,BP,,2938
regulation of cardiac muscle cell membrane repolarization,21,0.443,0.362,1,GO:0099623,BP,,2939
neurological system process involved in regulation of systemic arterial blood pressure,12,0.576,0.362,1,GO:0001976,BP,,2940
regulation of G1/S transition of mitotic cell cycle,122,0.524,0.363,1,GO:2000045,BP,,2941
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,42,0.459,0.363,1,GO:1901028,BP,,2942
inflammatory cell apoptotic process,15,0.568,0.363,1,GO:0006925,BP,,2943
regulation of protein localization to membrane,132,0.477,0.363,1,GO:1905475,BP,,2944
regulation of type I interferon-mediated signaling pathway,25,0.552,0.364,1,GO:0060338,BP,,2945
B cell receptor signaling pathway,39,0.458,0.365,1,GO:0050853,BP,,2946
metanephric nephron development,38,0.543,0.365,1,GO:0072210,BP,,2947
phosphatidylserine acyl-chain remodeling,17,0.563,0.365,1,GO:0036150,BP,,2948
autophagosome,74,0.53,0.365,1,GO:0005776,CC,,2949
norepinephrine secretion,15,0.432,0.365,1,GO:0048243,BP,,2950
myeloid leukocyte differentiation,153,0.479,0.365,1,GO:0002573,BP,,2951
neurotransmitter reuptake,17,0.437,0.365,1,GO:0098810,BP,,2952
store-operated calcium entry,12,0.425,0.366,1,GO:0002115,BP,,2953
eating behavior,25,0.448,0.366,1,GO:0042755,BP,,2954
positive regulation of lymphocyte mediated immunity,53,0.536,0.366,1,GO:0002708,BP,,2955
negative regulation of oxidoreductase activity,16,0.435,0.366,1,GO:0051354,BP,,2956
C21-steroid hormone metabolic process,27,0.45,0.366,1,GO:0008207,BP,,2957
glomerular visceral epithelial cell development,11,0.579,0.366,1,GO:0072015,BP,,2958
positive regulation of immunoglobulin production,26,0.449,0.366,1,GO:0002639,BP,,2959
glucose catabolic process,28,0.451,0.367,1,GO:0006007,BP,,2960
developmental pigmentation,38,0.458,0.367,1,GO:0048066,BP,,2961
pancreas development,59,0.534,0.367,1,GO:0031016,BP,,2962
2'-deoxyribonucleotide metabolic process,27,0.45,0.367,1,GO:0009394,BP,,2963
lysosomal transport,70,0.531,0.368,1,GO:0007041,BP,,2964
5'-nucleotidase activity,10,0.418,0.368,1,GO:0008253,MF,,2965
pyrimidine ribonucleotide metabolic process,25,0.448,0.368,1,GO:0009218,BP,,2966
Cul4-RING E3 ubiquitin ligase complex,24,0.447,0.368,1,GO:0080008,CC,,2967
vitamin metabolic process,111,0.475,0.368,1,GO:0006766,BP,,2968
mammary gland morphogenesis,42,0.46,0.368,1,GO:0060443,BP,,2969
plasma membrane receptor complex,152,0.479,0.368,1,GO:0098802,CC,,2970
hair cell differentiation,34,0.545,0.368,1,GO:0035315,BP,,2971
hexose transmembrane transport,14,0.431,0.369,1,"GO:0035428,GO:1904659,GO:1905950,GO:0005355",BP,"glucose transmembrane transport,monosaccharide transmembrane transport,glucose transmembrane transporter activity",2972
multi-organism behavior,59,0.466,0.369,1,GO:0051705,BP,,2973
snRNA transcription,64,0.467,0.369,1,"GO:0009301,GO:0042795",BP,snRNA transcription from RNA polymerase II promoter,2974
positive regulation of peptidyl-threonine phosphorylation,24,0.447,0.369,1,GO:0010800,BP,,2975
positive regulation of MAP kinase activity,194,0.481,0.369,1,GO:0043406,BP,,2976
growth hormone receptor signaling pathway,19,0.44,0.369,1,GO:0060396,BP,,2977
cardiac muscle cell action potential involved in contraction,45,0.539,0.369,1,GO:0086002,BP,,2978
positive regulation of catenin import into nucleus,11,0.422,0.37,1,GO:0035413,BP,,2979
heat generation,15,0.433,0.37,1,GO:0031649,BP,,2980
gas transport,16,0.435,0.37,1,GO:0015669,BP,,2981
auditory receptor cell development,16,0.565,0.37,1,GO:0060117,BP,,2982
response to amphetamine,25,0.448,0.37,1,GO:0001975,BP,,2983
protein palmitoylation,21,0.556,0.371,1,GO:0018345,BP,,2984
histone deacetylation,77,0.53,0.371,1,GO:0016575,BP,,2985
quinone binding,17,0.437,0.371,1,GO:0048038,MF,,2986
regulation of adaptive immune response,99,0.526,0.371,1,GO:0002819,BP,,2987
development of primary sexual characteristics,173,0.52,0.371,1,GO:0045137,BP,,2988
negative regulation of protein localization to nucleus,69,0.469,0.372,1,GO:1900181,BP,,2989
cofactor biosynthetic process,176,0.48,0.372,1,GO:0051188,BP,,2990
protein localization to microtubule cytoskeleton,31,0.454,0.372,1,GO:0072698,BP,,2991
growth factor receptor binding,104,0.525,0.373,1,GO:0070851,MF,,2992
cellular response to follicle-stimulating hormone stimulus,11,0.578,0.373,1,GO:0071372,BP,,2993
regulation of intracellular steroid hormone receptor signaling pathway,60,0.533,0.373,1,GO:0033143,BP,,2994
retina layer formation,20,0.442,0.373,1,GO:0010842,BP,,2995
male meiosis,30,0.453,0.373,1,GO:0007140,BP,,2996
acetyl-CoA biosynthetic process,19,0.559,0.374,1,GO:0006085,BP,,2997
intracellular calcium activated chloride channel activity,14,0.569,0.374,1,"GO:0005229,GO:0061778",MF,intracellular chloride channel activity,2998
aorta development,48,0.537,0.374,1,GO:0035904,BP,,2999
regulation of autophagosome assembly,32,0.455,0.374,1,GO:2000785,BP,,3000
acetylcholine binding,14,0.431,0.375,1,GO:0042166,MF,,3001
regulation of cell proliferation involved in heart morphogenesis,14,0.569,0.375,1,GO:2000136,BP,,3002
response to dsRNA,69,0.531,0.375,1,GO:0043331,BP,,3003
mast cell activation involved in immune response,40,0.459,0.375,1,"GO:0002279,GO:0043303",BP,mast cell degranulation,3004
mitotic cell cycle checkpoint,129,0.523,0.375,1,GO:0007093,BP,,3005
positive regulation of cardiac muscle cell proliferation,18,0.56,0.375,1,GO:0060045,BP,,3006
positive regulation of cell cycle G1/S phase transition,27,0.451,0.375,1,GO:1902808,BP,,3007
nuclear pore,69,0.531,0.375,1,GO:0005643,CC,,3008
"hydrolase activity, hydrolyzing N-glycosyl compounds",16,0.564,0.376,1,GO:0016799,MF,,3009
non-motile cilium,104,0.475,0.376,1,GO:0097730,CC,,3010
ribonucleoprotein complex subunit organization,183,0.481,0.376,1,GO:0071826,BP,,3011
metanephric nephron tubule development,18,0.44,0.376,1,GO:0072234,BP,,3012
protein localization to cytoskeleton,34,0.456,0.377,1,GO:0044380,BP,,3013
nuclear replisome,27,0.549,0.377,1,GO:0043601,CC,,3014
female gamete generation,87,0.527,0.377,1,GO:0007292,BP,,3015
ubiquitin conjugating enzyme activity,28,0.452,0.377,1,GO:0061631,MF,,3016
hormone receptor binding,144,0.521,0.377,1,GO:0051427,MF,,3017
cGMP binding,12,0.426,0.377,1,GO:0030553,MF,,3018
regulation of mitotic sister chromatid segregation,48,0.463,0.378,1,GO:0033047,BP,,3019
regulation of steroid hormone secretion,13,0.571,0.378,1,GO:2000831,BP,,3020
endocardial cushion formation,21,0.556,0.378,1,GO:0003272,BP,,3021
myosin binding,49,0.464,0.378,1,GO:0017022,MF,,3022
90S preribosome,25,0.449,0.378,1,GO:0030686,CC,,3023
maternal behavior,14,0.568,0.378,1,"GO:0042711,GO:0060746",BP,parental behavior,3024
protein hydroxylation,20,0.557,0.379,1,GO:0018126,BP,,3025
mesenchymal cell differentiation,166,0.52,0.379,1,GO:0048762,BP,,3026
negative regulation of response to endoplasmic reticulum stress,36,0.458,0.38,1,GO:1903573,BP,,3027
negative regulation of cytokine production,181,0.481,0.38,1,GO:0001818,BP,,3028
regulation of glucose import in response to insulin stimulus,16,0.563,0.38,1,GO:2001273,BP,,3029
5'-3' RNA polymerase activity,35,0.457,0.38,1,"GO:0034062,GO:0097747",MF,RNA polymerase activity,3030
G-protein coupled peptide receptor activity,89,0.473,0.38,1,GO:0008528,MF,,3031
peptidase inhibitor activity,129,0.522,0.38,1,GO:0030414,MF,,3032
platelet activation,140,0.478,0.38,1,GO:0030168,BP,,3033
membrane depolarization during cardiac muscle cell action potential,21,0.555,0.38,1,GO:0086012,BP,,3034
secondary metabolite biosynthetic process,19,0.442,0.38,1,GO:0044550,BP,,3035
nucleotidyltransferase activity,110,0.524,0.381,1,GO:0016779,MF,,3036
trans-Golgi network transport vesicle membrane,14,0.432,0.381,1,GO:0012510,CC,,3037
regulation of oxidative stress-induced neuron death,18,0.44,0.381,1,GO:1903203,BP,,3038
negative regulation of androgen receptor signaling pathway,12,0.573,0.381,1,GO:0060766,BP,,3039
"translation regulator activity, nucleic acid binding",18,0.56,0.381,1,GO:0090079,MF,,3040
short-term memory,10,0.42,0.382,1,GO:0007614,BP,,3041
endoribonuclease complex,24,0.552,0.382,1,"GO:1902555,GO:1905348",CC,endonuclease complex,3042
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,13,0.43,0.382,1,GO:1902166,BP,,3043
metanephric epithelium development,24,0.448,0.382,1,GO:0072207,BP,,3044
positive regulation of carbohydrate metabolic process,57,0.533,0.382,1,GO:0045913,BP,,3045
cerebellar Purkinje cell layer formation,10,0.58,0.382,1,"GO:0021694,GO:0021702",BP,cerebellar Purkinje cell differentiation,3046
positive regulation of inflammatory response,76,0.471,0.382,1,GO:0050729,BP,,3047
regulation of muscle tissue development,107,0.524,0.382,1,GO:1901861,BP,,3048
regulation of pseudopodium assembly,11,0.576,0.382,1,GO:0031272,BP,,3049
actomyosin structure organization,153,0.521,0.382,1,GO:0031032,BP,,3050
regulation of mitotic nuclear division,137,0.478,0.383,1,GO:0007088,BP,,3051
regulation of cell-matrix adhesion,90,0.527,0.383,1,GO:0001952,BP,,3052
macrophage derived foam cell differentiation,27,0.549,0.383,1,"GO:0010742,GO:0090077",BP,foam cell differentiation,3053
protein binding involved in heterotypic cell-cell adhesion,10,0.58,0.384,1,GO:0086080,MF,,3054
formation of primary germ layer,105,0.525,0.384,1,GO:0001704,BP,,3055
positive regulation of muscle tissue development,55,0.534,0.384,1,GO:1901863,BP,,3056
regulation of mitotic metaphase/anaphase transition,39,0.46,0.384,1,"GO:0030071,GO:1902099",BP,regulation of metaphase/anaphase transition of cell cycle,3057
protein kinase A regulatory subunit binding,17,0.561,0.385,1,GO:0034237,MF,,3058
mast cell mediated immunity,42,0.461,0.385,1,GO:0002448,BP,,3059
fascia adherens,10,0.421,0.385,1,GO:0005916,CC,,3060
cytokine binding,77,0.471,0.385,1,GO:0019955,MF,,3061
response to vitamin,77,0.529,0.385,1,GO:0033273,BP,,3062
MKS complex,12,0.428,0.385,1,GO:0036038,CC,,3063
somatic diversification of immune receptors via somatic mutation,10,0.579,0.385,1,"GO:0002566,GO:0016446",BP,somatic hypermutation of immunoglobulin genes,3064
cardiac epithelial to mesenchymal transition,30,0.546,0.386,1,GO:0060317,BP,,3065
alcohol binding,60,0.532,0.386,1,GO:0043178,MF,,3066
regulation of muscle organ development,106,0.524,0.386,1,GO:0048634,BP,,3067
osteoblast development,14,0.433,0.386,1,GO:0002076,BP,,3068
guanylate kinase activity,12,0.428,0.386,1,GO:0004385,MF,,3069
cellular response to amino acid stimulus,57,0.467,0.386,1,GO:0071230,BP,,3070
negative regulation of interleukin-10 production,11,0.575,0.387,1,GO:0032693,BP,,3071
protein-DNA complex assembly,170,0.481,0.387,1,GO:0065004,BP,,3072
negative regulation of blood pressure,37,0.459,0.387,1,GO:0045776,BP,,3073
negative regulation of receptor-mediated endocytosis,14,0.433,0.387,1,GO:0048261,BP,,3074
ciliary transition zone,52,0.465,0.387,1,GO:0035869,CC,,3075
L-serine metabolic process,10,0.421,0.387,1,GO:0006563,BP,,3076
contractile actin filament bundle assembly,78,0.528,0.387,1,"GO:0030038,GO:0043149",BP,stress fiber assembly,3077
cellular response to fluid shear stress,17,0.561,0.387,1,GO:0071498,BP,,3078
maintenance of protein localization in organelle,27,0.548,0.387,1,GO:0072595,BP,,3079
lung development,158,0.52,0.387,1,GO:0030324,BP,,3080
adaptation of signaling pathway,16,0.438,0.388,1,GO:0023058,BP,,3081
negative regulation of potassium ion transmembrane transport,17,0.561,0.388,1,GO:1901380,BP,,3082
negative regulation of Ras protein signal transduction,40,0.461,0.388,1,GO:0046580,BP,,3083
regulation of glycolytic process,29,0.546,0.388,1,GO:0006110,BP,,3084
alpha-amino acid biosynthetic process,59,0.467,0.388,1,GO:1901607,BP,,3085
sodium:amino acid symporter activity,11,0.575,0.388,1,GO:0005283,MF,,3086
regulation of steroid metabolic process,59,0.468,0.388,1,GO:0019218,BP,,3087
auditory receptor cell differentiation,27,0.548,0.389,1,GO:0042491,BP,,3088
cell adhesion mediated by integrin,50,0.535,0.389,1,GO:0033627,BP,,3089
T cell migration,29,0.454,0.389,1,GO:0072678,BP,,3090
kinetochore organization,15,0.436,0.389,1,GO:0051383,BP,,3091
endochondral bone morphogenesis,45,0.537,0.389,1,GO:0060350,BP,,3092
strand displacement,20,0.556,0.389,1,GO:0000732,BP,,3093
regulation of spindle checkpoint,15,0.564,0.389,1,GO:0090231,BP,,3094
cytoplasmic microtubule,42,0.538,0.389,1,GO:0005881,CC,,3095
galactosyltransferase activity,30,0.455,0.389,1,GO:0008378,MF,,3096
AV node cell to bundle of His cell communication,10,0.579,0.389,1,GO:0086067,BP,,3097
"phagocytosis, recognition",14,0.566,0.39,1,GO:0006910,BP,,3098
cellular response to reactive nitrogen species,17,0.56,0.39,1,GO:1902170,BP,,3099
guanosine-containing compound metabolic process,45,0.463,0.39,1,GO:1901068,BP,,3100
secondary lysosome,13,0.569,0.39,1,GO:0005767,CC,,3101
integral component of peroxisomal membrane,13,0.431,0.39,1,"GO:0005779,GO:0031231",CC,intrinsic component of peroxisomal membrane,3102
adenosine receptor signaling pathway,10,0.422,0.39,1,GO:0001973,BP,,3103
regulation of response to reactive oxygen species,33,0.543,0.391,1,GO:1901031,BP,,3104
establishment of epithelial cell polarity,20,0.555,0.391,1,GO:0090162,BP,,3105
embryonic eye morphogenesis,28,0.547,0.391,1,GO:0048048,BP,,3106
actin filament-based movement,107,0.476,0.391,1,GO:0030048,BP,,3107
positive regulation of interleukin-8 production,35,0.458,0.391,1,GO:0032757,BP,,3108
protein-DNA complex subunit organization,196,0.482,0.392,1,GO:0071824,BP,,3109
animal organ formation,50,0.535,0.392,1,GO:0048645,BP,,3110
sprouting angiogenesis,64,0.531,0.392,1,GO:0002040,BP,,3111
positive regulation of cardiocyte differentiation,18,0.442,0.392,1,GO:1905209,BP,,3112
protein-chromophore linkage,10,0.578,0.392,1,GO:0018298,BP,,3113
positive regulation of myelination,11,0.575,0.392,1,GO:0031643,BP,,3114
integrin activation,14,0.434,0.392,1,GO:0033622,BP,,3115
error-prone translesion synthesis,19,0.443,0.392,1,GO:0042276,BP,,3116
response to platelet-derived growth factor,19,0.557,0.393,1,GO:0036119,BP,,3117
oxalate transport,10,0.422,0.393,1,"GO:0019532,GO:1902358,GO:0019531",BP,"sulfate transmembrane transport,oxalate transmembrane transporter activity",3118
epithelial cell-cell adhesion,15,0.436,0.393,1,GO:0090136,BP,,3119
"DNA damage response, signal transduction resulting in transcription",15,0.564,0.393,1,GO:0042772,BP,,3120
positive regulation of viral life cycle,81,0.473,0.393,1,GO:1903902,BP,,3121
sterol binding,37,0.541,0.393,1,GO:0032934,MF,,3122
unsaturated fatty acid biosynthetic process,35,0.458,0.393,1,GO:0006636,BP,,3123
Rap protein signal transduction,13,0.432,0.393,1,GO:0032486,BP,,3124
regulation of secondary metabolic process,11,0.426,0.393,1,GO:0043455,BP,,3125
ear morphogenesis,99,0.525,0.393,1,GO:0042471,BP,,3126
NuRD complex,17,0.56,0.393,1,"GO:0016581,GO:0090545",CC,CHD-type complex,3127
regulation of striated muscle tissue development,105,0.524,0.393,1,GO:0016202,BP,,3128
neurotransmitter uptake,22,0.447,0.394,1,GO:0001504,BP,,3129
negative regulation of neuron projection development,115,0.477,0.394,1,GO:0010977,BP,,3130
brown fat cell differentiation,33,0.457,0.394,1,GO:0050873,BP,,3131
clathrin adaptor activity,11,0.426,0.395,1,"GO:0035615,GO:0098748",MF,endocytic adaptor activity,3132
cellular response to cholesterol,11,0.426,0.395,1,GO:0071397,BP,,3133
fatty-acyl-CoA biosynthetic process,40,0.461,0.395,1,GO:0046949,BP,,3134
phosphatidylglycerol metabolic process,24,0.55,0.395,1,GO:0046471,BP,,3135
regulation of cyclin-dependent protein kinase activity,79,0.528,0.396,1,GO:1904029,BP,,3136
positive regulation of microtubule polymerization or depolymerization,20,0.555,0.396,1,GO:0031112,BP,,3137
regulation of cysteine-type endopeptidase activity involved in apoptotic process,173,0.519,0.396,1,GO:0043281,BP,,3138
phospholipase C activity,26,0.452,0.396,1,GO:0004629,MF,,3139
methyltransferase activity,181,0.518,0.396,1,GO:0008168,MF,,3140
ribonucleoprotein complex binding,87,0.526,0.397,1,GO:0043021,MF,,3141
regulation of centrosome duplication,36,0.541,0.397,1,GO:0010824,BP,,3142
negative regulation of fat cell differentiation,37,0.54,0.397,1,GO:0045599,BP,,3143
cytokinesis,123,0.522,0.397,1,GO:0000910,BP,,3144
maturation of LSU-rRNA,18,0.442,0.397,1,GO:0000470,BP,,3145
adrenergic receptor binding,17,0.441,0.397,1,GO:0031690,MF,,3146
endoplasmic reticulum organization,40,0.461,0.397,1,GO:0007029,BP,,3147
deoxyribonuclease activity,56,0.533,0.397,1,GO:0004536,MF,,3148
purine nucleoside metabolic process,67,0.47,0.397,1,GO:0042278,BP,,3149
melanin biosynthetic process,16,0.439,0.398,1,GO:0042438,BP,,3150
neutral lipid biosynthetic process,40,0.539,0.398,1,"GO:0046460,GO:0046463",BP,acylglycerol biosynthetic process,3151
DNA double-strand break processing,19,0.556,0.398,1,GO:0000729,BP,,3152
renal tubule development,83,0.527,0.399,1,GO:0061326,BP,,3153
M band,27,0.453,0.399,1,GO:0031430,CC,,3154
positive regulation of ossification,76,0.472,0.399,1,GO:0045778,BP,,3155
inositol lipid-mediated signaling,185,0.518,0.4,1,GO:0048017,BP,,3156
transcription factor TFIID complex,29,0.455,0.4,1,GO:0005669,CC,,3157
epidermal growth factor receptor signaling pathway,114,0.523,0.4,1,GO:0007173,BP,,3158
dendritic spine organization,57,0.468,0.4,1,GO:0097061,BP,,3159
CoA-ligase activity,10,0.423,0.401,1,GO:0016405,MF,,3160
negative regulation of calcium ion-dependent exocytosis,11,0.573,0.401,1,"GO:0045955,GO:0045125",BP,bioactive lipid receptor activity,3161
cell differentiation in spinal cord,37,0.54,0.401,1,GO:0021515,BP,,3162
acrosomal vesicle,79,0.527,0.401,1,GO:0001669,CC,,3163
ion channel binding,108,0.477,0.401,1,GO:0044325,MF,,3164
olfactory lobe development,32,0.457,0.401,1,GO:0021988,BP,,3165
endoderm development,67,0.53,0.401,1,GO:0007492,BP,,3166
S100 protein binding,13,0.433,0.402,1,GO:0044548,MF,,3167
sterol transport,67,0.53,0.402,1,GO:0015918,BP,,3168
eukaryotic translation initiation factor 3 complex,14,0.435,0.402,1,GO:0005852,CC,,3169
spermatid development,104,0.476,0.402,1,GO:0007286,BP,,3170
response to insecticide,10,0.577,0.402,1,GO:0017085,BP,,3171
platelet-derived growth factor receptor binding,14,0.435,0.402,1,GO:0005161,MF,,3172
response to exogenous dsRNA,30,0.456,0.402,1,GO:0043330,BP,,3173
cellular response to nitric oxide,14,0.565,0.402,1,GO:0071732,BP,,3174
interleukin-6 production,89,0.474,0.403,1,GO:0032635,BP,,3175
thyroid hormone generation,12,0.57,0.403,1,GO:0006590,BP,,3176
T cell chemotaxis,12,0.43,0.403,1,GO:0010818,BP,,3177
U2 snRNP,14,0.436,0.404,1,GO:0005686,CC,,3178
keratinocyte development,11,0.573,0.404,1,GO:0003334,BP,,3179
regulation of cell cycle G1/S phase transition,133,0.521,0.404,1,GO:1902806,BP,,3180
spermatid differentiation,108,0.477,0.405,1,GO:0048515,BP,,3181
positive regulation of epithelial cell differentiation,48,0.535,0.405,1,GO:0030858,BP,,3182
regulation of transcription factor import into nucleus,77,0.473,0.405,1,GO:0042990,BP,,3183
insulin secretion involved in cellular response to glucose stimulus,47,0.465,0.405,1,GO:0035773,BP,,3184
cytoplasmic pattern recognition receptor signaling pathway,46,0.535,0.405,1,GO:0002753,BP,,3185
NADH regeneration,23,0.45,0.405,1,"GO:0006735,GO:0061621,GO:0061718",BP,"canonical glycolysis,glucose catabolic process to pyruvate",3186
positive regulation of pseudopodium assembly,10,0.576,0.405,1,GO:0031274,BP,,3187
regulation of vasoconstriction,50,0.466,0.405,1,GO:0019229,BP,,3188
pyrimidine ribonucleotide biosynthetic process,23,0.45,0.405,1,GO:0009220,BP,,3189
regulation of metallopeptidase activity,12,0.431,0.406,1,GO:1905048,BP,,3190
forebrain regionalization,21,0.552,0.406,1,GO:0021871,BP,,3191
inorganic anion transport,136,0.521,0.406,1,GO:0015698,BP,,3192
regulation of nuclear division,149,0.48,0.406,1,GO:0051783,BP,,3193
"phosphatidylinositol-4,5-bisphosphate binding",51,0.466,0.406,1,GO:0005546,MF,,3194
outer membrane,161,0.481,0.406,1,GO:0019867,CC,,3195
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,55,0.532,0.406,1,GO:0002824,BP,,3196
photoreceptor connecting cilium,29,0.455,0.407,1,GO:0032391,CC,,3197
response to fibroblast growth factor,127,0.521,0.407,1,GO:0071774,BP,,3198
cyclin-dependent protein kinase holoenzyme complex,39,0.538,0.407,1,GO:0000307,CC,,3199
protein phosphatase binding,106,0.477,0.407,1,GO:0019903,MF,,3200
regulation of protein depolymerization,59,0.469,0.407,1,GO:1901879,BP,,3201
positive regulation of mesonephros development,20,0.553,0.408,1,GO:0061213,BP,,3202
serotonin receptor signaling pathway,18,0.444,0.408,1,"GO:0007210,GO:0098664,GO:0004993,GO:0099589",BP,"G-protein coupled serotonin receptor signaling pathway,G-protein coupled serotonin receptor activity,serotonin receptor activity",3203
interleukin-2 production,47,0.465,0.408,1,GO:0032623,BP,,3204
serine-type endopeptidase activity,129,0.521,0.409,1,GO:0004252,MF,,3205
GPI anchor metabolic process,26,0.547,0.409,1,GO:0006505,BP,,3206
positive regulation of transcription from RNA polymerase II promoter in response to stress,23,0.55,0.409,1,GO:0036003,BP,,3207
B cell mediated immunity,83,0.474,0.409,1,GO:0019724,BP,,3208
dendrite membrane,21,0.448,0.41,1,GO:0032590,CC,,3209
"transferase activity, transferring nitrogenous groups",19,0.445,0.41,1,GO:0016769,MF,,3210
positive regulation of lamellipodium organization,20,0.447,0.41,1,GO:1902745,BP,,3211
regulation of erythrocyte differentiation,33,0.541,0.41,1,GO:0045646,BP,,3212
bone morphogenesis,73,0.528,0.41,1,GO:0060349,BP,,3213
regulation of microtubule-based movement,16,0.559,0.411,1,GO:0060632,BP,,3214
mitotic sister chromatid separation,43,0.464,0.411,1,GO:0051306,BP,,3215
RNA polymerase II transcription factor complex,95,0.476,0.411,1,GO:0090575,CC,,3216
nonribosomal peptide biosynthetic process,17,0.558,0.411,1,GO:0019184,BP,,3217
very long-chain fatty acid metabolic process,25,0.453,0.411,1,GO:0000038,BP,,3218
regulation of sterol transport,32,0.458,0.412,1,"GO:0032371,GO:0032374",BP,regulation of cholesterol transport,3219
clathrin-coated endocytic vesicle,61,0.47,0.412,1,GO:0045334,CC,,3220
DNA-directed 5'-3' RNA polymerase activity,33,0.459,0.412,1,GO:0003899,MF,,3221
regulation of cilium movement,11,0.571,0.412,1,"GO:0003352,GO:0003356",BP,regulation of cilium beat frequency,3222
regulation of retinoic acid receptor signaling pathway,14,0.563,0.412,1,GO:0048385,BP,,3223
regulation of oxidoreductase activity,72,0.472,0.412,1,GO:0051341,BP,,3224
hormone metabolic process,143,0.52,0.413,1,GO:0042445,BP,,3225
"positive regulation of CD4-positive, alpha-beta T cell differentiation",18,0.444,0.413,1,GO:0043372,BP,,3226
metalloexopeptidase activity,49,0.534,0.413,1,GO:0008235,MF,,3227
negative regulation of platelet activation,16,0.441,0.413,1,GO:0010544,BP,,3228
spleen development,30,0.543,0.413,1,GO:0048536,BP,,3229
establishment of spindle localization,25,0.547,0.413,1,GO:0051293,BP,,3230
regulation of spindle assembly,15,0.561,0.413,1,GO:0090169,BP,,3231
negative regulation of lipid storage,15,0.561,0.413,1,GO:0010888,BP,,3232
regulation of gonadotropin secretion,10,0.425,0.414,1,GO:0032276,BP,,3233
natural killer cell activation,43,0.536,0.414,1,GO:0030101,BP,,3234
modification by host of symbiont morphology or physiology,45,0.535,0.414,1,GO:0051851,BP,,3235
cation:cation antiporter activity,27,0.545,0.414,1,GO:0015491,MF,,3236
mediator complex,31,0.458,0.414,1,GO:0016592,CC,,3237
histone H4-K5 acetylation,15,0.561,0.415,1,"GO:0043981,GO:0043982",BP,histone H4-K8 acetylation,3238
rough endoplasmic reticulum,61,0.47,0.415,1,GO:0005791,CC,,3239
regulation of cilium assembly,40,0.537,0.415,1,GO:1902017,BP,,3240
regulation of telomerase activity,38,0.462,0.415,1,GO:0051972,BP,,3241
long-chain fatty acid metabolic process,79,0.473,0.415,1,GO:0001676,BP,,3242
somatic recombination of immunoglobulin genes involved in immune response,30,0.457,0.415,1,"GO:0002204,GO:0002208,GO:0045190",BP,"somatic diversification of immunoglobulins involved in immune response,isotype switching",3243
cerebellar Purkinje cell layer morphogenesis,14,0.563,0.416,1,GO:0021692,BP,,3244
positive regulation of alpha-beta T cell differentiation,30,0.457,0.416,1,GO:0046638,BP,,3245
ncRNA catabolic process,17,0.557,0.416,1,GO:0034661,BP,,3246
transcytosis,12,0.432,0.417,1,GO:0045056,BP,,3247
somatic recombination of immunoglobulin gene segments,33,0.459,0.417,1,GO:0016447,BP,,3248
BAF-type complex,23,0.549,0.417,1,GO:0090544,CC,,3249
R-SMAD binding,20,0.552,0.417,1,GO:0070412,MF,,3250
negative regulation of cardiac muscle hypertrophy,14,0.437,0.418,1,GO:0010614,BP,,3251
positive regulation of protein binding,70,0.528,0.418,1,GO:0032092,BP,,3252
negative regulation of cell projection organization,138,0.48,0.418,1,GO:0031345,BP,,3253
regulation of cellular pH,85,0.475,0.418,1,GO:0030641,BP,,3254
heparan sulfate proteoglycan metabolic process,30,0.457,0.418,1,GO:0030201,BP,,3255
calcium ion regulated exocytosis,100,0.477,0.418,1,GO:0017156,BP,,3256
pyrimidine nucleoside monophosphate biosynthetic process,13,0.565,0.418,1,GO:0009130,BP,,3257
DNA demethylation,14,0.562,0.419,1,GO:0080111,BP,,3258
bone mineralization,87,0.475,0.419,1,GO:0030282,BP,,3259
negative regulation of anoikis,16,0.558,0.419,1,GO:2000811,BP,,3260
positive regulation of myeloid leukocyte differentiation,37,0.462,0.419,1,GO:0002763,BP,,3261
ventral spinal cord development,34,0.54,0.419,1,GO:0021517,BP,,3262
regulation of mitophagy,46,0.466,0.42,1,GO:1903146,BP,,3263
inner cell mass cell proliferation,10,0.426,0.42,1,GO:0001833,BP,,3264
O-methyltransferase activity,17,0.443,0.42,1,GO:0008171,MF,,3265
signal transduction involved in regulation of gene expression,14,0.438,0.42,1,GO:0023019,BP,,3266
positive regulation of chondrocyte differentiation,17,0.444,0.42,1,GO:0032332,BP,,3267
positive regulation of G1/S transition of mitotic cell cycle,22,0.45,0.42,1,GO:1900087,BP,,3268
neuromuscular junction,53,0.532,0.42,1,GO:0031594,CC,,3269
positive regulation of telomerase activity,30,0.457,0.42,1,GO:0051973,BP,,3270
maintenance of protein location in cell,76,0.527,0.42,1,GO:0032507,BP,,3271
cysteine-type endopeptidase activator activity involved in apoptotic process,16,0.442,0.421,1,GO:0008656,MF,,3272
anterior/posterior axis specification,38,0.538,0.421,1,GO:0009948,BP,,3273
SNAP receptor activity,33,0.46,0.421,1,GO:0005484,MF,,3274
negative regulation of T cell mediated immunity,13,0.564,0.421,1,GO:0002710,BP,,3275
glutathione biosynthetic process,15,0.56,0.421,1,GO:0006750,BP,,3276
N-glycan processing,17,0.444,0.422,1,GO:0006491,BP,,3277
retromer complex,20,0.448,0.422,1,GO:0030904,CC,,3278
cellular response to estradiol stimulus,26,0.546,0.422,1,GO:0071392,BP,,3279
peptide receptor activity,90,0.475,0.422,1,GO:0001653,MF,,3280
negative regulation of macrophage derived foam cell differentiation,12,0.567,0.422,1,GO:0010745,BP,,3281
positive regulation of fibroblast proliferation,48,0.467,0.423,1,GO:0048146,BP,,3282
replicative senescence,11,0.57,0.423,1,GO:0090399,BP,,3283
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,181,0.517,0.423,1,GO:0090092,BP,,3284
phosphate ion binding,10,0.573,0.423,1,GO:0042301,MF,,3285
prostate gland epithelium morphogenesis,21,0.55,0.424,1,GO:0060740,BP,,3286
regulation of sprouting angiogenesis,27,0.545,0.424,1,GO:1903670,BP,,3287
recycling endosome membrane,56,0.531,0.424,1,GO:0055038,CC,,3288
respiratory tube development,162,0.518,0.424,1,GO:0030323,BP,,3289
neural tube formation,92,0.524,0.424,1,GO:0001841,BP,,3290
primary active transmembrane transporter activity,102,0.523,0.424,1,"GO:0015399,GO:0015405",MF,P-P-bond-hydrolysis-driven transmembrane transporter activity,3291
antiporter activity,74,0.527,0.424,1,GO:0015297,MF,,3292
entrainment of circadian clock by photoperiod,19,0.553,0.424,1,GO:0043153,BP,,3293
aldehyde dehydrogenase (NAD) activity,13,0.436,0.424,1,GO:0004029,MF,,3294
recycling endosome,132,0.52,0.425,1,GO:0055037,CC,,3295
mitochondrial RNA metabolic process,27,0.544,0.425,1,GO:0000959,BP,,3296
SWI/SNF complex,15,0.56,0.425,1,GO:0016514,CC,,3297
mast cell activation,49,0.467,0.425,1,GO:0045576,BP,,3298
nephron epithelium development,98,0.523,0.425,1,GO:0072009,BP,,3299
gamma-aminobutyric acid signaling pathway,21,0.45,0.425,1,GO:0007214,BP,,3300
maternal placenta development,30,0.542,0.425,1,GO:0001893,BP,,3301
anaphase-promoting complex,17,0.444,0.425,1,GO:0005680,CC,,3302
angiotensin receptor binding,11,0.431,0.426,1,GO:0031701,MF,,3303
cell fate commitment involved in formation of primary germ layer,29,0.457,0.426,1,GO:0060795,BP,,3304
regulation of collagen biosynthetic process,26,0.545,0.426,1,GO:0032965,BP,,3305
regulation of respiratory system process,13,0.564,0.426,1,GO:0044065,BP,,3306
regulation of T-helper 1 type immune response,13,0.436,0.427,1,GO:0002825,BP,,3307
fertilization,112,0.522,0.427,1,GO:0009566,BP,,3308
pigment metabolic process,56,0.469,0.428,1,GO:0042440,BP,,3309
regulation of muscle contraction,134,0.48,0.428,1,GO:0006937,BP,,3310
histone-lysine N-methyltransferase activity,40,0.536,0.428,1,GO:0018024,MF,,3311
negative regulation of lipid localization,30,0.542,0.428,1,GO:1905953,BP,,3312
motor neuron axon guidance,24,0.547,0.429,1,GO:0008045,BP,,3313
response to pain,26,0.455,0.429,1,GO:0048265,BP,,3314
acyl-CoA hydrolase activity,14,0.439,0.43,1,GO:0047617,MF,,3315
adherens junction assembly,74,0.527,0.43,1,GO:0034333,BP,,3316
cell cortex part,109,0.522,0.43,1,GO:0044448,CC,,3317
protein serine/threonine/tyrosine kinase activity,37,0.538,0.43,1,GO:0004712,MF,,3318
phosphatidylinositol-mediated signaling,182,0.517,0.43,1,GO:0048015,BP,,3319
epiboly,24,0.547,0.43,1,GO:0090504,BP,,3320
acid-thiol ligase activity,22,0.451,0.43,1,GO:0016878,MF,,3321
axis elongation,27,0.544,0.431,1,GO:0003401,BP,,3322
regulation of interleukin-1 beta production,39,0.536,0.431,1,GO:0032651,BP,,3323
cardiac atrium morphogenesis,23,0.453,0.431,1,GO:0003209,BP,,3324
sperm part,133,0.52,0.431,1,GO:0097223,CC,,3325
negative regulation of intracellular transport,104,0.478,0.431,1,GO:0032387,BP,,3326
DNA dealkylation,19,0.552,0.431,1,GO:0035510,BP,,3327
inhibitory synapse,10,0.572,0.432,1,GO:0060077,CC,,3328
response to starvation,139,0.481,0.432,1,GO:0042594,BP,,3329
phosphatidylinositol phosphate binding,116,0.521,0.432,1,GO:1901981,MF,,3330
iron-sulfur cluster binding,57,0.53,0.432,1,"GO:0051536,GO:0051540",MF,metal cluster binding,3331
regulation of lipase activity,61,0.471,0.432,1,GO:0060191,BP,,3332
regulation of neurological system process,56,0.47,0.432,1,GO:0031644,BP,,3333
endothelial cell development,49,0.532,0.433,1,GO:0001885,BP,,3334
positive regulation of T cell receptor signaling pathway,10,0.572,0.433,1,GO:0050862,BP,,3335
mRNA polyadenylation,34,0.539,0.434,1,GO:0006378,BP,,3336
lung alveolus development,29,0.542,0.434,1,GO:0048286,BP,,3337
retinoic acid receptor signaling pathway,27,0.544,0.434,1,GO:0048384,BP,,3338
activation of NF-kappaB-inducing kinase activity,15,0.558,0.434,1,GO:0007250,BP,,3339
nucleoside biosynthetic process,48,0.533,0.434,1,GO:0009163,BP,,3340
positive regulation of adherens junction organization,23,0.453,0.434,1,GO:1903393,BP,,3341
muscle hypertrophy in response to stress,16,0.556,0.435,1,"GO:0003299,GO:0014887,GO:0014898",BP,"cardiac muscle adaptation,cardiac muscle hypertrophy in response to stress",3342
regulation of insulin receptor signaling pathway,45,0.466,0.435,1,GO:0046626,BP,,3343
muscle fiber development,45,0.466,0.435,1,GO:0048747,BP,,3344
translation elongation factor activity,14,0.56,0.435,1,GO:0003746,MF,,3345
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",65,0.472,0.435,1,GO:0000288,BP,,3346
regulation of cytokine production involved in immune response,49,0.468,0.435,1,GO:0002718,BP,,3347
fatty acid elongation,10,0.571,0.435,1,"GO:0030497,GO:0042761",BP,very long-chain fatty acid biosynthetic process,3348
positive regulation of receptor activity,45,0.466,0.436,1,GO:2000273,BP,,3349
regulation of vascular endothelial growth factor receptor signaling pathway,24,0.546,0.436,1,GO:0030947,BP,,3350
positive regulation of natural killer cell activation,13,0.562,0.437,1,GO:0032816,BP,,3351
histone acetyltransferase binding,25,0.545,0.437,1,GO:0035035,MF,,3352
receptor activator activity,33,0.461,0.437,1,GO:0030546,MF,,3353
regulation of protein complex disassembly,72,0.473,0.437,1,GO:0043244,BP,,3354
positive regulation of cilium assembly,18,0.553,0.437,1,GO:0045724,BP,,3355
Z disc,107,0.478,0.437,1,GO:0030018,CC,,3356
motile cilium,115,0.479,0.438,1,GO:0031514,CC,,3357
regulation of dendrite morphogenesis,70,0.473,0.438,1,GO:0048814,BP,,3358
synaptic vesicle exocytosis,78,0.475,0.438,1,GO:0016079,BP,,3359
negative regulation of blood circulation,29,0.542,0.438,1,GO:1903523,BP,,3360
photoreceptor inner segment,33,0.539,0.438,1,GO:0001917,CC,,3361
locomotory exploration behavior,12,0.435,0.438,1,GO:0035641,BP,,3362
germinal center formation,15,0.558,0.439,1,GO:0002467,BP,,3363
hyaluronic acid binding,17,0.554,0.439,1,GO:0005540,MF,,3364
ubiquitin-like protein ligase activity,180,0.483,0.439,1,GO:0061659,MF,,3365
response to vitamin A,13,0.562,0.439,1,GO:0033189,BP,,3366
N-acetyltransferase activity,74,0.526,0.439,1,GO:0008080,MF,,3367
fatty acid binding,22,0.452,0.439,1,GO:0005504,MF,,3368
pyrimidine-containing compound transmembrane transport,10,0.571,0.439,1,GO:0072531,BP,,3369
dynein complex binding,22,0.452,0.44,1,GO:0070840,MF,,3370
regulation of actin filament bundle assembly,79,0.525,0.44,1,GO:0032231,BP,,3371
regulation of phosphatidylinositol 3-kinase signaling,126,0.52,0.44,1,GO:0014066,BP,,3372
aspartate family amino acid biosynthetic process,20,0.55,0.44,1,GO:0009067,BP,,3373
fibrillar collagen trimer,11,0.567,0.441,1,"GO:0005583,GO:0098643",CC,banded collagen fibril,3374
positive regulation of potassium ion transmembrane transporter activity,14,0.44,0.441,1,GO:1901018,BP,,3375
3'-UTR-mediated mRNA stabilization,11,0.567,0.441,1,GO:0070935,BP,,3376
regulation of sphingolipid biosynthetic process,13,0.562,0.441,1,"GO:0090153,GO:1905038,GO:2000303",BP,"regulation of membrane lipid metabolic process,regulation of ceramide biosynthetic process",3377
acrosome assembly,12,0.436,0.441,1,GO:0001675,BP,,3378
negative regulation of necroptotic process,10,0.57,0.441,1,GO:0060546,BP,,3379
negative regulation of smooth muscle cell migration,17,0.554,0.442,1,GO:0014912,BP,,3380
chloride channel activity,68,0.473,0.442,1,GO:0005254,MF,,3381
endoplasmic reticulum quality control compartment,21,0.451,0.442,1,GO:0044322,CC,,3382
heme biosynthetic process,18,0.552,0.442,1,GO:0006783,BP,,3383
positive regulation of ion transmembrane transporter activity,66,0.473,0.442,1,GO:0032414,BP,,3384
glucocorticoid biosynthetic process,12,0.564,0.442,1,GO:0006704,BP,,3385
negative regulation of neuron projection regeneration,13,0.438,0.442,1,GO:0070571,BP,,3386
positive regulation of actin filament bundle assembly,49,0.532,0.443,1,GO:0032233,BP,,3387
gastrulation,155,0.518,0.443,1,GO:0007369,BP,,3388
pyrimidine nucleoside triphosphate biosynthetic process,20,0.45,0.443,1,GO:0009148,BP,,3389
vesicle docking involved in exocytosis,42,0.466,0.443,1,GO:0006904,BP,,3390
peptide hormone receptor binding,14,0.441,0.443,1,GO:0051428,MF,,3391
positive regulation of leukocyte mediated immunity,65,0.528,0.444,1,GO:0002705,BP,,3392
cell aging,80,0.475,0.444,1,GO:0007569,BP,,3393
protein phosphatase inhibitor activity,33,0.461,0.444,1,GO:0004864,MF,,3394
mesoderm formation,61,0.528,0.444,1,GO:0001707,BP,,3395
negative regulation of response to biotic stimulus,32,0.539,0.444,1,GO:0002832,BP,,3396
endopeptidase inhibitor activity,124,0.52,0.444,1,GO:0004866,MF,,3397
positive regulation of collagen metabolic process,20,0.549,0.444,1,"GO:0010714,GO:0032967,GO:0044253",BP,"positive regulation of collagen biosynthetic process,positive regulation of multicellular organismal metabolic process",3398
positive regulation of interleukin-10 production,22,0.453,0.444,1,GO:0032733,BP,,3399
meiotic spindle organization,10,0.43,0.445,1,GO:0000212,BP,,3400
"mRNA cis splicing, via spliceosome",14,0.559,0.445,1,GO:0045292,BP,,3401
hair follicle morphogenesis,23,0.454,0.445,1,GO:0031069,BP,,3402
prostate gland morphogenesis,22,0.547,0.445,1,GO:0060512,BP,,3403
"transferase activity, transferring acyl groups other than amino-acyl groups",183,0.516,0.445,1,GO:0016747,MF,,3404
blood vessel endothelial cell proliferation involved in sprouting angiogenesis,11,0.566,0.446,1,GO:0002043,BP,,3405
2-oxoglutarate metabolic process,15,0.443,0.446,1,GO:0006103,BP,,3406
negative regulation of sequence-specific DNA binding transcription factor activity,120,0.52,0.446,1,GO:0043433,BP,,3407
peptidyl-arginine modification,20,0.451,0.446,1,GO:0018195,BP,,3408
inorganic anion exchanger activity,21,0.548,0.446,1,GO:0005452,MF,,3409
regulation of mesenchymal cell proliferation,33,0.538,0.446,1,GO:0010464,BP,,3410
liver regeneration,27,0.542,0.446,1,GO:0097421,BP,,3411
activating transcription factor binding,56,0.529,0.447,1,GO:0033613,MF,,3412
antibacterial humoral response,22,0.453,0.447,1,GO:0019731,BP,,3413
TBP-class protein binding,19,0.45,0.447,1,GO:0017025,MF,,3414
cellular biogenic amine catabolic process,22,0.453,0.447,1,GO:0042402,BP,,3415
inositol trisphosphate kinase activity,11,0.566,0.447,1,GO:0051766,MF,,3416
regulation of interferon-alpha production,17,0.447,0.447,1,GO:0032647,BP,,3417
regulation of centrosome cycle,47,0.532,0.447,1,GO:0046605,BP,,3418
alpha-beta T cell proliferation,23,0.454,0.448,1,GO:0046633,BP,,3419
folic acid-containing compound metabolic process,26,0.543,0.448,1,GO:0006760,BP,,3420
keratinocyte proliferation,36,0.463,0.448,1,GO:0043616,BP,,3421
kinase regulator activity,184,0.484,0.448,1,GO:0019207,MF,,3422
regulation of microtubule polymerization or depolymerization,48,0.532,0.448,1,GO:0031110,BP,,3423
stem cell division,31,0.539,0.449,1,GO:0017145,BP,,3424
positive regulation of response to wounding,43,0.533,0.449,1,GO:1903036,BP,,3425
monosaccharide transport,130,0.519,0.449,1,GO:0015749,BP,,3426
response to redox state,12,0.437,0.449,1,GO:0051775,BP,,3427
regulation of neural precursor cell proliferation,70,0.474,0.449,1,GO:2000177,BP,,3428
regeneration,153,0.518,0.449,1,GO:0031099,BP,,3429
positive regulation of cardiac muscle hypertrophy,22,0.547,0.45,1,"GO:0010613,GO:0014742",BP,positive regulation of muscle hypertrophy,3430
walking behavior,27,0.542,0.45,1,GO:0090659,BP,,3431
cellular response to epidermal growth factor stimulus,38,0.535,0.45,1,GO:0071364,BP,,3432
TOR complex,13,0.439,0.45,1,GO:0038201,CC,,3433
positive regulation of tissue remodeling,22,0.547,0.45,1,GO:0034105,BP,,3434
phosphatidylinositol phospholipase C activity,24,0.455,0.45,1,GO:0004435,MF,,3435
glial cell fate commitment,11,0.566,0.45,1,GO:0021781,BP,,3436
endosome organization,65,0.473,0.45,1,GO:0007032,BP,,3437
regulation of glial cell proliferation,22,0.453,0.45,1,GO:0060251,BP,,3438
NADP binding,42,0.466,0.451,1,GO:0050661,MF,,3439
cell division site,53,0.53,0.451,1,"GO:0032153,GO:0032155",CC,cell division site part,3440
reactive nitrogen species metabolic process,62,0.472,0.451,1,GO:2001057,BP,,3441
regulation of receptor internalization,33,0.462,0.451,1,GO:0002090,BP,,3442
regulation of exit from mitosis,17,0.553,0.451,1,GO:0007096,BP,,3443
negative regulation of small GTPase mediated signal transduction,41,0.466,0.452,1,GO:0051058,BP,,3444
regulation of non-canonical Wnt signaling pathway,19,0.55,0.452,1,GO:2000050,BP,,3445
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,82,0.524,0.453,1,GO:0090100,BP,,3446
sarcoplasmic reticulum membrane,35,0.463,0.453,1,GO:0033017,CC,,3447
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,26,0.458,0.453,1,GO:1902230,BP,,3448
regulation of interleukin-8 production,49,0.469,0.453,1,GO:0032677,BP,,3449
phagolysosome assembly,11,0.435,0.454,1,GO:0001845,BP,,3450
regulation of B cell apoptotic process,14,0.442,0.454,1,GO:0002902,BP,,3451
regulation of lamellipodium assembly,26,0.458,0.454,1,GO:0010591,BP,,3452
negative regulation of reactive oxygen species biosynthetic process,17,0.552,0.454,1,GO:1903427,BP,,3453
monocyte chemotactic protein-1 production,11,0.565,0.455,1,"GO:0071605,GO:0071637",BP,regulation of monocyte chemotactic protein-1 production,3454
regulation of lysosomal lumen pH,10,0.568,0.455,1,GO:0035751,BP,,3455
temperature homeostasis,32,0.462,0.455,1,GO:0001659,BP,,3456
alcohol catabolic process,35,0.463,0.455,1,GO:0046164,BP,,3457
C-terminal protein amino acid modification,63,0.473,0.455,1,GO:0018410,BP,,3458
negative regulation of pri-miRNA transcription from RNA polymerase II promoter,10,0.432,0.455,1,GO:1902894,BP,,3459
sugar:proton symporter activity,14,0.558,0.455,1,"GO:0005351,GO:0005402",MF,cation:sugar symporter activity,3460
"phosphatidylinositol-3,5-bisphosphate binding",19,0.549,0.455,1,GO:0080025,MF,,3461
TORC2 complex,11,0.435,0.455,1,GO:0031932,CC,,3462
protein nitrosylation,11,0.435,0.456,1,"GO:0017014,GO:0018119",BP,peptidyl-cysteine S-nitrosylation,3463
regulation of anoikis,22,0.546,0.456,1,GO:2000209,BP,,3464
beta-amyloid formation,14,0.558,0.456,1,GO:0034205,BP,,3465
external side of plasma membrane,178,0.516,0.456,1,GO:0009897,CC,,3466
purine nucleotide catabolic process,44,0.468,0.456,1,GO:0006195,BP,,3467
interferon-gamma biosynthetic process,14,0.442,0.456,1,GO:0042095,BP,,3468
S-adenosylmethionine-dependent methyltransferase activity,127,0.519,0.456,1,GO:0008757,MF,,3469
negative regulation of endothelial cell apoptotic process,19,0.549,0.457,1,GO:2000352,BP,,3470
pseudopodium,15,0.445,0.457,1,GO:0031143,CC,,3471
Leydig cell differentiation,10,0.568,0.457,1,GO:0033327,BP,,3472
stereocilium bundle,41,0.534,0.458,1,GO:0032421,CC,,3473
membrane protein ectodomain proteolysis,38,0.535,0.458,1,GO:0006509,BP,,3474
"translation factor activity, RNA binding",77,0.524,0.458,1,GO:0008135,MF,,3475
protein demannosylation,20,0.452,0.458,1,"GO:0036507,GO:0036508",BP,"protein alpha-1,2-demannosylation",3476
cholesterol efflux,29,0.46,0.458,1,GO:0033344,BP,,3477
ventricular system development,24,0.456,0.459,1,GO:0021591,BP,,3478
cell differentiation involved in embryonic placenta development,18,0.55,0.459,1,GO:0060706,BP,,3479
regulation of leukocyte adhesion to vascular endothelial cell,10,0.432,0.459,1,GO:1904994,BP,,3480
regulation of brown fat cell differentiation,10,0.568,0.459,1,GO:0090335,BP,,3481
syntaxin-1 binding,19,0.549,0.459,1,GO:0017075,MF,,3482
response to tumor cell,15,0.555,0.46,1,GO:0002347,BP,,3483
metanephric nephron epithelium development,21,0.453,0.46,1,GO:0072243,BP,,3484
rRNA binding,50,0.47,0.46,1,GO:0019843,MF,,3485
glutathione metabolic process,41,0.467,0.46,1,GO:0006749,BP,,3486
lipid storage,57,0.472,0.46,1,GO:0019915,BP,,3487
protein N-terminus binding,91,0.478,0.461,1,GO:0047485,MF,,3488
steroid dehydrogenase activity,20,0.452,0.461,1,GO:0016229,MF,,3489
C-terminal protein lipidation,56,0.472,0.461,1,GO:0006501,BP,,3490
positive regulation of nuclease activity,14,0.557,0.461,1,GO:0032075,BP,,3491
negative regulation of T cell proliferation,45,0.468,0.462,1,GO:0042130,BP,,3492
neuroepithelial cell differentiation,43,0.532,0.462,1,GO:0060563,BP,,3493
myoblast fusion,31,0.538,0.462,1,GO:0007520,BP,,3494
renal sodium excretion,20,0.548,0.462,1,"GO:0035812,GO:0035813",BP,regulation of renal sodium excretion,3495
CoA hydrolase activity,16,0.447,0.462,1,GO:0016289,MF,,3496
regulation of lipid catabolic process,45,0.468,0.463,1,GO:0050994,BP,,3497
regulation of oligodendrocyte differentiation,27,0.459,0.463,1,GO:0048713,BP,,3498
positive regulation of interleukin-2 production,22,0.455,0.463,1,GO:0032743,BP,,3499
histone ubiquitination,35,0.536,0.463,1,GO:0016574,BP,,3500
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,19,0.451,0.463,1,GO:1902176,BP,,3501
negative regulation of insulin secretion,34,0.536,0.464,1,GO:0046676,BP,,3502
SCF ubiquitin ligase complex,48,0.469,0.464,1,GO:0019005,CC,,3503
nuclear envelope reassembly,15,0.445,0.464,1,GO:0031468,BP,,3504
regulation of hydrogen peroxide metabolic process,12,0.439,0.464,1,GO:0010310,BP,,3505
response to mineralocorticoid,30,0.461,0.464,1,GO:0051385,BP,,3506
endoplasmic reticulum-Golgi intermediate compartment,96,0.478,0.464,1,GO:0005793,CC,,3507
positive regulation of cAMP metabolic process,68,0.474,0.464,1,GO:0030816,BP,,3508
ligand-dependent nuclear receptor transcription coactivator activity,51,0.47,0.465,1,GO:0030374,MF,,3509
condensed chromosome kinetochore,86,0.477,0.465,1,GO:0000777,CC,,3510
ER to Golgi transport vesicle membrane,53,0.471,0.465,1,GO:0012507,CC,,3511
negative regulation of stress-activated MAPK cascade,37,0.465,0.465,1,"GO:0032873,GO:0070303",BP,negative regulation of stress-activated protein kinase signaling cascade,3512
ATPase regulator activity,35,0.464,0.466,1,GO:0060590,MF,,3513
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,11,0.436,0.466,1,GO:1990440,BP,,3514
glucosyltransferase activity,15,0.554,0.466,1,GO:0046527,MF,,3515
histone H2A ubiquitination,18,0.55,0.466,1,GO:0033522,BP,,3516
acylglycerol metabolic process,94,0.522,0.466,1,GO:0006639,BP,,3517
pyrimidine nucleoside catabolic process,18,0.45,0.467,1,GO:0046135,BP,,3518
methionine metabolic process,19,0.452,0.468,1,GO:0006555,BP,,3519
mitotic spindle,58,0.528,0.468,1,GO:0072686,CC,,3520
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,104,0.521,0.468,1,GO:0043280,BP,,3521
positive regulation of stem cell proliferation,32,0.463,0.468,1,GO:2000648,BP,,3522
interleukin-8 production,53,0.471,0.469,1,GO:0032637,BP,,3523
central nervous system projection neuron axonogenesis,22,0.545,0.469,1,GO:0021952,BP,,3524
regulation of cardiac muscle cell contraction,32,0.537,0.469,1,GO:0086004,BP,,3525
beta-amyloid binding,33,0.464,0.469,1,GO:0001540,MF,,3526
FAD binding,15,0.446,0.469,1,GO:0071949,MF,,3527
negative regulation of growth,200,0.485,0.469,1,GO:0045926,BP,,3528
"positive regulation of CD4-positive, alpha-beta T cell activation",22,0.455,0.469,1,GO:2000516,BP,,3529
MHC protein complex,25,0.458,0.469,1,GO:0042611,CC,,3530
alpha-tubulin binding,22,0.545,0.47,1,GO:0043014,MF,,3531
cerebral cortex GABAergic interneuron differentiation,12,0.44,0.47,1,GO:0021892,BP,,3532
regulation of glycogen metabolic process,26,0.541,0.47,1,GO:0070873,BP,,3533
serine hydrolase activity,151,0.517,0.47,1,GO:0017171,MF,,3534
positive regulation of autophagy,92,0.522,0.47,1,GO:0010508,BP,,3535
thioester biosynthetic process,60,0.473,0.471,1,"GO:0035384,GO:0071616",BP,acyl-CoA biosynthetic process,3536
negative regulation of JUN kinase activity,12,0.44,0.471,1,GO:0043508,BP,,3537
dendrite development,188,0.485,0.471,1,GO:0016358,BP,,3538
epithelial cell fate commitment,14,0.556,0.471,1,GO:0072148,BP,,3539
G-protein beta/gamma-subunit complex binding,15,0.446,0.471,1,GO:0031683,MF,,3540
positive regulation of muscle contraction,37,0.466,0.471,1,GO:0045933,BP,,3541
voltage-gated ion channel activity,175,0.516,0.472,1,"GO:0005244,GO:0022832",MF,voltage-gated channel activity,3542
regulation of cytokine production involved in inflammatory response,18,0.549,0.472,1,GO:1900015,BP,,3543
negative regulation of acute inflammatory response,11,0.437,0.472,1,GO:0002674,BP,,3544
protein depolymerization,78,0.476,0.472,1,GO:0051261,BP,,3545
transforming growth factor beta receptor binding,40,0.533,0.472,1,GO:0005160,MF,,3546
nitric-oxide synthase biosynthetic process,16,0.552,0.473,1,"GO:0051767,GO:0051769",BP,regulation of nitric-oxide synthase biosynthetic process,3547
neuron apoptotic process,200,0.485,0.473,1,GO:0051402,BP,,3548
protein localization to lysosome,27,0.54,0.473,1,GO:0061462,BP,,3549
oocyte differentiation,37,0.466,0.473,1,GO:0009994,BP,,3550
positive regulation of cysteine-type endopeptidase activity,111,0.52,0.473,1,GO:2001056,BP,,3551
neutrophil migration,64,0.526,0.473,1,GO:1990266,BP,,3552
endochondral bone growth,19,0.452,0.473,1,GO:0003416,BP,,3553
negative regulation of peptidyl-tyrosine phosphorylation,39,0.533,0.473,1,GO:0050732,BP,,3554
neurotransmitter catabolic process,11,0.438,0.474,1,GO:0042135,BP,,3555
cell proliferation involved in heart morphogenesis,14,0.555,0.474,1,GO:0061323,BP,,3556
positive regulation of lipase activity,49,0.47,0.474,1,GO:0060193,BP,,3557
response to cAMP,85,0.522,0.474,1,GO:0051591,BP,,3558
tumor necrosis factor-activated receptor activity,22,0.544,0.475,1,"GO:0005031,GO:0005035",MF,death receptor activity,3559
RISC complex,10,0.565,0.475,1,GO:0016442,CC,,3560
negative regulation of lymphocyte apoptotic process,23,0.543,0.475,1,GO:0070229,BP,,3561
regulation of histone modification,112,0.52,0.475,1,GO:0031056,BP,,3562
purine-containing compound salvage,13,0.557,0.475,1,GO:0043101,BP,,3563
regulation of respiratory gaseous exchange,19,0.547,0.476,1,GO:0043576,BP,,3564
tripartite regional subdivision,10,0.435,0.476,1,"GO:0007351,GO:0008595",BP,"anterior/posterior axis specification, embryo",3565
dopamine biosynthetic process,12,0.441,0.476,1,GO:0042416,BP,,3566
neuromuscular process,87,0.522,0.476,1,GO:0050905,BP,,3567
beta-amyloid metabolic process,23,0.543,0.476,1,GO:0050435,BP,,3568
mesoderm morphogenesis,63,0.526,0.476,1,GO:0048332,BP,,3569
regulation of substrate adhesion-dependent cell spreading,40,0.533,0.476,1,GO:1900024,BP,,3570
positive regulation of T cell mediated cytotoxicity,11,0.562,0.476,1,GO:0001916,BP,,3571
negative thymic T cell selection,10,0.435,0.476,1,GO:0045060,BP,,3572
positive regulation of cell junction assembly,28,0.461,0.476,1,GO:1901890,BP,,3573
regulation of protein exit from endoplasmic reticulum,20,0.546,0.476,1,GO:0070861,BP,,3574
integral component of organelle membrane,148,0.483,0.476,1,GO:0031301,CC,,3575
tooth mineralization,17,0.55,0.477,1,GO:0034505,BP,,3576
protein heterotrimerization,13,0.557,0.477,1,GO:0070208,BP,,3577
ATF6-mediated unfolded protein response,10,0.435,0.477,1,GO:0036500,BP,,3578
lamellipodium assembly,54,0.472,0.477,1,GO:0030032,BP,,3579
sister chromatid segregation,186,0.515,0.478,1,GO:0000819,BP,,3580
peptide alpha-N-acetyltransferase activity,10,0.435,0.478,1,GO:0004596,MF,,3581
regulation of ketone biosynthetic process,12,0.559,0.478,1,GO:0010566,BP,,3582
renal system process involved in regulation of blood volume,11,0.438,0.478,1,GO:0001977,BP,,3583
renal system vasculature development,24,0.542,0.479,1,"GO:0061437,GO:0061440",BP,kidney vasculature development,3584
negative regulation of cartilage development,21,0.455,0.479,1,GO:0061037,BP,,3585
regulation of vacuole organization,42,0.468,0.479,1,GO:0044088,BP,,3586
retinol binding,10,0.435,0.479,1,GO:0019841,MF,,3587
long-chain fatty-acyl-CoA biosynthetic process,39,0.467,0.48,1,GO:0035338,BP,,3588
endoplasmic reticulum calcium ion homeostasis,20,0.454,0.48,1,GO:0032469,BP,,3589
pore complex,12,0.441,0.48,1,GO:0046930,CC,,3590
positive regulation of viral release from host cell,14,0.446,0.48,1,GO:1902188,BP,,3591
positive regulation of chromosome organization,134,0.482,0.481,1,GO:2001252,BP,,3592
positive regulation of adaptive immune response,59,0.527,0.481,1,GO:0002821,BP,,3593
"transferase activity, transferring one-carbon groups",192,0.515,0.481,1,GO:0016741,MF,,3594
interferon-gamma-mediated signaling pathway,80,0.523,0.481,1,GO:0060333,BP,,3595
retinoid X receptor binding,13,0.444,0.481,1,GO:0046965,MF,,3596
mismatch repair,31,0.537,0.482,1,GO:0006298,BP,,3597
negative regulation of amino acid transport,10,0.436,0.482,1,GO:0051956,BP,,3598
clathrin coat of coated pit,18,0.452,0.483,1,GO:0030132,CC,,3599
U6 snRNA binding,10,0.436,0.483,1,GO:0017070,MF,,3600
response to interferon-gamma,131,0.518,0.483,1,GO:0034341,BP,,3601
regulation of interleukin-1 secretion,27,0.539,0.483,1,GO:0050704,BP,,3602
maintenance of protein location,83,0.522,0.483,1,GO:0045185,BP,,3603
regulation of neurotrophin TRK receptor signaling pathway,11,0.439,0.483,1,GO:0051386,BP,,3604
"wound healing, spreading of cells",23,0.542,0.483,1,"GO:0044319,GO:0090505",BP,epiboly involved in wound healing,3605
metallocarboxypeptidase activity,22,0.543,0.484,1,GO:0004181,MF,,3606
protein O-linked glycosylation,86,0.522,0.484,1,GO:0006493,BP,,3607
regulation of respiratory gaseous exchange by neurological system process,10,0.564,0.484,1,GO:0002087,BP,,3608
nucleoside catabolic process,26,0.46,0.484,1,GO:0009164,BP,,3609
regulation of cardiac muscle cell action potential,25,0.54,0.484,1,GO:0098901,BP,,3610
calmodulin-dependent protein kinase activity,28,0.462,0.484,1,GO:0004683,MF,,3611
intrinsic component of organelle membrane,156,0.484,0.485,1,GO:0031300,CC,,3612
positive regulation of nitric-oxide synthase activity,17,0.451,0.485,1,GO:0051000,BP,,3613
vasoconstriction,66,0.475,0.485,1,GO:0042310,BP,,3614
grooming behavior,16,0.55,0.485,1,GO:0007625,BP,,3615
response to prostaglandin,25,0.46,0.485,1,GO:0034694,BP,,3616
"retrograde transport, endosome to Golgi",64,0.475,0.485,1,GO:0042147,BP,,3617
pyrimidine deoxyribonucleotide catabolic process,10,0.436,0.485,1,GO:0009223,BP,,3618
ventricular septum development,55,0.527,0.486,1,GO:0003281,BP,,3619
pore complex assembly,15,0.552,0.486,1,GO:0046931,BP,,3620
non-recombinational repair,56,0.527,0.486,1,GO:0000726,BP,,3621
regulation of cellular response to oxidative stress,63,0.525,0.486,1,GO:1900407,BP,,3622
photoperiodism,22,0.543,0.486,1,GO:0009648,BP,,3623
chromatoid body,10,0.564,0.486,1,GO:0033391,CC,,3624
growth factor binding,119,0.519,0.486,1,GO:0019838,MF,,3625
nephron tubule formation,17,0.549,0.487,1,GO:0072079,BP,,3626
growth hormone secretion,14,0.446,0.487,1,GO:0030252,BP,,3627
nucleoside diphosphate metabolic process,101,0.48,0.487,1,GO:0009132,BP,,3628
"RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding",42,0.531,0.487,1,"GO:0004879,GO:0098531",MF,"transcription factor activity, direct ligand regulated sequence-specific DNA binding",3629
regulation of vascular endothelial growth factor signaling pathway,10,0.436,0.487,1,"GO:1900746,GO:1902547",BP,regulation of cellular response to vascular endothelial growth factor stimulus,3630
endocytic vesicle lumen,14,0.446,0.487,1,GO:0071682,CC,,3631
positive regulation of regulatory T cell differentiation,10,0.437,0.487,1,GO:0045591,BP,,3632
negative regulation of bone mineralization,14,0.446,0.487,1,GO:0030502,BP,,3633
"preribosome, small subunit precursor",10,0.563,0.487,1,GO:0030688,CC,,3634
neuron projection membrane,36,0.467,0.487,1,GO:0032589,CC,,3635
membrane invagination,44,0.47,0.488,1,GO:0010324,BP,,3636
cellular polysaccharide biosynthetic process,53,0.472,0.488,1,GO:0033692,BP,,3637
proline-rich region binding,17,0.451,0.488,1,GO:0070064,MF,,3638
positive regulation by host of viral process,12,0.442,0.488,1,GO:0044794,BP,,3639
acute inflammatory response,100,0.48,0.489,1,GO:0002526,BP,,3640
negative regulation of peptidyl-lysine acetylation,17,0.548,0.489,1,GO:2000757,BP,,3641
positive regulation of cyclin-dependent protein kinase activity,34,0.534,0.489,1,GO:1904031,BP,,3642
store-operated calcium channel activity,10,0.563,0.49,1,GO:0015279,MF,,3643
NAD+ kinase activity,17,0.548,0.49,1,GO:0003951,MF,,3644
regulation of cardiac muscle cell differentiation,26,0.461,0.49,1,GO:2000725,BP,,3645
renal filtration,16,0.45,0.49,1,GO:0097205,BP,,3646
protein localization to endosome,13,0.555,0.491,1,GO:0036010,BP,,3647
regulation of actin nucleation,24,0.459,0.491,1,GO:0051125,BP,,3648
positive regulation of leukocyte migration,88,0.521,0.491,1,GO:0002687,BP,,3649
hormone activity,77,0.523,0.491,1,GO:0005179,MF,,3650
Cul3-RING ubiquitin ligase complex,60,0.474,0.491,1,GO:0031463,CC,,3651
pyrimidine nucleoside metabolic process,48,0.471,0.491,1,GO:0006213,BP,,3652
translation initiation factor activity,46,0.529,0.492,1,GO:0003743,MF,,3653
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,14,0.447,0.492,1,GO:1902165,BP,,3654
cysteine-type endopeptidase activity involved in execution phase of apoptosis,12,0.557,0.492,1,GO:0097200,MF,,3655
response to follicle-stimulating hormone,15,0.551,0.492,1,GO:0032354,BP,,3656
regulation of striated muscle cell apoptotic process,23,0.541,0.493,1,GO:0010662,BP,,3657
protein phosphatase regulator activity,67,0.476,0.493,1,GO:0019888,MF,,3658
regulation of muscle cell apoptotic process,41,0.531,0.493,1,GO:0010660,BP,,3659
regulation of Notch signaling pathway,62,0.475,0.493,1,GO:0008593,BP,,3660
zymogen activation,33,0.466,0.493,1,GO:0031638,BP,,3661
muscle organ morphogenesis,62,0.525,0.494,1,GO:0048644,BP,,3662
IkappaB kinase complex,10,0.562,0.495,1,GO:0008385,CC,,3663
cytochrome-c oxidase activity,23,0.459,0.495,1,"GO:0004129,GO:0015002,GO:0016676",MF,"heme-copper terminal oxidase activity,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor",3664
intestinal absorption,21,0.457,0.495,1,GO:0050892,BP,,3665
pigment biosynthetic process,46,0.471,0.495,1,GO:0046148,BP,,3666
platelet-derived growth factor binding,10,0.562,0.495,1,GO:0048407,MF,,3667
cell-substrate junction assembly,81,0.522,0.495,1,GO:0007044,BP,,3668
intra-Golgi vesicle-mediated transport,40,0.531,0.495,1,GO:0006891,BP,,3669
regulation of T cell apoptotic process,28,0.537,0.496,1,GO:0070232,BP,,3670
regulation of epithelial cell migration,158,0.516,0.496,1,GO:0010632,BP,,3671
"regulation of DNA damage response, signal transduction by p53 class mediator",27,0.538,0.496,1,GO:0043516,BP,,3672
nuclear periphery,109,0.519,0.496,1,GO:0034399,CC,,3673
calcium-transporting ATPase activity,12,0.557,0.497,1,GO:0005388,MF,,3674
mitotic spindle assembly,46,0.529,0.497,1,GO:0090307,BP,,3675
deoxyribose phosphate catabolic process,18,0.454,0.497,1,GO:0046386,BP,,3676
actin filament capping,30,0.464,0.497,1,GO:0051693,BP,,3677
regulation of JUN kinase activity,74,0.523,0.497,1,GO:0043506,BP,,3678
protein methylation,152,0.516,0.497,1,"GO:0006479,GO:0008213",BP,protein alkylation,3679
negative regulation of leukocyte migration,24,0.46,0.498,1,GO:0002686,BP,,3680
regulation of interleukin-17 production,17,0.452,0.498,1,GO:0032660,BP,,3681
fucose metabolic process,14,0.448,0.498,1,GO:0006004,BP,,3682
amyloid fibril formation,11,0.559,0.498,1,GO:1990000,BP,,3683
inositol phosphate metabolic process,62,0.475,0.498,1,GO:0043647,BP,,3684
ribonucleoprotein complex assembly,172,0.485,0.498,1,GO:0022618,BP,,3685
negative regulation of reactive oxygen species metabolic process,43,0.47,0.498,1,GO:2000378,BP,,3686
cholesterol catabolic process,10,0.438,0.498,1,"GO:0006707,GO:0016127",BP,sterol catabolic process,3687
nephron tubule development,81,0.522,0.499,1,GO:0072080,BP,,3688
male genitalia development,18,0.546,0.499,1,GO:0030539,BP,,3689
negative regulation of autophagosome assembly,10,0.438,0.499,1,GO:1902902,BP,,3690
renal water homeostasis,29,0.464,0.499,1,GO:0003091,BP,,3691
sarcoplasm,62,0.475,0.499,1,GO:0016528,CC,,3692
positive regulation of vasoconstriction,25,0.461,0.499,1,GO:0045907,BP,,3693
hippo signaling,32,0.535,0.499,1,GO:0035329,BP,,3694
mesonephros development,90,0.521,0.499,1,GO:0001823,BP,,3695
phosphatidylinositol 3-kinase signaling,142,0.516,0.5,1,GO:0014065,BP,,3696
negative regulation of actin filament depolymerization,34,0.467,0.5,1,GO:0030835,BP,,3697
collagen biosynthetic process,32,0.534,0.501,1,GO:0032964,BP,,3698
spliceosomal complex,157,0.516,0.501,1,GO:0005681,CC,,3699
ureter development,11,0.559,0.501,1,GO:0072189,BP,,3700
positive regulation of macrophage chemotaxis,10,0.439,0.502,1,GO:0010759,BP,,3701
binding of sperm to zona pellucida,23,0.46,0.502,1,GO:0007339,BP,,3702
sperm midpiece,11,0.441,0.502,1,GO:0097225,CC,,3703
"nucleotide-excision repair, DNA incision, 5'-to lesion",32,0.466,0.502,1,GO:0006296,BP,,3704
response to ischemia,33,0.466,0.502,1,GO:0002931,BP,,3705
positive regulation of neutrophil migration,23,0.54,0.503,1,GO:1902624,BP,,3706
anatomical structure maturation,49,0.472,0.503,1,GO:0071695,BP,,3707
photoreceptor cell development,32,0.534,0.503,1,GO:0042461,BP,,3708
hexose transport,129,0.517,0.503,1,GO:0008645,BP,,3709
cellular response to misfolded protein,20,0.457,0.503,1,GO:0071218,BP,,3710
small protein activating enzyme activity,10,0.439,0.504,1,GO:0008641,MF,,3711
locomotion involved in locomotory behavior,10,0.561,0.504,1,GO:0031987,BP,,3712
extracellular matrix binding,43,0.529,0.504,1,GO:0050840,MF,,3713
negative regulation of muscle tissue development,37,0.532,0.504,1,GO:1901862,BP,,3714
positive regulation of alpha-beta T cell activation,40,0.469,0.504,1,GO:0046635,BP,,3715
interleukin-10 production,32,0.466,0.505,1,GO:0032613,BP,,3716
lung morphogenesis,48,0.528,0.505,1,GO:0060425,BP,,3717
nuclear cyclin-dependent protein kinase holoenzyme complex,15,0.45,0.505,1,GO:0019908,CC,,3718
regulation of histone acetylation,46,0.528,0.505,1,GO:0035065,BP,,3719
regulation of fatty acid beta-oxidation,14,0.449,0.506,1,GO:0031998,BP,,3720
regulation of tumor necrosis factor-mediated signaling pathway,43,0.529,0.506,1,GO:0010803,BP,,3721
positive regulation of nuclear division,50,0.473,0.506,1,GO:0051785,BP,,3722
apolipoprotein binding,14,0.449,0.507,1,GO:0034185,MF,,3723
negative regulation of homotypic cell-cell adhesion,11,0.558,0.507,1,GO:0034111,BP,,3724
positive regulation of release of sequestered calcium ion into cytosol,30,0.465,0.507,1,GO:0051281,BP,,3725
phospholipid catabolic process,29,0.536,0.507,1,GO:0009395,BP,,3726
neuropeptide receptor binding,22,0.459,0.507,1,GO:0071855,MF,,3727
signaling pattern recognition receptor activity,15,0.451,0.507,1,"GO:0008329,GO:0038187",MF,pattern recognition receptor activity,3728
regulation of granulocyte chemotaxis,34,0.533,0.507,1,GO:0071622,BP,,3729
negative regulation of mRNA processing,24,0.461,0.508,1,GO:0050686,BP,,3730
fibrillar center,110,0.518,0.508,1,GO:0001650,CC,,3731
vascular smooth muscle contraction,18,0.545,0.508,1,GO:0014829,BP,,3732
pancreatic juice secretion,11,0.558,0.508,1,GO:0030157,BP,,3733
calcium-mediated signaling using intracellular calcium source,15,0.451,0.508,1,GO:0035584,BP,,3734
purine ribonucleoside metabolic process,64,0.476,0.508,1,GO:0046128,BP,,3735
purine nucleoside diphosphate metabolic process,80,0.479,0.508,1,"GO:0009135,GO:0009179",BP,purine ribonucleoside diphosphate metabolic process,3736
cerebellum morphogenesis,34,0.467,0.508,1,GO:0021587,BP,,3737
negative regulation of T cell activation,75,0.478,0.508,1,GO:0050868,BP,,3738
palate development,78,0.522,0.508,1,GO:0060021,BP,,3739
protein localization to chromatin,16,0.452,0.509,1,GO:0071168,BP,,3740
deoxyribonucleotide metabolic process,30,0.465,0.509,1,GO:0009262,BP,,3741
"hydrolase activity, hydrolyzing O-glycosyl compounds",66,0.524,0.509,1,GO:0004553,MF,,3742
purine nucleobase biosynthetic process,10,0.44,0.509,1,GO:0009113,BP,,3743
defense response to Gram-negative bacterium,23,0.46,0.509,1,GO:0050829,BP,,3744
regulation of interleukin-2 biosynthetic process,14,0.551,0.51,1,GO:0045076,BP,,3745
pigment granule localization,25,0.462,0.51,1,GO:0051875,BP,,3746
skeletal muscle adaptation,19,0.544,0.51,1,GO:0043501,BP,,3747
cation:amino acid symporter activity,16,0.548,0.51,1,GO:0005416,MF,,3748
low-density lipoprotein particle,10,0.44,0.511,1,GO:0034362,CC,,3749
ephrin receptor binding,25,0.462,0.511,1,GO:0046875,MF,,3750
behavioral response to pain,12,0.555,0.511,1,GO:0048266,BP,,3751
alpha-actinin binding,30,0.465,0.511,1,GO:0051393,MF,,3752
regulation of protein targeting to membrane,31,0.466,0.512,1,GO:0090313,BP,,3753
negative regulation of transporter activity,55,0.474,0.512,1,GO:0032410,BP,,3754
regulation of relaxation of muscle,10,0.56,0.512,1,GO:1901077,BP,,3755
hyaluronan biosynthetic process,12,0.445,0.512,1,GO:0030213,BP,,3756
serine-type peptidase activity,149,0.516,0.513,1,GO:0008236,MF,,3757
regulation of intracellular pH,84,0.479,0.513,1,GO:0051453,BP,,3758
ubiquinone biosynthetic process,13,0.448,0.513,1,"GO:0006744,GO:1901663",BP,quinone biosynthetic process,3759
porphyrin-containing compound biosynthetic process,21,0.541,0.513,1,GO:0006779,BP,,3760
regulation of myoblast fusion,14,0.55,0.513,1,GO:1901739,BP,,3761
aorta morphogenesis,29,0.535,0.513,1,GO:0035909,BP,,3762
positive regulation of transporter activity,73,0.478,0.513,1,GO:0032411,BP,,3763
DNA N-glycosylase activity,10,0.56,0.514,1,GO:0019104,MF,,3764
DNA polymerase complex,15,0.549,0.514,1,GO:0042575,CC,,3765
glycolytic process through fructose-6-phosphate,24,0.461,0.514,1,"GO:0061615,GO:0061620",BP,glycolytic process through glucose-6-phosphate,3766
negative regulation of cell-cell adhesion,111,0.482,0.514,1,GO:0022408,BP,,3767
cellular zinc ion homeostasis,20,0.458,0.514,1,GO:0006882,BP,,3768
mammary gland duct morphogenesis,30,0.466,0.514,1,GO:0060603,BP,,3769
necrotic cell death,42,0.471,0.514,1,GO:0070265,BP,,3770
cardiac muscle cell differentiation,84,0.479,0.514,1,GO:0055007,BP,,3771
myosin complex,57,0.525,0.515,1,GO:0016459,CC,,3772
cyclin-dependent protein kinase activity,26,0.537,0.515,1,GO:0097472,MF,,3773
immunoglobulin mediated immune response,81,0.479,0.515,1,GO:0016064,BP,,3774
plasma lipoprotein particle clearance,25,0.462,0.515,1,GO:0034381,BP,,3775
ligand-gated cation channel activity,74,0.478,0.515,1,GO:0099094,MF,,3776
positive regulation of fatty acid biosynthetic process,11,0.557,0.515,1,GO:0045723,BP,,3777
glucose import in response to insulin stimulus,18,0.544,0.515,1,GO:0044381,BP,,3778
regulation of clathrin-dependent endocytosis,20,0.458,0.515,1,GO:2000369,BP,,3779
positive regulation of transcription factor import into nucleus,41,0.471,0.515,1,GO:0042993,BP,,3780
oxaloacetate metabolic process,12,0.446,0.515,1,"GO:0006107,GO:0006534",BP,cysteine metabolic process,3781
regulation of regulatory T cell differentiation,15,0.452,0.516,1,GO:0045589,BP,,3782
regulation of peroxisome proliferator activated receptor signaling pathway,11,0.557,0.516,1,GO:0035358,BP,,3783
muscle tissue morphogenesis,59,0.524,0.516,1,GO:0060415,BP,,3784
vasculogenesis,61,0.524,0.516,1,GO:0001570,BP,,3785
regulation of oxidative stress-induced cell death,54,0.526,0.516,1,GO:1903201,BP,,3786
cellular response to drug,61,0.524,0.516,1,GO:0035690,BP,,3787
positive regulation of mRNA processing,20,0.542,0.516,1,GO:0050685,BP,,3788
positive regulation of blood vessel endothelial cell migration,26,0.463,0.517,1,GO:0043536,BP,,3789
mature B cell differentiation involved in immune response,15,0.548,0.517,1,GO:0002313,BP,,3790
interleukin-8 biosynthetic process,10,0.441,0.517,1,"GO:0042228,GO:0045414",BP,regulation of interleukin-8 biosynthetic process,3791
glycosyl compound biosynthetic process,50,0.527,0.517,1,GO:1901659,BP,,3792
"transcriptional activator activity, RNA polymerase II transcription factor binding",47,0.527,0.517,1,"GO:0001190,GO:0098811",MF,"transcriptional repressor activity, RNA polymerase II activating transcription factor binding",3793
"protein binding, bridging",143,0.516,0.517,1,GO:0030674,MF,,3794
modification by symbiont of host morphology or physiology,35,0.468,0.517,1,GO:0044003,BP,,3795
negative regulation of lymphocyte mediated immunity,28,0.535,0.517,1,GO:0002707,BP,,3796
ephrin receptor activity,18,0.456,0.518,1,GO:0005003,MF,,3797
membranous septum morphogenesis,10,0.441,0.518,1,GO:0003149,BP,,3798
"negative regulation of CD4-positive, alpha-beta T cell activation",14,0.55,0.518,1,GO:2000515,BP,,3799
mesenchymal to epithelial transition,16,0.547,0.518,1,GO:0060231,BP,,3800
phagocytic vesicle membrane,68,0.477,0.518,1,GO:0030670,CC,,3801
neuron remodeling,11,0.444,0.519,1,GO:0016322,BP,,3802
double-strand break repair via nonhomologous end joining,50,0.526,0.519,1,GO:0006303,BP,,3803
negative regulation of peptidase activity,183,0.514,0.519,1,GO:0010466,BP,,3804
neural tube closure,79,0.521,0.519,1,GO:0001843,BP,,3805
cellular response to interferon-beta,13,0.448,0.52,1,GO:0035458,BP,,3806
ribonuclease activity,74,0.522,0.52,1,GO:0004540,MF,,3807
positive regulation of striated muscle tissue development,54,0.525,0.52,1,"GO:0045844,GO:0048636",BP,positive regulation of muscle organ development,3808
response to auditory stimulus,17,0.545,0.52,1,GO:0010996,BP,,3809
cell fate determination,33,0.532,0.52,1,GO:0001709,BP,,3810
cellular modified amino acid biosynthetic process,39,0.53,0.521,1,GO:0042398,BP,,3811
metanephric tubule morphogenesis,10,0.441,0.521,1,GO:0072173,BP,,3812
cysteine-type endopeptidase activity,78,0.521,0.521,1,GO:0004197,MF,,3813
sperm flagellum,61,0.476,0.521,1,"GO:0036126,GO:0097729",CC,9+2 motile cilium,3814
high-density lipoprotein particle remodeling,12,0.447,0.521,1,GO:0034375,BP,,3815
transcription from RNA polymerase III promoter,48,0.473,0.521,1,GO:0006383,BP,,3816
diacylglycerol metabolic process,13,0.551,0.522,1,GO:0046339,BP,,3817
primary amino compound metabolic process,14,0.451,0.522,1,GO:1901160,BP,,3818
triglyceride metabolic process,82,0.52,0.522,1,GO:0006641,BP,,3819
iron-sulfur cluster assembly,15,0.452,0.522,1,"GO:0016226,GO:0031163",BP,metallo-sulfur cluster assembly,3820
negative regulation of ion transmembrane transporter activity,48,0.473,0.522,1,GO:0032413,BP,,3821
estrogen metabolic process,14,0.549,0.522,1,GO:0008210,BP,,3822
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,171,0.514,0.522,1,GO:0002460,BP,,3823
inactivation of MAPK activity,21,0.46,0.523,1,GO:0000188,BP,,3824
pyrimidine nucleobase metabolic process,18,0.456,0.523,1,GO:0006206,BP,,3825
filamentous actin,27,0.464,0.523,1,GO:0031941,CC,,3826
outflow tract morphogenesis,64,0.523,0.523,1,GO:0003151,BP,,3827
O-acyltransferase activity,39,0.53,0.523,1,GO:0008374,MF,,3828
GTP biosynthetic process,12,0.447,0.523,1,GO:0006183,BP,,3829
pallium development,153,0.485,0.524,1,GO:0021543,BP,,3830
RNA polymerase binding,43,0.472,0.524,1,GO:0070063,MF,,3831
response to monoamine,36,0.531,0.524,1,"GO:0071867,GO:0071869",BP,response to catecholamine,3832
regulation of epithelial tube formation,16,0.546,0.524,1,GO:1905276,BP,,3833
anchored component of membrane,127,0.484,0.524,1,GO:0031225,CC,,3834
tube closure,80,0.521,0.525,1,GO:0060606,BP,,3835
response to oxygen radical,27,0.465,0.525,1,GO:0000305,BP,,3836
regulation of antigen receptor-mediated signaling pathway,42,0.472,0.525,1,GO:0050854,BP,,3837
cellular response to vitamin,22,0.539,0.525,1,GO:0071295,BP,,3838
ncRNA transcription,94,0.481,0.526,1,GO:0098781,BP,,3839
positive regulation of neuroblast proliferation,17,0.456,0.526,1,GO:0002052,BP,,3840
hexose transmembrane transporter activity,15,0.453,0.526,1,GO:0015149,MF,,3841
insulin-like growth factor binding,27,0.535,0.526,1,GO:0005520,MF,,3842
glutathione peroxidase activity,17,0.456,0.526,1,GO:0004602,MF,,3843
multicellular organism growth,123,0.517,0.526,1,GO:0035264,BP,,3844
histone deacetylase activity,39,0.529,0.526,1,"GO:0004407,GO:0033558",MF,protein deacetylase activity,3845
intronic transcription regulatory region sequence-specific DNA binding,10,0.442,0.526,1,"GO:0001161,GO:0044213",MF,intronic transcription regulatory region DNA binding,3846
regulation of inclusion body assembly,13,0.551,0.526,1,GO:0090083,BP,,3847
embryonic axis specification,28,0.465,0.526,1,GO:0000578,BP,,3848
eosinophil migration,12,0.447,0.526,1,GO:0072677,BP,,3849
rhythmic behavior,39,0.529,0.527,1,GO:0007622,BP,,3850
regulation of fatty acid transport,19,0.458,0.527,1,GO:2000191,BP,,3851
podosome,29,0.534,0.528,1,GO:0002102,CC,,3852
hydro-lyase activity,45,0.527,0.528,1,GO:0016836,MF,,3853
regulation of fatty acid metabolic process,68,0.478,0.528,1,GO:0019217,BP,,3854
epoxygenase P450 pathway,12,0.447,0.528,1,GO:0019373,BP,,3855
negative regulation of platelet-derived growth factor receptor signaling pathway,15,0.453,0.528,1,GO:0010642,BP,,3856
otic vesicle development,13,0.551,0.528,1,GO:0071599,BP,,3857
negative regulation of ERAD pathway,12,0.447,0.529,1,GO:1904293,BP,,3858
renal vesicle development,18,0.543,0.529,1,GO:0072087,BP,,3859
regulation of circadian rhythm,88,0.519,0.529,1,GO:0042752,BP,,3860
carbohydrate catabolic process,130,0.484,0.529,1,GO:0016052,BP,,3861
neuronal stem cell division,12,0.552,0.53,1,"GO:0036445,GO:0055057",BP,neuroblast division,3862
aldehyde biosynthetic process,12,0.448,0.53,1,GO:0046184,BP,,3863
regulation of triglyceride metabolic process,23,0.462,0.53,1,GO:0090207,BP,,3864
mannosylation,28,0.466,0.53,1,GO:0097502,BP,,3865
histone H2B ubiquitination,10,0.443,0.53,1,GO:0033523,BP,,3866
positive regulation of fibroblast migration,11,0.445,0.53,1,GO:0010763,BP,,3867
regulation of calcineurin-NFAT signaling cascade,16,0.455,0.531,1,GO:0070884,BP,,3868
actin-dependent ATPase activity,11,0.445,0.531,1,GO:0030898,MF,,3869
bronchus development,10,0.443,0.531,1,GO:0060433,BP,,3870
interleukin-2 biosynthetic process,17,0.544,0.531,1,GO:0042094,BP,,3871
molting cycle process,79,0.52,0.532,1,"GO:0022404,GO:0022405",BP,hair cycle process,3872
phototransduction,45,0.473,0.532,1,GO:0007602,BP,,3873
histone acetyltransferase complex,76,0.521,0.532,1,GO:0000123,CC,,3874
alpha-catenin binding,10,0.557,0.532,1,GO:0045294,MF,,3875
plasma membrane fusion,29,0.533,0.533,1,GO:0045026,BP,,3876
cleavage furrow,45,0.527,0.533,1,"GO:0032154,GO:0097610",CC,cell surface furrow,3877
epithelial cell proliferation involved in prostate gland development,10,0.557,0.533,1,GO:0060767,BP,,3878
GMP metabolic process,19,0.459,0.533,1,GO:0046037,BP,,3879
circadian behavior,38,0.529,0.533,1,GO:0048512,BP,,3880
cellular glucose homeostasis,111,0.483,0.534,1,GO:0001678,BP,,3881
regulation of carbohydrate catabolic process,37,0.53,0.534,1,GO:0043470,BP,,3882
DNA strand elongation involved in DNA replication,15,0.454,0.534,1,GO:0006271,BP,,3883
SNARE binding,105,0.482,0.534,1,GO:0000149,MF,,3884
nucleophagy,13,0.55,0.534,1,GO:0044804,BP,,3885
tryptophan metabolic process,11,0.554,0.535,1,GO:0006568,BP,,3886
GDP binding,53,0.475,0.535,1,GO:0019003,MF,,3887
negative regulation of focal adhesion assembly,15,0.546,0.535,1,GO:0051895,BP,,3888
osteoclast development,15,0.454,0.535,1,GO:0036035,BP,,3889
SMAD protein signal transduction,44,0.527,0.535,1,GO:0060395,BP,,3890
negative regulation of interleukin-1 beta production,10,0.557,0.535,1,GO:0032691,BP,,3891
ubiquitin binding,93,0.481,0.536,1,GO:0043130,MF,,3892
regulation of keratinocyte differentiation,24,0.537,0.536,1,GO:0045616,BP,,3893
negative regulation of ERBB signaling pathway,48,0.526,0.536,1,GO:1901185,BP,,3894
negative regulation of neurotransmitter secretion,12,0.552,0.536,1,GO:0046929,BP,,3895
digestive tract development,107,0.517,0.537,1,GO:0048565,BP,,3896
negative regulation of signal transduction by p53 class mediator,27,0.466,0.537,1,GO:1901797,BP,,3897
negative regulation of cellular response to oxidative stress,38,0.471,0.537,1,"GO:1900408,GO:1902883,GO:1903202",BP,"negative regulation of response to oxidative stress,negative regulation of oxidative stress-induced cell death",3898
outward rectifier potassium channel activity,11,0.446,0.537,1,GO:0015271,MF,,3899
cytoplasmic ribonucleoprotein granule,156,0.486,0.537,1,GO:0036464,CC,,3900
excretion,55,0.476,0.537,1,GO:0007588,BP,,3901
positive regulation of T cell migration,14,0.452,0.538,1,GO:2000406,BP,,3902
regulation of beta-amyloid formation,10,0.556,0.538,1,GO:1902003,BP,,3903
single-stranded DNA binding,81,0.52,0.538,1,GO:0003697,MF,,3904
negative regulation of glycoprotein metabolic process,13,0.549,0.538,1,GO:1903019,BP,,3905
positive regulation of embryonic development,30,0.532,0.538,1,GO:0040019,BP,,3906
T cell differentiation,178,0.513,0.538,1,GO:0030217,BP,,3907
positive T cell selection,20,0.54,0.538,1,GO:0043368,BP,,3908
peptide N-acetyltransferase activity,59,0.523,0.539,1,GO:0034212,MF,,3909
anatomical structure arrangement,16,0.544,0.539,1,GO:0048532,BP,,3910
peptidase activator activity,35,0.47,0.539,1,GO:0016504,MF,,3911
response to nicotine,42,0.473,0.539,1,GO:0035094,BP,,3912
gamma-tubulin complex,18,0.542,0.539,1,GO:0000930,CC,,3913
regulation of pri-miRNA transcription from RNA polymerase II promoter,26,0.465,0.539,1,GO:1902893,BP,,3914
regulation of Ras protein signal transduction,187,0.487,0.539,1,GO:0046578,BP,,3915
regulation of necrotic cell death,23,0.537,0.539,1,GO:0010939,BP,,3916
regulation of keratinocyte proliferation,26,0.465,0.54,1,GO:0010837,BP,,3917
mRNA catabolic process,200,0.487,0.54,1,GO:0006402,BP,,3918
response to temperature stimulus,194,0.513,0.54,1,GO:0009266,BP,,3919
"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen",18,0.458,0.54,1,GO:0016712,MF,,3920
positive regulation of cell adhesion mediated by integrin,15,0.454,0.541,1,GO:0033630,BP,,3921
cysteine-type endopeptidase regulator activity involved in apoptotic process,38,0.529,0.541,1,GO:0043028,MF,,3922
pigment granule transport,22,0.462,0.541,1,GO:0051904,BP,,3923
caveola,70,0.521,0.542,1,GO:0005901,CC,,3924
ADP binding,30,0.468,0.542,1,GO:0043531,MF,,3925
positive regulation of mononuclear cell migration,15,0.454,0.542,1,GO:0071677,BP,,3926
sulfotransferase activity,42,0.473,0.542,1,GO:0008146,MF,,3927
positive regulation of mitotic nuclear division,42,0.473,0.542,1,GO:0045840,BP,,3928
glial cell differentiation,168,0.514,0.542,1,GO:0010001,BP,,3929
tropomyosin binding,12,0.449,0.542,1,GO:0005523,MF,,3930
collagen trimer,81,0.48,0.543,1,GO:0005581,CC,,3931
interferon-gamma production,76,0.48,0.543,1,GO:0032609,BP,,3932
regulation of epidermal cell differentiation,41,0.527,0.543,1,GO:0045604,BP,,3933
branching involved in blood vessel morphogenesis,25,0.535,0.543,1,GO:0001569,BP,,3934
receptor signaling complex scaffold activity,24,0.536,0.544,1,GO:0030159,MF,,3935
contractile ring,10,0.555,0.544,1,GO:0070938,CC,,3936
glycolipid catabolic process,11,0.447,0.544,1,GO:0019377,BP,,3937
negative regulation of mitotic metaphase/anaphase transition,27,0.466,0.544,1,"GO:0045841,GO:1902100,GO:1905819,GO:2000816",BP,"negative regulation of metaphase/anaphase transition of cell cycle,negative regulation of chromosome separation,negative regulation of mitotic sister chromatid separation",3938
cellular response to nutrient,31,0.531,0.545,1,GO:0031670,BP,,3939
peptide hormone binding,32,0.531,0.545,1,GO:0017046,MF,,3940
drug binding,88,0.481,0.545,1,GO:0008144,MF,,3941
response to estrogen,62,0.478,0.545,1,GO:0043627,BP,,3942
transmembrane receptor protein tyrosine kinase activity,61,0.478,0.545,1,GO:0004714,MF,,3943
"oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor",11,0.553,0.546,1,GO:0016653,MF,,3944
lymphocyte mediated immunity,165,0.514,0.546,1,GO:0002449,BP,,3945
cellular amino acid biosynthetic process,74,0.48,0.546,1,GO:0008652,BP,,3946
regulation of cellular response to insulin stimulus,60,0.523,0.546,1,GO:1900076,BP,,3947
middle ear morphogenesis,15,0.455,0.546,1,GO:0042474,BP,,3948
MyD88-dependent toll-like receptor signaling pathway,32,0.469,0.546,1,GO:0002755,BP,,3949
skin epidermis development,83,0.519,0.547,1,GO:0098773,BP,,3950
pyrimidine ribonucleoside biosynthetic process,22,0.463,0.547,1,GO:0046132,BP,,3951
positive regulation of glucose import in response to insulin stimulus,12,0.55,0.547,1,GO:2001275,BP,,3952
regulation of protein localization to plasma membrane,64,0.522,0.547,1,GO:1903076,BP,,3953
defense response to fungus,17,0.542,0.548,1,GO:0050832,BP,,3954
nucleotide salvage,12,0.45,0.548,1,GO:0043173,BP,,3955
bone trabecula morphogenesis,10,0.555,0.548,1,GO:0061430,BP,,3956
cellular response to interferon-gamma,113,0.516,0.548,1,GO:0071346,BP,,3957
CENP-A containing nucleosome assembly,26,0.534,0.549,1,"GO:0034080,GO:0061641",BP,CENP-A containing chromatin organization,3958
protein complex localization,114,0.516,0.549,1,GO:0031503,BP,,3959
"RNA phosphodiester bond hydrolysis, endonucleolytic",51,0.524,0.549,1,GO:0090502,BP,,3960
response to ionizing radiation,127,0.515,0.549,1,GO:0010212,BP,,3961
low-density lipoprotein particle binding,12,0.45,0.549,1,GO:0030169,MF,,3962
dendritic spine morphogenesis,45,0.474,0.549,1,GO:0060997,BP,,3963
positive regulation of muscle cell apoptotic process,15,0.455,0.549,1,GO:0010661,BP,,3964
regulation of cardiac muscle contraction by calcium ion signaling,23,0.464,0.549,1,GO:0010882,BP,,3965
monovalent cation:proton antiporter activity,13,0.548,0.549,1,GO:0005451,MF,,3966
hindbrain morphogenesis,36,0.471,0.549,1,GO:0021575,BP,,3967
myeloid cell homeostasis,107,0.517,0.55,1,GO:0002262,BP,,3968
positive regulation of transcription regulatory region DNA binding,17,0.458,0.55,1,GO:2000679,BP,,3969
regulation of peptidyl-lysine acetylation,49,0.525,0.55,1,GO:2000756,BP,,3970
tumor necrosis factor superfamily cytokine production,92,0.518,0.551,1,GO:0071706,BP,,3971
leukocyte chemotaxis,137,0.485,0.551,1,GO:0030595,BP,,3972
animal organ regeneration,65,0.521,0.551,1,GO:0031100,BP,,3973
nucleoside diphosphate phosphorylation,78,0.48,0.551,1,GO:0006165,BP,,3974
negative regulation of myotube differentiation,12,0.55,0.551,1,GO:0010832,BP,,3975
regulation of anion transport,87,0.482,0.552,1,GO:0044070,BP,,3976
mitochondrial fission,36,0.529,0.552,1,GO:0000266,BP,,3977
neutrophil chemotaxis,60,0.522,0.552,1,GO:0030593,BP,,3978
negative regulation of insulin receptor signaling pathway,30,0.469,0.552,1,GO:0046627,BP,,3979
gamma-tubulin binding,23,0.536,0.552,1,GO:0043015,MF,,3980
negative regulation of blood vessel diameter,70,0.479,0.552,1,GO:0097756,BP,,3981
positive regulation of organ growth,38,0.472,0.552,1,GO:0046622,BP,,3982
regulation of vesicle fusion,59,0.478,0.552,1,GO:0031338,BP,,3983
negative regulation of production of molecular mediator of immune response,24,0.465,0.553,1,GO:0002701,BP,,3984
"nucleotide-excision repair, DNA incision",34,0.471,0.553,1,GO:0033683,BP,,3985
glomerular filtration,15,0.456,0.553,1,GO:0003094,BP,,3986
somatic diversification of immune receptors,45,0.526,0.553,1,GO:0002200,BP,,3987
"phosphotransferase activity, phosphate group as acceptor",39,0.473,0.553,1,GO:0016776,MF,,3988
negative regulation of defense response to virus,20,0.538,0.553,1,GO:0050687,BP,,3989
oxidoreduction coenzyme metabolic process,135,0.485,0.553,1,GO:0006733,BP,,3990
cell death in response to hydrogen peroxide,24,0.535,0.554,1,GO:0036474,BP,,3991
integrin complex,30,0.531,0.554,1,"GO:0008305,GO:0098636",CC,protein complex involved in cell adhesion,3992
postsynaptic neurotransmitter receptor activity,17,0.459,0.554,1,GO:0098960,MF,,3993
microvillus membrane,17,0.541,0.555,1,GO:0031528,CC,,3994
positive regulation of potassium ion transport,33,0.53,0.555,1,GO:0043268,BP,,3995
response to hepatocyte growth factor,13,0.547,0.555,1,GO:0035728,BP,,3996
phosphatase regulator activity,78,0.481,0.555,1,GO:0019208,MF,,3997
negative regulation of myeloid cell differentiation,65,0.521,0.555,1,GO:0045638,BP,,3998
positive regulation of response to oxidative stress,16,0.543,0.555,1,GO:1902884,BP,,3999
positive regulation of interleukin-1 production,30,0.469,0.556,1,GO:0032732,BP,,4000
organelle transport along microtubule,64,0.479,0.556,1,GO:0072384,BP,,4001
regulation of viral transcription,55,0.523,0.556,1,GO:0046782,BP,,4002
aromatase activity,16,0.458,0.557,1,GO:0070330,MF,,4003
cardiolipin metabolic process,10,0.446,0.557,1,GO:0032048,BP,,4004
rRNA methylation,19,0.539,0.557,1,GO:0031167,BP,,4005
"oxidoreductase activity, acting on peroxide as acceptor",42,0.474,0.557,1,GO:0016684,MF,,4006
regulation of alpha-beta T cell proliferation,19,0.461,0.557,1,GO:0046640,BP,,4007
icosanoid receptor activity,13,0.453,0.557,1,GO:0004953,MF,,4008
adult locomotory behavior,67,0.479,0.558,1,GO:0008344,BP,,4009
positive regulation of striated muscle cell differentiation,45,0.475,0.558,1,GO:0051155,BP,,4010
sarcoplasmic reticulum,55,0.477,0.558,1,GO:0016529,CC,,4011
circadian rhythm,177,0.513,0.559,1,GO:0007623,BP,,4012
phosphatase inhibitor activity,35,0.471,0.559,1,GO:0019212,MF,,4013
non-motile cilium assembly,45,0.525,0.559,1,GO:1905515,BP,,4014
regulation of B cell receptor signaling pathway,12,0.451,0.559,1,GO:0050855,BP,,4015
regulation of deoxyribonuclease activity,10,0.553,0.559,1,GO:0032070,BP,,4016
MLL1/2 complex,24,0.466,0.56,1,"GO:0044665,GO:0071339",CC,MLL1 complex,4017
protein kinase C binding,40,0.527,0.56,1,GO:0005080,MF,,4018
negative regulation of chemotaxis,29,0.469,0.56,1,GO:0050922,BP,,4019
regulation of water loss via skin,16,0.542,0.56,1,GO:0033561,BP,,4020
protein localization to cell surface,50,0.476,0.56,1,GO:0034394,BP,,4021
histone H3-K9 trimethylation,14,0.545,0.56,1,GO:0036124,BP,,4022
response to muscle stretch,17,0.459,0.56,1,GO:0035994,BP,,4023
neuronal stem cell population maintenance,19,0.539,0.56,1,GO:0097150,BP,,4024
regulation of tube diameter,110,0.484,0.561,1,"GO:0035296,GO:0097746",BP,regulation of blood vessel diameter,4025
regulation of delayed rectifier potassium channel activity,14,0.455,0.561,1,GO:1902259,BP,,4026
positive regulation of histone modification,73,0.52,0.561,1,GO:0031058,BP,,4027
transcription cofactor binding,32,0.53,0.562,1,GO:0001221,MF,,4028
mitochondrial respiratory chain complex IV biogenesis,15,0.457,0.562,1,GO:0097034,BP,,4029
multi-organism metabolic process,192,0.488,0.562,1,GO:0044033,BP,,4030
columnar/cuboidal epithelial cell development,50,0.524,0.562,1,GO:0002066,BP,,4031
regulation of protein acetylation,54,0.523,0.562,1,GO:1901983,BP,,4032
mesonephric epithelium development,88,0.518,0.563,1,"GO:0072163,GO:0072164",BP,mesonephric tubule development,4033
acrosome reaction,24,0.534,0.563,1,GO:0007340,BP,,4034
ferrous iron binding,20,0.537,0.563,1,GO:0008198,MF,,4035
secondary active sulfate transmembrane transporter activity,11,0.45,0.563,1,"GO:0008271,GO:0015116",MF,sulfate transmembrane transporter activity,4036
regulation of podosome assembly,12,0.452,0.563,1,GO:0071801,BP,,4037
positive regulation of cellular carbohydrate metabolic process,45,0.525,0.563,1,GO:0010676,BP,,4038
histone deacetylase complex,58,0.522,0.564,1,GO:0000118,CC,,4039
negative regulation of protein secretion,89,0.482,0.564,1,GO:0050709,BP,,4040
replication fork,58,0.522,0.564,1,GO:0005657,CC,,4041
positive regulation of pri-miRNA transcription from RNA polymerase II promoter,18,0.461,0.564,1,GO:1902895,BP,,4042
"endoribonuclease activity, producing 5'-phosphomonoesters",21,0.464,0.564,1,GO:0016891,MF,,4043
vascular endothelial growth factor production,30,0.47,0.564,1,GO:0010573,BP,,4044
regulation of epidermal growth factor receptor signaling pathway,72,0.52,0.565,1,GO:0042058,BP,,4045
negative regulation of cardiocyte differentiation,14,0.544,0.565,1,GO:1905208,BP,,4046
nucleotide diphosphatase activity,13,0.454,0.565,1,GO:0004551,MF,,4047
telomere maintenance in response to DNA damage,10,0.553,0.565,1,GO:0043247,BP,,4048
cellular senescence,51,0.477,0.565,1,GO:0090398,BP,,4049
natural killer cell mediated immunity,41,0.474,0.566,1,GO:0002228,BP,,4050
ovulation cycle process,70,0.52,0.566,1,GO:0022602,BP,,4051
establishment of chromosome localization,56,0.478,0.566,1,GO:0051303,BP,,4052
regulation of lamellipodium organization,34,0.472,0.566,1,GO:1902743,BP,,4053
mechanosensory behavior,11,0.45,0.567,1,GO:0007638,BP,,4054
regulation of sister chromatid segregation,58,0.478,0.567,1,GO:0033045,BP,,4055
negative regulation of carbohydrate metabolic process,35,0.472,0.567,1,GO:0045912,BP,,4056
bone cell development,29,0.531,0.568,1,GO:0098751,BP,,4057
extrinsic apoptotic signaling pathway via death domain receptors,65,0.48,0.568,1,GO:0008625,BP,,4058
negative regulation of stem cell proliferation,10,0.448,0.568,1,GO:2000647,BP,,4059
pyrimidine nucleotide catabolic process,11,0.45,0.568,1,GO:0006244,BP,,4060
protein kinase A signaling,27,0.532,0.568,1,GO:0010737,BP,,4061
response to water,13,0.454,0.569,1,GO:0009415,BP,,4062
regulation of heart rate,84,0.518,0.569,1,GO:0002027,BP,,4063
positive regulation of cholesterol efflux,12,0.453,0.57,1,GO:0010875,BP,,4064
platelet aggregation,49,0.477,0.57,1,GO:0070527,BP,,4065
leukocyte apoptotic process,86,0.518,0.57,1,GO:0071887,BP,,4066
endoplasmic reticulum mannose trimming,16,0.459,0.57,1,GO:1904380,BP,,4067
reactive oxygen species biosynthetic process,77,0.481,0.571,1,GO:1903409,BP,,4068
sodium ion import across plasma membrane,12,0.547,0.571,1,"GO:0098719,GO:1990118",BP,sodium ion import into cell,4069
negative regulation of cell aging,13,0.455,0.571,1,GO:0090344,BP,,4070
glycosphingolipid catabolic process,10,0.448,0.571,1,"GO:0046479,GO:0046514",BP,ceramide catabolic process,4071
cytokine production involved in inflammatory response,20,0.537,0.571,1,GO:0002534,BP,,4072
response to cholesterol,18,0.461,0.572,1,GO:0070723,BP,,4073
fibroblast migration,37,0.473,0.572,1,GO:0010761,BP,,4074
histone methyltransferase complex,59,0.521,0.572,1,GO:0035097,CC,,4075
positive regulation of T cell differentiation in thymus,10,0.552,0.573,1,GO:0033089,BP,,4076
regulation of sister chromatid cohesion,20,0.536,0.573,1,GO:0007063,BP,,4077
enamel mineralization,11,0.549,0.573,1,GO:0070166,BP,,4078
positive regulation of epidermal cell differentiation,18,0.538,0.573,1,GO:0045606,BP,,4079
peptide disulfide oxidoreductase activity,12,0.547,0.573,1,GO:0015037,MF,,4080
atrial septum morphogenesis,10,0.449,0.574,1,GO:0060413,BP,,4081
response to vitamin E,12,0.453,0.574,1,GO:0033197,BP,,4082
"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen",24,0.467,0.574,1,GO:0016709,MF,,4083
mRNA modification,12,0.547,0.574,1,GO:0016556,BP,,4084
regulation of sulfur metabolic process,20,0.536,0.574,1,GO:0042762,BP,,4085
bone growth,21,0.465,0.574,1,GO:0098868,BP,,4086
progesterone metabolic process,11,0.549,0.574,1,GO:0042448,BP,,4087
imidazole-containing compound metabolic process,10,0.449,0.574,1,GO:0052803,BP,,4088
serine family amino acid metabolic process,37,0.527,0.574,1,GO:0009069,BP,,4089
embryonic camera-type eye development,33,0.528,0.574,1,GO:0031076,BP,,4090
3'-5' DNA helicase activity,11,0.549,0.575,1,GO:0043138,MF,,4091
response to epidermal growth factor,42,0.525,0.575,1,GO:0070849,BP,,4092
neuron death in response to oxidative stress,19,0.463,0.575,1,GO:0036475,BP,,4093
receptor inhibitor activity,11,0.549,0.575,1,GO:0030547,MF,,4094
regulation of sodium ion transmembrane transport,54,0.478,0.576,1,GO:1902305,BP,,4095
cell-substrate adherens junction assembly,66,0.52,0.576,1,"GO:0007045,GO:0048041",BP,focal adhesion assembly,4096
retina vasculature development in camera-type eye,16,0.46,0.576,1,GO:0061298,BP,,4097
cell fate commitment,190,0.512,0.576,1,GO:0045165,BP,,4098
organic cation transmembrane transporter activity,14,0.543,0.576,1,GO:0015101,MF,,4099
fatty acid ligase activity,17,0.461,0.577,1,GO:0015645,MF,,4100
receptor metabolic process,140,0.486,0.577,1,GO:0043112,BP,,4101
peroxidase activity,39,0.474,0.577,1,GO:0004601,MF,,4102
positive regulation of leukocyte chemotaxis,63,0.52,0.577,1,GO:0002690,BP,,4103
retinoid binding,23,0.466,0.577,1,GO:0005501,MF,,4104
optic nerve development,12,0.546,0.577,1,GO:0021554,BP,,4105
response to antibiotic,41,0.525,0.577,1,GO:0046677,BP,,4106
cellular response to oxygen radical,21,0.465,0.578,1,"GO:0071450,GO:0071451",BP,cellular response to superoxide,4107
monosaccharide biosynthetic process,77,0.482,0.578,1,GO:0046364,BP,,4108
salivary gland development,35,0.527,0.578,1,GO:0007431,BP,,4109
nucleus organization,124,0.514,0.578,1,GO:0006997,BP,,4110
regulation of nuclease activity,25,0.532,0.578,1,GO:0032069,BP,,4111
epithelial to mesenchymal transition involved in endocardial cushion formation,17,0.539,0.578,1,GO:0003198,BP,,4112
interferon-alpha production,18,0.462,0.579,1,GO:0032607,BP,,4113
mRNA cleavage and polyadenylation specificity factor complex,11,0.548,0.579,1,GO:0005847,CC,,4114
Hsp90 protein binding,29,0.47,0.579,1,GO:0051879,MF,,4115
retinoic acid binding,12,0.454,0.58,1,GO:0001972,MF,,4116
positive regulation of DNA repair,39,0.526,0.58,1,GO:0045739,BP,,4117
positive regulation of macrophage migration,11,0.452,0.58,1,GO:1905523,BP,,4118
p53 binding,62,0.52,0.581,1,GO:0002039,MF,,4119
detection of external biotic stimulus,11,0.452,0.581,1,GO:0098581,BP,,4120
negative regulation of protein autophosphorylation,11,0.548,0.581,1,GO:0031953,BP,,4121
defense response to bacterium,135,0.514,0.581,1,GO:0042742,BP,,4122
response to fungus,29,0.53,0.581,1,GO:0009620,BP,,4123
osteoclast differentiation,72,0.481,0.581,1,GO:0030316,BP,,4124
regulation of cardiac muscle cell apoptotic process,21,0.535,0.581,1,GO:0010665,BP,,4125
cAMP catabolic process,19,0.537,0.581,1,GO:0006198,BP,,4126
melanosome localization,24,0.467,0.581,1,GO:0032400,BP,,4127
interaction with host,165,0.512,0.581,1,GO:0051701,BP,,4128
regulation of plasminogen activation,10,0.45,0.581,1,GO:0010755,BP,,4129
lipoprotein particle receptor activity,14,0.457,0.582,1,GO:0030228,MF,,4130
endocrine pancreas development,35,0.527,0.582,1,GO:0031018,BP,,4131
synaptonemal complex,24,0.532,0.582,1,"GO:0000795,GO:0099086",CC,synaptonemal structure,4132
regulation of growth of symbiont in host,10,0.45,0.582,1,"GO:0044126,GO:0044144",BP,modulation of growth of symbiont involved in interaction with host,4133
negative regulation of NF-kappaB import into nucleus,19,0.536,0.582,1,GO:0042347,BP,,4134
segment specification,12,0.546,0.583,1,GO:0007379,BP,,4135
detection of visible light,42,0.475,0.583,1,GO:0009584,BP,,4136
zinc ion transmembrane transporter activity,18,0.463,0.583,1,GO:0005385,MF,,4137
T-helper 1 cell differentiation,12,0.454,0.583,1,GO:0045063,BP,,4138
ubiquitin conjugating enzyme binding,32,0.528,0.583,1,GO:0031624,MF,,4139
heart valve development,32,0.528,0.583,1,GO:0003170,BP,,4140
inorganic anion transmembrane transport,97,0.516,0.583,1,GO:0098661,BP,,4141
neutral lipid metabolic process,95,0.516,0.584,1,GO:0006638,BP,,4142
import into cell,65,0.52,0.584,1,GO:0098657,BP,,4143
positive regulation of leukocyte differentiation,109,0.485,0.584,1,GO:1902107,BP,,4144
nucleotide-activated protein kinase complex,10,0.55,0.584,1,GO:0031588,CC,,4145
structural molecule activity conferring elasticity,15,0.459,0.584,1,GO:0097493,MF,,4146
protein C-terminus binding,165,0.512,0.584,1,GO:0008022,MF,,4147
protein phosphatase type 1 complex,10,0.45,0.584,1,GO:0000164,CC,,4148
ammonium transmembrane transport,17,0.538,0.585,1,GO:0072488,BP,,4149
regulation of norepinephrine secretion,14,0.458,0.585,1,GO:0014061,BP,,4150
lysosome organization,54,0.479,0.585,1,"GO:0007040,GO:0080171",BP,lytic vacuole organization,4151
positive regulation of endothelial cell migration,66,0.519,0.585,1,GO:0010595,BP,,4152
cardiac atrium development,27,0.47,0.585,1,GO:0003230,BP,,4153
cis-Golgi network,39,0.525,0.586,1,GO:0005801,CC,,4154
nuclear nucleosome,13,0.544,0.586,1,GO:0000788,CC,,4155
"DNA-templated transcription, termination",91,0.483,0.586,1,GO:0006353,BP,,4156
cellular response to fibroblast growth factor stimulus,123,0.514,0.586,1,GO:0044344,BP,,4157
regulation of gluconeogenesis,32,0.528,0.586,1,GO:0006111,BP,,4158
organelle disassembly,90,0.483,0.586,1,GO:1903008,BP,,4159
iron ion binding,124,0.514,0.587,1,GO:0005506,MF,,4160
negative regulation of glycolytic process,11,0.547,0.587,1,"GO:0045820,GO:0051195,GO:0051198",BP,"negative regulation of cofactor metabolic process,negative regulation of coenzyme metabolic process",4161
positive regulation of amino acid transport,15,0.459,0.587,1,GO:0051957,BP,,4162
homophilic cell adhesion via plasma membrane adhesion molecules,125,0.486,0.587,1,GO:0007156,BP,,4163
insulin-like growth factor receptor binding,14,0.458,0.588,1,GO:0005159,MF,,4164
regulation of chromosome segregation,72,0.482,0.588,1,GO:0051983,BP,,4165
cell communication by electrical coupling,26,0.531,0.588,1,GO:0010644,BP,,4166
dendritic cell migration,22,0.467,0.588,1,GO:0036336,BP,,4167
nucleobase metabolic process,34,0.473,0.588,1,GO:0009112,BP,,4168
clathrin-coated pit,67,0.519,0.589,1,GO:0005905,CC,,4169
circadian sleep/wake cycle process,21,0.534,0.589,1,GO:0022410,BP,,4170
voltage-gated cation channel activity,118,0.514,0.589,1,GO:0022843,MF,,4171
protein-lysine N-methyltransferase activity,51,0.522,0.589,1,GO:0016279,MF,,4172
ribonucleoprotein granule,165,0.488,0.589,1,GO:0035770,CC,,4173
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,25,0.469,0.59,1,GO:0016339,BP,,4174
positive regulation of lipid catabolic process,20,0.465,0.59,1,GO:0050996,BP,,4175
protein kinase B binding,11,0.547,0.59,1,GO:0043422,MF,,4176
trophectodermal cell differentiation,12,0.455,0.59,1,GO:0001829,BP,,4177
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,14,0.542,0.59,1,GO:2001269,BP,,4178
regulation of blood vessel endothelial cell migration,50,0.478,0.59,1,GO:0043535,BP,,4179
glucose transport,127,0.514,0.59,1,GO:0015758,BP,,4180
blastocyst development,49,0.478,0.591,1,GO:0001824,BP,,4181
aspartate family amino acid metabolic process,53,0.479,0.591,1,GO:0009066,BP,,4182
sensory perception of mechanical stimulus,137,0.513,0.591,1,GO:0050954,BP,,4183
regulation of receptor binding,20,0.535,0.592,1,GO:1900120,BP,,4184
positive regulation of leukocyte mediated cytotoxicity,22,0.533,0.592,1,GO:0001912,BP,,4185
positive regulation of positive chemotaxis,19,0.464,0.592,1,GO:0050927,BP,,4186
tissue homeostasis,167,0.512,0.592,1,GO:0001894,BP,,4187
cellular response to sterol,14,0.459,0.592,1,GO:0036315,BP,,4188
cytokine activity,138,0.513,0.592,1,GO:0005125,MF,,4189
neuron projection regeneration,47,0.477,0.592,1,GO:0031102,BP,,4190
regulation of hydrogen peroxide-mediated programmed cell death,10,0.549,0.592,1,GO:1901298,BP,,4191
"inositol-1,4,5-trisphosphate 3-kinase activity",10,0.549,0.592,1,GO:0008440,MF,,4192
cellular response to pH,16,0.539,0.593,1,GO:0071467,BP,,4193
negative regulation of ion transmembrane transport,66,0.481,0.593,1,GO:0034766,BP,,4194
mitotic G2 DNA damage checkpoint,15,0.54,0.593,1,GO:0007095,BP,,4195
transposition,10,0.451,0.594,1,GO:0032196,BP,,4196
actin filament bundle,56,0.479,0.594,1,GO:0032432,CC,,4197
1-acylglycerol-3-phosphate O-acyltransferase activity,18,0.536,0.594,1,"GO:0003841,GO:0042171,GO:0071617",MF,"lysophosphatidic acid acyltransferase activity,lysophospholipid acyltransferase activity",4198
transmembrane receptor protein kinase activity,76,0.482,0.594,1,GO:0019199,MF,,4199
positive regulation of insulin-like growth factor receptor signaling pathway,10,0.451,0.594,1,GO:0043568,BP,,4200
"blood coagulation, fibrin clot formation",19,0.535,0.594,1,GO:0072378,BP,,4201
termination of RNA polymerase II transcription,59,0.52,0.594,1,GO:0006369,BP,,4202
negative regulation of cellular response to growth factor stimulus,116,0.514,0.595,1,GO:0090288,BP,,4203
glomerulus development,59,0.48,0.595,1,GO:0032835,BP,,4204
single-organism carbohydrate catabolic process,125,0.486,0.595,1,GO:0044724,BP,,4205
cellular response to starvation,110,0.485,0.595,1,GO:0009267,BP,,4206
striatum development,16,0.538,0.595,1,GO:0021756,BP,,4207
"retrograde protein transport, ER to cytosol",24,0.469,0.595,1,"GO:0030970,GO:1903513",BP,endoplasmic reticulum to cytosol transport,4208
genitalia development,34,0.526,0.595,1,GO:0048806,BP,,4209
gamma-aminobutyric acid transport,12,0.456,0.596,1,GO:0015812,BP,,4210
regulation of protein export from nucleus,36,0.526,0.596,1,GO:0046825,BP,,4211
regulation of macrophage derived foam cell differentiation,23,0.532,0.596,1,GO:0010743,BP,,4212
Rho GTPase binding,82,0.517,0.596,1,GO:0017048,MF,,4213
positive regulation of myoblast fusion,13,0.542,0.596,1,GO:1901741,BP,,4214
cellular response to alkaloid,36,0.474,0.596,1,GO:0071312,BP,,4215
peptidyl-threonine modification,106,0.485,0.596,1,GO:0018210,BP,,4216
regulation of endothelial cell migration,108,0.515,0.596,1,GO:0010594,BP,,4217
digestive system process,67,0.481,0.596,1,GO:0022600,BP,,4218
negative regulation of macroautophagy,24,0.531,0.596,1,GO:0016242,BP,,4219
deoxyribonucleotide catabolic process,17,0.463,0.597,1,GO:0009264,BP,,4220
negative regulation of proteasomal ubiquitin-dependent protein catabolic process,21,0.533,0.597,1,GO:0032435,BP,,4221
negative regulation of chondrocyte differentiation,15,0.461,0.597,1,GO:0032331,BP,,4222
transforming growth factor beta binding,17,0.537,0.597,1,GO:0050431,MF,,4223
positive regulation of mitotic cell cycle,113,0.486,0.597,1,GO:0045931,BP,,4224
regulation of protein localization to cell periphery,65,0.519,0.598,1,GO:1904375,BP,,4225
cellular response to nutrient levels,147,0.487,0.598,1,GO:0031669,BP,,4226
dendritic shaft,34,0.474,0.598,1,GO:0043198,CC,,4227
endodeoxyribonuclease activity,40,0.524,0.598,1,GO:0004520,MF,,4228
positive regulation of phosphoprotein phosphatase activity,15,0.461,0.599,1,GO:0032516,BP,,4229
adult walking behavior,26,0.53,0.599,1,GO:0007628,BP,,4230
phosphatidylcholine acyl-chain remodeling,22,0.532,0.599,1,GO:0036151,BP,,4231
glomerulus vasculature development,22,0.532,0.6,1,GO:0072012,BP,,4232
blastoderm segmentation,13,0.458,0.6,1,GO:0007350,BP,,4233
phosphatidylinositol phosphate kinase activity,15,0.539,0.6,1,GO:0016307,MF,,4234
negative regulation of axonogenesis,49,0.478,0.6,1,GO:0050771,BP,,4235
positive regulation of tumor necrosis factor production,50,0.479,0.6,1,GO:0032760,BP,,4236
potassium channel activity,111,0.514,0.6,1,GO:0005267,MF,,4237
triglyceride catabolic process,23,0.468,0.6,1,GO:0019433,BP,,4238
muscle cell proliferation,148,0.513,0.6,1,GO:0033002,BP,,4239
chromosome localization,57,0.48,0.601,1,GO:0050000,BP,,4240
regulation of excretion,22,0.532,0.601,1,GO:0044062,BP,,4241
glyceraldehyde-3-phosphate metabolic process,20,0.466,0.601,1,GO:0019682,BP,,4242
smooth muscle cell differentiation,46,0.478,0.601,1,GO:0051145,BP,,4243
neurotransmitter binding,18,0.464,0.601,1,GO:0042165,MF,,4244
regulation of digestive system process,28,0.529,0.601,1,GO:0044058,BP,,4245
calcium-dependent protein kinase activity,12,0.456,0.601,1,GO:0010857,MF,,4246
membrane hyperpolarization,12,0.456,0.601,1,GO:0060081,BP,,4247
negative regulation of cellular protein catabolic process,47,0.478,0.601,1,GO:1903363,BP,,4248
mRNA cleavage involved in mRNA processing,10,0.548,0.602,1,GO:0098787,BP,,4249
snRNA processing,15,0.539,0.602,1,GO:0016180,BP,,4250
cytokine receptor activity,67,0.518,0.602,1,GO:0004896,MF,,4251
P-body,92,0.484,0.602,1,GO:0000932,CC,,4252
embryonic viscerocranium morphogenesis,10,0.548,0.602,1,GO:0048703,BP,,4253
potassium ion antiporter activity,14,0.54,0.602,1,GO:0022821,MF,,4254
regulation of double-strand break repair via homologous recombination,17,0.536,0.603,1,GO:0010569,BP,,4255
regulation of interleukin-1 production,46,0.522,0.603,1,GO:0032652,BP,,4256
regulation of SMAD protein import into nucleus,16,0.538,0.603,1,GO:0060390,BP,,4257
myeloid cell development,48,0.478,0.604,1,GO:0061515,BP,,4258
regulation of transcription involved in cell fate commitment,14,0.54,0.604,1,GO:0060850,BP,,4259
COPII vesicle coat,10,0.453,0.604,1,GO:0030127,CC,,4260
heart field specification,10,0.547,0.604,1,GO:0003128,BP,,4261
protein activation cascade,61,0.481,0.605,1,GO:0072376,BP,,4262
definitive hemopoiesis,16,0.537,0.605,1,GO:0060216,BP,,4263
inhibitory postsynaptic potential,12,0.457,0.605,1,GO:0060080,BP,,4264
Notch signaling pathway,145,0.512,0.605,1,GO:0007219,BP,,4265
positive regulation of mast cell activation,13,0.459,0.605,1,GO:0033005,BP,,4266
phosphatidylethanolamine metabolic process,15,0.461,0.605,1,GO:0046337,BP,,4267
apoptotic cell clearance,31,0.473,0.606,1,GO:0043277,BP,,4268
regulation of leukocyte chemotaxis,74,0.517,0.606,1,GO:0002688,BP,,4269
negative regulation of DNA repair,13,0.459,0.606,1,GO:0045738,BP,,4270
branching involved in mammary gland duct morphogenesis,22,0.468,0.606,1,GO:0060444,BP,,4271
positive regulation of DNA binding,40,0.476,0.607,1,GO:0043388,BP,,4272
protein peptidyl-prolyl isomerization,31,0.473,0.607,1,"GO:0000413,GO:0003755",BP,peptidyl-prolyl cis-trans isomerase activity,4273
"negative regulation of DNA-templated transcription, elongation",10,0.453,0.607,1,GO:0032785,BP,,4274
negative regulation of dendrite morphogenesis,14,0.54,0.607,1,GO:0050774,BP,,4275
negative regulation of vasculature development,70,0.518,0.608,1,GO:1901343,BP,,4276
cellular response to corticosteroid stimulus,54,0.52,0.608,1,GO:0071384,BP,,4277
regulation of cellular extravasation,19,0.466,0.608,1,GO:0002691,BP,,4278
regulation of viral release from host cell,28,0.528,0.608,1,GO:1902186,BP,,4279
atrial cardiac muscle cell membrane repolarization,10,0.453,0.608,1,GO:0099624,BP,,4280
inorganic anion transmembrane transporter activity,109,0.514,0.609,1,GO:0015103,MF,,4281
blood vessel remodeling,39,0.524,0.609,1,GO:0001974,BP,,4282
cellular modified amino acid catabolic process,21,0.468,0.61,1,GO:0042219,BP,,4283
GTPase activating protein binding,14,0.461,0.61,1,GO:0032794,MF,,4284
response to X-ray,25,0.471,0.61,1,GO:0010165,BP,,4285
negative regulation of protein binding,74,0.483,0.61,1,GO:0032091,BP,,4286
positive regulation of T cell apoptotic process,11,0.456,0.61,1,GO:0070234,BP,,4287
positive regulation of chemotaxis,99,0.485,0.611,1,GO:0050921,BP,,4288
regulation of interleukin-1 beta secretion,25,0.529,0.611,1,GO:0050706,BP,,4289
long-chain fatty-acyl-CoA metabolic process,43,0.478,0.611,1,GO:0035336,BP,,4290
macromolecular complex remodeling,17,0.464,0.612,1,"GO:0034367,GO:0034368,GO:0034369",BP,"protein-lipid complex remodeling,plasma lipoprotein particle remodeling",4291
establishment of mitotic spindle orientation,15,0.538,0.612,1,GO:0000132,BP,,4292
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,12,0.542,0.612,1,GO:2000059,BP,,4293
regulation of RIG-I signaling pathway,12,0.458,0.612,1,GO:0039535,BP,,4294
phosphotyrosine binding,34,0.475,0.612,1,GO:0001784,MF,,4295
NADH metabolic process,33,0.475,0.612,1,GO:0006734,BP,,4296
hormone biosynthetic process,52,0.48,0.613,1,GO:0042446,BP,,4297
regulation of triglyceride biosynthetic process,15,0.462,0.613,1,GO:0010866,BP,,4298
type 1 angiotensin receptor binding,10,0.454,0.614,1,GO:0031702,MF,,4299
histone H3 acetylation,50,0.521,0.614,1,GO:0043966,BP,,4300
gland morphogenesis,105,0.486,0.614,1,GO:0022612,BP,,4301
sleep,30,0.527,0.614,1,GO:0030431,BP,,4302
membrane repolarization,39,0.477,0.614,1,GO:0086009,BP,,4303
substrate adhesion-dependent cell spreading,75,0.517,0.615,1,GO:0034446,BP,,4304
polyol biosynthetic process,35,0.475,0.615,1,GO:0046173,BP,,4305
pinocytosis,18,0.534,0.616,1,GO:0006907,BP,,4306
polyubiquitin binding,38,0.524,0.616,1,GO:0031593,MF,,4307
interleukin-1 production,52,0.48,0.616,1,GO:0032612,BP,,4308
dynein light intermediate chain binding,12,0.542,0.617,1,GO:0051959,MF,,4309
thyroid gland development,20,0.468,0.617,1,GO:0030878,BP,,4310
regulation of translational initiation by eIF2 alpha phosphorylation,10,0.546,0.617,1,GO:0010998,BP,,4311
pyrimidine nucleotide biosynthetic process,31,0.474,0.618,1,GO:0006221,BP,,4312
nucleotide kinase activity,22,0.469,0.618,1,GO:0019201,MF,,4313
GPI anchor biosynthetic process,25,0.529,0.618,1,GO:0006506,BP,,4314
cardiac muscle cell proliferation,39,0.523,0.618,1,GO:0060038,BP,,4315
CDP-diacylglycerol biosynthetic process,13,0.54,0.619,1,GO:0016024,BP,,4316
telencephalon regionalization,10,0.545,0.619,1,GO:0021978,BP,,4317
post-translational protein modification,83,0.484,0.619,1,GO:0043687,BP,,4318
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,21,0.469,0.619,1,GO:0051482,BP,,4319
melanosome transport,21,0.469,0.619,1,GO:0032402,BP,,4320
positive regulation of leukocyte apoptotic process,24,0.471,0.62,1,GO:2000108,BP,,4321
nuclear body organization,10,0.455,0.62,1,GO:0030575,BP,,4322
negative regulation of centrosome duplication,10,0.545,0.62,1,"GO:0010826,GO:0046606",BP,negative regulation of centrosome cycle,4323
positive regulation of bone resorption,12,0.541,0.62,1,"GO:0045780,GO:0046852",BP,positive regulation of bone remodeling,4324
lamellipodium organization,68,0.483,0.62,1,GO:0097581,BP,,4325
macrophage cytokine production,13,0.46,0.62,1,GO:0010934,BP,,4326
response to lead ion,16,0.536,0.621,1,GO:0010288,BP,,4327
negative regulation of transforming growth factor beta receptor signaling pathway,61,0.518,0.621,1,GO:0030512,BP,,4328
regulation of neuron migration,27,0.527,0.622,1,GO:2001222,BP,,4329
"3',5'-cyclic-AMP phosphodiesterase activity",15,0.537,0.622,1,GO:0004115,MF,,4330
transcriptionally active chromatin,18,0.466,0.622,1,GO:0035327,CC,,4331
heparan sulfate proteoglycan biosynthetic process,24,0.471,0.622,1,GO:0015012,BP,,4332
positive regulation of endothelial cell chemotaxis,12,0.459,0.623,1,GO:2001028,BP,,4333
regulation of platelet aggregation,15,0.463,0.623,1,GO:0090330,BP,,4334
substrate-dependent cell migration,28,0.527,0.623,1,GO:0006929,BP,,4335
regulation of defense response to bacterium,12,0.541,0.623,1,GO:1900424,BP,,4336
positive regulation of cardiac muscle cell differentiation,16,0.465,0.623,1,GO:2000727,BP,,4337
negative regulation of cardiac muscle cell differentiation,10,0.455,0.623,1,GO:2000726,BP,,4338
mesenchyme morphogenesis,45,0.521,0.624,1,GO:0072132,BP,,4339
mitophagy,72,0.483,0.624,1,"GO:0000422,GO:0061726",BP,mitochondrion disassembly,4340
negative regulation of potassium ion transport,24,0.529,0.624,1,GO:0043267,BP,,4341
"endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters",27,0.473,0.624,1,GO:0016893,MF,,4342
positive regulation of cytokine biosynthetic process,43,0.478,0.624,1,GO:0042108,BP,,4343
transforming growth factor beta receptor signaling pathway,156,0.511,0.624,1,GO:0007179,BP,,4344
protein kinase regulator activity,166,0.489,0.625,1,GO:0019887,MF,,4345
receptor tyrosine kinase binding,50,0.52,0.626,1,GO:0030971,MF,,4346
prostate gland development,36,0.523,0.626,1,GO:0030850,BP,,4347
indolalkylamine metabolic process,16,0.535,0.626,1,GO:0006586,BP,,4348
acetylcholine-gated channel complex,14,0.462,0.627,1,GO:0005892,CC,,4349
hexosaminidase activity,12,0.541,0.627,1,GO:0015929,MF,,4350
negative regulation of blood vessel endothelial cell migration,21,0.469,0.627,1,GO:0043537,BP,,4351
positive regulation of nucleocytoplasmic transport,105,0.486,0.627,1,GO:0046824,BP,,4352
solute:proton symporter activity,26,0.528,0.628,1,GO:0015295,MF,,4353
positive regulation of apoptotic signaling pathway,159,0.511,0.628,1,GO:2001235,BP,,4354
leukotriene metabolic process,21,0.531,0.628,1,GO:0006691,BP,,4355
membrane protein intracellular domain proteolysis,15,0.536,0.628,1,GO:0031293,BP,,4356
extrinsic component of plasma membrane,130,0.488,0.628,1,GO:0019897,CC,,4357
nucleolar part,146,0.488,0.628,1,GO:0044452,CC,,4358
hepatocyte growth factor receptor signaling pathway,14,0.537,0.629,1,GO:0048012,BP,,4359
negative regulation of lipid catabolic process,19,0.468,0.629,1,GO:0050995,BP,,4360
detection of temperature stimulus involved in sensory perception,14,0.537,0.629,1,"GO:0050961,GO:0050965",BP,detection of temperature stimulus involved in sensory perception of pain,4361
positive regulation of interleukin-1 secretion,21,0.47,0.629,1,GO:0050716,BP,,4362
tetrapyrrole metabolic process,47,0.52,0.629,1,GO:0033013,BP,,4363
ruffle organization,38,0.477,0.629,1,GO:0031529,BP,,4364
nucleotide phosphorylation,82,0.485,0.629,1,GO:0046939,BP,,4365
citrate metabolic process,33,0.524,0.629,1,GO:0006101,BP,,4366
response to dexamethasone,36,0.523,0.629,1,GO:0071548,BP,,4367
positive regulation of protein sumoylation,11,0.542,0.629,1,GO:0033235,BP,,4368
cytoplasmic mRNA processing body assembly,20,0.531,0.629,1,GO:0033962,BP,,4369
lysine N-methyltransferase activity,52,0.519,0.63,1,GO:0016278,MF,,4370
sodium-independent organic anion transmembrane transporter activity,12,0.54,0.63,1,GO:0015347,MF,,4371
vinculin binding,10,0.544,0.63,1,GO:0017166,MF,,4372
"transferase activity, transferring sulfur-containing groups",57,0.482,0.63,1,GO:0016782,MF,,4373
cell redox homeostasis,63,0.482,0.63,1,GO:0045454,BP,,4374
"oxidoreductase activity, acting on the CH-NH2 group of donors",18,0.467,0.63,1,GO:0016638,MF,,4375
response to food,34,0.476,0.63,1,GO:0032094,BP,,4376
regulation of mitotic spindle assembly,14,0.537,0.631,1,GO:1901673,BP,,4377
kidney epithelium development,127,0.512,0.631,1,GO:0072073,BP,,4378
cardiac conduction,129,0.488,0.631,1,GO:0061337,BP,,4379
regulation of monocyte differentiation,18,0.467,0.632,1,GO:0045655,BP,,4380
exploration behavior,23,0.471,0.632,1,GO:0035640,BP,,4381
negative regulation of heart rate,10,0.456,0.632,1,GO:0010459,BP,,4382
positive regulation of membrane depolarization,11,0.542,0.632,1,GO:1904181,BP,,4383
regulation of actin filament-based movement,35,0.523,0.633,1,GO:1903115,BP,,4384
MHC protein binding,25,0.472,0.633,1,GO:0042287,MF,,4385
inclusion body assembly,19,0.532,0.633,1,GO:0070841,BP,,4386
DNA synthesis involved in DNA repair,64,0.517,0.633,1,GO:0000731,BP,,4387
"regulation of alternative mRNA splicing, via spliceosome",32,0.524,0.633,1,GO:0000381,BP,,4388
presynaptic membrane organization,10,0.456,0.634,1,GO:0097090,BP,,4389
vitamin D metabolic process,13,0.462,0.634,1,GO:0042359,BP,,4390
negative regulation of RNA splicing,20,0.469,0.634,1,GO:0033119,BP,,4391
stem cell development,56,0.482,0.634,1,GO:0048864,BP,,4392
1-phosphatidylinositol binding,16,0.534,0.635,1,GO:0005545,MF,,4393
trans-Golgi network,175,0.49,0.635,1,GO:0005802,CC,,4394
positive regulation of cell morphogenesis involved in differentiation,123,0.488,0.635,1,GO:0010770,BP,,4395
embryonic camera-type eye morphogenesis,21,0.53,0.635,1,GO:0048596,BP,,4396
cell chemotaxis,188,0.49,0.635,1,GO:0060326,BP,,4397
DNA duplex unwinding,64,0.517,0.635,1,GO:0032508,BP,,4398
negative regulation of tumor necrosis factor-mediated signaling pathway,12,0.54,0.635,1,GO:0010804,BP,,4399
regulation of cardiac muscle contraction,66,0.517,0.636,1,GO:0055117,BP,,4400
regulation of endothelial cell proliferation,86,0.515,0.636,1,GO:0001936,BP,,4401
fatty acid synthase activity,10,0.543,0.636,1,GO:0004312,MF,,4402
negative regulation of smooth muscle cell proliferation,34,0.523,0.636,1,GO:0048662,BP,,4403
histone mRNA metabolic process,20,0.469,0.636,1,GO:0008334,BP,,4404
regulation of respiratory burst,10,0.457,0.636,1,GO:0060263,BP,,4405
negative regulation of cellular response to insulin stimulus,31,0.475,0.637,1,GO:1900077,BP,,4406
cardiac muscle hypertrophy,59,0.518,0.637,1,GO:0003300,BP,,4407
phosphatidic acid binding,16,0.466,0.637,1,GO:0070300,MF,,4408
positive regulation of erythrocyte differentiation,21,0.53,0.637,1,GO:0045648,BP,,4409
regulatory T cell differentiation,17,0.467,0.637,1,GO:0045066,BP,,4410
positive regulation of phospholipase C activity,29,0.475,0.638,1,GO:0010863,BP,,4411
IRES-dependent translational initiation,11,0.541,0.638,1,GO:0002192,BP,,4412
ganglioside metabolic process,12,0.461,0.638,1,GO:0001573,BP,,4413
negative regulation of leukocyte mediated cytotoxicity,12,0.539,0.638,1,GO:0001911,BP,,4414
mitochondrial respiratory chain complex IV,10,0.543,0.638,1,GO:0005751,CC,,4415
mitotic sister chromatid segregation,117,0.513,0.638,1,GO:0000070,BP,,4416
negative regulation of mitotic sister chromatid segregation,29,0.475,0.638,1,GO:0033048,BP,,4417
chromatin remodeling at centromere,29,0.525,0.638,1,GO:0031055,BP,,4418
Rac GTPase binding,42,0.479,0.638,1,GO:0048365,MF,,4419
response to glucagon,42,0.479,0.639,1,GO:0033762,BP,,4420
hematopoietic stem cell proliferation,18,0.468,0.639,1,GO:0071425,BP,,4421
respiratory gaseous exchange,58,0.518,0.639,1,GO:0007585,BP,,4422
telomeric loop disassembly,10,0.457,0.639,1,GO:0090657,BP,,4423
positive regulation of phospholipase activity,40,0.479,0.639,1,GO:0010518,BP,,4424
endothelial cell chemotaxis,25,0.473,0.639,1,GO:0035767,BP,,4425
mRNA stabilization,28,0.526,0.639,1,GO:0048255,BP,,4426
production of molecular mediator of immune response,127,0.488,0.639,1,GO:0002440,BP,,4427
response to caffeine,15,0.535,0.64,1,GO:0031000,BP,,4428
cellular response to hydrogen peroxide,76,0.484,0.64,1,GO:0070301,BP,,4429
positive regulation of phagocytosis,36,0.477,0.64,1,GO:0050766,BP,,4430
regulation of cell migration involved in sprouting angiogenesis,18,0.468,0.64,1,GO:0090049,BP,,4431
cardiocyte differentiation,107,0.487,0.64,1,GO:0035051,BP,,4432
telencephalon cell migration,55,0.482,0.641,1,GO:0022029,BP,,4433
reverse cholesterol transport,12,0.461,0.641,1,GO:0043691,BP,,4434
spectrin binding,25,0.527,0.641,1,GO:0030507,MF,,4435
regulation of Rac protein signal transduction,12,0.539,0.641,1,GO:0035020,BP,,4436
negative regulation of coagulation,42,0.521,0.642,1,GO:0050819,BP,,4437
telomere localization,12,0.539,0.642,1,GO:0034397,BP,,4438
response to magnesium ion,16,0.466,0.642,1,GO:0032026,BP,,4439
"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines",25,0.473,0.642,1,GO:0016814,MF,,4440
lung epithelium development,35,0.523,0.643,1,GO:0060428,BP,,4441
trans-Golgi network membrane,76,0.485,0.643,1,GO:0032588,CC,,4442
RNA polymerase core enzyme binding,30,0.476,0.643,1,GO:0043175,MF,,4443
regulation of TOR signaling,79,0.515,0.643,1,GO:0032006,BP,,4444
positive regulation of cytokine production involved in immune response,27,0.474,0.643,1,GO:0002720,BP,,4445
mRNA 5'-UTR binding,17,0.468,0.643,1,GO:0048027,MF,,4446
negative regulation of TOR signaling,36,0.522,0.644,1,GO:0032007,BP,,4447
mitotic spindle checkpoint,26,0.474,0.644,1,GO:0071174,BP,,4448
cellular response to carbohydrate stimulus,110,0.487,0.644,1,GO:0071322,BP,,4449
phospholipid transport,48,0.481,0.644,1,GO:0015914,BP,,4450
"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",15,0.534,0.645,1,"GO:1900151,GO:1900153",BP,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",4451
positive regulation of TOR signaling,32,0.476,0.645,1,GO:0032008,BP,,4452
locomotor rhythm,10,0.542,0.645,1,GO:0045475,BP,,4453
rough endoplasmic reticulum membrane,22,0.528,0.645,1,GO:0030867,CC,,4454
regulation of tolerance induction,16,0.533,0.646,1,GO:0002643,BP,,4455
neural tube patterning,33,0.523,0.646,1,GO:0021532,BP,,4456
acetyltransferase activity,88,0.514,0.646,1,GO:0016407,MF,,4457
response to growth hormone,32,0.477,0.646,1,GO:0060416,BP,,4458
hematopoietic stem cell differentiation,12,0.538,0.647,1,GO:0060218,BP,,4459
regulation of interleukin-4 production,20,0.47,0.647,1,GO:0032673,BP,,4460
pattern recognition receptor signaling pathway,141,0.489,0.647,1,GO:0002221,BP,,4461
organophosphate ester transport,70,0.516,0.647,1,GO:0015748,BP,,4462
alpha-beta T cell differentiation,69,0.516,0.647,1,GO:0046632,BP,,4463
left/right pattern formation,19,0.53,0.647,1,GO:0060972,BP,,4464
vacuolar acidification,18,0.469,0.647,1,GO:0007035,BP,,4465
nucleotidase activity,12,0.462,0.647,1,GO:0008252,MF,,4466
regulation of tumor necrosis factor superfamily cytokine production,88,0.514,0.648,1,GO:1903555,BP,,4467
positive regulation of G-protein coupled receptor protein signaling pathway,22,0.528,0.648,1,GO:0045745,BP,,4468
myeloid leukocyte migration,120,0.488,0.648,1,GO:0097529,BP,,4469
inward rectifier potassium channel activity,21,0.529,0.648,1,GO:0005242,MF,,4470
pteridine-containing compound metabolic process,32,0.523,0.648,1,GO:0042558,BP,,4471
programmed necrotic cell death,36,0.478,0.648,1,GO:0097300,BP,,4472
tetrahydrofolate metabolic process,18,0.531,0.648,1,GO:0046653,BP,,4473
negative regulation of developmental growth,69,0.484,0.648,1,GO:0048640,BP,,4474
phosphorus-oxygen lyase activity,18,0.469,0.649,1,GO:0016849,MF,,4475
cyclooxygenase pathway,11,0.54,0.649,1,GO:0019371,BP,,4476
coreceptor activity,33,0.477,0.649,1,GO:0015026,MF,,4477
"oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor",14,0.535,0.649,1,GO:0016641,MF,,4478
activation of adenylate cyclase activity,32,0.523,0.65,1,GO:0007190,BP,,4479
regulation of interferon-gamma biosynthetic process,13,0.464,0.65,1,GO:0045072,BP,,4480
platelet alpha granule membrane,16,0.467,0.65,1,GO:0031092,CC,,4481
ammonium transmembrane transporter activity,27,0.525,0.65,1,GO:0008519,MF,,4482
peptidyl-proline modification,46,0.481,0.651,1,GO:0018208,BP,,4483
protein localization to cell junction,10,0.541,0.651,1,GO:1902414,BP,,4484
regulation of cytokinesis,55,0.518,0.651,1,GO:0032465,BP,,4485
regulation of interferon-gamma production,69,0.484,0.651,1,GO:0032649,BP,,4486
intra-S DNA damage checkpoint,12,0.538,0.651,1,GO:0031573,BP,,4487
regulation of histone H4 acetylation,11,0.539,0.651,1,GO:0090239,BP,,4488
negative regulation of axon regeneration,12,0.462,0.651,1,GO:0048681,BP,,4489
regulation of glucose transport,90,0.514,0.652,1,GO:0010827,BP,,4490
centromere complex assembly,36,0.522,0.652,1,GO:0034508,BP,,4491
acylglycerol O-acyltransferase activity,23,0.527,0.652,1,GO:0016411,MF,,4492
muscle cell apoptotic process,43,0.52,0.652,1,GO:0010657,BP,,4493
regulation of vasculogenesis,11,0.539,0.652,1,GO:2001212,BP,,4494
misfolded or incompletely synthesized protein catabolic process,21,0.472,0.652,1,GO:0006515,BP,,4495
astrocyte development,23,0.527,0.652,1,GO:0014002,BP,,4496
mannosyltransferase activity,20,0.529,0.652,1,GO:0000030,MF,,4497
positive regulation of protein localization to plasma membrane,38,0.521,0.653,1,"GO:1903078,GO:1904377",BP,positive regulation of protein localization to cell periphery,4498
muscle cell cellular homeostasis,17,0.532,0.653,1,GO:0046716,BP,,4499
negative regulation of cell migration involved in sprouting angiogenesis,10,0.459,0.653,1,GO:0090051,BP,,4500
NLS-bearing protein import into nucleus,21,0.528,0.653,1,GO:0006607,BP,,4501
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,28,0.475,0.653,1,GO:1902175,BP,,4502
gastrulation with mouth forming second,26,0.525,0.654,1,GO:0001702,BP,,4503
response to heat,141,0.511,0.654,1,GO:0009408,BP,,4504
ribonucleoside diphosphate metabolic process,82,0.486,0.654,1,GO:0009185,BP,,4505
negative regulation of response to reactive oxygen species,16,0.468,0.654,1,"GO:1901032,GO:1903206",BP,negative regulation of hydrogen peroxide-induced cell death,4506
detection of calcium ion,12,0.463,0.654,1,GO:0005513,BP,,4507
regulation of hepatocyte proliferation,12,0.537,0.654,1,GO:2000345,BP,,4508
ureteric bud development,87,0.514,0.654,1,GO:0001657,BP,,4509
hair follicle development,77,0.515,0.655,1,GO:0001942,BP,,4510
positive regulation of cell killing,24,0.526,0.655,1,GO:0031343,BP,,4511
regulation of carbohydrate biosynthetic process,72,0.485,0.655,1,GO:0043255,BP,,4512
serotonin metabolic process,11,0.461,0.655,1,GO:0042428,BP,,4513
negative regulation of transcription factor import into nucleus,35,0.478,0.655,1,GO:0042992,BP,,4514
endoderm formation,48,0.519,0.656,1,GO:0001706,BP,,4515
positive regulation of RNA splicing,24,0.526,0.656,1,GO:0033120,BP,,4516
adrenal gland development,18,0.47,0.656,1,GO:0030325,BP,,4517
mucosal immune response,16,0.468,0.656,1,GO:0002385,BP,,4518
regulation of smooth muscle cell proliferation,101,0.513,0.656,1,GO:0048660,BP,,4519
integral component of lumenal side of endoplasmic reticulum membrane,28,0.476,0.656,1,"GO:0071556,GO:0098553",CC,lumenal side of endoplasmic reticulum membrane,4520
negative regulation of signal transduction in absence of ligand,27,0.525,0.656,1,"GO:1901099,GO:2001240",BP,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,4521
SUMO binding,12,0.537,0.657,1,GO:0032183,MF,,4522
cortical actin cytoskeleton,49,0.518,0.657,1,GO:0030864,CC,,4523
notochord development,16,0.468,0.657,1,GO:0030903,BP,,4524
zinc II ion transmembrane transport,19,0.471,0.657,1,GO:0071577,BP,,4525
spindle microtubule,44,0.519,0.657,1,GO:0005876,CC,,4526
peptidase regulator activity,163,0.51,0.657,1,GO:0061134,MF,,4527
sphingolipid catabolic process,17,0.531,0.657,1,GO:0030149,BP,,4528
response to cold,37,0.521,0.658,1,GO:0009409,BP,,4529
Wnt signalosome,11,0.539,0.658,1,GO:1990909,CC,,4530
immunoglobulin binding,16,0.468,0.658,1,GO:0019865,MF,,4531
regulation of IRE1-mediated unfolded protein response,11,0.538,0.658,1,GO:1903894,BP,,4532
regulation of interleukin-13 production,13,0.535,0.659,1,GO:0032656,BP,,4533
porphyrin-containing compound metabolic process,31,0.523,0.659,1,GO:0006778,BP,,4534
"phosphotransferase activity, for other substituted phosphate groups",17,0.531,0.659,1,GO:0016780,MF,,4535
ATP hydrolysis coupled transmembrane transport,67,0.484,0.66,1,GO:0090662,BP,,4536
positive regulation of cell growth,135,0.489,0.66,1,GO:0030307,BP,,4537
regulation of generation of precursor metabolites and energy,75,0.485,0.66,1,GO:0043467,BP,,4538
fatty acid transport,79,0.486,0.661,1,GO:0015908,BP,,4539
positive regulation of interferon-alpha production,13,0.465,0.661,1,GO:0032727,BP,,4540
ribosome binding,41,0.52,0.661,1,GO:0043022,MF,,4541
positive regulation of protein kinase B signaling,69,0.515,0.661,1,GO:0051897,BP,,4542
multicellular organismal signaling,176,0.49,0.661,1,GO:0035637,BP,,4543
positive regulation of heart rate,21,0.528,0.662,1,GO:0010460,BP,,4544
negative regulation of histone acetylation,15,0.533,0.662,1,GO:0035067,BP,,4545
cAMP binding,21,0.528,0.662,1,GO:0030552,MF,,4546
positive regulation of cytokinesis,27,0.524,0.662,1,GO:0032467,BP,,4547
positive regulation of interleukin-1 beta secretion,20,0.472,0.662,1,GO:0050718,BP,,4548
cell killing,69,0.515,0.662,1,GO:0001906,BP,,4549
chaperone-mediated autophagy,11,0.462,0.662,1,GO:0061684,BP,,4550
development of primary female sexual characteristics,81,0.514,0.662,1,GO:0046545,BP,,4551
ventricular cardiac muscle cell differentiation,15,0.467,0.663,1,GO:0055012,BP,,4552
nucleotide catabolic process,61,0.484,0.663,1,GO:0009166,BP,,4553
actin filament bundle organization,126,0.489,0.663,1,GO:0061572,BP,,4554
calcium channel complex,58,0.483,0.663,1,GO:0034704,CC,,4555
response to protozoan,14,0.534,0.663,1,GO:0001562,BP,,4556
insulin receptor binding,28,0.476,0.664,1,GO:0005158,MF,,4557
negative regulation of B cell apoptotic process,10,0.46,0.664,1,GO:0002903,BP,,4558
nuclear ubiquitin ligase complex,30,0.523,0.664,1,GO:0000152,CC,,4559
protein autoubiquitination,47,0.518,0.665,1,GO:0051865,BP,,4560
negative regulation of ATP metabolic process,19,0.471,0.665,1,GO:1903579,BP,,4561
negative regulation of heart contraction,21,0.527,0.665,1,GO:0045822,BP,,4562
mitochondrial genome maintenance,26,0.525,0.665,1,GO:0000002,BP,,4563
plasma membrane tubulation,17,0.53,0.665,1,GO:0097320,BP,,4564
prostanoid metabolic process,29,0.477,0.666,1,"GO:0006692,GO:0006693",BP,prostaglandin metabolic process,4565
fatty-acyl-CoA metabolic process,45,0.481,0.666,1,GO:0035337,BP,,4566
response to laminar fluid shear stress,14,0.533,0.667,1,GO:0034616,BP,,4567
aspartate metabolic process,10,0.461,0.667,1,GO:0006531,BP,,4568
lens development in camera-type eye,52,0.483,0.667,1,GO:0002088,BP,,4569
nucleoside metabolic process,112,0.488,0.667,1,GO:0009116,BP,,4570
regulation of muscle adaptation,64,0.516,0.668,1,GO:0043502,BP,,4571
cellular response to cAMP,46,0.518,0.668,1,GO:0071320,BP,,4572
phospholipase binding,15,0.532,0.669,1,GO:0043274,MF,,4573
negative regulation of endopeptidase activity,176,0.509,0.669,1,GO:0010951,BP,,4574
regulation of cell fate specification,12,0.464,0.669,1,GO:0042659,BP,,4575
tRNA-specific ribonuclease activity,12,0.536,0.669,1,GO:0004549,MF,,4576
L-alpha-amino acid transmembrane transport,26,0.524,0.669,1,GO:1902475,BP,,4577
protein targeting to plasma membrane,23,0.474,0.669,1,GO:0072661,BP,,4578
negative regulation of B cell activation,26,0.476,0.669,1,GO:0050869,BP,,4579
endoplasmic reticulum tubular network organization,12,0.536,0.669,1,GO:0071786,BP,,4580
positive regulation of vascular associated smooth muscle cell migration,11,0.537,0.67,1,GO:1904754,BP,,4581
positive regulation of release of cytochrome c from mitochondria,26,0.476,0.67,1,GO:0090200,BP,,4582
cellular carbohydrate biosynthetic process,66,0.485,0.67,1,GO:0034637,BP,,4583
serine-type endopeptidase inhibitor activity,70,0.515,0.67,1,GO:0004867,MF,,4584
negative regulation of NF-kappaB transcription factor activity,61,0.516,0.67,1,GO:0032088,BP,,4585
exodeoxyribonuclease activity,15,0.532,0.67,1,"GO:0004529,GO:0016895",MF,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters",4586
Cajal body,47,0.482,0.67,1,GO:0015030,CC,,4587
negative regulation of proteasomal protein catabolic process,27,0.476,0.67,1,GO:1901799,BP,,4588
tyrosine phosphorylation of Stat5 protein,13,0.534,0.67,1,GO:0042506,BP,,4589
SNARE complex assembly,15,0.468,0.67,1,GO:0035493,BP,,4590
antimicrobial humoral response,48,0.482,0.671,1,GO:0019730,BP,,4591
microvillus assembly,16,0.531,0.671,1,GO:0030033,BP,,4592
corticosteroid hormone secretion,12,0.535,0.671,1,"GO:0035930,GO:2000846",BP,regulation of corticosteroid hormone secretion,4593
"CD4-positive, alpha-beta T cell differentiation",45,0.518,0.671,1,GO:0043367,BP,,4594
cardiac muscle contraction,110,0.512,0.671,1,GO:0060048,BP,,4595
regulation of DNA recombination,53,0.483,0.671,1,GO:0000018,BP,,4596
water homeostasis,52,0.483,0.671,1,GO:0030104,BP,,4597
cell proliferation in hindbrain,10,0.461,0.671,1,GO:0021534,BP,,4598
protein-DNA complex disassembly,17,0.53,0.671,1,GO:0032986,BP,,4599
establishment of blood-brain barrier,10,0.461,0.672,1,GO:0060856,BP,,4600
deaminase activity,21,0.473,0.672,1,GO:0019239,MF,,4601
regulation of sodium ion transport,78,0.486,0.672,1,GO:0002028,BP,,4602
liposaccharide metabolic process,95,0.513,0.672,1,GO:1903509,BP,,4603
adrenergic receptor signaling pathway,20,0.473,0.672,1,GO:0071875,BP,,4604
neuronal ion channel clustering,10,0.539,0.672,1,GO:0045161,BP,,4605
regulation of peptidyl-tyrosine phosphorylation,181,0.509,0.672,1,GO:0050730,BP,,4606
B cell apoptotic process,19,0.472,0.673,1,GO:0001783,BP,,4607
RNA polymerase II core binding,23,0.475,0.673,1,GO:0000993,MF,,4608
anion:anion antiporter activity,28,0.477,0.673,1,GO:0015301,MF,,4609
positive regulation of smooth muscle contraction,24,0.475,0.674,1,GO:0045987,BP,,4610
mitochondrial respiratory chain complex IV assembly,14,0.468,0.674,1,GO:0033617,BP,,4611
bile acid and bile salt transport,22,0.526,0.674,1,GO:0015721,BP,,4612
tumor necrosis factor biosynthetic process,15,0.469,0.674,1,"GO:0042533,GO:0042534",BP,regulation of tumor necrosis factor biosynthetic process,4613
chloride transport,87,0.487,0.675,1,GO:0006821,BP,,4614
N-terminal protein amino acid modification,26,0.524,0.675,1,GO:0031365,BP,,4615
retinal ganglion cell axon guidance,18,0.471,0.675,1,GO:0031290,BP,,4616
defense response to protozoan,13,0.534,0.675,1,GO:0042832,BP,,4617
protein heterotetramerization,24,0.475,0.676,1,GO:0051290,BP,,4618
basal lamina,19,0.472,0.676,1,GO:0005605,CC,,4619
regulation of intrinsic apoptotic signaling pathway,135,0.51,0.676,1,GO:2001242,BP,,4620
purine nucleoside biosynthetic process,21,0.474,0.676,1,"GO:0042451,GO:0046129",BP,purine ribonucleoside biosynthetic process,4621
regulation of translation in response to stress,19,0.528,0.677,1,GO:0043555,BP,,4622
fibrinolysis,20,0.527,0.677,1,GO:0042730,BP,,4623
ossification involved in bone maturation,16,0.53,0.677,1,GO:0043931,BP,,4624
interaction with symbiont,49,0.517,0.677,1,GO:0051702,BP,,4625
actin-based cell projection,166,0.509,0.677,1,GO:0098858,CC,,4626
low-density lipoprotein receptor activity,12,0.465,0.677,1,GO:0005041,MF,,4627
glycolipid metabolic process,94,0.512,0.678,1,GO:0006664,BP,,4628
negative regulation of cytokine biosynthetic process,25,0.524,0.678,1,GO:0042036,BP,,4629
positive regulation of fatty acid oxidation,14,0.468,0.678,1,GO:0046321,BP,,4630
glycosphingolipid metabolic process,56,0.484,0.679,1,GO:0006687,BP,,4631
decidualization,19,0.527,0.679,1,GO:0046697,BP,,4632
nephron development,124,0.511,0.679,1,GO:0072006,BP,,4633
activation of phospholipase C activity,20,0.473,0.679,1,GO:0007202,BP,,4634
NuA4 histone acetyltransferase complex,17,0.529,0.679,1,"GO:0035267,GO:0043189",CC,H4/H2A histone acetyltransferase complex,4635
positive regulation of neuron apoptotic process,44,0.482,0.679,1,GO:0043525,BP,,4636
response to increased oxygen levels,17,0.471,0.679,1,"GO:0036296,GO:0055093",BP,response to hyperoxia,4637
long-chain fatty acid-CoA ligase activity,13,0.467,0.679,1,GO:0004467,MF,,4638
regulation of lipid kinase activity,43,0.482,0.68,1,GO:0043550,BP,,4639
histone methyltransferase activity (H3-K4 specific),15,0.469,0.68,1,GO:0042800,MF,,4640
prenyltransferase activity,15,0.469,0.681,1,GO:0004659,MF,,4641
response to carbohydrate,177,0.491,0.681,1,GO:0009743,BP,,4642
Sertoli cell development,12,0.466,0.681,1,GO:0060009,BP,,4643
regulation of signal transduction by p53 class mediator,148,0.49,0.681,1,GO:1901796,BP,,4644
positive regulation of protein exit from endoplasmic reticulum,10,0.537,0.682,1,GO:0070863,BP,,4645
homeostasis of number of cells,195,0.509,0.682,1,GO:0048872,BP,,4646
"endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters",17,0.529,0.682,1,GO:0016894,MF,,4647
chloride transmembrane transport,77,0.486,0.682,1,"GO:1902476,GO:0015108",BP,chloride transmembrane transporter activity,4648
eyelid development in camera-type eye,10,0.463,0.683,1,GO:0061029,BP,,4649
positive regulation of multicellular organism growth,27,0.523,0.683,1,GO:0040018,BP,,4650
diencephalon development,66,0.485,0.683,1,GO:0021536,BP,,4651
atrioventricular valve morphogenesis,19,0.527,0.683,1,GO:0003181,BP,,4652
cellular carbohydrate catabolic process,39,0.481,0.683,1,GO:0044275,BP,,4653
type 2 immune response,23,0.525,0.683,1,GO:0042092,BP,,4654
tricarboxylic acid cycle,29,0.522,0.683,1,GO:0006099,BP,,4655
regulation of double-strand break repair,37,0.519,0.684,1,GO:2000779,BP,,4656
negative regulation of bone remodeling,12,0.534,0.684,1,GO:0046851,BP,,4657
cyclin-dependent protein serine/threonine kinase activity,25,0.524,0.684,1,GO:0004693,MF,,4658
benzene-containing compound metabolic process,16,0.471,0.684,1,GO:0042537,BP,,4659
MHC class I protein binding,17,0.471,0.684,1,GO:0042288,MF,,4660
atrial cardiac muscle cell action potential,18,0.472,0.684,1,"GO:0086014,GO:0086026,GO:0086066",BP,"atrial cardiac muscle cell to AV node cell signaling,atrial cardiac muscle cell to AV node cell communication",4661
"regulation of retrograde protein transport, ER to cytosol",12,0.466,0.684,1,GO:1904152,BP,,4662
spinal cord dorsal/ventral patterning,18,0.528,0.684,1,GO:0021513,BP,,4663
diacylglycerol binding,10,0.537,0.685,1,GO:0019992,MF,,4664
brush border membrane,40,0.481,0.685,1,GO:0031526,CC,,4665
regulation of striated muscle cell differentiation,75,0.486,0.685,1,GO:0051153,BP,,4666
ankyrin binding,19,0.527,0.686,1,GO:0030506,MF,,4667
regulation of nucleobase-containing compound transport,11,0.535,0.686,1,GO:0032239,BP,,4668
four-way junction DNA binding,13,0.468,0.686,1,GO:0000400,MF,,4669
regulation of glucose import,53,0.516,0.686,1,GO:0046324,BP,,4670
camera-type eye photoreceptor cell differentiation,13,0.532,0.686,1,GO:0060219,BP,,4671
peptidyl-glutamic acid modification,27,0.478,0.686,1,GO:0018200,BP,,4672
regulation of developmental pigmentation,13,0.532,0.687,1,GO:0048070,BP,,4673
ncRNA 3'-end processing,15,0.47,0.687,1,GO:0043628,BP,,4674
positive regulation of vascular endothelial growth factor production,25,0.523,0.687,1,GO:0010575,BP,,4675
RNA cap binding,15,0.53,0.687,1,GO:0000339,MF,,4676
negative regulation of protein acetylation,18,0.527,0.688,1,GO:1901984,BP,,4677
regulation of stem cell differentiation,31,0.479,0.688,1,GO:2000736,BP,,4678
sulfate transport,12,0.467,0.688,1,GO:0008272,BP,,4679
astrocyte differentiation,57,0.485,0.688,1,GO:0048708,BP,,4680
negative regulation of cellular response to transforming growth factor beta stimulus,63,0.515,0.688,1,GO:1903845,BP,,4681
L-amino acid transmembrane transporter activity,46,0.517,0.689,1,GO:0015179,MF,,4682
negative chemotaxis,21,0.525,0.689,1,GO:0050919,BP,,4683
cell migration involved in heart development,13,0.468,0.689,1,GO:0060973,BP,,4684
"circadian sleep/wake cycle, sleep",20,0.526,0.689,1,GO:0050802,BP,,4685
npBAF complex,12,0.533,0.69,1,GO:0071564,CC,,4686
peptidyl-threonine phosphorylation,102,0.489,0.69,1,GO:0018107,BP,,4687
negative regulation of potassium ion transmembrane transporter activity,13,0.532,0.69,1,GO:1901017,BP,,4688
response to fatty acid,66,0.486,0.69,1,GO:0070542,BP,,4689
purine-containing compound catabolic process,50,0.484,0.69,1,GO:0072523,BP,,4690
NAD binding,51,0.516,0.69,1,GO:0051287,MF,,4691
negative regulation of regulated secretory pathway,20,0.474,0.69,1,GO:1903306,BP,,4692
interstrand cross-link repair,43,0.518,0.691,1,GO:0036297,BP,,4693
activation-induced cell death of T cells,11,0.535,0.691,1,GO:0006924,BP,,4694
long term synaptic depression,22,0.475,0.691,1,GO:0060292,BP,,4695
nBAF complex,14,0.469,0.691,1,GO:0071565,CC,,4696
positive regulation of calcium ion transport into cytosol,38,0.481,0.691,1,GO:0010524,BP,,4697
mitochondrial DNA replication,12,0.467,0.692,1,GO:0006264,BP,,4698
positive regulation of nitric oxide biosynthetic process,33,0.48,0.692,1,"GO:0045429,GO:1904407",BP,positive regulation of nitric oxide metabolic process,4699
regulation of platelet-derived growth factor receptor signaling pathway,21,0.525,0.692,1,GO:0010640,BP,,4700
membrane repolarization during ventricular cardiac muscle cell action potential,11,0.466,0.692,1,GO:0098915,BP,,4701
regulation of cell maturation,16,0.529,0.692,1,GO:1903429,BP,,4702
positive regulation of transcription from RNA polymerase III promoter,10,0.536,0.692,1,GO:0045945,BP,,4703
Rho protein signal transduction,157,0.509,0.692,1,GO:0007266,BP,,4704
extrinsic component of cytoplasmic side of plasma membrane,93,0.488,0.693,1,GO:0031234,CC,,4705
podosome assembly,19,0.474,0.693,1,GO:0071800,BP,,4706
neuropeptide binding,15,0.471,0.694,1,GO:0042923,MF,,4707
cell-cell adhesion via plasma-membrane adhesion molecules,186,0.492,0.694,1,GO:0098742,BP,,4708
folic acid metabolic process,18,0.527,0.694,1,GO:0046655,BP,,4709
"hydrolase activity, acting on glycosyl bonds",85,0.512,0.694,1,GO:0016798,MF,,4710
peroxisome,112,0.489,0.694,1,"GO:0005777,GO:0042579",CC,microbody,4711
B cell activation involved in immune response,49,0.484,0.694,1,GO:0002312,BP,,4712
H4 histone acetyltransferase activity,15,0.529,0.694,1,GO:0010485,MF,,4713
flagellated sperm motility,61,0.485,0.694,1,GO:0030317,BP,,4714
positive regulation of triglyceride biosynthetic process,10,0.464,0.695,1,GO:0010867,BP,,4715
aromatic amino acid family catabolic process,18,0.473,0.695,1,GO:0009074,BP,,4716
peroxisome proliferator activated receptor signaling pathway,19,0.526,0.695,1,GO:0035357,BP,,4717
negative regulation of endothelial cell migration,33,0.48,0.695,1,GO:0010596,BP,,4718
pentose metabolic process,11,0.466,0.695,1,GO:0019321,BP,,4719
B cell homeostasis,25,0.477,0.695,1,GO:0001782,BP,,4720
negative regulation of autophagy,55,0.485,0.695,1,GO:0010507,BP,,4721
neuroblast proliferation,49,0.516,0.696,1,GO:0007405,BP,,4722
regulation of dendrite development,117,0.49,0.696,1,GO:0050773,BP,,4723
positive regulation of tyrosine phosphorylation of STAT protein,36,0.481,0.696,1,GO:0042531,BP,,4724
cytoplasmic side of plasma membrane,146,0.491,0.697,1,GO:0009898,CC,,4725
endocrine process,63,0.514,0.697,1,GO:0050886,BP,,4726
positive regulation of action potential,10,0.536,0.697,1,GO:0045760,BP,,4727
calcineurin-NFAT signaling cascade,22,0.476,0.697,1,"GO:0033173,GO:0097720",BP,calcineurin-mediated signaling,4728
exocyst,18,0.473,0.697,1,GO:0000145,CC,,4729
positive regulation of dendrite development,61,0.514,0.697,1,GO:1900006,BP,,4730
positive regulation of glucose transport,37,0.482,0.698,1,GO:0010828,BP,,4731
regulation of natural killer cell mediated cytotoxicity,25,0.522,0.698,1,GO:0042269,BP,,4732
regulation of synaptic vesicle exocytosis,27,0.478,0.698,1,GO:2000300,BP,,4733
Golgi-associated vesicle membrane,46,0.483,0.698,1,GO:0030660,CC,,4734
production of molecular mediator involved in inflammatory response,34,0.481,0.698,1,GO:0002532,BP,,4735
positive regulation of ERAD pathway,13,0.531,0.698,1,GO:1904294,BP,,4736
cellular hormone metabolic process,84,0.488,0.698,1,GO:0034754,BP,,4737
protein serine/threonine kinase inhibitor activity,32,0.48,0.698,1,GO:0030291,MF,,4738
galactose metabolic process,12,0.468,0.699,1,GO:0006012,BP,,4739
regulation of coagulation,73,0.513,0.699,1,GO:0050818,BP,,4740
smooth muscle contraction,87,0.488,0.699,1,GO:0006939,BP,,4741
disordered domain specific binding,29,0.479,0.7,1,GO:0097718,MF,,4742
natural killer cell differentiation,16,0.472,0.701,1,GO:0001779,BP,,4743
lipase activity,100,0.489,0.701,1,GO:0016298,MF,,4744
glomerular epithelium development,22,0.524,0.701,1,GO:0072010,BP,,4745
G-protein coupled chemoattractant receptor activity,14,0.47,0.701,1,"GO:0001637,GO:0004950",MF,chemokine receptor activity,4746
positive regulation of cation transmembrane transport,94,0.489,0.701,1,GO:1904064,BP,,4747
phosphatidylinositol 3-kinase complex,15,0.529,0.701,1,GO:0005942,CC,,4748
positive regulation of organelle assembly,52,0.515,0.701,1,GO:1902117,BP,,4749
chromosome localization to nuclear envelope involved in homologous chromosome segregation,11,0.533,0.701,1,GO:0090220,BP,,4750
locomotory behavior,170,0.491,0.701,1,GO:0007626,BP,,4751
regulation of DNA repair,71,0.513,0.702,1,GO:0006282,BP,,4752
amino acid transport,124,0.49,0.702,1,GO:0006865,BP,,4753
response to prostaglandin E,21,0.476,0.702,1,GO:0034695,BP,,4754
nodal signaling pathway,12,0.532,0.702,1,GO:0038092,BP,,4755
condensed chromosome,169,0.509,0.703,1,GO:0000793,CC,,4756
positive regulation of ATP metabolic process,24,0.478,0.703,1,GO:1903580,BP,,4757
phosphatidylinositol acyl-chain remodeling,13,0.531,0.703,1,GO:0036149,BP,,4758
protein deglycosylation,30,0.48,0.703,1,GO:0006517,BP,,4759
establishment of pigment granule localization,23,0.477,0.704,1,GO:0051905,BP,,4760
positive regulation of renal sodium excretion,13,0.53,0.704,1,GO:0035815,BP,,4761
regulation of attachment of spindle microtubules to kinetochore,11,0.467,0.705,1,GO:0051988,BP,,4762
cartilage development involved in endochondral bone morphogenesis,20,0.524,0.705,1,GO:0060351,BP,,4763
SH2 domain binding,28,0.479,0.705,1,GO:0042169,MF,,4764
negative regulation of response to DNA damage stimulus,51,0.485,0.705,1,GO:2001021,BP,,4765
positive regulation of viral genome replication,26,0.479,0.705,1,GO:0045070,BP,,4766
cellular response to glucose stimulus,99,0.489,0.705,1,GO:0071333,BP,,4767
homotypic cell-cell adhesion,64,0.486,0.705,1,GO:0034109,BP,,4768
semi-lunar valve development,12,0.468,0.706,1,GO:1905314,BP,,4769
cis-trans isomerase activity,33,0.481,0.706,1,GO:0016859,MF,,4770
DNA strand elongation,22,0.477,0.706,1,GO:0022616,BP,,4771
mammary gland epithelial cell differentiation,14,0.471,0.706,1,GO:0060644,BP,,4772
"carbon-nitrogen ligase activity, with glutamine as amido-N-donor",10,0.534,0.706,1,GO:0016884,MF,,4773
photoreceptor disc membrane,12,0.469,0.707,1,GO:0097381,CC,,4774
mitochondrial protein processing,10,0.466,0.707,1,GO:0034982,BP,,4775
protein K48-linked deubiquitination,27,0.479,0.707,1,GO:0071108,BP,,4776
positive regulation of epidermal growth factor-activated receptor activity,11,0.467,0.707,1,GO:0045741,BP,,4777
positive regulation of dendrite morphogenesis,30,0.48,0.707,1,GO:0050775,BP,,4778
detection of light stimulus involved in visual perception,11,0.533,0.707,1,"GO:0050908,GO:0050962",BP,detection of light stimulus involved in sensory perception,4779
fibronectin binding,23,0.523,0.708,1,GO:0001968,MF,,4780
mRNA cleavage factor complex,16,0.527,0.708,1,GO:0005849,CC,,4781
"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor",18,0.474,0.708,1,GO:0016646,MF,,4782
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,15,0.472,0.708,1,GO:0043162,BP,,4783
cytoplasmic translational initiation,21,0.524,0.708,1,GO:0002183,BP,,4784
regulation of cardiac muscle tissue development,58,0.486,0.708,1,GO:0055024,BP,,4785
cytoplasmic side of membrane,160,0.491,0.708,1,GO:0098562,CC,,4786
translation repressor activity,23,0.523,0.709,1,GO:0030371,MF,,4787
heart trabecula morphogenesis,32,0.481,0.709,1,GO:0061384,BP,,4788
negative regulation of striated muscle cell differentiation,25,0.521,0.71,1,GO:0051154,BP,,4789
glucocorticoid receptor signaling pathway,15,0.472,0.71,1,GO:0042921,BP,,4790
response to monosaccharide,161,0.509,0.71,1,GO:0034284,BP,,4791
striated muscle cell apoptotic process,25,0.521,0.71,1,GO:0010658,BP,,4792
nuclear matrix,88,0.511,0.71,1,GO:0016363,CC,,4793
desensitization of G-protein coupled receptor protein signaling pathway,14,0.471,0.711,1,"GO:0002029,GO:0022401",BP,negative adaptation of signaling pathway,4794
photoreceptor cell differentiation,47,0.516,0.711,1,GO:0046530,BP,,4795
calcium-dependent protein binding,55,0.486,0.711,1,GO:0048306,MF,,4796
membrane fission,12,0.531,0.711,1,GO:0090148,BP,,4797
positive regulation of heart contraction,30,0.52,0.711,1,GO:0045823,BP,,4798
"protein import into nucleus, translocation",43,0.516,0.712,1,GO:0000060,BP,,4799
modified amino acid transmembrane transporter activity,13,0.47,0.712,1,GO:0072349,MF,,4800
regulation of leukocyte migration,122,0.51,0.713,1,GO:0002685,BP,,4801
metalloendopeptidase inhibitor activity,14,0.528,0.713,1,GO:0008191,MF,,4802
regulation of interleukin-10 production,31,0.481,0.713,1,GO:0032653,BP,,4803
positive regulation of neuron migration,10,0.466,0.713,1,GO:2001224,BP,,4804
ribosomal subunit export from nucleus,11,0.468,0.713,1,"GO:0000054,GO:0033750,GO:0033753",BP,"ribosome localization,establishment of ribosome localization",4805
heat shock protein binding,86,0.489,0.713,1,GO:0031072,MF,,4806
O-glycan processing,45,0.484,0.714,1,GO:0016266,BP,,4807
negative regulation of protein kinase B signaling,34,0.482,0.714,1,GO:0051898,BP,,4808
linoleic acid metabolic process,17,0.526,0.714,1,GO:0043651,BP,,4809
positive regulation of endothelial cell proliferation,62,0.513,0.714,1,GO:0001938,BP,,4810
voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,11,0.532,0.714,1,GO:0086008,MF,,4811
plasminogen activation,16,0.526,0.714,1,GO:0031639,BP,,4812
monocyte differentiation,31,0.481,0.714,1,"GO:0030224,GO:1903131",BP,mononuclear cell differentiation,4813
positive regulation of response to cytokine stimulus,29,0.48,0.714,1,GO:0060760,BP,,4814
regulation of JNK cascade,143,0.509,0.715,1,GO:0046328,BP,,4815
cerebellar Purkinje cell layer development,25,0.479,0.715,1,GO:0021680,BP,,4816
regulation of amyloid precursor protein catabolic process,13,0.471,0.715,1,GO:1902991,BP,,4817
mesoderm development,105,0.51,0.715,1,GO:0007498,BP,,4818
regulation of epidermis development,61,0.514,0.715,1,GO:0045682,BP,,4819
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,28,0.52,0.715,1,GO:1902235,BP,,4820
fatty acid homeostasis,11,0.532,0.715,1,GO:0055089,BP,,4821
positive regulation of blood vessel diameter,50,0.515,0.715,1,GO:0097755,BP,,4822
JAK-STAT cascade,118,0.51,0.715,1,"GO:0007259,GO:0097696",BP,STAT cascade,4823
positive regulation of protein polymerization,98,0.489,0.715,1,GO:0032273,BP,,4824
tRNA threonylcarbamoyladenosine metabolic process,11,0.532,0.716,1,GO:0070525,BP,,4825
positive regulation of bone mineralization,32,0.481,0.716,1,GO:0030501,BP,,4826
phospholipid dephosphorylation,35,0.518,0.716,1,GO:0046839,BP,,4827
specific granule lumen,49,0.485,0.716,1,GO:0035580,CC,,4828
regulation of heart rate by cardiac conduction,32,0.519,0.716,1,GO:0086091,BP,,4829
pteridine-containing compound biosynthetic process,16,0.474,0.716,1,GO:0042559,BP,,4830
Rac guanyl-nucleotide exchange factor activity,15,0.527,0.717,1,GO:0030676,MF,,4831
positive regulation of developmental growth,143,0.509,0.717,1,GO:0048639,BP,,4832
growth factor activity,126,0.509,0.717,1,GO:0008083,MF,,4833
glycerol metabolic process,13,0.529,0.717,1,GO:0006071,BP,,4834
"transcription factor activity, RNA polymerase II core promoter sequence-specific",21,0.523,0.718,1,GO:0000983,MF,,4835
STAGA complex,12,0.47,0.719,1,GO:0030914,CC,,4836
monosaccharide transmembrane transporter activity,16,0.474,0.719,1,GO:0015145,MF,,4837
peroxisome organization,27,0.48,0.719,1,GO:0007031,BP,,4838
negative regulation of receptor activity,32,0.518,0.72,1,GO:2000272,BP,,4839
hemidesmosome assembly,10,0.467,0.72,1,GO:0031581,BP,,4840
negative regulation of lymphocyte differentiation,31,0.519,0.72,1,GO:0045620,BP,,4841
omega peptidase activity,11,0.531,0.72,1,GO:0008242,MF,,4842
cellular response to arsenic-containing substance,12,0.53,0.72,1,GO:0071243,BP,,4843
negative regulation of bone resorption,10,0.533,0.72,1,GO:0045779,BP,,4844
cardiac muscle cell contraction,54,0.514,0.72,1,GO:0086003,BP,,4845
cytoplasmic translation,45,0.515,0.72,1,GO:0002181,BP,,4846
negative regulation of anion transport,21,0.523,0.72,1,GO:1903792,BP,,4847
photoreceptor outer segment,58,0.514,0.721,1,GO:0001750,CC,,4848
regulation of tissue remodeling,58,0.486,0.721,1,GO:0034103,BP,,4849
sensory perception of light stimulus,166,0.508,0.721,1,GO:0050953,BP,,4850
ribonucleoside biosynthetic process,38,0.517,0.721,1,GO:0042455,BP,,4851
cilium movement involved in cell motility,17,0.475,0.722,1,GO:0060294,BP,,4852
neurotransmitter receptor transport to plasma membrane,11,0.469,0.722,1,GO:0098877,BP,,4853
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,28,0.519,0.722,1,GO:1902042,BP,,4854
regulation of humoral immune response,37,0.517,0.723,1,GO:0002920,BP,,4855
exocrine system development,42,0.516,0.723,1,GO:0035272,BP,,4856
negative regulation of tumor necrosis factor superfamily cytokine production,36,0.517,0.723,1,GO:1903556,BP,,4857
heart valve morphogenesis,28,0.519,0.723,1,GO:0003179,BP,,4858
extrinsic component of organelle membrane,24,0.479,0.723,1,GO:0031312,CC,,4859
endoribonuclease activity,39,0.484,0.723,1,GO:0004521,MF,,4860
SMAD protein import into nucleus,22,0.522,0.723,1,GO:0007184,BP,,4861
chemokine-mediated signaling pathway,49,0.515,0.723,1,GO:0070098,BP,,4862
anion channel activity,77,0.488,0.723,1,GO:0005253,MF,,4863
"mitochondrial electron transport, cytochrome c to oxygen",16,0.474,0.724,1,GO:0006123,BP,,4864
telomere maintenance via recombination,31,0.518,0.724,1,GO:0000722,BP,,4865
animal organ maturation,20,0.523,0.724,1,GO:0048799,BP,,4866
positive regulation of BMP signaling pathway,27,0.52,0.724,1,GO:0030513,BP,,4867
regulation of receptor biosynthetic process,16,0.525,0.724,1,GO:0010869,BP,,4868
positive regulation of cytoskeleton organization,170,0.492,0.724,1,GO:0051495,BP,,4869
activation of transmembrane receptor protein tyrosine kinase activity,12,0.471,0.725,1,GO:0007171,BP,,4870
thioesterase binding,12,0.471,0.725,1,GO:0031996,MF,,4871
positive regulation of blood pressure,32,0.518,0.725,1,GO:0045777,BP,,4872
regulation of systemic arterial blood pressure,69,0.488,0.725,1,GO:0003073,BP,,4873
chromosome condensation,28,0.519,0.725,1,GO:0030261,BP,,4874
DNA polymerase binding,12,0.529,0.725,1,GO:0070182,MF,,4875
positive regulation of lymphocyte apoptotic process,14,0.473,0.725,1,GO:0070230,BP,,4876
cardiac muscle tissue morphogenesis,50,0.514,0.725,1,GO:0055008,BP,,4877
positive regulation of macrophage differentiation,10,0.468,0.725,1,GO:0045651,BP,,4878
cell differentiation involved in kidney development,51,0.486,0.726,1,GO:0061005,BP,,4879
response to lipoprotein particle,20,0.477,0.726,1,GO:0055094,BP,,4880
neuronal action potential,31,0.518,0.726,1,GO:0019228,BP,,4881
polysaccharide catabolic process,26,0.48,0.726,1,GO:0000272,BP,,4882
pre-autophagosomal structure membrane,12,0.529,0.726,1,GO:0034045,CC,,4883
ARF guanyl-nucleotide exchange factor activity,19,0.477,0.727,1,GO:0005086,MF,,4884
positive regulation of urine volume,12,0.471,0.727,1,GO:0035810,BP,,4885
nucleoside triphosphate catabolic process,11,0.47,0.727,1,GO:0009143,BP,,4886
arachidonic acid secretion,22,0.522,0.727,1,"GO:0050482,GO:1903963",BP,arachidonate transport,4887
estrous cycle,13,0.472,0.727,1,GO:0044849,BP,,4888
response to vitamin D,27,0.481,0.727,1,GO:0033280,BP,,4889
anchored component of plasma membrane,43,0.485,0.727,1,GO:0046658,CC,,4890
interleukin-1 secretion,32,0.482,0.727,1,GO:0050701,BP,,4891
DNA methylation involved in gamete generation,15,0.474,0.727,1,GO:0043046,BP,,4892
RNA polymerase II activating transcription factor binding,32,0.518,0.728,1,GO:0001102,MF,,4893
hindbrain radial glia guided cell migration,10,0.532,0.728,1,GO:0021932,BP,,4894
homocysteine metabolic process,13,0.528,0.728,1,GO:0050667,BP,,4895
protein acetyltransferase complex,84,0.511,0.728,1,"GO:0031248,GO:1902493",CC,acetyltransferase complex,4896
immunological synapse formation,11,0.47,0.729,1,GO:0001771,BP,,4897
tetrapyrrole binding,103,0.51,0.729,1,GO:0046906,MF,,4898
secretion by tissue,30,0.482,0.729,1,GO:0032941,BP,,4899
transcription elongation factor complex,46,0.485,0.729,1,GO:0008023,CC,,4900
adenohypophysis development,11,0.47,0.73,1,GO:0021984,BP,,4901
response to sterol,21,0.478,0.73,1,GO:0036314,BP,,4902
interleukin-1 beta production,45,0.485,0.73,1,GO:0032611,BP,,4903
regulation of mitochondrial fission,21,0.478,0.73,1,GO:0090140,BP,,4904
regulation of cAMP-mediated signaling,13,0.528,0.731,1,GO:0043949,BP,,4905
ethanol metabolic process,12,0.529,0.731,1,GO:0006067,BP,,4906
oligosaccharide metabolic process,47,0.486,0.731,1,GO:0009311,BP,,4907
negative regulation of neural precursor cell proliferation,18,0.477,0.731,1,GO:2000178,BP,,4908
calmodulin binding,172,0.508,0.731,1,GO:0005516,MF,,4909
phosphatidylinositol 3-kinase binding,30,0.482,0.732,1,GO:0043548,MF,,4910
"CD4-positive, alpha-beta T cell activation",52,0.514,0.732,1,GO:0035710,BP,,4911
WW domain binding,19,0.523,0.732,1,GO:0050699,MF,,4912
response to superoxide,24,0.48,0.732,1,GO:0000303,BP,,4913
"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen",127,0.509,0.732,1,GO:0016705,MF,,4914
negative regulation of phosphatidylinositol 3-kinase signaling,10,0.469,0.733,1,GO:0014067,BP,,4915
"nucleotide-excision repair, DNA gap filling",20,0.478,0.733,1,GO:0006297,BP,,4916
mesodermal cell fate specification,12,0.472,0.733,1,GO:0007501,BP,,4917
regulation of myeloid cell differentiation,145,0.508,0.733,1,GO:0045637,BP,,4918
fucosyltransferase activity,11,0.47,0.734,1,GO:0008417,MF,,4919
erythrocyte differentiation,80,0.511,0.734,1,GO:0030218,BP,,4920
negative regulation of stem cell differentiation,17,0.524,0.734,1,GO:2000737,BP,,4921
hexose biosynthetic process,72,0.488,0.734,1,GO:0019319,BP,,4922
endosome to lysosome transport,36,0.484,0.735,1,GO:0008333,BP,,4923
basal transcription machinery binding,33,0.483,0.735,1,"GO:0001098,GO:0001099",MF,basal RNA polymerase II transcription machinery binding,4924
intraciliary transport involved in cilium assembly,40,0.485,0.735,1,GO:0035735,BP,,4925
positive regulation of phosphatidylinositol 3-kinase signaling,55,0.487,0.735,1,GO:0014068,BP,,4926
negative regulation of dendritic spine development,12,0.528,0.736,1,GO:0061000,BP,,4927
biomineral tissue development,109,0.491,0.736,1,GO:0031214,BP,,4928
somatic diversification of immunoglobulins,37,0.484,0.736,1,GO:0016445,BP,,4929
positive regulation of T-helper cell differentiation,13,0.473,0.737,1,GO:0045624,BP,,4930
platelet dense granule,16,0.524,0.737,1,GO:0042827,CC,,4931
post-anal tail morphogenesis,15,0.525,0.737,1,GO:0036342,BP,,4932
hyaluronan metabolic process,32,0.483,0.737,1,GO:0030212,BP,,4933
peptide transmembrane transporter activity,25,0.481,0.738,1,GO:1904680,MF,,4934
regulation of blood vessel size,118,0.491,0.738,1,GO:0050880,BP,,4935
positive regulation of proteasomal protein catabolic process,86,0.49,0.738,1,GO:1901800,BP,,4936
organophosphate catabolic process,109,0.509,0.739,1,GO:0046434,BP,,4937
non-membrane spanning protein tyrosine kinase activity,43,0.485,0.739,1,GO:0004715,MF,,4938
regulation of granulocyte differentiation,12,0.472,0.739,1,GO:0030852,BP,,4939
axis specification,72,0.511,0.739,1,GO:0009798,BP,,4940
regulation of cellular response to transforming growth factor beta stimulus,93,0.49,0.74,1,GO:1903844,BP,,4941
pentose-phosphate shunt,15,0.475,0.74,1,GO:0006098,BP,,4942
cAMP response element binding,13,0.473,0.74,1,GO:0035497,MF,,4943
viral transcription,160,0.492,0.74,1,GO:0019083,BP,,4944
specification of symmetry,113,0.509,0.74,1,GO:0009799,BP,,4945
multi-organism transport,68,0.488,0.741,1,"GO:0044766,GO:1902579",BP,multi-organism localization,4946
synaptonemal complex organization,17,0.477,0.741,1,GO:0070193,BP,,4947
regulation of chemotaxis,137,0.492,0.741,1,GO:0050920,BP,,4948
tricarboxylic acid cycle enzyme complex,11,0.471,0.741,1,GO:0045239,CC,,4949
glucose metabolic process,175,0.493,0.741,1,GO:0006006,BP,,4950
monocarboxylic acid biosynthetic process,161,0.492,0.741,1,GO:0072330,BP,,4951
carbohydrate kinase activity,18,0.477,0.741,1,GO:0019200,MF,,4952
SNARE complex,44,0.486,0.741,1,GO:0031201,CC,,4953
positive regulation of tumor necrosis factor superfamily cytokine production,52,0.487,0.741,1,GO:1903557,BP,,4954
transcription of nuclear large rRNA transcript from RNA polymerase I promoter,12,0.528,0.741,1,GO:0042790,BP,,4955
positive regulation of defense response to virus by host,14,0.474,0.741,1,GO:0002230,BP,,4956
positive regulation of glucose import,34,0.516,0.741,1,GO:0046326,BP,,4957
Notch binding,20,0.479,0.742,1,GO:0005112,MF,,4958
response to hydrogen peroxide,114,0.491,0.742,1,GO:0042542,BP,,4959
lamellipodium morphogenesis,13,0.526,0.742,1,GO:0072673,BP,,4960
regulation of skeletal muscle adaptation,11,0.471,0.742,1,GO:0014733,BP,,4961
positive regulation of endopeptidase activity,120,0.509,0.742,1,GO:0010950,BP,,4962
spinal cord motor neuron differentiation,24,0.519,0.743,1,GO:0021522,BP,,4963
regulation of leukocyte apoptotic process,70,0.511,0.743,1,GO:2000106,BP,,4964
negative regulation of angiogenesis,63,0.512,0.743,1,GO:0016525,BP,,4965
hyperosmotic response,17,0.523,0.743,1,GO:0006972,BP,,4966
positive regulation of histone H3-K4 methylation,14,0.525,0.744,1,GO:0051571,BP,,4967
membrane raft localization,10,0.53,0.744,1,GO:0051665,BP,,4968
G-protein coupled receptor internalization,11,0.472,0.744,1,GO:0002031,BP,,4969
sulfur compound transmembrane transporter activity,25,0.519,0.744,1,GO:1901682,MF,,4970
negative regulation of innate immune response,31,0.483,0.744,1,GO:0045824,BP,,4971
myotube differentiation,84,0.49,0.744,1,GO:0014902,BP,,4972
regulation of peptide hormone secretion,162,0.507,0.744,1,GO:0090276,BP,,4973
phospholipase activity,82,0.49,0.745,1,GO:0004620,MF,,4974
vascular associated smooth muscle cell migration,13,0.526,0.745,1,"GO:1904738,GO:1904752",BP,regulation of vascular associated smooth muscle cell migration,4975
muscle hypertrophy,62,0.512,0.745,1,GO:0014896,BP,,4976
endocrine hormone secretion,37,0.485,0.745,1,GO:0060986,BP,,4977
regulation of protein homooligomerization,16,0.477,0.745,1,GO:0032462,BP,,4978
centriolar satellite,25,0.519,0.745,1,GO:0034451,CC,,4979
regulation of biomineral tissue development,63,0.512,0.746,1,GO:0070167,BP,,4980
regulation of mesoderm development,14,0.475,0.746,1,GO:2000380,BP,,4981
negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,27,0.518,0.746,1,GO:0002823,BP,,4982
drug metabolic process,22,0.52,0.747,1,GO:0017144,BP,,4983
Golgi-associated vesicle,77,0.489,0.747,1,GO:0005798,CC,,4984
deoxyribonucleoside triphosphate metabolic process,16,0.477,0.747,1,GO:0009200,BP,,4985
cell-cell contact zone,61,0.512,0.747,1,GO:0044291,CC,,4986
proton-transporting two-sector ATPase complex assembly,12,0.527,0.747,1,GO:0070071,BP,,4987
leukocyte mediated cytotoxicity,58,0.512,0.748,1,GO:0001909,BP,,4988
determination of left/right symmetry,105,0.509,0.748,1,GO:0007368,BP,,4989
"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",18,0.478,0.748,1,GO:0033764,MF,,4990
rRNA transcription,28,0.518,0.748,1,GO:0009303,BP,,4991
peptidyl-proline dioxygenase activity,13,0.526,0.748,1,GO:0031543,MF,,4992
NAD metabolic process,64,0.488,0.748,1,GO:0019674,BP,,4993
membrane repolarization during cardiac muscle cell action potential,20,0.521,0.748,1,GO:0086013,BP,,4994
respiratory system process,27,0.482,0.749,1,GO:0003016,BP,,4995
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,10,0.529,0.749,1,GO:0097296,BP,,4996
embryonic camera-type eye formation,11,0.472,0.749,1,GO:0060900,BP,,4997
interleukin-1 beta secretion,29,0.483,0.749,1,GO:0050702,BP,,4998
regulation of fibroblast growth factor receptor signaling pathway,24,0.481,0.75,1,GO:0040036,BP,,4999
endopeptidase regulator activity,129,0.508,0.75,1,GO:0061135,MF,,5000
negative regulation of DNA recombination,19,0.521,0.75,1,GO:0045910,BP,,5001
negative regulation of glycoprotein biosynthetic process,10,0.529,0.75,1,GO:0010561,BP,,5002
negative regulation of cytokine production involved in immune response,17,0.478,0.75,1,GO:0002719,BP,,5003
regulation of phosphatidylinositol 3-kinase activity,35,0.484,0.75,1,GO:0043551,BP,,5004
phosphatidylethanolamine biosynthetic process,12,0.474,0.751,1,GO:0006646,BP,,5005
positive regulation of neutrophil chemotaxis,21,0.52,0.751,1,GO:0090023,BP,,5006
intrinsic component of the cytoplasmic side of the plasma membrane,12,0.474,0.751,1,GO:0031235,CC,,5007
protein localization to kinetochore,12,0.474,0.751,1,GO:0034501,BP,,5008
deoxyribonucleotide biosynthetic process,11,0.528,0.752,1,GO:0009263,BP,,5009
cell death in response to oxidative stress,69,0.489,0.752,1,GO:0036473,BP,,5010
positive regulation of interleukin-4 production,17,0.478,0.752,1,GO:0032753,BP,,5011
regulation of urine volume,18,0.521,0.753,1,GO:0035809,BP,,5012
interleukin-6 secretion,23,0.519,0.753,1,GO:0072604,BP,,5013
negative regulation of leukocyte differentiation,70,0.489,0.753,1,GO:1902106,BP,,5014
positive regulation of fat cell differentiation,49,0.487,0.753,1,GO:0045600,BP,,5015
lipoprotein particle binding,20,0.48,0.753,1,"GO:0071813,GO:0071814",MF,protein-lipid complex binding,5016
folic acid-containing compound biosynthetic process,11,0.527,0.753,1,GO:0009396,BP,,5017
uterus development,14,0.476,0.753,1,GO:0060065,BP,,5018
immune response to tumor cell,12,0.526,0.753,1,GO:0002418,BP,,5019
regulation of growth hormone secretion,10,0.471,0.754,1,GO:0060123,BP,,5020
cytoskeletal adaptor activity,11,0.473,0.754,1,GO:0008093,MF,,5021
regulation of cytokine-mediated signaling pathway,109,0.509,0.754,1,GO:0001959,BP,,5022
metanephros development,78,0.51,0.754,1,GO:0001656,BP,,5023
paraxial mesoderm morphogenesis,10,0.471,0.754,1,GO:0048340,BP,,5024
acyl-CoA metabolic process,86,0.49,0.754,1,"GO:0006637,GO:0035383",BP,thioester metabolic process,5025
negative regulation of epithelial cell differentiation,30,0.517,0.754,1,GO:0030857,BP,,5026
negative regulation of cell division,14,0.524,0.754,1,GO:0051782,BP,,5027
apical dendrite,13,0.475,0.754,1,GO:0097440,CC,,5028
striated muscle contraction,146,0.492,0.755,1,GO:0006941,BP,,5029
regulation of cell shape,134,0.508,0.755,1,GO:0008360,BP,,5030
specific granule,133,0.492,0.756,1,GO:0042581,CC,,5031
motor activity,110,0.491,0.756,1,GO:0003774,MF,,5032
neural crest formation,10,0.472,0.756,1,GO:0014029,BP,,5033
granulocyte differentiation,20,0.48,0.756,1,GO:0030851,BP,,5034
Golgi organization,88,0.51,0.756,1,GO:0007030,BP,,5035
regulation of tube size,119,0.492,0.756,1,GO:0035150,BP,,5036
multicellular organism aging,21,0.52,0.756,1,GO:0010259,BP,,5037
positive regulation of ERBB signaling pathway,34,0.515,0.756,1,GO:1901186,BP,,5038
lymphocyte apoptotic process,60,0.512,0.757,1,GO:0070227,BP,,5039
laminin binding,24,0.482,0.757,1,GO:0043236,MF,,5040
hepatocyte differentiation,11,0.527,0.757,1,GO:0070365,BP,,5041
vascular endothelial growth factor receptor signaling pathway,88,0.51,0.757,1,GO:0048010,BP,,5042
cardiac chamber development,138,0.492,0.757,1,GO:0003205,BP,,5043
tricarboxylic acid metabolic process,37,0.515,0.757,1,GO:0072350,BP,,5044
negative regulation of actin filament bundle assembly,21,0.519,0.758,1,GO:0032232,BP,,5045
ubiquitin-protein transferase regulator activity,11,0.473,0.758,1,GO:0055106,MF,,5046
cellular response to hepatocyte growth factor stimulus,11,0.527,0.759,1,GO:0035729,BP,,5047
regulation of lipopolysaccharide-mediated signaling pathway,15,0.477,0.759,1,GO:0031664,BP,,5048
alpha-beta T cell activation,92,0.509,0.759,1,GO:0046631,BP,,5049
negative regulation of interferon-gamma production,22,0.481,0.76,1,GO:0032689,BP,,5050
positive regulation of lipid metabolic process,109,0.492,0.76,1,GO:0045834,BP,,5051
negative regulation of lipid transport,19,0.52,0.76,1,GO:0032369,BP,,5052
TRIF-dependent toll-like receptor signaling pathway,23,0.518,0.76,1,GO:0035666,BP,,5053
calcium-dependent cysteine-type endopeptidase activity,17,0.521,0.76,1,GO:0004198,MF,,5054
chromatin disassembly,17,0.521,0.76,1,GO:0031498,BP,,5055
ubiquitin-like protein binding,108,0.491,0.761,1,GO:0032182,MF,,5056
NFAT protein import into nucleus,14,0.476,0.761,1,GO:0051531,BP,,5057
positive regulation of posttranscriptional gene silencing,21,0.481,0.761,1,GO:0060148,BP,,5058
mitochondrion distribution,12,0.525,0.761,1,GO:0048311,BP,,5059
fucosylation,22,0.519,0.761,1,GO:0036065,BP,,5060
signaling adaptor activity,68,0.511,0.762,1,GO:0035591,MF,,5061
negative regulation of sister chromatid segregation,31,0.484,0.762,1,"GO:0033046,GO:0051985",BP,negative regulation of chromosome segregation,5062
regulation of tyrosine phosphorylation of Stat5 protein,10,0.528,0.762,1,GO:0042522,BP,,5063
ATPase coupled ion transmembrane transporter activity,66,0.489,0.762,1,GO:0042625,MF,,5064
protein mannosylation,18,0.479,0.762,1,GO:0035268,BP,,5065
cerebellar cortex formation,20,0.48,0.762,1,GO:0021697,BP,,5066
actin filament bundle assembly,123,0.492,0.762,1,GO:0051017,BP,,5067
regulation of cellular response to heat,70,0.51,0.763,1,GO:1900034,BP,,5068
protein binding involved in cell adhesion,36,0.515,0.763,1,GO:0098631,MF,,5069
microtubule motor activity,66,0.489,0.763,1,GO:0003777,MF,,5070
glycerolipid catabolic process,42,0.513,0.763,1,GO:0046503,BP,,5071
insemination,11,0.526,0.763,1,GO:0007320,BP,,5072
response to manganese ion,14,0.477,0.764,1,GO:0010042,BP,,5073
tRNA metabolic process,147,0.507,0.764,1,GO:0006399,BP,,5074
entry of bacterium into host cell,16,0.522,0.764,1,GO:0035635,BP,,5075
otic vesicle morphogenesis,10,0.473,0.764,1,GO:0071600,BP,,5076
regulation of interleukin-12 production,37,0.514,0.764,1,GO:0032655,BP,,5077
long-chain fatty acid transport,56,0.488,0.764,1,GO:0015909,BP,,5078
peroxisomal transport,14,0.477,0.764,1,GO:0043574,BP,,5079
ribonucleoside metabolic process,88,0.491,0.764,1,GO:0009119,BP,,5080
histone H3-K4 trimethylation,13,0.476,0.764,1,GO:0080182,BP,,5081
response to pH,33,0.485,0.765,1,GO:0009268,BP,,5082
positive regulation of extracellular matrix organization,15,0.522,0.765,1,GO:1903055,BP,,5083
regulation of cellular carbohydrate catabolic process,10,0.473,0.766,1,GO:0043471,BP,,5084
indole-containing compound metabolic process,24,0.518,0.766,1,GO:0042430,BP,,5085
mast cell chemotaxis,11,0.526,0.766,1,GO:0002551,BP,,5086
establishment of mitotic spindle localization,18,0.52,0.766,1,GO:0040001,BP,,5087
positive regulation of granulocyte chemotaxis,22,0.518,0.766,1,GO:0071624,BP,,5088
receptor biosynthetic process,19,0.52,0.766,1,GO:0032800,BP,,5089
protein autoprocessing,11,0.526,0.766,1,GO:0016540,BP,,5090
response to electrical stimulus,37,0.486,0.766,1,GO:0051602,BP,,5091
regulation of positive chemotaxis,20,0.481,0.767,1,GO:0050926,BP,,5092
regulation of acyl-CoA biosynthetic process,13,0.476,0.767,1,GO:0050812,BP,,5093
COPI vesicle coat,12,0.475,0.767,1,GO:0030126,CC,,5094
peptidyl-methionine modification,10,0.527,0.767,1,GO:0018206,BP,,5095
negative regulation of fibroblast proliferation,27,0.484,0.767,1,GO:0048147,BP,,5096
transcription factor TFTC complex,14,0.477,0.768,1,GO:0033276,CC,,5097
embryo implantation,39,0.486,0.768,1,GO:0007566,BP,,5098
negative regulation of cell morphogenesis involved in differentiation,75,0.51,0.768,1,GO:0010771,BP,,5099
response to immobilization stress,21,0.519,0.768,1,GO:0035902,BP,,5100
tumor necrosis factor production,87,0.509,0.768,1,GO:0032640,BP,,5101
cellular response to hexose stimulus,102,0.492,0.768,1,GO:0071331,BP,,5102
positive regulation of phosphatase activity,26,0.517,0.768,1,GO:0010922,BP,,5103
neutrophil homeostasis,11,0.526,0.768,1,GO:0001780,BP,,5104
acetylcholine receptor activity,19,0.48,0.769,1,GO:0015464,MF,,5105
regulation of leukocyte mediated immunity,123,0.508,0.769,1,GO:0002703,BP,,5106
cellular potassium ion transport,173,0.506,0.769,1,"GO:0071804,GO:0071805",BP,potassium ion transmembrane transport,5107
regulation of type 2 immune response,19,0.481,0.77,1,GO:0002828,BP,,5108
transepithelial transport,15,0.522,0.77,1,GO:0070633,BP,,5109
microtubule polymerization,52,0.512,0.77,1,GO:0046785,BP,,5110
inositol phosphate catabolic process,11,0.525,0.77,1,GO:0071545,BP,,5111
chemokine binding,16,0.479,0.77,1,GO:0019956,MF,,5112
hormone binding,58,0.511,0.771,1,GO:0042562,MF,,5113
regulation of bone remodeling,37,0.486,0.771,1,GO:0046850,BP,,5114
diacylglycerol kinase activity,11,0.475,0.771,1,GO:0004143,MF,,5115
body fluid secretion,74,0.49,0.771,1,GO:0007589,BP,,5116
cellular response to low-density lipoprotein particle stimulus,12,0.524,0.771,1,GO:0071404,BP,,5117
positive regulation of peptidase activity,136,0.507,0.772,1,GO:0010952,BP,,5118
N-acyltransferase activity,88,0.509,0.772,1,GO:0016410,MF,,5119
DNA-dependent DNA replication,128,0.507,0.772,1,GO:0006261,BP,,5120
cellular polysaccharide metabolic process,77,0.49,0.772,1,GO:0044264,BP,,5121
protein serine/threonine phosphatase activity,63,0.511,0.772,1,GO:0004722,MF,,5122
labyrinthine layer blood vessel development,20,0.481,0.773,1,GO:0060716,BP,,5123
positive regulation of chromosome segregation,20,0.519,0.773,1,GO:0051984,BP,,5124
regulation of insulin secretion,145,0.507,0.773,1,GO:0050796,BP,,5125
negative regulation of osteoclast differentiation,22,0.518,0.773,1,GO:0045671,BP,,5126
positive regulation of epithelial cell proliferation,137,0.507,0.774,1,GO:0050679,BP,,5127
Rac protein signal transduction,31,0.485,0.774,1,GO:0016601,BP,,5128
positive regulation of fatty acid metabolic process,27,0.516,0.774,1,GO:0045923,BP,,5129
neuron maturation,39,0.513,0.775,1,GO:0042551,BP,,5130
protein-lipid complex subunit organization,28,0.516,0.775,1,GO:0071825,BP,,5131
I-SMAD binding,11,0.525,0.775,1,GO:0070411,MF,,5132
amyloid precursor protein catabolic process,21,0.482,0.776,1,GO:0042987,BP,,5133
cysteine-type endopeptidase activity involved in apoptotic process,14,0.522,0.776,1,GO:0097153,MF,,5134
actin filament binding,129,0.507,0.776,1,GO:0051015,MF,,5135
modulation by host of viral process,20,0.518,0.776,1,GO:0044788,BP,,5136
biotin metabolic process,11,0.475,0.777,1,GO:0006768,BP,,5137
"synaptic transmission, GABAergic",36,0.514,0.777,1,GO:0051932,BP,,5138
stem cell proliferation,98,0.492,0.777,1,GO:0072089,BP,,5139
cytoplasmic dynein complex,22,0.483,0.777,1,GO:0005868,CC,,5140
striated muscle hypertrophy,60,0.511,0.778,1,GO:0014897,BP,,5141
glandular epithelial cell differentiation,39,0.513,0.778,1,GO:0002067,BP,,5142
neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,16,0.48,0.778,1,"GO:0099529,GO:1904315",MF,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,5143
sensory perception of sound,123,0.507,0.779,1,GO:0007605,BP,,5144
Cul4A-RING E3 ubiquitin ligase complex,10,0.526,0.78,1,GO:0031464,CC,,5145
nucleosome disassembly,15,0.521,0.78,1,GO:0006337,BP,,5146
cytosolic transport,119,0.507,0.78,1,GO:0016482,BP,,5147
forebrain morphogenesis,12,0.477,0.78,1,GO:0048853,BP,,5148
Golgi localization,12,0.477,0.78,1,GO:0051645,BP,,5149
germ cell development,183,0.506,0.78,1,GO:0007281,BP,,5150
MAP kinase kinase activity,12,0.523,0.781,1,GO:0004708,MF,,5151
"binding, bridging",160,0.506,0.781,1,GO:0060090,MF,,5152
regulation of microvillus organization,11,0.524,0.781,1,GO:0032530,BP,,5153
viral gene expression,170,0.494,0.781,1,GO:0019080,BP,,5154
semaphorin receptor binding,10,0.525,0.781,1,GO:0030215,MF,,5155
hindbrain development,128,0.493,0.781,1,GO:0030902,BP,,5156
cellular response to dexamethasone stimulus,30,0.515,0.782,1,GO:0071549,BP,,5157
nephron tubule epithelial cell differentiation,13,0.478,0.782,1,GO:0072160,BP,,5158
photoreceptor cell maintenance,30,0.515,0.782,1,GO:0045494,BP,,5159
exosome (RNase complex),18,0.481,0.782,1,"GO:0000178,GO:1905354",CC,exoribonuclease complex,5160
regulation of extracellular matrix disassembly,14,0.521,0.782,1,GO:0010715,BP,,5161
response to lithium ion,22,0.483,0.782,1,GO:0010226,BP,,5162
cytokine production involved in immune response,61,0.51,0.782,1,GO:0002367,BP,,5163
cellular response to retinoic acid,63,0.51,0.782,1,GO:0071300,BP,,5164
blood vessel endothelial cell migration,71,0.49,0.782,1,GO:0043534,BP,,5165
cell-cell signaling involved in cardiac conduction,29,0.485,0.782,1,GO:0086019,BP,,5166
regulation of transmission of nerve impulse,11,0.524,0.783,1,GO:0051969,BP,,5167
protein phosphatase 1 binding,17,0.481,0.783,1,GO:0008157,MF,,5168
amide transmembrane transporter activity,30,0.485,0.783,1,GO:0042887,MF,,5169
nitric oxide metabolic process,59,0.49,0.783,1,GO:0046209,BP,,5170
dorsal spinal cord development,15,0.52,0.784,1,GO:0021516,BP,,5171
INO80-type complex,17,0.519,0.784,1,GO:0097346,CC,,5172
inner ear development,162,0.506,0.784,1,GO:0048839,BP,,5173
regulation of ER to Golgi vesicle-mediated transport,11,0.476,0.784,1,GO:0060628,BP,,5174
pri-miRNA transcription from RNA polymerase II promoter,28,0.485,0.785,1,GO:0061614,BP,,5175
semaphorin-plexin signaling pathway,23,0.484,0.785,1,GO:0071526,BP,,5176
cellular response to exogenous dsRNA,11,0.476,0.785,1,GO:0071360,BP,,5177
pyruvate metabolic process,93,0.492,0.786,1,GO:0006090,BP,,5178
ion antiporter activity,55,0.511,0.786,1,GO:0099516,MF,,5179
"condensed chromosome, centromeric region",96,0.492,0.786,1,GO:0000779,CC,,5180
regulation by virus of viral protein levels in host cell,10,0.525,0.786,1,GO:0046719,BP,,5181
mitotic centrosome separation,13,0.478,0.786,1,GO:0007100,BP,,5182
parturition,17,0.481,0.787,1,GO:0007567,BP,,5183
lymphoid progenitor cell differentiation,16,0.48,0.787,1,GO:0002320,BP,,5184
methionine biosynthetic process,12,0.523,0.787,1,GO:0009086,BP,,5185
ear development,182,0.506,0.787,1,GO:0043583,BP,,5186
protein K63-linked ubiquitination,38,0.513,0.787,1,GO:0070534,BP,,5187
chemokine secretion,10,0.475,0.787,1,GO:0090195,BP,,5188
palmitoyltransferase activity,33,0.514,0.787,1,GO:0016409,MF,,5189
natural killer cell mediated cytotoxicity,38,0.487,0.788,1,GO:0042267,BP,,5190
positive regulation of cardiac muscle contraction,10,0.475,0.788,1,GO:0060452,BP,,5191
response to amine,36,0.487,0.788,1,GO:0014075,BP,,5192
regulation of mitochondrial depolarization,19,0.518,0.788,1,GO:0051900,BP,,5193
plasma lipoprotein particle assembly,14,0.479,0.789,1,GO:0034377,BP,,5194
"complement activation, classical pathway",28,0.485,0.789,1,GO:0006958,BP,,5195
negative regulation of cysteine-type endopeptidase activity,73,0.509,0.789,1,GO:2000117,BP,,5196
female pregnancy,148,0.494,0.789,1,GO:0007565,BP,,5197
cellular response to reactive oxygen species,135,0.493,0.789,1,GO:0034614,BP,,5198
stem cell differentiation,136,0.507,0.79,1,GO:0048863,BP,,5199
meiotic telomere clustering,10,0.524,0.79,1,GO:0045141,BP,,5200
positive regulation of peptidyl-lysine acetylation,27,0.485,0.79,1,GO:2000758,BP,,5201
filopodium tip,12,0.478,0.79,1,GO:0032433,CC,,5202
endocrine system development,102,0.508,0.79,1,GO:0035270,BP,,5203
activation of cysteine-type endopeptidase activity involved in apoptotic process,71,0.509,0.79,1,GO:0006919,BP,,5204
Notch receptor processing,16,0.519,0.79,1,GO:0007220,BP,,5205
pyridine nucleotide metabolic process,121,0.493,0.791,1,"GO:0019362,GO:0046496",BP,nicotinamide nucleotide metabolic process,5206
ovarian follicle development,47,0.511,0.791,1,GO:0001541,BP,,5207
autophagosome organization,69,0.491,0.791,1,GO:1905037,BP,,5208
regulation of transforming growth factor beta receptor signaling pathway,91,0.492,0.791,1,GO:0017015,BP,,5209
purine nucleobase metabolic process,17,0.481,0.791,1,GO:0006144,BP,,5210
Sin3 complex,13,0.479,0.791,1,GO:0016580,CC,,5211
photoreceptor outer segment membrane,10,0.524,0.791,1,GO:0042622,CC,,5212
negative regulation of biomineral tissue development,16,0.481,0.792,1,GO:0070168,BP,,5213
negative regulation of cell killing,14,0.52,0.792,1,GO:0031342,BP,,5214
nucleoid,31,0.486,0.792,1,"GO:0009295,GO:0042645",CC,mitochondrial nucleoid,5215
establishment of melanosome localization,22,0.484,0.792,1,GO:0032401,BP,,5216
regulation of phospholipase activity,48,0.489,0.792,1,GO:0010517,BP,,5217
embryonic digestive tract morphogenesis,14,0.48,0.793,1,GO:0048557,BP,,5218
adherens junction organization,111,0.493,0.793,1,GO:0034332,BP,,5219
regulation of response to wounding,128,0.493,0.793,1,GO:1903034,BP,,5220
"phosphatidylinositol-3,4-bisphosphate binding",17,0.518,0.794,1,GO:0043325,MF,,5221
atrioventricular valve development,20,0.517,0.794,1,GO:0003171,BP,,5222
granulocyte chemotaxis,74,0.509,0.794,1,GO:0071621,BP,,5223
leukocyte homeostasis,71,0.509,0.794,1,GO:0001776,BP,,5224
establishment of planar polarity involved in neural tube closure,14,0.52,0.794,1,GO:0090177,BP,,5225
actomyosin,61,0.49,0.794,1,GO:0042641,CC,,5226
endosome lumen,20,0.517,0.795,1,GO:0031904,CC,,5227
alpha-linolenic acid metabolic process,13,0.479,0.795,1,GO:0036109,BP,,5228
muscle adaptation,73,0.509,0.796,1,GO:0043500,BP,,5229
negative regulation of adaptive immune response,29,0.486,0.796,1,GO:0002820,BP,,5230
pyrimidine-containing compound biosynthetic process,41,0.488,0.797,1,GO:0072528,BP,,5231
C21-steroid hormone biosynthetic process,19,0.483,0.797,1,GO:0006700,BP,,5232
establishment of planar polarity of embryonic epithelium,16,0.481,0.798,1,GO:0042249,BP,,5233
mitotic recombination,42,0.511,0.798,1,GO:0006312,BP,,5234
glycogen metabolic process,65,0.509,0.798,1,"GO:0005977,GO:0006073,GO:0044042",BP,"cellular glucan metabolic process,glucan metabolic process",5235
ventricular cardiac muscle cell action potential,28,0.514,0.798,1,GO:0086005,BP,,5236
kinesin complex,46,0.489,0.798,1,GO:0005871,CC,,5237
regulation of translational elongation,25,0.515,0.798,1,GO:0006448,BP,,5238
regulation of T-helper cell differentiation,19,0.517,0.799,1,GO:0045622,BP,,5239
regulation of T cell receptor signaling pathway,32,0.487,0.799,1,GO:0050856,BP,,5240
DNA ligation,19,0.483,0.799,1,GO:0006266,BP,,5241
adenylate cyclase-activating adrenergic receptor signaling pathway,13,0.48,0.799,1,GO:0071880,BP,,5242
protein methyltransferase activity,74,0.509,0.799,1,GO:0008276,MF,,5243
renal system process involved in regulation of systemic arterial blood pressure,16,0.482,0.8,1,GO:0003071,BP,,5244
leucine zipper domain binding,11,0.478,0.8,1,GO:0043522,MF,,5245
"transforming growth factor beta receptor, cytoplasmic mediator activity",10,0.523,0.8,1,GO:0005072,MF,,5246
heme binding,96,0.507,0.8,1,GO:0020037,MF,,5247
regulation of peptidyl-serine phosphorylation,100,0.493,0.801,1,GO:0033135,BP,,5248
epidermis morphogenesis,26,0.486,0.801,1,GO:0048730,BP,,5249
platelet formation,15,0.481,0.801,1,GO:0030220,BP,,5250
signal sequence binding,38,0.488,0.801,1,GO:0005048,MF,,5251
regulation of organelle assembly,134,0.506,0.801,1,GO:1902115,BP,,5252
steroid hydroxylase activity,10,0.523,0.801,1,GO:0008395,MF,,5253
activation of protein kinase A activity,15,0.519,0.802,1,GO:0034199,BP,,5254
positive regulation of chromatin binding,10,0.523,0.802,1,GO:0035563,BP,,5255
ubiquitin-ubiquitin ligase activity,13,0.48,0.802,1,GO:0034450,MF,,5256
regulation of endothelial cell chemotaxis,18,0.517,0.802,1,GO:2001026,BP,,5257
regulation of reactive oxygen species biosynthetic process,59,0.509,0.803,1,GO:1903426,BP,,5258
regulation of protein autophosphorylation,39,0.488,0.803,1,GO:0031952,BP,,5259
iron ion transmembrane transport,11,0.478,0.804,1,GO:0034755,BP,,5260
positive regulation of establishment of protein localization to plasma membrane,29,0.513,0.804,1,GO:0090004,BP,,5261
cellular response to calcium ion,47,0.49,0.804,1,GO:0071277,BP,,5262
growth involved in symbiotic interaction,11,0.478,0.804,1,"GO:0044110,GO:0044116,GO:0044117",BP,"growth of symbiont involved in interaction with host,growth of symbiont in host",5263
germ cell nucleus,15,0.482,0.805,1,GO:0043073,CC,,5264
cytolysis,23,0.515,0.805,1,GO:0019835,BP,,5265
regulation of translational initiation,62,0.509,0.805,1,GO:0006446,BP,,5266
"negative regulation of mRNA splicing, via spliceosome",16,0.482,0.805,1,GO:0048025,BP,,5267
adhesion of symbiont to host,11,0.521,0.805,1,GO:0044406,BP,,5268
calcium:cation antiporter activity,10,0.522,0.805,1,GO:0015368,MF,,5269
dorsal/ventral neural tube patterning,20,0.516,0.806,1,GO:0021904,BP,,5270
membrane depolarization,92,0.493,0.806,1,GO:0051899,BP,,5271
regulation of blood pressure,139,0.506,0.807,1,GO:0008217,BP,,5272
developmental growth involved in morphogenesis,195,0.495,0.807,1,GO:0060560,BP,,5273
protein tyrosine kinase binding,57,0.509,0.807,1,GO:1990782,MF,,5274
neurotrophin TRK receptor signaling pathway,23,0.515,0.807,1,GO:0048011,BP,,5275
cytoskeletal anchoring at plasma membrane,10,0.522,0.807,1,GO:0007016,BP,,5276
telomeric DNA binding,29,0.513,0.807,1,GO:0042162,MF,,5277
interleukin-1 receptor binding,14,0.481,0.808,1,GO:0005149,MF,,5278
cellular response to monosaccharide stimulus,103,0.493,0.808,1,GO:0071326,BP,,5279
mammary gland alveolus development,14,0.481,0.808,1,"GO:0060749,GO:0061377",BP,mammary gland lobule development,5280
positive regulation of humoral immune response,12,0.48,0.808,1,GO:0002922,BP,,5281
centriole-centriole cohesion,10,0.522,0.808,1,GO:0010457,BP,,5282
regulation of tumor necrosis factor production,85,0.508,0.809,1,GO:0032680,BP,,5283
regulation of protein binding,163,0.494,0.809,1,GO:0043393,BP,,5284
regulation of meiotic nuclear division,16,0.517,0.809,1,GO:0040020,BP,,5285
retinal binding,12,0.48,0.81,1,GO:0016918,MF,,5286
syntaxin binding,74,0.492,0.81,1,GO:0019905,MF,,5287
negative regulation of tumor necrosis factor production,34,0.512,0.81,1,GO:0032720,BP,,5288
embryonic digit morphogenesis,52,0.51,0.81,1,GO:0042733,BP,,5289
vesicle-mediated transport to the plasma membrane,63,0.509,0.81,1,GO:0098876,BP,,5290
negative regulation of protein depolymerization,48,0.51,0.811,1,GO:1901880,BP,,5291
cellular response to vitamin D,14,0.482,0.811,1,GO:0071305,BP,,5292
lysophospholipase activity,17,0.483,0.811,1,GO:0004622,MF,,5293
transmission of nerve impulse,61,0.509,0.812,1,GO:0019226,BP,,5294
sodium channel activity,42,0.489,0.812,1,GO:0005272,MF,,5295
lymphocyte chemotaxis,33,0.512,0.812,1,GO:0048247,BP,,5296
cytokinetic process,18,0.516,0.813,1,GO:0032506,BP,,5297
T cell activation involved in immune response,58,0.491,0.813,1,GO:0002286,BP,,5298
epithelial structure maintenance,18,0.516,0.813,1,GO:0010669,BP,,5299
tolerance induction,21,0.485,0.813,1,GO:0002507,BP,,5300
glycolipid binding,13,0.519,0.813,1,GO:0051861,MF,,5301
receptor agonist activity,18,0.484,0.813,1,GO:0048018,MF,,5302
cardiac right ventricle morphogenesis,14,0.518,0.813,1,GO:0003215,BP,,5303
protein K63-linked deubiquitination,26,0.513,0.813,1,GO:0070536,BP,,5304
positive regulation of lipid kinase activity,30,0.488,0.813,1,GO:0090218,BP,,5305
cyclase activity,18,0.484,0.814,1,GO:0009975,MF,,5306
epithelial cell proliferation involved in lung morphogenesis,10,0.522,0.814,1,GO:0060502,BP,,5307
extracellular matrix component,109,0.507,0.814,1,GO:0044420,CC,,5308
MAP kinase phosphatase activity,13,0.481,0.814,1,GO:0033549,MF,,5309
response to salt stress,13,0.519,0.814,1,GO:0009651,BP,,5310
endoplasmic reticulum lumen,177,0.505,0.814,1,GO:0005788,CC,,5311
regulation of protein polyubiquitination,13,0.519,0.814,1,GO:1902914,BP,,5312
receptor regulator activity,45,0.49,0.815,1,GO:0030545,MF,,5313
lens morphogenesis in camera-type eye,16,0.483,0.815,1,GO:0002089,BP,,5314
regulation of Rho protein signal transduction,115,0.506,0.815,1,GO:0035023,BP,,5315
Ran GTPase binding,30,0.488,0.815,1,GO:0008536,MF,,5316
lipase inhibitor activity,10,0.521,0.815,1,GO:0055102,MF,,5317
LRR domain binding,17,0.484,0.815,1,GO:0030275,MF,,5318
protein exit from endoplasmic reticulum,34,0.512,0.815,1,GO:0032527,BP,,5319
regulation of defense response to virus by host,23,0.486,0.816,1,GO:0050691,BP,,5320
protein tyrosine kinase activity,162,0.505,0.816,1,GO:0004713,MF,,5321
polyol catabolic process,16,0.517,0.817,1,GO:0046174,BP,,5322
delayed rectifier potassium channel activity,18,0.484,0.817,1,GO:0005251,MF,,5323
dendritic cell chemotaxis,18,0.516,0.817,1,GO:0002407,BP,,5324
9+0 non-motile cilium,79,0.492,0.817,1,"GO:0097731,GO:0097733",CC,photoreceptor cell cilium,5325
pyrimidine deoxyribonucleotide metabolic process,16,0.517,0.817,1,GO:0009219,BP,,5326
positive regulation of protein processing,19,0.485,0.817,1,GO:0010954,BP,,5327
phosphatidylinositol-4-phosphate binding,20,0.485,0.818,1,GO:0070273,MF,,5328
venous blood vessel development,14,0.482,0.818,1,GO:0060841,BP,,5329
negative regulation of type I interferon production,40,0.489,0.818,1,GO:0032480,BP,,5330
regulation of wound healing,106,0.506,0.818,1,GO:0061041,BP,,5331
phosphatidylinositol bisphosphate binding,73,0.492,0.818,1,GO:1902936,MF,,5332
positive regulation of T cell differentiation,60,0.491,0.819,1,GO:0045582,BP,,5333
regulation of ventricular cardiac muscle cell membrane repolarization,17,0.484,0.819,1,GO:0060307,BP,,5334
somatic stem cell division,20,0.515,0.819,1,GO:0048103,BP,,5335
fatty acid transmembrane transport,16,0.483,0.819,1,GO:1902001,BP,,5336
negative regulation of dendrite development,26,0.513,0.819,1,GO:2000171,BP,,5337
cardiac muscle cell apoptotic process,23,0.514,0.819,1,GO:0010659,BP,,5338
midbrain dopaminergic neuron differentiation,15,0.517,0.819,1,GO:1904948,BP,,5339
actin monomer binding,24,0.487,0.82,1,GO:0003785,MF,,5340
negative regulation of lipase activity,11,0.48,0.82,1,GO:0060192,BP,,5341
midgut development,11,0.52,0.82,1,GO:0007494,BP,,5342
embryonic pattern specification,52,0.491,0.82,1,GO:0009880,BP,,5343
negative regulation of telomere maintenance,26,0.513,0.821,1,GO:0032205,BP,,5344
glucocorticoid metabolic process,18,0.485,0.821,1,GO:0008211,BP,,5345
14-3-3 protein binding,23,0.486,0.821,1,GO:0071889,MF,,5346
heme metabolic process,25,0.513,0.821,1,GO:0042168,BP,,5347
neuromuscular process controlling balance,45,0.49,0.822,1,GO:0050885,BP,,5348
peptidyl-proline hydroxylation,14,0.517,0.822,1,GO:0019511,BP,,5349
positive regulation of substrate adhesion-dependent cell spreading,27,0.487,0.822,1,GO:1900026,BP,,5350
cell differentiation involved in metanephros development,24,0.487,0.822,1,GO:0072202,BP,,5351
phosphatase activator activity,10,0.52,0.822,1,GO:0019211,MF,,5352
positive regulation of endocytosis,95,0.493,0.822,1,GO:0045807,BP,,5353
nucleoside phosphate catabolic process,66,0.492,0.823,1,GO:1901292,BP,,5354
COPI-coated vesicle membrane,15,0.483,0.823,1,GO:0030663,CC,,5355
atrial septum development,14,0.483,0.823,1,GO:0003283,BP,,5356
smooth muscle cell apoptotic process,13,0.482,0.823,1,"GO:0034390,GO:0034391",BP,regulation of smooth muscle cell apoptotic process,5357
organelle membrane contact site,10,0.48,0.823,1,GO:0044232,CC,,5358
enteroendocrine cell differentiation,23,0.487,0.823,1,GO:0035883,BP,,5359
interleukin-5 production,12,0.519,0.824,1,"GO:0032634,GO:0032674",BP,regulation of interleukin-5 production,5360
voltage-gated potassium channel complex,82,0.507,0.824,1,GO:0008076,CC,,5361
response to iron ion,31,0.512,0.824,1,GO:0010039,BP,,5362
regulation of nephron tubule epithelial cell differentiation,11,0.481,0.824,1,GO:0072182,BP,,5363
regulation of smooth muscle cell differentiation,23,0.513,0.824,1,GO:0051150,BP,,5364
glucose import,65,0.508,0.824,1,GO:0046323,BP,,5365
positive regulation of myeloid cell differentiation,63,0.492,0.824,1,GO:0045639,BP,,5366
retinol dehydrogenase activity,15,0.517,0.824,1,GO:0004745,MF,,5367
phospholipase A2 activity,25,0.487,0.825,1,GO:0004623,MF,,5368
SAGA-type complex,26,0.513,0.825,1,GO:0070461,CC,,5369
attachment of spindle microtubules to kinetochore,26,0.487,0.825,1,GO:0008608,BP,,5370
positive regulation of interleukin-13 production,11,0.519,0.825,1,GO:0032736,BP,,5371
azole transport,15,0.516,0.826,1,GO:0045117,BP,,5372
chloride channel complex,42,0.49,0.826,1,GO:0034707,CC,,5373
oocyte maturation,19,0.485,0.826,1,GO:0001556,BP,,5374
granulocyte migration,81,0.507,0.827,1,GO:0097530,BP,,5375
steroid catabolic process,17,0.485,0.827,1,GO:0006706,BP,,5376
bundle of His cell to Purkinje myocyte communication,12,0.518,0.827,1,GO:0086069,BP,,5377
negative regulation of cation channel activity,27,0.488,0.827,1,GO:2001258,BP,,5378
sphingomyelin metabolic process,13,0.483,0.828,1,GO:0006684,BP,,5379
trans-Golgi network transport vesicle,26,0.488,0.828,1,GO:0030140,CC,,5380
histone exchange,34,0.511,0.828,1,GO:0043486,BP,,5381
stress fiber,49,0.491,0.828,1,"GO:0001725,GO:0097517",CC,contractile actin filament bundle,5382
positive regulation of transmembrane transport,110,0.494,0.828,1,GO:0034764,BP,,5383
mRNA cleavage,22,0.513,0.828,1,GO:0006379,BP,,5384
positive regulation of NF-kappaB import into nucleus,21,0.486,0.828,1,GO:0042346,BP,,5385
intraciliary transport particle B,19,0.486,0.829,1,GO:0030992,CC,,5386
GABAergic neuron differentiation,14,0.483,0.829,1,GO:0097154,BP,,5387
protein localization to vacuole,38,0.51,0.829,1,GO:0072665,BP,,5388
positive regulation of histone deacetylation,16,0.484,0.829,1,GO:0031065,BP,,5389
MyD88-independent toll-like receptor signaling pathway,27,0.512,0.83,1,GO:0002756,BP,,5390
negative regulation of apoptotic signaling pathway,179,0.495,0.83,1,GO:2001234,BP,,5391
endothelial cell migration,144,0.505,0.83,1,GO:0043542,BP,,5392
regulation of T cell migration,19,0.514,0.83,1,GO:2000404,BP,,5393
visual perception,162,0.505,0.83,1,GO:0007601,BP,,5394
cobalamin metabolic process,16,0.515,0.831,1,GO:0009235,BP,,5395
regulation of phosphatase activity,102,0.506,0.831,1,GO:0010921,BP,,5396
ruffle assembly,28,0.488,0.831,1,GO:0097178,BP,,5397
vitamin D receptor binding,14,0.516,0.831,1,GO:0042809,MF,,5398
chronic inflammatory response,17,0.485,0.831,1,GO:0002544,BP,,5399
somatic diversification of immune receptors via germline recombination within a single locus,41,0.51,0.831,1,"GO:0002562,GO:0016444",BP,somatic cell DNA recombination,5400
microbody part,82,0.507,0.831,1,"GO:0044438,GO:0044439",CC,peroxisomal part,5401
positive regulation of hemopoiesis,136,0.495,0.832,1,GO:1903708,BP,,5402
nucleus localization,21,0.513,0.832,1,GO:0051647,BP,,5403
response to hexose,156,0.505,0.832,1,GO:0009746,BP,,5404
"regulation of synaptic transmission, GABAergic",29,0.511,0.832,1,GO:0032228,BP,,5405
protein kinase A binding,42,0.491,0.832,1,GO:0051018,MF,,5406
regulation of epithelial cell differentiation involved in kidney development,16,0.485,0.832,1,GO:2000696,BP,,5407
skeletal muscle tissue regeneration,27,0.512,0.832,1,GO:0043403,BP,,5408
water transport,13,0.517,0.833,1,GO:0006833,BP,,5409
protein serine/threonine phosphatase complex,45,0.509,0.833,1,"GO:0008287,GO:1903293",CC,phosphatase complex,5410
cellular response to heat,99,0.506,0.833,1,GO:0034605,BP,,5411
myeloid leukocyte cytokine production,21,0.487,0.834,1,GO:0061082,BP,,5412
positive regulation of dendritic spine development,35,0.51,0.834,1,GO:0060999,BP,,5413
peptidyl-serine dephosphorylation,12,0.518,0.834,1,GO:0070262,BP,,5414
positive regulation of blood coagulation,19,0.486,0.834,1,"GO:0030194,GO:1900048",BP,positive regulation of hemostasis,5415
neutral lipid catabolic process,28,0.489,0.834,1,"GO:0046461,GO:0046464",BP,acylglycerol catabolic process,5416
metanephros morphogenesis,31,0.511,0.835,1,GO:0003338,BP,,5417
mature B cell differentiation,19,0.514,0.835,1,GO:0002335,BP,,5418
negative regulation of gluconeogenesis,11,0.482,0.835,1,GO:0045721,BP,,5419
L-amino acid transport,57,0.508,0.835,1,GO:0015807,BP,,5420
nucleoside-diphosphatase activity,10,0.481,0.835,1,GO:0017110,MF,,5421
phospholipid transporter activity,44,0.509,0.835,1,GO:0005548,MF,,5422
negative T cell selection,11,0.482,0.835,1,GO:0043383,BP,,5423
induction of positive chemotaxis,11,0.518,0.835,1,GO:0050930,BP,,5424
G2 DNA damage checkpoint,32,0.511,0.836,1,GO:0031572,BP,,5425
positive regulation of protein targeting to membrane,28,0.489,0.836,1,GO:0090314,BP,,5426
vascular smooth muscle cell differentiation,16,0.485,0.836,1,GO:0035886,BP,,5427
spinal cord patterning,20,0.513,0.836,1,GO:0021511,BP,,5428
regulation of cell aging,31,0.489,0.837,1,GO:0090342,BP,,5429
translesion synthesis,39,0.491,0.838,1,GO:0019985,BP,,5430
positive regulation of vacuole organization,17,0.514,0.838,1,GO:0044090,BP,,5431
sulfur amino acid metabolic process,35,0.51,0.838,1,GO:0000096,BP,,5432
circadian sleep/wake cycle,23,0.512,0.838,1,GO:0042745,BP,,5433
DNA-(apurinic or apyrimidinic site) lyase activity,11,0.482,0.838,1,GO:0003906,MF,,5434
peptidase activator activity involved in apoptotic process,19,0.487,0.84,1,GO:0016505,MF,,5435
regulation of natural killer cell mediated immunity,27,0.511,0.84,1,GO:0002715,BP,,5436
cellular response to vascular endothelial growth factor stimulus,35,0.49,0.84,1,GO:0035924,BP,,5437
regulation of sodium ion transmembrane transporter activity,44,0.491,0.84,1,GO:2000649,BP,,5438
regulation of histone H3-K4 methylation,21,0.487,0.84,1,GO:0051569,BP,,5439
voltage-gated calcium channel complex,38,0.509,0.84,1,GO:0005891,CC,,5440
high voltage-gated calcium channel activity,12,0.483,0.84,1,GO:0008331,MF,,5441
positive regulation of activated T cell proliferation,19,0.513,0.84,1,GO:0042104,BP,,5442
lysine catabolic process,12,0.483,0.84,1,GO:0006554,BP,,5443
ciliary basal body docking,90,0.494,0.841,1,GO:0097711,BP,,5444
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,19,0.487,0.841,1,GO:1902254,BP,,5445
"regulation of Wnt signaling pathway, planar cell polarity pathway",12,0.517,0.841,1,GO:2000095,BP,,5446
inositol phosphate-mediated signaling,31,0.49,0.842,1,GO:0048016,BP,,5447
metanephric glomerulus development,16,0.514,0.842,1,GO:0072224,BP,,5448
axolemma,16,0.514,0.842,1,GO:0030673,CC,,5449
negative regulation of epidermis development,13,0.516,0.842,1,GO:0045683,BP,,5450
regulation of transcription from RNA polymerase III promoter,24,0.512,0.843,1,GO:0006359,BP,,5451
response to purine-containing compound,130,0.495,0.843,1,GO:0014074,BP,,5452
lactation,36,0.51,0.843,1,GO:0007595,BP,,5453
positive regulation of interferon-beta production,26,0.489,0.843,1,GO:0032728,BP,,5454
CDP-diacylglycerol metabolic process,14,0.515,0.843,1,GO:0046341,BP,,5455
positive regulation of protein maturation,20,0.487,0.843,1,GO:1903319,BP,,5456
regulation of lipoprotein metabolic process,14,0.515,0.843,1,GO:0050746,BP,,5457
positive regulation of heart growth,28,0.489,0.843,1,GO:0060421,BP,,5458
endodermal cell differentiation,40,0.509,0.843,1,GO:0035987,BP,,5459
positive regulation of striated muscle contraction,13,0.484,0.843,1,GO:0045989,BP,,5460
regulation of nitric oxide biosynthetic process,43,0.509,0.843,1,GO:0045428,BP,,5461
negative regulation of mRNA metabolic process,32,0.49,0.844,1,GO:1903312,BP,,5462
protein phosphatase type 2A complex,20,0.513,0.844,1,GO:0000159,CC,,5463
H4 histone acetyltransferase complex,33,0.51,0.844,1,GO:1902562,CC,,5464
double-stranded RNA binding,55,0.508,0.844,1,GO:0003725,MF,,5465
dystrophin-associated glycoprotein complex,21,0.488,0.845,1,"GO:0016010,GO:0090665",CC,glycoprotein complex,5466
labyrinthine layer development,41,0.491,0.845,1,GO:0060711,BP,,5467
relaxation of muscle,27,0.511,0.846,1,GO:0090075,BP,,5468
negative regulation of transcription from RNA polymerase II promoter in response to stress,13,0.484,0.846,1,GO:0097201,BP,,5469
response to organophosphorus,116,0.495,0.846,1,GO:0046683,BP,,5470
regulation of activin receptor signaling pathway,19,0.513,0.846,1,GO:0032925,BP,,5471
"transcription factor activity, transcription factor recruiting",12,0.516,0.846,1,GO:0001134,MF,,5472
intraciliary transport particle,29,0.49,0.846,1,GO:0030990,CC,,5473
bone development,155,0.505,0.846,1,GO:0060348,BP,,5474
cell-cell recognition,47,0.508,0.846,1,GO:0009988,BP,,5475
positive regulation of steroid biosynthetic process,13,0.515,0.847,1,GO:0010893,BP,,5476
regulation of lipid storage,38,0.491,0.847,1,GO:0010883,BP,,5477
nucleoside salvage,16,0.514,0.847,1,GO:0043174,BP,,5478
cell differentiation in hindbrain,18,0.487,0.847,1,GO:0021533,BP,,5479
"transferase activity, transferring amino-acyl groups",18,0.513,0.848,1,GO:0016755,MF,,5480
acetylcholine-gated cation-selective channel activity,13,0.485,0.848,1,GO:0022848,MF,,5481
negative regulation of necrotic cell death,12,0.516,0.848,1,GO:0060547,BP,,5482
bone remodeling,61,0.493,0.848,1,GO:0046849,BP,,5483
chromosome separation,60,0.493,0.848,1,GO:0051304,BP,,5484
eye morphogenesis,123,0.505,0.849,1,GO:0048592,BP,,5485
pyridine-containing compound biosynthetic process,31,0.51,0.849,1,GO:0072525,BP,,5486
regulation of protein oligomerization,30,0.51,0.849,1,GO:0032459,BP,,5487
amelogenesis,18,0.513,0.849,1,GO:0097186,BP,,5488
positive regulation of type 2 immune response,12,0.484,0.849,1,GO:0002830,BP,,5489
negative regulation of neurotransmitter transport,15,0.514,0.849,1,GO:0051589,BP,,5490
positive regulation of supramolecular fiber organization,150,0.495,0.849,1,GO:1902905,BP,,5491
placenta blood vessel development,28,0.51,0.849,1,GO:0060674,BP,,5492
regulation of osteoclast differentiation,49,0.508,0.851,1,GO:0045670,BP,,5493
dorsal/ventral axis specification,15,0.514,0.851,1,GO:0009950,BP,,5494
tongue development,18,0.513,0.851,1,GO:0043586,BP,,5495
response to folic acid,11,0.484,0.851,1,GO:0051593,BP,,5496
entrainment of circadian clock,24,0.511,0.851,1,GO:0009649,BP,,5497
chromatin-mediated maintenance of transcription,10,0.483,0.851,1,GO:0048096,BP,,5498
regulation of acetyl-CoA biosynthetic process from pyruvate,12,0.516,0.852,1,GO:0010510,BP,,5499
oligodendrocyte differentiation,77,0.506,0.852,1,GO:0048709,BP,,5500
negative regulation of dephosphorylation,77,0.494,0.852,1,GO:0035305,BP,,5501
positive regulation of smoothened signaling pathway,23,0.511,0.852,1,GO:0045880,BP,,5502
asymmetric cell division,16,0.487,0.852,1,GO:0008356,BP,,5503
"preribosome, large subunit precursor",17,0.513,0.853,1,GO:0030687,CC,,5504
tyrosine phosphorylation of STAT protein,48,0.492,0.853,1,GO:0007260,BP,,5505
FMN binding,12,0.485,0.853,1,GO:0010181,MF,,5506
regulation of carbohydrate metabolic process,126,0.505,0.854,1,GO:0006109,BP,,5507
intracellular lipid transport,30,0.51,0.854,1,GO:0032365,BP,,5508
paraxial mesoderm development,17,0.487,0.854,1,GO:0048339,BP,,5509
detection of temperature stimulus,18,0.513,0.854,1,GO:0016048,BP,,5510
negative regulation of telomere maintenance via telomerase,15,0.514,0.854,1,GO:0032211,BP,,5511
transcription export complex,13,0.515,0.855,1,GO:0000346,CC,,5512
negative regulation of B cell proliferation,11,0.484,0.855,1,GO:0030889,BP,,5513
negative regulation of digestive system process,10,0.483,0.855,1,GO:0060457,BP,,5514
regulation of striated muscle contraction,75,0.494,0.855,1,GO:0006942,BP,,5515
regulation of T-helper 2 cell differentiation,10,0.483,0.855,1,GO:0045628,BP,,5516
regulation of interleukin-6 biosynthetic process,14,0.486,0.855,1,GO:0045408,BP,,5517
negative regulation of cell adhesion,195,0.496,0.855,1,GO:0007162,BP,,5518
negative regulation of translational initiation,20,0.512,0.856,1,GO:0045947,BP,,5519
T cell homeostasis,33,0.509,0.856,1,GO:0043029,BP,,5520
DNA replication initiation,37,0.491,0.856,1,GO:0006270,BP,,5521
pre-autophagosomal structure,25,0.51,0.856,1,GO:0000407,CC,,5522
positive regulation of proteasomal ubiquitin-dependent protein catabolic process,73,0.506,0.856,1,GO:0032436,BP,,5523
response to salt,11,0.516,0.856,1,GO:1902074,BP,,5524
negative regulation of chemokine production,12,0.515,0.857,1,GO:0032682,BP,,5525
centrosome separation,14,0.486,0.857,1,GO:0051299,BP,,5526
negative regulation of cell cycle arrest,21,0.511,0.857,1,GO:0071157,BP,,5527
protein targeting to peroxisome,13,0.486,0.857,1,"GO:0006625,GO:0072662,GO:0072663",BP,"protein localization to peroxisome,establishment of protein localization to peroxisome",5528
positive regulation of protein tyrosine kinase activity,36,0.509,0.857,1,GO:0061098,BP,,5529
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,15,0.487,0.858,1,GO:1902043,BP,,5530
ciliary membrane,59,0.493,0.858,1,GO:0060170,CC,,5531
establishment of nucleus localization,13,0.514,0.859,1,GO:0040023,BP,,5532
regulation of response to tumor cell,11,0.485,0.859,1,"GO:0002834,GO:0002837,GO:2000780",BP,"regulation of immune response to tumor cell,negative regulation of double-strand break repair",5533
maintenance of gastrointestinal epithelium,12,0.485,0.859,1,GO:0030277,BP,,5534
regulation of myelination,29,0.51,0.859,1,GO:0031641,BP,,5535
ganglion development,11,0.515,0.859,1,GO:0061548,BP,,5536
cytoplasmic pattern recognition receptor signaling pathway in response to virus,20,0.489,0.86,1,GO:0039528,BP,,5537
exit from mitosis,27,0.51,0.86,1,GO:0010458,BP,,5538
negative regulation of protein oligomerization,12,0.515,0.86,1,GO:0032460,BP,,5539
prostaglandin biosynthetic process,21,0.489,0.86,1,"GO:0001516,GO:0046457",BP,prostanoid biosynthetic process,5540
DNA replication factor A complex,14,0.486,0.86,1,GO:0005662,CC,,5541
endoplasmic reticulum-Golgi intermediate compartment membrane,52,0.507,0.86,1,GO:0033116,CC,,5542
cerebral cortex development,102,0.495,0.861,1,GO:0021987,BP,,5543
convergent extension,15,0.513,0.861,1,GO:0060026,BP,,5544
DNA repair complex,35,0.509,0.861,1,GO:1990391,CC,,5545
determination of bilateral symmetry,112,0.505,0.861,1,GO:0009855,BP,,5546
nucleotide-excision repair complex,13,0.514,0.861,1,GO:0000109,CC,,5547
nuclear transcription factor complex,118,0.495,0.862,1,GO:0044798,CC,,5548
positive regulation of cardiac muscle tissue development,34,0.509,0.862,1,GO:0055025,BP,,5549
regulation of macrophage differentiation,17,0.512,0.862,1,GO:0045649,BP,,5550
sperm motility,63,0.494,0.863,1,GO:0097722,BP,,5551
negative regulation of interleukin-8 production,15,0.487,0.863,1,GO:0032717,BP,,5552
trabecula morphogenesis,44,0.492,0.863,1,GO:0061383,BP,,5553
dendritic spine development,79,0.494,0.863,1,GO:0060996,BP,,5554
multi-multicellular organism process,170,0.496,0.863,1,GO:0044706,BP,,5555
organic hydroxy compound transport,178,0.496,0.863,1,GO:0015850,BP,,5556
single-stranded telomeric DNA binding,10,0.484,0.863,1,"GO:0043047,GO:0098847",MF,sequence-specific single stranded DNA binding,5557
regulation of dendritic spine development,58,0.493,0.863,1,GO:0060998,BP,,5558
regulation of fatty acid biosynthetic process,30,0.509,0.863,1,GO:0042304,BP,,5559
methyltransferase complex,75,0.506,0.864,1,GO:0034708,CC,,5560
gamma-delta T cell activation,12,0.486,0.864,1,GO:0046629,BP,,5561
substrate-independent telencephalic tangential migration,10,0.484,0.864,1,"GO:0021826,GO:0021843",BP,substrate-independent telencephalic tangential interneuron migration,5562
acute-phase response,30,0.491,0.865,1,GO:0006953,BP,,5563
protein tyrosine kinase activator activity,16,0.488,0.865,1,GO:0030296,MF,,5564
negative regulation of leukocyte mediated immunity,37,0.492,0.865,1,GO:0002704,BP,,5565
cluster of actin-based cell projections,113,0.505,0.865,1,GO:0098862,CC,,5566
microtubule associated complex,127,0.496,0.865,1,GO:0005875,CC,,5567
smoothened signaling pathway involved in dorsal/ventral neural tube patterning,14,0.513,0.865,1,GO:0060831,BP,,5568
cell migration involved in sprouting angiogenesis,31,0.491,0.865,1,GO:0002042,BP,,5569
voltage-gated sodium channel complex,13,0.514,0.865,1,GO:0001518,CC,,5570
intracellular sterol transport,17,0.512,0.865,1,"GO:0032366,GO:0032367",BP,intracellular cholesterol transport,5571
positive regulation of intracellular steroid hormone receptor signaling pathway,14,0.513,0.865,1,GO:0033145,BP,,5572
regulation of alpha-beta T cell differentiation,39,0.492,0.866,1,GO:0046637,BP,,5573
tissue remodeling,124,0.496,0.866,1,GO:0048771,BP,,5574
MAP kinase tyrosine/serine/threonine phosphatase activity,12,0.514,0.866,1,GO:0017017,MF,,5575
respiratory chain complex IV,11,0.515,0.866,1,GO:0045277,CC,,5576
copulation,17,0.488,0.867,1,GO:0007620,BP,,5577
ovulation cycle,90,0.495,0.867,1,GO:0042698,BP,,5578
maternal process involved in female pregnancy,51,0.493,0.867,1,GO:0060135,BP,,5579
T cell differentiation in thymus,61,0.506,0.867,1,GO:0033077,BP,,5580
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,13,0.513,0.868,1,GO:2001241,BP,,5581
cardiac muscle tissue development,163,0.504,0.868,1,GO:0048738,BP,,5582
interferon-beta production,43,0.507,0.868,1,GO:0032608,BP,,5583
regulation of myeloid cell apoptotic process,21,0.51,0.869,1,GO:0033032,BP,,5584
histone phosphorylation,32,0.492,0.869,1,GO:0016572,BP,,5585
nuclear inclusion body,10,0.485,0.869,1,GO:0042405,CC,,5586
fat cell differentiation,184,0.496,0.869,1,GO:0045444,BP,,5587
"regulation of CD4-positive, alpha-beta T cell differentiation",25,0.491,0.87,1,GO:0043370,BP,,5588
erythrocyte homeostasis,88,0.505,0.87,1,GO:0034101,BP,,5589
regulation of systemic arterial blood pressure mediated by a chemical signal,36,0.508,0.87,1,GO:0003044,BP,,5590
regulation of polysaccharide biosynthetic process,30,0.509,0.87,1,GO:0032885,BP,,5591
regulation of extrinsic apoptotic signaling pathway via death domain receptors,47,0.493,0.87,1,GO:1902041,BP,,5592
positive regulation of cellular extravasation,10,0.485,0.87,1,GO:0002693,BP,,5593
lipid particle,64,0.506,0.87,1,GO:0005811,CC,,5594
sulfur amino acid biosynthetic process,16,0.488,0.87,1,GO:0000097,BP,,5595
glycosylceramide metabolic process,14,0.487,0.87,1,GO:0006677,BP,,5596
response to low-density lipoprotein particle,15,0.488,0.87,1,GO:0055098,BP,,5597
negative regulation of cell growth,147,0.496,0.871,1,GO:0030308,BP,,5598
membrane raft organization,23,0.49,0.871,1,GO:0031579,BP,,5599
negative regulation of immune effector process,84,0.505,0.871,1,GO:0002698,BP,,5600
positive regulation of biomineral tissue development,34,0.492,0.871,1,GO:0070169,BP,,5601
gap junction,25,0.509,0.871,1,GO:0005921,CC,,5602
positive regulation of leukocyte degranulation,13,0.487,0.871,1,GO:0043302,BP,,5603
regulation of cytokine biosynthetic process,74,0.505,0.871,1,GO:0042035,BP,,5604
UMP biosynthetic process,10,0.485,0.872,1,"GO:0006222,GO:0009173,GO:0009174,GO:0046049",BP,"pyrimidine ribonucleoside monophosphate metabolic process,pyrimidine ribonucleoside monophosphate biosynthetic process,UMP metabolic process",5605
positive regulation of muscle cell differentiation,79,0.495,0.872,1,GO:0051149,BP,,5606
TOR signaling,92,0.505,0.872,1,GO:0031929,BP,,5607
"chromosome, centromeric region",157,0.504,0.872,1,GO:0000775,CC,,5608
fibroblast growth factor receptor signaling pathway,96,0.495,0.872,1,GO:0008543,BP,,5609
spindle checkpoint,31,0.508,0.872,1,GO:0031577,BP,,5610
suckling behavior,11,0.514,0.872,1,GO:0001967,BP,,5611
cardiac chamber morphogenesis,105,0.495,0.872,1,GO:0003206,BP,,5612
establishment of protein localization to plasma membrane,129,0.504,0.872,1,GO:0090002,BP,,5613
transport of virus,64,0.506,0.872,1,GO:0046794,BP,,5614
"chromosome, telomeric region",132,0.496,0.873,1,GO:0000781,CC,,5615
positive regulation of gene silencing by miRNA,20,0.49,0.873,1,GO:2000637,BP,,5616
voltage-gated calcium channel activity,39,0.493,0.873,1,GO:0005245,MF,,5617
regulation of alpha-beta T cell activation,58,0.506,0.873,1,GO:0046634,BP,,5618
vasodilation,29,0.491,0.874,1,GO:0042311,BP,,5619
positive regulation of meiotic cell cycle,10,0.515,0.874,1,GO:0051446,BP,,5620
vascular endothelial growth factor signaling pathway,23,0.51,0.874,1,GO:0038084,BP,,5621
A band,36,0.508,0.874,1,GO:0031672,CC,,5622
cochlea morphogenesis,20,0.49,0.875,1,GO:0090103,BP,,5623
digestion,109,0.504,0.875,1,GO:0007586,BP,,5624
catalytic step 2 spliceosome,84,0.505,0.875,1,GO:0071013,CC,,5625
adenyl-nucleotide exchange factor activity,10,0.514,0.876,1,GO:0000774,MF,,5626
cellular response to insulin stimulus,183,0.497,0.876,1,GO:0032869,BP,,5627
negative regulation of alpha-beta T cell differentiation,13,0.513,0.876,1,GO:0046639,BP,,5628
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,19,0.51,0.876,1,GO:2001267,BP,,5629
regulation of heterotypic cell-cell adhesion,15,0.488,0.877,1,GO:0034114,BP,,5630
cellular extravasation,40,0.493,0.877,1,GO:0045123,BP,,5631
ATP transport,10,0.514,0.877,1,GO:0015867,BP,,5632
calcium-dependent protein serine/threonine kinase activity,11,0.487,0.877,1,GO:0009931,MF,,5633
protein localization to cilium,30,0.492,0.878,1,GO:0061512,BP,,5634
mannosidase activity,14,0.512,0.878,1,GO:0015923,MF,,5635
cellular response to X-ray,10,0.514,0.878,1,GO:0071481,BP,,5636
modification of morphology or physiology of other organism involved in symbiotic interaction,73,0.495,0.879,1,GO:0051817,BP,,5637
regulation of acrosome reaction,12,0.513,0.879,1,GO:0060046,BP,,5638
superoxide anion generation,21,0.49,0.879,1,GO:0042554,BP,,5639
negative regulation of hemopoiesis,101,0.504,0.879,1,GO:1903707,BP,,5640
Rab GTPase binding,125,0.496,0.879,1,GO:0017137,MF,,5641
"guanylate cyclase complex, soluble",15,0.489,0.88,1,"GO:0008074,GO:0004383",CC,guanylate cyclase activity,5642
N-methyltransferase activity,76,0.495,0.88,1,GO:0008170,MF,,5643
regulation of polysaccharide metabolic process,32,0.492,0.88,1,GO:0032881,BP,,5644
cellular component assembly involved in morphogenesis,85,0.505,0.88,1,GO:0010927,BP,,5645
stem cell population maintenance,132,0.504,0.881,1,GO:0019827,BP,,5646
condensed chromosome outer kinetochore,10,0.514,0.882,1,GO:0000940,CC,,5647
cap-independent translational initiation,14,0.511,0.882,1,GO:0002190,BP,,5648
cardiac ventricle development,101,0.504,0.882,1,GO:0003231,BP,,5649
chemoattractant activity,24,0.491,0.882,1,GO:0042056,MF,,5650
negative regulation of lipid biosynthetic process,37,0.507,0.883,1,GO:0051055,BP,,5651
regulation of axonogenesis,147,0.504,0.883,1,GO:0050770,BP,,5652
positive regulation of epidermal growth factor receptor signaling pathway,32,0.508,0.883,1,GO:0045742,BP,,5653
arachidonic acid metabolic process,40,0.493,0.883,1,GO:0019369,BP,,5654
interferon-gamma secretion,12,0.488,0.884,1,GO:0072643,BP,,5655
midbody,138,0.504,0.885,1,GO:0030496,CC,,5656
positive regulation of neurological system process,17,0.49,0.885,1,GO:0031646,BP,,5657
negative regulation of blood vessel morphogenesis,64,0.505,0.885,1,GO:2000181,BP,,5658
cellular response to monoamine stimulus,33,0.493,0.885,1,"GO:0071868,GO:0071870",BP,cellular response to catecholamine stimulus,5659
organic cation transport,20,0.491,0.886,1,GO:0015695,BP,,5660
T cell selection,31,0.493,0.886,1,GO:0045058,BP,,5661
histone H3-K4 methylation,42,0.494,0.886,1,GO:0051568,BP,,5662
positive regulation of steroid metabolic process,18,0.51,0.886,1,GO:0045940,BP,,5663
sodium:proton antiporter activity,12,0.512,0.886,1,GO:0015385,MF,,5664
insulin secretion,169,0.503,0.887,1,GO:0030073,BP,,5665
response to interleukin-4,30,0.492,0.887,1,GO:0070670,BP,,5666
epidermal growth factor receptor binding,28,0.508,0.887,1,GO:0005154,MF,,5667
regulation of hematopoietic progenitor cell differentiation,15,0.511,0.887,1,GO:1901532,BP,,5668
glandular epithelial cell development,24,0.492,0.887,1,GO:0002068,BP,,5669
macrophage differentiation,30,0.493,0.888,1,GO:0030225,BP,,5670
ciliary base,26,0.492,0.888,1,GO:0097546,CC,,5671
translation regulator activity,33,0.493,0.888,1,GO:0045182,MF,,5672
G-protein activated inward rectifier potassium channel activity,10,0.513,0.888,1,GO:0015467,MF,,5673
negative regulation of Rho protein signal transduction,16,0.51,0.889,1,GO:0035024,BP,,5674
positive regulation of interleukin-12 production,26,0.508,0.889,1,"GO:0032735,GO:0046039",BP,GTP metabolic process,5675
regulation of gliogenesis,82,0.504,0.89,1,GO:0014013,BP,,5676
cardiac left ventricle morphogenesis,12,0.512,0.89,1,GO:0003214,BP,,5677
response to retinoic acid,97,0.496,0.89,1,GO:0032526,BP,,5678
type B pancreatic cell development,19,0.509,0.89,1,GO:0003323,BP,,5679
negative regulation of telomere maintenance via telomere lengthening,21,0.509,0.89,1,GO:1904357,BP,,5680
negative regulation of neurological system process,12,0.489,0.89,1,GO:0031645,BP,,5681
regulation of RNA binding,10,0.513,0.89,1,GO:1905214,BP,,5682
positive regulation of ATPase activity,40,0.494,0.891,1,GO:0032781,BP,,5683
spliceosomal complex assembly,48,0.494,0.891,1,GO:0000245,BP,,5684
negative regulation of tissue remodeling,17,0.49,0.891,1,GO:0034104,BP,,5685
purine ribonucleoside bisphosphate metabolic process,14,0.489,0.892,1,"GO:0034035,GO:0050427",BP,3'-phosphoadenosine 5'-phosphosulfate metabolic process,5686
smooth muscle cell proliferation,104,0.504,0.892,1,GO:0048659,BP,,5687
regulation of NF-kappaB import into nucleus,39,0.506,0.892,1,"GO:0042345,GO:0042348",BP,NF-kappaB import into nucleus,5688
protein kinase C activity,16,0.51,0.892,1,GO:0004697,MF,,5689
"nuclear chromosome, telomeric region",98,0.496,0.892,1,GO:0000784,CC,,5690
bone resorption,42,0.494,0.892,1,GO:0045453,BP,,5691
regulation of cell projection assembly,136,0.503,0.893,1,GO:0060491,BP,,5692
C-acyltransferase activity,16,0.49,0.893,1,GO:0016408,MF,,5693
carbohydrate transmembrane transport,19,0.509,0.893,1,GO:0034219,BP,,5694
regulation of protein glycosylation,17,0.491,0.893,1,GO:0060049,BP,,5695
pyridine-containing compound metabolic process,126,0.497,0.893,1,GO:0072524,BP,,5696
cellular response to epinephrine stimulus,13,0.489,0.893,1,GO:0071872,BP,,5697
regulation of action potential,43,0.506,0.894,1,GO:0098900,BP,,5698
cell proliferation in forebrain,25,0.508,0.895,1,GO:0021846,BP,,5699
positive regulation of myotube differentiation,24,0.508,0.895,1,GO:0010831,BP,,5700
toll-like receptor 9 signaling pathway,16,0.49,0.895,1,GO:0034162,BP,,5701
isoprenoid binding,25,0.492,0.895,1,GO:0019840,MF,,5702
integrator complex,12,0.511,0.895,1,GO:0032039,CC,,5703
carnitine shuttle,11,0.511,0.896,1,GO:0006853,BP,,5704
sialylation,20,0.492,0.896,1,"GO:0097503,GO:0008373",BP,sialyltransferase activity,5705
cellular monovalent inorganic cation homeostasis,99,0.504,0.896,1,GO:0030004,BP,,5706
innervation,24,0.492,0.896,1,GO:0060384,BP,,5707
response to glucocorticoid,118,0.503,0.896,1,GO:0051384,BP,,5708
sperm-egg recognition,31,0.493,0.896,1,GO:0035036,BP,,5709
negative regulation of cytokine-mediated signaling pathway,30,0.507,0.896,1,GO:0001960,BP,,5710
regulation of cardiocyte differentiation,32,0.493,0.897,1,GO:1905207,BP,,5711
"phosphatidylinositol-3,4,5-trisphosphate binding",31,0.493,0.897,1,GO:0005547,MF,,5712
positive regulation of B cell mediated immunity,23,0.492,0.897,1,"GO:0002714,GO:0002891",BP,positive regulation of immunoglobulin mediated immune response,5713
anchored component of external side of plasma membrane,21,0.492,0.897,1,GO:0031362,CC,,5714
positive regulation of non-canonical Wnt signaling pathway,10,0.488,0.897,1,GO:2000052,BP,,5715
regulation of B cell differentiation,22,0.492,0.897,1,GO:0045577,BP,,5716
intramolecular oxidoreductase activity,43,0.494,0.898,1,GO:0016860,MF,,5717
multi-organism cellular localization,62,0.495,0.898,1,"GO:1902581,GO:1902583",BP,multi-organism intracellular transport,5718
membrane depolarization during action potential,45,0.494,0.898,1,GO:0086010,BP,,5719
cell communication involved in cardiac conduction,51,0.495,0.898,1,GO:0086065,BP,,5720
protein transport along microtubule,47,0.495,0.898,1,"GO:0098840,GO:0099118",BP,microtubule-based protein transport,5721
smoothened signaling pathway,112,0.504,0.898,1,GO:0007224,BP,,5722
positive regulation of cartilage development,26,0.493,0.898,1,GO:0061036,BP,,5723
"ligase activity, forming carbon-nitrogen bonds",47,0.495,0.899,1,GO:0016879,MF,,5724
pericentric heterochromatin,17,0.509,0.899,1,GO:0005721,CC,,5725
base-excision repair,32,0.494,0.899,1,GO:0006284,BP,,5726
mesenchymal cell development,56,0.495,0.899,1,GO:0014031,BP,,5727
mitotic spindle assembly checkpoint,24,0.493,0.9,1,GO:0007094,BP,,5728
membrane lipid catabolic process,19,0.508,0.9,1,GO:0046466,BP,,5729
lipoprotein biosynthetic process,123,0.497,0.9,1,GO:0042158,BP,,5730
ARF protein signal transduction,16,0.491,0.9,1,"GO:0032011,GO:0032012",BP,regulation of ARF protein signal transduction,5731
positive regulation of DNA-dependent DNA replication,14,0.51,0.9,1,GO:2000105,BP,,5732
thyroid hormone metabolic process,15,0.509,0.9,1,GO:0042403,BP,,5733
regulation of extrinsic apoptotic signaling pathway in absence of ligand,40,0.506,0.9,1,GO:2001239,BP,,5734
glycolipid biosynthetic process,46,0.505,0.9,1,GO:0009247,BP,,5735
positive regulation of axon extension,38,0.494,0.9,1,GO:0045773,BP,,5736
DNA geometric change,73,0.496,0.901,1,GO:0032392,BP,,5737
histone H2A acetylation,14,0.51,0.901,1,GO:0043968,BP,,5738
positive regulation of macroautophagy,52,0.495,0.901,1,GO:0016239,BP,,5739
regulation of establishment of planar polarity involved in neural tube closure,13,0.51,0.901,1,GO:0090178,BP,,5740
regulation of membrane depolarization,40,0.494,0.901,1,GO:0003254,BP,,5741
modification of morphology or physiology of other organism,82,0.504,0.902,1,GO:0035821,BP,,5742
response to corticosteroid,134,0.497,0.902,1,GO:0031960,BP,,5743
cell maturation,130,0.497,0.902,1,GO:0048469,BP,,5744
peptidyl-cysteine modification,26,0.507,0.902,1,GO:0018198,BP,,5745
positive regulation of triglyceride metabolic process,13,0.51,0.902,1,GO:0090208,BP,,5746
hematopoietic progenitor cell differentiation,78,0.504,0.903,1,GO:0002244,BP,,5747
transcription from RNA polymerase I promoter,54,0.505,0.903,1,GO:0006360,BP,,5748
planar cell polarity pathway involved in neural tube closure,12,0.49,0.903,1,GO:0090179,BP,,5749
resolution of meiotic recombination intermediates,12,0.51,0.903,1,GO:0000712,BP,,5750
deacetylase activity,49,0.495,0.904,1,GO:0019213,MF,,5751
monovalent inorganic cation homeostasis,128,0.497,0.904,1,GO:0055067,BP,,5752
male germ cell nucleus,12,0.51,0.904,1,GO:0001673,CC,,5753
sodium channel complex,18,0.492,0.904,1,GO:0034706,CC,,5754
cellular response to virus,34,0.506,0.904,1,GO:0098586,BP,,5755
protein-cysteine S-palmitoyltransferase activity,22,0.507,0.904,1,"GO:0019706,GO:0019707",MF,protein-cysteine S-acyltransferase activity,5756
embryonic forelimb morphogenesis,24,0.493,0.904,1,GO:0035115,BP,,5757
regulation of protein deacetylation,33,0.506,0.904,1,GO:0090311,BP,,5758
"positive regulation of protein import into nucleus, translocation",10,0.489,0.905,1,GO:0033160,BP,,5759
leukocyte adhesion to vascular endothelial cell,22,0.493,0.905,1,GO:0061756,BP,,5760
regulation of cell adhesion mediated by integrin,35,0.506,0.905,1,GO:0033628,BP,,5761
regulation of T cell differentiation in thymus,22,0.493,0.905,1,GO:0033081,BP,,5762
regulation of dendritic spine morphogenesis,33,0.506,0.905,1,GO:0061001,BP,,5763
oligosaccharide catabolic process,10,0.511,0.905,1,GO:0009313,BP,,5764
epithelial cell differentiation involved in kidney development,42,0.505,0.905,1,GO:0035850,BP,,5765
positive regulation of peptidyl-tyrosine phosphorylation,129,0.497,0.906,1,GO:0050731,BP,,5766
blastocyst formation,25,0.507,0.906,1,GO:0001825,BP,,5767
positive regulation of long-term synaptic potentiation,11,0.49,0.906,1,GO:1900273,BP,,5768
positive regulation of epidermis development,30,0.506,0.906,1,GO:0045684,BP,,5769
ventricular cardiac muscle cell development,11,0.49,0.906,1,GO:0055015,BP,,5770
interleukin-13 production,14,0.509,0.906,1,GO:0032616,BP,,5771
RNA polymerase II transcription coactivator activity,32,0.506,0.906,1,GO:0001105,MF,,5772
regulation of stem cell proliferation,53,0.505,0.907,1,GO:0072091,BP,,5773
positive regulation of interleukin-1 beta production,26,0.493,0.907,1,GO:0032731,BP,,5774
axon regeneration,40,0.495,0.907,1,GO:0031103,BP,,5775
positive regulation of cytokine-mediated signaling pathway,28,0.494,0.908,1,GO:0001961,BP,,5776
myelin sheath,160,0.503,0.908,1,GO:0043209,CC,,5777
pericardium development,18,0.508,0.908,1,GO:0060039,BP,,5778
response to nutrient,146,0.497,0.908,1,GO:0007584,BP,,5779
myoblast proliferation,12,0.49,0.908,1,GO:0051450,BP,,5780
positive regulation of ion transmembrane transport,104,0.497,0.908,1,GO:0034767,BP,,5781
alditol metabolic process,16,0.508,0.908,1,GO:0019400,BP,,5782
regulation of intrinsic apoptotic signaling pathway by p53 class mediator,23,0.507,0.909,1,GO:1902253,BP,,5783
cellular iron ion homeostasis,41,0.495,0.909,1,GO:0006879,BP,,5784
regulation of blood coagulation,69,0.496,0.909,1,"GO:0030193,GO:1900046",BP,regulation of hemostasis,5785
regulation of neuroblast proliferation,24,0.493,0.91,1,GO:1902692,BP,,5786
alpha-beta T cell activation involved in immune response,37,0.495,0.91,1,"GO:0002287,GO:0002293",BP,alpha-beta T cell differentiation involved in immune response,5787
regulation of myotube differentiation,41,0.505,0.91,1,GO:0010830,BP,,5788
negative regulation of protein localization to plasma membrane,17,0.508,0.91,1,GO:1903077,BP,,5789
regulation of stress-activated MAPK cascade,174,0.502,0.91,1,GO:0032872,BP,,5790
cytoplasmic stress granule,36,0.495,0.91,1,GO:0010494,CC,,5791
cytoplasmic sequestering of transcription factor,18,0.492,0.911,1,GO:0042994,BP,,5792
negative regulation of interferon-beta production,11,0.51,0.911,1,GO:0032688,BP,,5793
regulation of bone mineralization,58,0.496,0.911,1,GO:0030500,BP,,5794
regulation of lipoprotein particle clearance,10,0.51,0.911,1,GO:0010984,BP,,5795
negative regulation of hormone secretion,56,0.496,0.912,1,GO:0046888,BP,,5796
negative regulation of endothelial cell proliferation,27,0.506,0.912,1,GO:0001937,BP,,5797
cellular response to nerve growth factor stimulus,40,0.505,0.912,1,GO:1990090,BP,,5798
JNK cascade,167,0.498,0.912,1,GO:0007254,BP,,5799
acylglycerol homeostasis,24,0.506,0.913,1,"GO:0055090,GO:0070328",BP,triglyceride homeostasis,5800
neural crest cell differentiation,59,0.504,0.913,1,GO:0014033,BP,,5801
acetyl-CoA metabolic process,32,0.506,0.913,1,GO:0006084,BP,,5802
histone H4-K20 methylation,10,0.51,0.913,1,GO:0034770,BP,,5803
subpallium development,21,0.507,0.913,1,GO:0021544,BP,,5804
mitotic G2/M transition checkpoint,19,0.493,0.913,1,GO:0044818,BP,,5805
glycogen catabolic process,25,0.494,0.913,1,"GO:0005980,GO:0009251,GO:0044247",BP,"glucan catabolic process,cellular polysaccharide catabolic process",5806
lymphocyte activation involved in immune response,106,0.497,0.914,1,GO:0002285,BP,,5807
potassium:proton antiporter activity,10,0.51,0.914,1,GO:0015386,MF,,5808
negative regulation of cellular carbohydrate metabolic process,32,0.494,0.914,1,GO:0010677,BP,,5809
regulation of histone deacetylation,23,0.494,0.914,1,GO:0031063,BP,,5810
negative regulation of microtubule polymerization or depolymerization,24,0.506,0.915,1,GO:0031111,BP,,5811
negative regulation of lipid metabolic process,61,0.504,0.915,1,GO:0045833,BP,,5812
regulation of fat cell differentiation,99,0.503,0.915,1,GO:0045598,BP,,5813
glutamine metabolic process,23,0.494,0.916,1,GO:0006541,BP,,5814
positive regulation of interleukin-6 secretion,15,0.492,0.916,1,GO:2000778,BP,,5815
positive regulation of viral transcription,35,0.495,0.916,1,GO:0050434,BP,,5816
regulation of steroid biosynthetic process,42,0.505,0.916,1,GO:0050810,BP,,5817
leukocyte tethering or rolling,19,0.493,0.916,1,GO:0050901,BP,,5818
ribonucleoprotein complex disassembly,12,0.509,0.916,1,GO:0032988,BP,,5819
sympathetic nervous system development,17,0.493,0.917,1,GO:0048485,BP,,5820
intermediate filament binding,10,0.51,0.917,1,GO:0019215,MF,,5821
water-soluble vitamin metabolic process,78,0.497,0.917,1,GO:0006767,BP,,5822
tyrosine phosphorylation of Stat3 protein,32,0.495,0.917,1,GO:0042503,BP,,5823
cellular response to interleukin-4,27,0.494,0.917,1,GO:0071353,BP,,5824
negative regulation of osteoblast differentiation,38,0.505,0.918,1,GO:0045668,BP,,5825
"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor",30,0.495,0.918,1,GO:0016620,MF,,5826
positive regulation of phosphatidylinositol 3-kinase activity,27,0.494,0.918,1,GO:0043552,BP,,5827
response to ether,11,0.509,0.918,1,GO:0045472,BP,,5828
positive regulation of osteoclast differentiation,17,0.493,0.918,1,GO:0045672,BP,,5829
carbon-oxygen lyase activity,59,0.496,0.919,1,GO:0016835,MF,,5830
central nervous system neuron axonogenesis,27,0.506,0.92,1,GO:0021955,BP,,5831
neurotransmitter receptor transport,14,0.492,0.92,1,GO:0099637,BP,,5832
regulation of interferon-beta production,41,0.505,0.92,1,GO:0032648,BP,,5833
calcium-activated potassium channel activity,16,0.507,0.92,1,GO:0015269,MF,,5834
activin binding,12,0.492,0.92,1,GO:0048185,MF,,5835
negative regulation of Notch signaling pathway,28,0.505,0.92,1,GO:0045746,BP,,5836
sarcolemma,112,0.497,0.921,1,GO:0042383,CC,,5837
neuromuscular junction development,40,0.505,0.921,1,GO:0007528,BP,,5838
cholesterol transporter activity,11,0.509,0.921,1,GO:0017127,MF,,5839
histone methyltransferase activity,50,0.504,0.921,1,GO:0042054,MF,,5840
import across plasma membrane,28,0.495,0.921,1,GO:0098739,BP,,5841
neural crest cell development,52,0.504,0.921,1,GO:0014032,BP,,5842
positive regulation of lymphocyte differentiation,71,0.497,0.922,1,GO:0045621,BP,,5843
sensory perception of temperature stimulus,19,0.506,0.923,1,GO:0050951,BP,,5844
interleukin-12 production,39,0.504,0.923,1,GO:0032615,BP,,5845
positive regulation of natural killer cell mediated immunity,15,0.493,0.923,1,GO:0002717,BP,,5846
B cell activation,178,0.502,0.923,1,GO:0042113,BP,,5847
interleukin-6 biosynthetic process,15,0.507,0.924,1,GO:0042226,BP,,5848
reciprocal meiotic recombination,36,0.495,0.924,1,"GO:0007131,GO:0035825",BP,reciprocal DNA recombination,5849
negative regulation of interleukin-6 production,30,0.495,0.924,1,GO:0032715,BP,,5850
regulation of proton transport,13,0.508,0.924,1,GO:0010155,BP,,5851
"2 iron, 2 sulfur cluster binding",21,0.494,0.924,1,GO:0051537,MF,,5852
maintenance of cell polarity,16,0.507,0.924,1,GO:0030011,BP,,5853
regulation of myeloid leukocyte differentiation,89,0.503,0.924,1,GO:0002761,BP,,5854
establishment of endothelial barrier,35,0.505,0.925,1,GO:0061028,BP,,5855
myeloid cell apoptotic process,23,0.506,0.925,1,GO:0033028,BP,,5856
regulation of lipid biosynthetic process,112,0.503,0.925,1,GO:0046890,BP,,5857
leukotriene biosynthetic process,15,0.507,0.925,1,GO:0019370,BP,,5858
female meiotic division,22,0.506,0.926,1,GO:0007143,BP,,5859
positive regulation of cellular amide metabolic process,106,0.503,0.926,1,GO:0034250,BP,,5860
cholesterol transport,61,0.497,0.926,1,GO:0030301,BP,,5861
ribonucleoside catabolic process,15,0.493,0.926,1,GO:0042454,BP,,5862
humoral immune response mediated by circulating immunoglobulin,37,0.504,0.926,1,GO:0002455,BP,,5863
negative regulation of response to cytokine stimulus,34,0.495,0.926,1,GO:0060761,BP,,5864
cellular response to lipoprotein particle stimulus,14,0.507,0.927,1,GO:0071402,BP,,5865
mesodermal cell fate commitment,16,0.493,0.928,1,GO:0001710,BP,,5866
negative regulation of T cell differentiation,25,0.505,0.928,1,GO:0045581,BP,,5867
positive regulation of protein localization to cell surface,11,0.492,0.928,1,GO:2000010,BP,,5868
positive regulation of antigen receptor-mediated signaling pathway,17,0.494,0.928,1,GO:0050857,BP,,5869
glycolytic process,60,0.503,0.928,1,GO:0006096,BP,,5870
regulation of cell projection size,11,0.492,0.928,1,GO:0032536,BP,,5871
"positive regulation of mRNA splicing, via spliceosome",13,0.493,0.929,1,GO:0048026,BP,,5872
positive regulation of I-kappaB kinase/NF-kappaB signaling,156,0.502,0.93,1,GO:0043123,BP,,5873
corticosteroid receptor signaling pathway,17,0.494,0.93,1,GO:0031958,BP,,5874
positive regulation of autophagosome assembly,10,0.492,0.931,1,GO:2000786,BP,,5875
calcium ion import into cell,11,0.492,0.931,1,GO:1990035,BP,,5876
positive regulation of actin nucleation,13,0.507,0.932,1,GO:0051127,BP,,5877
regulation of potassium ion transmembrane transport,62,0.497,0.932,1,GO:1901379,BP,,5878
meiotic chromosome separation,14,0.507,0.932,1,GO:0051307,BP,,5879
N-terminal protein amino acid acetylation,15,0.506,0.932,1,GO:0006474,BP,,5880
regulation of protein activation cascade,24,0.505,0.932,1,GO:2000257,BP,,5881
fibroblast growth factor binding,23,0.495,0.933,1,GO:0017134,MF,,5882
wide pore channel activity,17,0.494,0.933,1,GO:0022829,MF,,5883
iron ion homeostasis,64,0.503,0.933,1,GO:0055072,BP,,5884
protein kinase B signaling,131,0.502,0.934,1,GO:0043491,BP,,5885
icosanoid biosynthetic process,39,0.504,0.934,1,"GO:0046456,GO:1901570",BP,fatty acid derivative biosynthetic process,5886
type B pancreatic cell differentiation,20,0.505,0.934,1,GO:0003309,BP,,5887
rRNA methyltransferase activity,14,0.506,0.934,1,GO:0008649,MF,,5888
specific granule membrane,77,0.497,0.934,1,GO:0035579,CC,,5889
pyrimidine-containing compound salvage,12,0.493,0.934,1,"GO:0008655,GO:0043097",BP,pyrimidine nucleoside salvage,5890
carbohydrate homeostasis,179,0.498,0.934,1,"GO:0033500,GO:0042593",BP,glucose homeostasis,5891
bone maturation,17,0.506,0.935,1,GO:0070977,BP,,5892
plasma membrane raft,83,0.503,0.935,1,GO:0044853,CC,,5893
RNA stabilization,31,0.496,0.935,1,GO:0043489,BP,,5894
positive regulation of protein deacetylation,20,0.505,0.935,1,GO:0090312,BP,,5895
IMP metabolic process,12,0.493,0.935,1,GO:0046040,BP,,5896
clathrin-coated vesicle,164,0.498,0.936,1,GO:0030136,CC,,5897
response to calcium ion,102,0.498,0.936,1,GO:0051592,BP,,5898
regulation of phospholipase C activity,31,0.496,0.936,1,GO:1900274,BP,,5899
zymogen granule,13,0.506,0.936,1,GO:0042588,CC,,5900
regulation of cellular senescence,27,0.504,0.936,1,GO:2000772,BP,,5901
osteoblast differentiation,187,0.498,0.936,1,GO:0001649,BP,,5902
regulation of lymphocyte chemotaxis,13,0.506,0.937,1,GO:1901623,BP,,5903
regulation of bone resorption,29,0.504,0.937,1,GO:0045124,BP,,5904
branch elongation of an epithelium,16,0.506,0.937,1,GO:0060602,BP,,5905
positive regulation of coagulation,20,0.505,0.937,1,GO:0050820,BP,,5906
necroptotic process,33,0.504,0.937,1,GO:0070266,BP,,5907
gastric acid secretion,14,0.506,0.937,1,GO:0001696,BP,,5908
startle response,24,0.505,0.938,1,GO:0001964,BP,,5909
regulation of osteoblast differentiation,101,0.498,0.938,1,GO:0045667,BP,,5910
positive regulation of reactive oxygen species biosynthetic process,39,0.504,0.938,1,GO:1903428,BP,,5911
regulation of NFAT protein import into nucleus,13,0.494,0.938,1,GO:0051532,BP,,5912
myoblast migration,10,0.507,0.938,1,GO:0051451,BP,,5913
extracellular regulation of signal transduction,11,0.493,0.938,1,"GO:1900115,GO:1900116",BP,extracellular negative regulation of signal transduction,5914
organ or tissue specific immune response,17,0.495,0.938,1,GO:0002251,BP,,5915
triglyceride lipase activity,13,0.506,0.94,1,GO:0004806,MF,,5916
"regulation of protein import into nucleus, translocation",17,0.495,0.94,1,GO:0033158,BP,,5917
icosanoid transport,35,0.496,0.94,1,"GO:0071715,GO:1901571",BP,fatty acid derivative transport,5918
lipoprotein transport,12,0.506,0.94,1,"GO:0042953,GO:0044872",BP,lipoprotein localization,5919
sperm capacitation,17,0.505,0.94,1,GO:0048240,BP,,5920
basement membrane,85,0.502,0.94,1,GO:0005604,CC,,5921
spinal cord development,81,0.498,0.94,1,GO:0021510,BP,,5922
regulation of transcription involved in G1/S transition of mitotic cell cycle,23,0.505,0.94,1,GO:0000083,BP,,5923
regulation of JAK-STAT cascade,103,0.502,0.94,1,"GO:0046425,GO:1904892",BP,regulation of STAT cascade,5924
transcription coactivator binding,17,0.505,0.941,1,GO:0001223,MF,,5925
fatty acid biosynthetic process,104,0.498,0.941,1,GO:0006633,BP,,5926
potassium ion export,11,0.494,0.941,1,GO:0071435,BP,,5927
response to progesterone,36,0.496,0.941,1,GO:0032570,BP,,5928
regulation of cofactor metabolic process,47,0.503,0.941,1,"GO:0051193,GO:0051196",BP,regulation of coenzyme metabolic process,5929
DNA-dependent ATPase activity,63,0.497,0.942,1,GO:0008094,MF,,5930
acid-amino acid ligase activity,16,0.505,0.942,1,GO:0016881,MF,,5931
toxin metabolic process,10,0.507,0.942,1,GO:0009404,BP,,5932
regulation of translational initiation in response to stress,15,0.495,0.942,1,GO:0043558,BP,,5933
negative regulation of epithelial to mesenchymal transition,23,0.496,0.942,1,GO:0010719,BP,,5934
negative regulation of behavior,10,0.507,0.942,1,GO:0048521,BP,,5935
regulation of cardiac muscle hypertrophy,38,0.503,0.942,1,GO:0010611,BP,,5936
retina morphogenesis in camera-type eye,42,0.503,0.942,1,GO:0060042,BP,,5937
superoxide metabolic process,50,0.503,0.942,1,GO:0006801,BP,,5938
nucleobase biosynthetic process,15,0.505,0.942,1,GO:0046112,BP,,5939
nitric oxide biosynthetic process,54,0.497,0.942,1,GO:0006809,BP,,5940
positive regulation of smooth muscle cell proliferation,63,0.503,0.942,1,GO:0048661,BP,,5941
regulation of lymphocyte migration,29,0.504,0.942,1,GO:2000401,BP,,5942
ficolin-1-rich granule membrane,53,0.497,0.943,1,GO:0101003,CC,,5943
positive regulation of macrophage derived foam cell differentiation,11,0.494,0.943,1,GO:0010744,BP,,5944
glycosphingolipid biosynthetic process,15,0.495,0.943,1,GO:0006688,BP,,5945
regulation of response to cytokine stimulus,115,0.502,0.944,1,GO:0060759,BP,,5946
intrinsic component of external side of plasma membrane,26,0.496,0.944,1,GO:0031233,CC,,5947
positive regulation of potassium ion transmembrane transport,26,0.504,0.944,1,GO:1901381,BP,,5948
cellular metabolic compound salvage,33,0.496,0.944,1,GO:0043094,BP,,5949
heart valve formation,11,0.494,0.944,1,GO:0003188,BP,,5950
pyrimidine nucleoside biosynthetic process,32,0.504,0.944,1,GO:0046134,BP,,5951
ketone biosynthetic process,30,0.496,0.944,1,GO:0042181,BP,,5952
L-ascorbic acid metabolic process,10,0.494,0.945,1,GO:0019852,BP,,5953
forelimb morphogenesis,30,0.496,0.945,1,GO:0035136,BP,,5954
killing of cells of other organism,13,0.506,0.945,1,"GO:0031640,GO:0044364",BP,disruption of cells of other organism,5955
regulation of isotype switching,21,0.504,0.945,1,GO:0045191,BP,,5956
regulation of lymphocyte apoptotic process,45,0.497,0.945,1,GO:0070228,BP,,5957
positive regulation of reproductive process,37,0.497,0.945,1,GO:2000243,BP,,5958
regulation of renal system process,31,0.496,0.946,1,GO:0098801,BP,,5959
vacuolar transport,90,0.498,0.946,1,GO:0007034,BP,,5960
Ino80 complex,10,0.494,0.946,1,"GO:0031011,GO:0033202",CC,DNA helicase complex,5961
XY body,10,0.506,0.946,1,GO:0001741,CC,,5962
lung cell differentiation,24,0.504,0.947,1,GO:0060479,BP,,5963
neural precursor cell proliferation,121,0.498,0.947,1,GO:0061351,BP,,5964
sodium-independent organic anion transport,20,0.504,0.947,1,GO:0043252,BP,,5965
cytoplasmic microtubule organization,43,0.503,0.947,1,GO:0031122,BP,,5966
long-chain fatty acid binding,10,0.506,0.947,1,GO:0036041,MF,,5967
positive regulation of cell-substrate adhesion,98,0.498,0.948,1,GO:0010811,BP,,5968
regulation of DNA damage checkpoint,14,0.505,0.948,1,GO:2000001,BP,,5969
negative regulation of protein complex disassembly,51,0.497,0.948,1,GO:0043242,BP,,5970
chemosensory behavior,13,0.495,0.948,1,GO:0007635,BP,,5971
trachea development,17,0.495,0.949,1,GO:0060438,BP,,5972
positive regulation of monocyte chemotaxis,11,0.494,0.949,1,GO:0090026,BP,,5973
epithelial cilium movement,19,0.504,0.949,1,GO:0003351,BP,,5974
eye photoreceptor cell development,24,0.504,0.949,1,GO:0042462,BP,,5975
spermatid nucleus differentiation,13,0.495,0.95,1,GO:0007289,BP,,5976
clathrin coat of endocytic vesicle,14,0.495,0.95,1,GO:0030128,CC,,5977
defense response to virus,181,0.499,0.95,1,GO:0051607,BP,,5978
eye photoreceptor cell differentiation,34,0.503,0.95,1,GO:0001754,BP,,5979
RIG-I signaling pathway,15,0.505,0.951,1,GO:0039529,BP,,5980
mitochondrial depolarization,22,0.496,0.951,1,GO:0051882,BP,,5981
mitochondrial DNA metabolic process,17,0.496,0.951,1,GO:0032042,BP,,5982
homeostasis of number of cells within a tissue,27,0.503,0.951,1,GO:0048873,BP,,5983
positive regulation of mast cell activation involved in immune response,10,0.506,0.951,1,"GO:0033008,GO:0043306",BP,positive regulation of mast cell degranulation,5984
plasma lipoprotein particle organization,26,0.503,0.952,1,GO:0071827,BP,,5985
positive regulation of sterol transport,16,0.496,0.952,1,"GO:0032373,GO:0032376",BP,positive regulation of cholesterol transport,5986
bicarbonate transmembrane transporter activity,18,0.496,0.952,1,GO:0015106,MF,,5987
histone deubiquitination,21,0.504,0.952,1,GO:0016578,BP,,5988
response to acidic pH,18,0.496,0.952,1,GO:0010447,BP,,5989
ATP generation from ADP,61,0.498,0.952,1,GO:0006757,BP,,5990
cytoskeleton-dependent intracellular transport,135,0.498,0.952,1,GO:0030705,BP,,5991
cell migration involved in gastrulation,13,0.495,0.952,1,GO:0042074,BP,,5992
regulation of type B pancreatic cell proliferation,10,0.495,0.952,1,GO:0061469,BP,,5993
retinal metabolic process,12,0.505,0.953,1,GO:0042574,BP,,5994
aspartate family amino acid catabolic process,20,0.504,0.953,1,GO:0009068,BP,,5995
salivary gland morphogenesis,31,0.503,0.953,1,GO:0007435,BP,,5996
low-density lipoprotein particle clearance,13,0.505,0.953,1,GO:0034383,BP,,5997
ventricular cardiac muscle cell membrane repolarization,21,0.496,0.953,1,GO:0099625,BP,,5998
positive regulation of transforming growth factor beta receptor signaling pathway,23,0.497,0.954,1,"GO:0030511,GO:1903846",BP,positive regulation of cellular response to transforming growth factor beta stimulus,5999
regulation of removal of superoxide radicals,10,0.505,0.954,1,GO:2000121,BP,,6000
U12-type spliceosomal complex,22,0.504,0.954,1,GO:0005689,CC,,6001
cellular response to estrogen stimulus,11,0.495,0.954,1,GO:0071391,BP,,6002
positive regulation of DNA recombination,17,0.496,0.955,1,GO:0045911,BP,,6003
mitotic chromosome condensation,13,0.495,0.955,1,GO:0007076,BP,,6004
negative regulation of cytokine secretion,36,0.497,0.955,1,GO:0050710,BP,,6005
regulation of megakaryocyte differentiation,16,0.504,0.955,1,GO:0045652,BP,,6006
ventricular septum morphogenesis,34,0.503,0.956,1,GO:0060412,BP,,6007
positive regulation of blood circulation,53,0.498,0.956,1,GO:1903524,BP,,6008
regulation of protein kinase B signaling,108,0.502,0.956,1,GO:0051896,BP,,6009
female sex differentiation,92,0.502,0.956,1,GO:0046660,BP,,6010
regulation of cardiac muscle cell proliferation,29,0.497,0.956,1,GO:0060043,BP,,6011
cornification,57,0.502,0.957,1,GO:0070268,BP,,6012
host cell part,10,0.495,0.957,1,GO:0033643,CC,,6013
transport along microtubule,119,0.499,0.957,1,"GO:0010970,GO:0099111",BP,microtubule-based transport,6014
ER to Golgi transport vesicle,71,0.502,0.957,1,GO:0030134,CC,,6015
basolateral plasma membrane,181,0.499,0.957,1,GO:0016323,CC,,6016
growth plate cartilage development,14,0.496,0.958,1,GO:0003417,BP,,6017
cardiac ventricle morphogenesis,60,0.502,0.958,1,GO:0003208,BP,,6018
regulation of antigen processing and presentation,14,0.504,0.958,1,GO:0002577,BP,,6019
negative regulation of epidermal growth factor receptor signaling pathway,36,0.503,0.958,1,GO:0042059,BP,,6020
ERBB2 signaling pathway,36,0.498,0.959,1,GO:0038128,BP,,6021
basic amino acid transport,12,0.496,0.959,1,GO:0015802,BP,,6022
cellular response to mechanical stimulus,70,0.502,0.959,1,GO:0071260,BP,,6023
craniofacial suture morphogenesis,15,0.504,0.959,1,GO:0097094,BP,,6024
"phagocytosis, engulfment",29,0.503,0.959,1,GO:0006911,BP,,6025
protein-lipid complex assembly,16,0.504,0.961,1,GO:0065005,BP,,6026
sulfur compound binding,188,0.499,0.961,1,GO:1901681,MF,,6027
nicotinamide nucleotide biosynthetic process,28,0.497,0.961,1,"GO:0019359,GO:0019363",BP,pyridine nucleotide biosynthetic process,6028
positive regulation of circadian rhythm,15,0.504,0.961,1,GO:0042753,BP,,6029
clathrin coat assembly,16,0.497,0.962,1,GO:0048268,BP,,6030
regulation of glial cell differentiation,50,0.502,0.962,1,GO:0045685,BP,,6031
melanocyte differentiation,23,0.497,0.962,1,GO:0030318,BP,,6032
regulation of homotypic cell-cell adhesion,19,0.503,0.963,1,GO:0034110,BP,,6033
polyol metabolic process,93,0.499,0.963,1,GO:0019751,BP,,6034
glomerular epithelial cell differentiation,19,0.503,0.963,1,GO:0072311,BP,,6035
"protein localization to chromosome, centromeric region",15,0.503,0.963,1,GO:0071459,BP,,6036
ciliary basal body,92,0.501,0.964,1,GO:0036064,CC,,6037
sodium ion transmembrane transport,127,0.501,0.965,1,GO:0035725,BP,,6038
plasma membrane invagination,37,0.502,0.965,1,GO:0099024,BP,,6039
regulation of T cell differentiation,94,0.501,0.965,1,GO:0045580,BP,,6040
metalloaminopeptidase activity,16,0.503,0.965,1,GO:0070006,MF,,6041
renal system process,96,0.499,0.965,1,GO:0003014,BP,,6042
neuromuscular synaptic transmission,24,0.497,0.966,1,GO:0007274,BP,,6043
positive regulation of cardiac muscle tissue growth,24,0.503,0.966,1,GO:0055023,BP,,6044
ADP metabolic process,66,0.498,0.966,1,GO:0046031,BP,,6045
S-adenosylmethionine metabolic process,12,0.497,0.967,1,GO:0046500,BP,,6046
negative regulation of JAK-STAT cascade,43,0.502,0.967,1,"GO:0046426,GO:1904893",BP,negative regulation of STAT cascade,6047
spongiotrophoblast layer development,13,0.497,0.968,1,GO:0060712,BP,,6048
lysine metabolic process,13,0.503,0.968,1,GO:0006553,BP,,6049
protein lipidation,117,0.499,0.968,1,GO:0006497,BP,,6050
autophagosome assembly,66,0.499,0.968,1,GO:0000045,BP,,6051
regulation of muscle hypertrophy,40,0.498,0.968,1,GO:0014743,BP,,6052
regulation of multicellular organism growth,58,0.502,0.968,1,GO:0040014,BP,,6053
response to glucose,151,0.501,0.968,1,GO:0009749,BP,,6054
interleukin-4 production,24,0.498,0.968,1,GO:0032633,BP,,6055
regulation of mitotic cell cycle spindle assembly checkpoint,12,0.497,0.968,1,"GO:0090266,GO:1903504",BP,regulation of mitotic spindle checkpoint,6056
platelet morphogenesis,16,0.503,0.969,1,GO:0036344,BP,,6057
"CD8-positive, alpha-beta T cell activation",14,0.503,0.969,1,GO:0036037,BP,,6058
nuclear pore outer ring,10,0.496,0.969,1,GO:0031080,CC,,6059
ER overload response,11,0.497,0.969,1,GO:0006983,BP,,6060
alpha-mannosidase activity,13,0.503,0.969,1,GO:0004559,MF,,6061
regulation of complement activation,23,0.502,0.969,1,GO:0030449,BP,,6062
regulation of ossification,166,0.499,0.969,1,GO:0030278,BP,,6063
transition metal ion transmembrane transporter activity,33,0.498,0.97,1,GO:0046915,MF,,6064
T cell differentiation involved in immune response,40,0.502,0.97,1,GO:0002292,BP,,6065
positive regulation of keratinocyte differentiation,12,0.497,0.97,1,GO:0045618,BP,,6066
negative regulation of mitotic nuclear division,36,0.498,0.97,1,GO:0045839,BP,,6067
lymphocyte homeostasis,54,0.501,0.971,1,GO:0002260,BP,,6068
response to corticosterone,19,0.502,0.971,1,GO:0051412,BP,,6069
negative regulation of nuclear division,40,0.498,0.971,1,GO:0051784,BP,,6070
lactate metabolic process,12,0.503,0.971,1,GO:0006089,BP,,6071
negative regulation of axon guidance,10,0.497,0.972,1,GO:1902668,BP,,6072
defense response to Gram-positive bacterium,39,0.502,0.972,1,GO:0050830,BP,,6073
cell-cell adhesion mediated by cadherin,11,0.503,0.972,1,GO:0044331,BP,,6074
lymphocyte migration,53,0.501,0.972,1,GO:0072676,BP,,6075
AP-2 adaptor complex,13,0.503,0.972,1,GO:0030122,CC,,6076
negative regulation of epithelial cell proliferation,105,0.499,0.973,1,GO:0050680,BP,,6077
T cell lineage commitment,12,0.503,0.973,1,GO:0002360,BP,,6078
axon extension involved in axon guidance,21,0.502,0.973,1,"GO:0048846,GO:1902284",BP,neuron projection extension involved in neuron projection guidance,6079
multicellular organismal water homeostasis,49,0.501,0.973,1,GO:0050891,BP,,6080
cell communication by electrical coupling involved in cardiac conduction,22,0.502,0.973,1,GO:0086064,BP,,6081
"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds",121,0.501,0.974,1,GO:0016810,MF,,6082
protein refolding,24,0.502,0.974,1,GO:0042026,BP,,6083
brush border,78,0.501,0.974,1,GO:0005903,CC,,6084
"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment",10,0.497,0.974,1,GO:0043369,BP,,6085
negative regulation of TORC1 signaling,11,0.503,0.975,1,GO:1904262,BP,,6086
detection of light stimulus,56,0.499,0.975,1,GO:0009583,BP,,6087
cardiac muscle cell membrane repolarization,31,0.498,0.975,1,GO:0099622,BP,,6088
low-density lipoprotein receptor particle metabolic process,11,0.503,0.975,1,GO:0032799,BP,,6089
negative regulation of sprouting angiogenesis,12,0.497,0.976,1,GO:1903671,BP,,6090
tRNA binding,43,0.499,0.976,1,GO:0000049,MF,,6091
regulation of microtubule polymerization,30,0.498,0.976,1,GO:0031113,BP,,6092
positive regulation of protein oligomerization,18,0.498,0.976,1,GO:0032461,BP,,6093
thyroid hormone receptor binding,25,0.498,0.976,1,GO:0046966,MF,,6094
snRNA binding,33,0.501,0.976,1,GO:0017069,MF,,6095
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,39,0.501,0.977,1,GO:0042771,BP,,6096
"CD4-positive, alpha-beta T cell differentiation involved in immune response",36,0.499,0.977,1,GO:0002294,BP,,6097
autophagosome membrane,25,0.498,0.977,1,GO:0000421,CC,,6098
negative regulation of cellular senescence,10,0.503,0.977,1,GO:2000773,BP,,6099
positive regulation of protein acetylation,31,0.499,0.977,1,GO:1901985,BP,,6100
site of double-strand break,22,0.502,0.977,1,"GO:0035861,GO:0090734",CC,site of DNA damage,6101
ubiquitin-like protein conjugating enzyme binding,37,0.499,0.977,1,GO:0044390,MF,,6102
regulation of potassium ion transmembrane transporter activity,40,0.499,0.977,1,GO:1901016,BP,,6103
host,15,0.498,0.978,1,"GO:0018995,GO:0043657",CC,host cell,6104
T-tubule,44,0.499,0.978,1,GO:0030315,CC,,6105
regulation of vascular endothelial growth factor production,28,0.501,0.978,1,GO:0010574,BP,,6106
cellular response to transforming growth factor beta stimulus,200,0.501,0.979,1,GO:0071560,BP,,6107
negative regulation of GTPase activity,37,0.501,0.979,1,GO:0034260,BP,,6108
synaptonemal complex assembly,15,0.502,0.979,1,GO:0007130,BP,,6109
neurotransmitter receptor transport to postsynaptic membrane,10,0.502,0.979,1,"GO:0098969,GO:1903539,GO:1903540",BP,"protein localization to postsynaptic membrane,establishment of protein localization to postsynaptic membrane",6110
positive regulation of receptor internalization,21,0.498,0.979,1,GO:0002092,BP,,6111
sulfation,10,0.498,0.979,1,GO:0051923,BP,,6112
regulation of potassium ion transport,75,0.501,0.98,1,GO:0043266,BP,,6113
positive regulation of B cell differentiation,13,0.498,0.98,1,GO:0045579,BP,,6114
regulation of receptor-mediated endocytosis,71,0.499,0.98,1,GO:0048259,BP,,6115
regulation of muscle system process,186,0.499,0.98,1,GO:0090257,BP,,6116
regulation of lymphocyte differentiation,116,0.501,0.98,1,GO:0045619,BP,,6117
serine family amino acid biosynthetic process,15,0.502,0.98,1,GO:0009070,BP,,6118
maintenance of apical/basal cell polarity,11,0.498,0.98,1,"GO:0035090,GO:0045199",BP,maintenance of epithelial cell apical/basal polarity,6119
axon initial segment,12,0.498,0.981,1,GO:0043194,CC,,6120
positive regulation of binding,131,0.501,0.981,1,GO:0051099,BP,,6121
regulation of response to oxidative stress,70,0.501,0.981,1,GO:1902882,BP,,6122
protein complex scaffold,68,0.501,0.981,1,GO:0032947,MF,,6123
regulation of plasma membrane organization,72,0.501,0.981,1,GO:1903729,BP,,6124
negative regulation of peptide hormone secretion,39,0.499,0.982,1,GO:0090278,BP,,6125
peroxisomal matrix,36,0.499,0.982,1,"GO:0005782,GO:0031907",CC,microbody lumen,6126
T-helper cell differentiation,35,0.501,0.982,1,GO:0042093,BP,,6127
positive regulation of histone acetylation,26,0.501,0.982,1,GO:0035066,BP,,6128
negative regulation of protein localization to cell periphery,18,0.499,0.983,1,GO:1904376,BP,,6129
glycogen biosynthetic process,42,0.499,0.983,1,"GO:0005978,GO:0009250",BP,glucan biosynthetic process,6130
negative regulation of ossification,65,0.501,0.983,1,GO:0030279,BP,,6131
transmembrane receptor protein serine/threonine kinase activity,15,0.502,0.983,1,GO:0004675,MF,,6132
Sertoli cell differentiation,18,0.499,0.983,1,GO:0060008,BP,,6133
Fanconi anaemia nuclear complex,13,0.502,0.984,1,GO:0043240,CC,,6134
protein heterooligomerization,93,0.501,0.984,1,GO:0051291,BP,,6135
platelet dense tubular network,11,0.498,0.984,1,GO:0031094,CC,,6136
macrolide binding,13,0.502,0.984,1,"GO:0005527,GO:0005528",MF,FK506 binding,6137
cortical cytoskeleton,70,0.501,0.984,1,GO:0030863,CC,,6138
regulation of leukocyte differentiation,195,0.5,0.985,1,GO:1902105,BP,,6139
action potential,121,0.5,0.985,1,GO:0001508,BP,,6140
cellular modified amino acid metabolic process,151,0.5,0.985,1,GO:0006575,BP,,6141
response to nerve growth factor,43,0.499,0.985,1,GO:1990089,BP,,6142
regulation of cell communication by electrical coupling,12,0.498,0.985,1,GO:0010649,BP,,6143
retinoic acid receptor binding,21,0.499,0.986,1,GO:0042974,MF,,6144
nuclear outer membrane,17,0.501,0.986,1,GO:0005640,CC,,6145
potassium channel regulator activity,41,0.499,0.986,1,GO:0015459,MF,,6146
glucocorticoid receptor binding,13,0.499,0.987,1,GO:0035259,MF,,6147
positive regulation of axonogenesis,71,0.499,0.987,1,GO:0050772,BP,,6148
oogenesis,60,0.499,0.987,1,GO:0048477,BP,,6149
camera-type eye morphogenesis,93,0.5,0.987,1,GO:0048593,BP,,6150
energy reserve metabolic process,78,0.499,0.987,1,GO:0006112,BP,,6151
neuron fate commitment,52,0.501,0.988,1,GO:0048663,BP,,6152
positive regulation of tyrosine phosphorylation of Stat3 protein,24,0.499,0.988,1,GO:0042517,BP,,6153
modulation by host of viral genome replication,11,0.501,0.988,1,GO:0044827,BP,,6154
preassembly of GPI anchor in ER membrane,14,0.499,0.988,1,GO:0016254,BP,,6155
protein monoubiquitination,52,0.501,0.989,1,GO:0006513,BP,,6156
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,53,0.501,0.989,1,GO:0070059,BP,,6157
postreplication repair,49,0.501,0.989,1,GO:0006301,BP,,6158
positive regulation of translation,90,0.5,0.989,1,GO:0045727,BP,,6159
regulation of tyrosine phosphorylation of STAT protein,45,0.501,0.989,1,GO:0042509,BP,,6160
regulation of tyrosine phosphorylation of Stat3 protein,31,0.499,0.989,1,GO:0042516,BP,,6161
regulation of ERAD pathway,26,0.499,0.99,1,GO:1904292,BP,,6162
cytokine biosynthetic process,81,0.5,0.99,1,"GO:0042089,GO:0042107",BP,cytokine metabolic process,6163
fluid transport,19,0.501,0.99,1,GO:0042044,BP,,6164
negative regulation of phosphatase activity,68,0.5,0.99,1,GO:0010923,BP,,6165
copper ion transport,17,0.499,0.99,1,GO:0006825,BP,,6166
regulation of mRNA 3'-end processing,17,0.501,0.99,1,GO:0031440,BP,,6167
rRNA-containing ribonucleoprotein complex export from nucleus,13,0.501,0.99,1,GO:0071428,BP,,6168
positive regulation of dendritic spine morphogenesis,16,0.501,0.991,1,GO:0061003,BP,,6169
regulation of proteasomal ubiquitin-dependent protein catabolic process,103,0.5,0.991,1,GO:0032434,BP,,6170
regulation of stress-activated protein kinase signaling cascade,175,0.5,0.991,1,GO:0070302,BP,,6171
lipoprotein metabolic process,170,0.5,0.991,1,GO:0042157,BP,,6172
"regulation of CD4-positive, alpha-beta T cell activation",31,0.501,0.991,1,GO:2000514,BP,,6173
regulation of intrinsic apoptotic signaling pathway in response to DNA damage,33,0.499,0.992,1,GO:1902229,BP,,6174
tetrapyrrole biosynthetic process,24,0.501,0.992,1,GO:0033014,BP,,6175
spindle assembly checkpoint,25,0.501,0.992,1,GO:0071173,BP,,6176
peptide hormone secretion,195,0.5,0.992,1,GO:0030072,BP,,6177
gluconeogenesis,69,0.5,0.993,1,GO:0006094,BP,,6178
monosaccharide binding,59,0.5,0.993,1,GO:0048029,MF,,6179
positive regulation of natural killer cell mediated cytotoxicity,13,0.499,0.993,1,GO:0045954,BP,,6180
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,69,0.5,0.993,1,GO:0043154,BP,,6181
icosanoid secretion,33,0.5,0.993,1,GO:0032309,BP,,6182
regulation of cellular carbohydrate metabolic process,106,0.5,0.993,1,GO:0010675,BP,,6183
cyclic nucleotide binding,32,0.5,0.993,1,GO:0030551,MF,,6184
negative regulation of alpha-beta T cell activation,22,0.499,0.993,1,GO:0046636,BP,,6185
filopodium membrane,17,0.501,0.994,1,GO:0031527,CC,,6186
regulation of extent of cell growth,88,0.5,0.994,1,GO:0061387,BP,,6187
intracellular transport of virus,61,0.5,0.994,1,GO:0075733,BP,,6188
cholesterol homeostasis,56,0.5,0.994,1,"GO:0042632,GO:0055092",BP,sterol homeostasis,6189
hydrogen peroxide-mediated programmed cell death,12,0.499,0.994,1,"GO:0010421,GO:0097468",BP,programmed cell death in response to reactive oxygen species,6190
regulation of behavior,50,0.5,0.994,1,GO:0050795,BP,,6191
other organism,16,0.501,0.994,1,"GO:0044215,GO:0044216,GO:0044217",CC,"other organism cell,other organism part",6192
negative regulation of myeloid leukocyte differentiation,40,0.5,0.994,1,GO:0002762,BP,,6193
brain morphogenesis,31,0.5,0.994,1,GO:0048854,BP,,6194
lung epithelial cell differentiation,23,0.5,0.995,1,GO:0060487,BP,,6195
DNA secondary structure binding,18,0.5,0.995,1,GO:0000217,MF,,6196
maintenance of cell number,135,0.5,0.995,1,GO:0098727,BP,,6197
branching involved in salivary gland morphogenesis,21,0.5,0.996,1,GO:0060445,BP,,6198
negative regulation of organic acid transport,16,0.5,0.996,1,GO:0032891,BP,,6199
heparan sulfate sulfotransferase activity,13,0.5,0.996,1,GO:0034483,MF,,6200
negative regulation of blood coagulation,39,0.5,0.996,1,"GO:0030195,GO:1900047",BP,negative regulation of hemostasis,6201
S-acyltransferase activity,26,0.5,0.996,1,GO:0016417,MF,,6202
glyoxylate metabolic process,22,0.5,0.996,1,GO:0046487,BP,,6203
positive regulation of isotype switching,14,0.5,0.996,1,GO:0045830,BP,,6204
T-helper 2 cell differentiation,12,0.5,0.997,1,GO:0045064,BP,,6205
regulation of membrane protein ectodomain proteolysis,20,0.5,0.997,1,GO:0051043,BP,,6206
lipid homeostasis,89,0.5,0.997,1,GO:0055088,BP,,6207
membrane repolarization during action potential,23,0.5,0.997,1,GO:0086011,BP,,6208
positive regulation of lipid biosynthetic process,53,0.5,0.997,1,GO:0046889,BP,,6209
pituitary gland development,37,0.5,0.997,1,GO:0021983,BP,,6210
renal filtration cell differentiation,18,0.5,0.997,1,"GO:0061318,GO:0072112",BP,glomerular visceral epithelial cell differentiation,6211
potassium channel complex,85,0.5,0.998,1,GO:0034705,CC,,6212
viral release from host cell,32,0.5,0.998,1,"GO:0019076,GO:0035890,GO:0035891,GO:0052126,GO:0052192",BP,"exit from host,exit from host cell,movement in host environment,movement in environment of other organism involved in symbiotic interaction",6213
negative regulation of steroid biosynthetic process,16,0.5,0.998,1,"GO:0010894,GO:0045939",BP,negative regulation of steroid metabolic process,6214
regulation of hair cycle,24,0.5,0.998,1,GO:0042634,BP,,6215
negative regulation of keratinocyte proliferation,14,0.5,0.998,1,GO:0010839,BP,,6216
"oxidoreductase activity, acting on the aldehyde or oxo group of donors",35,0.5,0.998,1,GO:0016903,MF,,6217
regulation of plasma lipoprotein particle levels,45,0.5,0.998,1,GO:0097006,BP,,6218
negative regulation of proteolysis involved in cellular protein catabolic process,37,0.5,0.998,1,GO:1903051,BP,,6219
sodium channel regulator activity,32,0.5,0.998,1,GO:0017080,MF,,6220
digestive tract morphogenesis,40,0.5,0.999,1,GO:0048546,BP,,6221
regulation of response to endoplasmic reticulum stress,67,0.5,0.999,1,GO:1905897,BP,,6222
intraciliary transport,46,0.5,0.999,1,GO:0042073,BP,,6223
negative regulation of natural killer cell mediated immunity,10,0.5,0.999,1,GO:0002716,BP,,6224
"3',5'-cyclic-GMP phosphodiesterase activity",13,0.5,0.999,1,GO:0047555,MF,,6225
forebrain neuron fate commitment,10,0.5,0.999,1,GO:0021877,BP,,6226
regulation of B cell mediated immunity,34,0.5,0.999,1,"GO:0002712,GO:0002889",BP,regulation of immunoglobulin mediated immune response,6227
regulation of endocrine process,35,0.5,0.999,1,GO:0044060,BP,,6228
tertiary granule membrane,59,0.5,1,1,GO:0070821,CC,,6229
thymic T cell selection,16,0.5,1,1,GO:0045061,BP,,6230
